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NOTICE TO READERS
This AICPA Audit and Accounting Guide has been prepared by the AICPA 
Health Care Committee to assist preparers of financial statements in preparing 
financial statements in conformity with generally accepted accounting princi­
ples and to assist auditors in auditing and reporting on such financial state­
ments in accordance with generally accepted auditing standards.
Descriptions of accounting principles and financial reporting practices in Audit 
and Accounting Guides are approved by the affirmative vote of at least two- 
thirds of the members of the Accounting Standards Executive Committee, 
which is the senior technical body of the AICPA authorized to speak for the 
AICPA in the areas of financial accounting and reporting. Statement on 
Auditing Standards (SAS) No. 69, The Meaning of Present Fairly in Conformity 
With Generally Accepted Accounting Principles in the Independent Auditor’s 
Report, identifies AICPA Audit and Accounting Guides that have been cleared 
by the Financial Accounting Standards Board (for financial statements of 
entities other than governmental entities) or Governmental Accounting Stand­
ards Board (for financial statements of Governmental entities) as sources of 
established accounting principles in category b of the hierarchy of generally 
accepted accounting principles that it establishes. This Audit and Accounting 
Guide has been cleared by the Financial Accounting Standards Board and the 
Governmental Accounting Standards Board. AICPA members should consider 
the accounting principles described in this Audit and Accounting Guide if the 
accounting treatment of a transaction or event is not specified by a pronounce­
ment covered by rule 203 of the AICPA Code of Professional Conduct. In such 
circumstances, the accounting treatments specified by this Audit and Account­
ing Guide should be used, or the member should be prepared to justify another 
treatment, as discussed in paragraph 7 of SAS No. 69.
The AICPA Auditing Standards Board has found the descriptions of auditing 
standards, procedures, and practices in this Audit and Accounting Guide to be 
consistent with existing standards covered by rule 202 of the AICPA Code of 
Professional Conduct. Descriptions of auditing standards, procedures, and 
practices in Audit and Accounting Guides are not as authoritative as pro­
nouncements of the Auditing Standards Board, but AICPA members should be 
aware that they may have to justify a departure from such descriptions if the 
quality of their work is questioned.
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VIn developing this Audit and Accounting Guide, the AICPA Health Care 
Committee and the Health Care Audit Guide Task Force considered 
guidance included in the following authoritative pronouncements through 
May 1, 2000:
•  FASB Statements through Statement No. 137, Accounting for 
Derivative Instruments and Hedging Activities—Deferral of the 
Effective Date of FASB Statement No. 133
•  FASB Interpretations through Interpretation No. 44, Accounting for 
Certain Transactions Involving Stock Compensation—an Interpretation 
of APB Opinion No. 25
•  FASB Technical Bulletins (TB) through TB 97-1, Accounting under 
Statement 123 for Certain Employee Stock Purchase Plans with a 
Look-Back Option
•  GASB Statements through Statement No. 35, Basic Financial 
Statements—and Management’s Discussion and Analysis—for Public 
Colleges and Universities
•  GASB Interpretations through Interpretation No. 5, Property Tax 
Revenue Recognition in Governmental Funds
•  GASB Technical Bulletins (TB) through TB 2000-1, Disclosures about 
Year 2000 Issues—a rescission of Technical Bulletins 98-1 and 99-1
•  AICPA Statements of Position (SOP) through SOP 00-1, Auditing 
Health Care Third-Party Revenues and Related Receivables
•  AICPA Practice Bulletins (PB) through PB 15, Accounting by the 
Issuer of Surplus Notes
•  Consensus positions of the FASB’s Emerging Issues Task Force 
reached through March 2000
•  AICPA Statements on Auditing Standards (SAS) through SAS No. 91, 
Federal GAAP Hierarchy
Users of this Guide should consider pronouncements issued subsequent to 
those listed above to determine their effect on entities covered by this Guide.
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Preface
Purpose
This Guide has been prepared to assist providers of health care services in 
preparing financial statements in conformity with generally accepted account­
ing principles (GAAP) and to assist independent auditors in auditing and 
reporting on those financial statements.
Applicability
This Guide applies to health care organizations that are either (a) inves­
tor-owned businesses or (b) not-for-profit enterprises that have no owner­
ship interest and are essentially self-sustaining from fees charged for goods 
and services, as defined in Financial Accounting Standards Board (FASB) 
Statement of Financial Accounting Concepts No. 4, Objectives o f Financial 
Reporting by Nonbusiness Organizations, paragraph 8,1 or (c) governmen­
tal. This Guide applies to organizations whose principal operations consist 
of providing or agreeing to provide health care services and that derive all 
or almost all of their revenues from the sale of goods or services; it also 
applies to organizations whose primary activities are the planning, organi­
zation, and oversight of such organizations, such as parent or holding 
companies of health care providers.
This Guide applies to the following types of health care organizations:
•  Clinics, medical group practices, individual practice associations, in­
dividual practitioners, emergency care facilities, laboratories, surgery 
centers, and other ambulatory care organizations
•  Continuing care retirement communities (CCRCs)
•  Health maintenance organizations (HMOs) and similar prepaid 
health care plans
•  Home health agencies
•  Hospitals
•  Nursing homes that provide skilled, intermediate, and less intensive 
levels of health care
•  Drug and alcohol rehabilitation centers and other rehabilitation facilities
This Guide also applies to integrated delivery systems that include one or 
more of the above types of organizations.
This Guide does not apply to voluntary health and welfare organizations, as 
defined in FASB Statement No. 117, Financial Statements of Not-for-Profit 
Organizations. These organizations should follow the American Institute of 
Certified Public Accountants (AICPA) Audit and Accounting Guide Not-for- 
Profit Organizations. Related fund-raising foundations that meet the definition 
of a not-for-profit organization given in FASB Statement No. 117 also should 
follow the AICPA Audit and Accounting Guide Not-for-Profit Organizations.
1 See paragraph 1.03 of this Guide.
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When separate financial statements are issued for a state or local governmen­
tal health care organization that uses enterprise fund accounting and report­
ing, the accounting, reporting, and disclosure requirements set forth in this 
Guide and by pronouncements of the Governmental Accounting Standards 
Board (GASB) apply. (See chapter 1 for a discussion of the application of GAAP.)
Limitations
This Guide does not discuss the application of all GAAP and all generally 
accepted auditing standards (GAAS) that are relevant to the preparation and 
audit of financial statements of health care organizations. The Guide is directed 
primarily to those aspects of the preparation and audit of health care organi­
zations’ financial statements that are unique to those organizations or areas 
considered particularly significant to them.
Other Literature
This Guide incorporates certain provisions of FASB Statements No. 116, 
Accounting for Contributions Received and Contributions Made, and No. 117, 
and No. 124, Accounting for Certain Investments Held by Not-for-Profit 
Organizations.* Not all guidance included in those Statements, however, is 
incorporated, repeated, or summarized in this Guide. Accordingly, those State­
ments, and all authoritative guidance,2 should be read in conjunction with this 
Guide.
This Guide supersedes the AICPA Audit and Accounting Guide Audits of 
Providers of Health Care Services. This Guide also incorporates and supersedes 
AICPA Statements of Position (SOP) 89-5, Financial Accounting and Reporting 
by Providers of Prepaid Health Care Services, 90-8, Financial Accounting and 
Reporting by Continuing Care Retirement Communities, and 94-2, The Appli­
cation of the Requirements of Accounting Research Bulletins, Opinions of the 
Accounting Principles Board, and Statements and Interpretations of the Finan­
cial Accounting Standards Board to Not-for-Profit Organizations.
Office of Management and Budget (OMB) Circular A-133, Audits of States, 
Local Governments, and Non-Profit Organizations, sets forth audit require­
ments for health care organizations expending federal awards. Institutions 
covered by OMB Circular A-133 include both not-for-profit hospitals and 
institutions of higher education, and their affiliated hospitals, voluntary health 
and welfare organizations and other community-based organizations. Auditors 
of health care organizations that are subject to the audit requirements of OMB 
Circular A-133 should refer to SOP 98-3, Audits of States, Local Governments, 
and Not-for-Profit Organizations Receiving Federal Awards for further assistance.
* In June 1999, the FASB issued Statement No. 136, Transfers o f Assets to a Not-for-Profit 
Organization or Charitable Trust That Raises or Holds Contributions for Others. A summary of FASB 
Statement No. 136 is included in appendix F to this guide. This guide will be modified to conform to 
the requirements of FASB Statement No. 136 in a future edition of the guide.
2 Other professional literature and authoritative guidance includes statements issued by the 
AICPA Accounting Standards Executive Committee (AcSEC) and the FASB—including its Emerging 
Issues Task Force (EITF). Authoritative literature for governmental health care entities includes 
GASB pronouncements, FASB and AICPA pronouncements specifically made applicable to state and 
local governmental entities by the GASB, and AICPA Audit and Accounting Guides, Industry Audit 
Guides, Statements of Position, and Practice Bulletins made applicable to governmental entities and 
cleared by the GASB.
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Effective Date and Transition
The provisions of this Guide, other than those included in paragraphs 1.27 
through 1.38, which are discussed below, are effective for financial statements 
for periods beginning after June 15, 1996.3 Earlier application is permitted.
The provisions included in paragraphs 1.27 through 1.38 are effective for 
financial statements issued for fiscal years beginning after December 15, 1994, 
except for organizations with less than $5 million in total assets and less than 
$1 million in annual expenses. For those organizations, the effective date is fiscal 
years beginning after December 15, 1995. Earlier application is permitted.
Unless the provisions of this Guide, other than those included in paragraphs
1.27 through 1.38, are applied retroactively under the provisions of the follow­
ing paragraph, the effect of initially applying this Guide shall be reported as 
the effect of a change in accounting principle, in a manner similar to the 
cumulative effect of a change in accounting principle (Accounting Principles 
Board [APB] Opinion No. 20, Accounting Changes, paragraph 19). The amount 
of the cumulative effect should be based on a retroactive computation. A 
not-for-profit organization should report the cumulative effect of a change in 
accounting on each class of net assets in the statement of activities between the 
captions extraordinary items, if any, and change in unrestricted net assets, 
change in temporarily restricted net assets, and change in permanently re­
stricted net assets. The cumulative effect on temporary and permanently re­
stricted net assets should be reflected in the statement of changes in net assets. 
An investor-owned business should report the amount of the cumulative effect 
in the income statement between the captions extraordinary items and net 
income (APB Opinion No. 20, paragraph 20).
This Guide, other than the guidance in paragraphs 1.27 through 1.38, may 
be applied retroactively by restating the opening net assets for the earliest year 
presented or for the year this Guide is first applied if no prior years are 
presented. In the period in which this Guide is first applied, that organization 
should disclose the nature of any restatement and its effect on the change in 
net assets for each period presented. An investor-owned business should 
account for any restatement as a change in accounting principle applied 
retroactively (APB Opinion No. 20, paragraphs 27 and 28).
In implementing the guidance in paragraphs 1.27 through 1.38, which incor­
porates the provisions of SOP 94-2 into this Guide, the transition rules of the 
APB Opinions and FASB Statements adopted, other than their effective dates, 
should be followed. However, if there is more than one change in accounting 
principle as a result of applying the guidance in paragraphs 1.27 through 1.38, 
organizations have the option of including the cumulative effect of adopting 
those accounting principles in the statement of activity or similar statement in 
the year this Guide is adopted, regardless of the transition rules of the APB 
Opinions and FASB Statements adopted,4 and the financial statements should 
disclose the nature of the cumulative adjustment. (Paragraphs 19 and 20 of
3 This Guide does not defer the effective date of any pronouncements that cover not-for-profit 
organizations.
4 Organizations that adopt the guidance in paragraphs 1.27 through 1.38 of this Guide in the 
same year in which they adopt FASB Statement No. 116 are permitted to apply the provisions of 
paragraph 17 of that Statement, concerning recognition of expirations of restrictions, prospectively, 
as specified in that Statement, regardless of whether they report the cumulative effect of adopting 
other accounting principles as a result of applying the guidance in paragraphs 1.27 through 1.38 of 
this Guide.
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XAPB Opinion No. 20 discuss reporting the cumulative effects of changes in 
accounting principles.) In circumstances in which there is more than one 
change in accounting principle resulting from applying this Guide and the 
cumulative effect of adopting those accounting principles is included in the 
statement of activity or similar statement in the year the guidance in para­
graphs 1.27 through 1.38 is adopted, this Guide does not require the pro forma 
disclosures required by paragraphs 19(d) and 21 of APB Opinion No. 20.
FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization 
or Charitable Trust That Raises or Holds Contributions for Others, except for 
the provisions of paragraph 12, is effective for financial statements issued for 
fiscal periods beginning after December 15, 1999. Earlier application is encour­
aged. The provisions of paragraph 12 of FASB Statement No. 136, which are 
carried forward from FASB Interpretation No. 42, Accounting for Transfers of 
Assets in Which a Not-for-Profit Organization Is Granted Variance Power, 
continue to be effective for fiscal years ending after September 15, 1996.
FASB Statement No. 136 may be applied retroactively by restating opening 
net assets for the earliest year presented or for the year in which FASB 
Statement No. 136 is first applied if no prior years are presented. In the period 
in which FASB Statement No. 136 is first applied, an entity shall disclose the 
nature of any restatement and its effect on the change in net assets and each 
class of net assets for each period presented. Unless FASB Statement No. 136 
is applied retroactively under these provisions, the effect of initially applying 
FASB Statement No. 136 shall be reported as the effect of a change in 
accounting principle in a manner similar to the cumulative effect of a change 
in accounting principle (APB Opinion No. 20, Accounting Changes, paragraph 
19). The amount of cumulative effect shall be based on a retroactive computation.
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Unique Considerations of Health Care Organizations 1
Chapter 1 
Unique Considerations of Health 
Care Organizations
Overview
1.01 Financial statements of health care organizations should be pre­
pared in conformity with generally accepted accounting principles (GAAP). 
AICPA Statement on Auditing Standards (SAS) No. 69, The Meaning of 
Present Fairly in Conformity With Generally Accepted Accounting Principles 
in the Independent Auditor’s Report (AICPA, Professional Standards, vol. 1, 
AU sec. 411), provides the GAAP hierarchy summary for both nongovernmen­
tal and governmental organizations.1
Classification of Health Care Organizations
1.02 Health care enterprises usually can be classified into the following 
categories on the basis of their operating characteristics:
a. Investor-Owned Health Care Enterprises. These are owned by in­
vestors or others with a private equity interest and provide goods or 
services with the objective of making a profit.
b. Not-for-Profit, Business-Oriented Organizations. These are charac­
terized by no ownership interests and essentially are self-sustaining 
from fees charged for goods and services. The fees charged by such 
organizations generally are intended to help the organization main­
tain its self-sustaining status rather than to maximize profits for the 
owner’s benefit. Such organizations often are exempt from federal 
income taxes and may receive contributions of relatively small 
amounts from resource providers that do not expect commensurate 
or proportionate pecuniary return.
1 Governmental Accounting Standards Board (GASB) Statement No. 20, Accounting and Finan­
cial Reporting for Proprietary Funds and Other Governmental Entities That Use Proprietary Fund 
Accounting, paragraph 6, provides interim guidance for governmental proprietary activities, such as 
governmental health care enterprises, until the GASB completes its projects on business-type 
activities and governmental financial reporting. Governmental proprietary activities should apply all 
applicable GASB pronouncements as well as any Financial Accounting Standards Board (FASB) 
Statements and Interpretations, Accounting Principles Board (APB) Opinions, and Accounting Re­
search Bulletins (ARBs) issued on or before November 30, 1989, that do not conflict with or contradict 
GASB pronouncements. Furthermore, paragraph 7 of GASB Statement No. 20 provides that govern­
mental proprietary activities may apply all FASB Statements and Interpretations issued after 
November 30, 1989, that do not conflict with or contradict GASB pronouncements. Entities that 
choose to apply these “new” FASB pronouncements must apply them on an “all or none” basis (that 
is, they may not select which pronouncements to apply). The requirements set forth in this Guide for 
governmental health care enterprises generally apply to such enterprises that apply paragraph 7 of 
GASB Statement No. 20. GASB Statement No. 34, Basic Financial Statements—and Management’s 
Discussion and Analysis—for State and Local Governments, establishes financial reporting stand­
ards for state and local governments. Among other matters, GASB Statement No. 34 supersedes 
footnote 1 and amends paragraphs 7 through 9 of GASB Statement No. 20. A brief summary of GASB 
Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. This chapter will be 
modified to conform to the requirements of GASB Statement No. 34 in a future edition of this Guide.
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c. Governmental Health Care Organizations. These are public corpo­
rations2 and bodies corporate and politic. Other organizations are 
governmental organizations if they have one or more of the following 
characteristics:
•  Popular election of officers or appointment (or approval) of a 
controlling majority of the members of the organization’s gov­
erning body by officials of one or more state or local governments;
•  The potential for unilateral dissolution by a government with 
the net assets reverting to a government; or
•  The power to enact and enforce a tax levy.
Furthermore, organizations are presumed to be governmental if they 
have the ability to issue directly (rather than through a state or 
municipal authority) debt that pays interest exempt from federal 
taxation. However, organizations possessing only that ability (to 
issue tax-exempt debt) and none of the other governmental charac­
teristics may rebut the presumption that they are governmental if 
their determination is supported by compelling, relevant evidence.
d. Not-for-Profit, Nonbusiness-Oriented Organizations. These are vol­
untary health and welfare organizations (see the Glossary) as de­
fined in FASB Statem ent No. 117, Financial Statements of 
Not-for-Profit Organizations. Such organizations are within the 
scope of the AICPA Audit and Accounting Guide Not-for-Profit Or­
ganizations rather than this Guide.
Financial Reporting of Health Care Organizations
1.03 The nature of the organization and its operating structure have a 
significant effect on the needs of financial statement users. According to FASB 
Statement of Financial Accounting Concepts (Concepts Statement) No. 4, Ob­
jectives of Financial Reporting by Nonbusiness Organizations, paragraph 8:
Some organizations have no ownership interests but are essentially self-sustain­
ing from fees they charge for goods and services. Examples are those private 
nonprofit hospitals . . .  that may receive relatively small amounts of contributions 
and grants but finance their capital needs largely from the proceeds of debt issues 
and their operating needs largely from service charges rather than from private 
philanthropy or governmental grants. As a result, assessment of amounts, timing, 
and uncertainty of cash flows becomes the dominant interest of their creditors and 
other resource providers and profitability becomes an important indicator of 
performance. Consequently, the objectives of FASB Concepts Statement No. 1 
[Objectives of Financial Reporting by Business Enterprises] may be more appro­
priate for those organizations. [Footnote reference omitted.]
1.04 The financial reporting for not-for-profit, business-oriented organi­
zations and investor-owned health care enterprises generally is consistent 
except for transactions that clearly are not applicable. For example, not-for- 
profit, business organizations would have nothing to report for shareholders’ 
equity. On the other hand, investor-owned health care enterprises typically
2  Health Care Organizations
2 Black’s Law Dictionary defines a public corporation as: An artificial person (e.g., [a] municipal­
ity or a governmental corporation) created for the administration of public affairs. Unlike a private 
corporation it has no protection against legislative acts altering or even repealing its charter. 
Instrumentalities created by [the] state, formed and owned by it in [the] public interest, supported in 
whole or part by public funds, and governed by managers deriving their authority from [the] state. 
Sharon Realty Co. v. Westlake, Ohio Com.Pl., 188 N.E.2d 318, 323, 25, 0.0.2d 322. A public 
corporation is an instrumentality of the state, founded and owned in the public interest, supported by 
public funds and governed by those deriving their authority from the state. York County Fair Ass’n v. 
South Carolina Tax Commission, 249 S.C. 337, 154 S.E.2d 361, 362.
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would not have anything to report for contributions. Reporting for governmen­
tal health care organizations that use enterprise fund accounting and report­
ing also is consistent except for matters unique to governmental entities.
1.05 The basic financial statements of health care organizations generally 
consist of a balance sheet, a statement of operations, a statement of changes in 
equity (or net assets/fund balance), a statement of cash flows, and notes to the 
financial statements.3 The statement of operations for not-for-profit organiza­
tions should report a performance indicator (see paragraph 10.16) as well as all 
other changes in unrestricted net assets for the period. The statement of opera­
tions may be combined with the statement of changes in equity (net assets). 
Illustrative financial statements are included in the appendix A of this Guide.
1.06 FASB Statement No. 1174 requires not-for-profit organizations to 
provide information about the liquidity of assets and liabilities in the balance 
sheet. Health care organizations should classify assets and liabilities as cur­
rent and noncurrent. However, rather than presenting a classified balance 
sheet, a continuing care retirement community (CCRC) instead may sequence 
assets according to their nearness of conversion to cash and may sequence 
liabilities according to the nearness of the maturity and resulting use of cash.
1.07 FASB Statement No. 95, Statement of Cash Flows, and GASB State­
ment No. 9, Reporting Cash Flows of Proprietary and Nonexpendable Trust Funds 
and Governmental Entities That Use Proprietary Fund Accounting,* estab­
lished standards for cash flow reporting for investor-owned organizations and 
governmental entities, respectively. FASB Statement No. 95 was amended by 
FASB Statement No. 117 to include not-for-profit organizations. The state­
ment of cash flows may be prepared using the direct or indirect method of 
reporting cash flows.
1.08 A health care organization may be a part of another organization, 
such as a general-purpose government, a medical school or a university, or a 
subsidiary of a corporation. The recommendations in this Guide apply to the 
separate financial statements of these organizations as defined above. There­
fore, when separate financial statements are prepared for a governmental 
health care organization that uses enterprise fund accounting and reporting, 
the accounting and disclosure requirements set forth by GASB pronounce­
ments and this Guide apply. The requirements in this Guide presume that 
governmental health care organizations apply paragraph 7 of GASB State­
ment No. 20. (See footnote 1.)
GASB Statement No. 34— New Financial Reporting 
Requirements for State and Local Governments
1.09 GASB Statement No. 34, Basic Financial Statements—and Manage­
ment’s Discussion and Analysis—for State and Local Governments, was issued
3 The terms balance sheet and statement of operations indicate the content and purpose of the 
respective statements and serve as possible titles for those statements. Other appropriately descrip­
tive titles may also be used. For example, a statement reporting financial position could be called a 
statement o f financial position as well as a balance sheet. Current practice and purpose suggest, 
however, that a statement of cash flows only be titled “Statement of Cash Flows.”
4 This pronouncement is not applicable to governmental health care enterprises. (See footnote 1.)
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, GASB Statement No. 34 amends GASB Statement No. 9 to 
require the direct method of reporting cash flows. A brief summary of GASB Statement No. 34 is 
provided in paragraphs 1.09 through 1.11 in this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 in a future edition of this Guide.
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in June 1999. This Statement establishes financial reporting standards for 
state and local governments. GASB Statement No. 34 was amended by GASB 
Statement No. 35, Basic Financial Statements and Management’s Discussion 
and Analysis—for Public Colleges and Universities, to include public colleges 
and universities in the scope of GASB Statement No. 34.
1.10 The governmental health care organizations included within the 
scope of this Guide are considered special purpose governments engaged in 
business-type activities for purposes of applying GASB Statement No. 34. 
Among its requirements, GASB Statement No. 34 requires that special-purpose 
governments that are engaged only in business-type activities should present 
financial statements required for enterprise funds, including required supple­
mentary information (RSI), which consist of:
•  Management’s Discussion and Analysis (MD&A)
•  Enterprise Fund Financial Statements, consisting of:
— Statement of net assets or balance sheet
— Statement of revenues, expenses, and changes in fund net assets
— Statement of cash flows
•  Notes to financial statements
•  RSI other than MD&A, if applicable
In addition, paragraph 94 of GASB Statement No. 34 states that enterprise 
funds may elect to apply all FASB Statements and Interpretations issued after 
November 30, 1989, except those that conflict with or contradict GASB pro­
nouncements, based on the provisions of paragraph 7 of GASB Statement No. 
20, as amended by GASB Statement No. 34.
1.11 GASB Statement No. 34 amends or supersedes various existing GASB 
and National Council on Governmental Accounting (NCGA) Statements and 
Interpretations, and the requirements of GASB Statement No. 34 are effective in 
three phases based on a government’s total annual revenues in the first fiscal year 
ending after June 15, 1999. Governments with total annual revenues (excluding 
extraordinary items) of $100 million or more (phase 1) should apply this Statement 
for periods beginning after June 15, 2001. Governments with at least $10 million 
but less than $100 million in revenues (phase 2) should apply this Statement for 
periods beginning after June 15, 2002. Governments with less than $10 million in 
revenues (phase 3) should apply this Statement for periods beginning after June 
15, 2003. Earlier application is encouraged, and governments that elect early 
implementation of GASB Statement No. 34 should also implement GASB State­
ment No. 33, Accounting and Financial Reporting for Nonexchange Transactions, 
at the same time. All component units should implement the requirements of 
GASB Statement No. 34 no later than the same year as their primary government, 
regardless of the amount of each component unit’s total revenues. If a primary 
government chooses early implementation of this Statement, all of its component 
units also should implement this standard early to provide the financial informa­
tion required for the government-wide financial statements. Readers should refer 
to the full text of this Statement.
Revenue From Health Care Services
1.12 In general, gross service revenue is recorded in the accounting 
records on an accrual basis at the provider’s established rates, regardless of 
whether the health care organization expects to collect that amount. Provisions
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recognizing contractual adjustments and other adjustments (see examples in 
paragraph 5.02) are recorded on an accrual basis and deducted from gross 
service revenue to determine net service revenue. For financial reporting 
purposes, gross revenue does not include charity care (see discussion in para­
graph 10.03) and service revenue is reported net of contractual and other 
adjustments in the statement of operations. Accounting and auditing issues 
related to receivables and revenue from health care services are discussed in 
chapters 5 and 10.
1.13 In many cases, revenues are generated as a result of an agreement 
to provide health care rather than from the actual provision of services. For 
example, an integrated delivery system may agree to provide all health-related 
services for a specified group residing within its primary service area for an 
agreed-upon amount per member per month (PMPM). These revenues are 
premium revenues, not patient service revenues, since they are earned by 
agreeing to provide care, regardless of whether services actually are rendered.
Third-Party Payor Considerations
1.14 Some third-party payors retrospectively determine final amounts 
reimbursable for services rendered to their beneficiaries based on allowable 
costs. These payors reimburse the health care organization on the basis of 
interim payment rates until the retrospective determination of allowable costs 
can be made. In most instances, the accumulation and allocation of allowable 
costs and other factors result in final settlements different from the interim 
payment rates. Final settlements are determined after the close of the fiscal 
periods to which they apply and may affect materially the health care organi­
zation’s financial position and results of operations. Consequently, a reason­
able estimate of the amount receivable from or payable to these payors should 
be made in the same period that the related services are rendered. Accounting 
and auditing issues related to receivables from third parties are discussed in 
chapter 5.
Classification and Reporting of Net Assets
1.15 Currently, many not-for-profit health care organizations use fund 
accounting for purposes of internal recordkeeping and managerial control. 
Many individual funds may be established by an organization to help in 
monitoring compliance with donor or grantor restrictions due to the fiduciary 
accountability associated with these resources. Each fund consists of a self- 
balancing group of accounts composed of assets, liabilities, and net assets. 
Consistent with FASB Concepts Statement No. 6, Elements of Financial State­
ments, FASB Statement No. 117 concluded that although some not-for-profit 
organizations may choose to classify assets and liabilities into fund groups, 
information about those groupings is not a necessary part of general-purpose 
external financial reporting. Although FASB Statement No. 117 does not 
preclude not-for-profit organizations from using fund accounting for internal 
recordkeeping and reporting, for purposes of external financial reporting each 
of the individual internal funds must be classified into one or more of the three 
broad classes of net assets: unrestricted net assets, temporarily restricted net 
assets, and permanently restricted net assets. These classifications are related 
to the existence or absence of donor-imposed restrictions and are discussed in 
more detail in paragraphs 1.16 through 1.20 and also chapter 9.
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1.16 Unrestricted Net Assets. These represent the part of net assets that 
have not been externally restricted for identified purposes by donors and 
grantors. Unrestricted net assets also include assets whose use is contractually 
limited, such as—
•  Proceeds of debt issues and funds of the health care organization 
deposited with a trustee and limited to use in accordance with the 
requirements of an indenture or a similar agreement. (See paragraph 
7.16.)
•  Other assets limited to use for identified purposes through an agree­
ment between the health care organization and an outside party other 
than a donor or grantor. Examples include assets set aside under debt 
agreements, assets set aside under self-insurance (risk-retention) 
funding arrangements, and assets set aside to meet statutory reserve 
requirements (such as those required under state law for many health 
maintenance organizations [HMOs]). (See paragraph 8.20.)
1.17 Information about significant contractual limits (for example, debt 
covenants and self-insurance trusts) generally is disclosed in the notes to the 
financial statements. Similarly, internally designated funds should be re­
ported separately from externally designated funds either on the face of the 
balance sheet or in the notes to the financial statements.
1.18 Temporarily Restricted and Permanently Restricted Net Assets. 
FASB Statement No. 117 defines two classes of donor-restricted net assets: 
temporarily restricted and permanently restricted. The distinction between 
these two types of restricted net assets is based on the nature of the donor’s 
restriction. Temporarily restricted net assets are those donor-restricted net 
assets that can be used by the not-for-profit organization for their specified 
purpose once the donor’s restriction is met. Generally, these restrictions are 
met either by the passage of time or by actions taken by the entity, such as use 
of the funds for the purpose intended. Permanently restricted net assets (for 
example, endowment funds) are those with donor restrictions that do not 
expire with the passage of time and cannot be removed by any actions taken 
by the entity. All donor-restricted net assets must be classified into one of these 
two broad categories for external reporting. Not-for-profit organizations may 
want to further classify temporarily and permanently restricted net assets into 
distinct groups that distinguish the nature or purpose of the donor’s restriction. 
Accounting and reporting considerations pertaining to gifts and grants that are 
externally restricted for identified purposes by donors and grantors are dis­
cussed in paragraphs 9.04 through 9.06 and 10.08 through 10.14.
1.19 It should be noted that donor restrictions generally relate to limita­
tions on the use of net assets rather than the use of specific assets. According 
to FASB Concepts Statement No. 6, paragraphs 101 and 102:
Restrictions impose responsibilities on management to ensure that the organi­
zation uses donated resources in the manner stipulated by resource providers. 
Sometimes donor-imposed restrictions limit an organization’s ability to sell or 
exchange the particular asset received. For example, a donor may give a 
painting to a museum stipulating that it must be publicly displayed, properly 
maintained, and never sold.
More commonly, donors’ stipulations permit the organization to pool the 
donated assets with other assets and to sell or exchange the donated assets for 
other suitable assets as long as the economic benefits of the donated assets are 
not consumed or used for a purpose that does not comply with the stipulation.
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For example, a donor may contribute 100 shares of Security A to an organiza­
tion’s endowment, thereby requiring that the amount of the gift be retained 
permanently but not requiring that the specified shares be held indefinitely. 
Thus, permanently restricted net assets and temporarily restricted net assets 
generally refer to amounts of net assets that are restricted by donor-imposed 
limits, not to specific assets.
1.20 A not-for-profit organization can report separate line items within 
any of the three classes of net assets either on the face of the balance sheet or 
in the notes to the financial statements to further distinguish the nature of 
donor restrictions within that category of net assets. For example, a health care 
organization may want to disclose the amount of temporarily restricted net 
assets restricted for a specific purpose such as indigent care. Further examples 
are provided in paragraph 15 of FASB Statement No. 117. An organization’s 
internal fund accounting can be used to account for these different types of 
resources within a specific class of net assets.
Health Care Contracting
1.21 Contracts between a health care provider and a payor based on 
anything other than full charges requires the provider to accept some financial 
risk. The nature and degree of risk for the provider varies depending on the 
contract terms (for example, the definition of the unit of service or the basis for 
payment). In planning the audit of the health care provider, the auditor 
considers the audit risk associated with the entity’s health care contracts. For 
example, contracts with payments for services based on a discount from the 
provider’s established rates may have different risks than contracts with 
payments for services based on a capitated arrangement.
1.22 Generally, capitation payments are made at the beginning of each 
month and obligate the provider to render covered services during the 
month. Revenue is earned as a result of agreeing to provide services to 
qualified beneficiaries and not as a result of actually providing the care. If 
the provider’s accounting system records patient charges and establishes 
patient receivables as services are rendered, appropriate valuation allow­
ances or adjustments should be recorded so only the amount of contract 
revenue is recorded.
1.23 A capitation contract may obligate the provider to assume the risk of 
physician referrals and other outside services. In this case, a liability for 
unpaid claims, including incurred but not reported claims, should be estab­
lished. A lag analysis may be helpful in estimating the liability.
1.24 In addition to the capitation payments, the amount of contract 
revenue may be affected by factors such as reinsurance recoveries, deductibles, 
coinsurance, and risk pool adjustments. Risk pool adjustments may be based 
on factors such as utilization or cost targets.
1.25 Sometimes health care providers enter preferred provider arrange­
ments with self-insured employers whereby the provider guarantees that the 
employer’s health care cost will not increase over a specified amount or 
percentage. In substance, these providers may have provided aggregate stop­
loss insurance to the self-insured employer, and a material liability to the 
provider may exist. FASB Statement No. 5, Accounting for Contingencies, 
provides guidance on accounting for these contingencies. GASB Statement No.
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10, Accounting and Financial Reporting for Risk Financing and Related Insur­
ance Issues, provides guidance on accounting for contingencies by governmen­
tal enterprises.*
GAAP Hierarchy for Not-for-Profit Organizations
1.26 SAS No. 69 states that the guidance provided by FASB Statements 
and Interpretations, Opinions of the APB, and ARBs shall be considered 
established accounting principles pursuant to Rule 203 of the AICPA Code of 
Professional Conduct. (Appendix G [paragraph 1.48] of this chapter discusses 
SAS No. 69 and the hierarchy of sources of GAAP.)
1.27 Not-for-profit organizations should follow the guidance in effective 
provisions of ARBs, APB Opinions, and FASB Statements and Interpretations 
unless the specific pronouncement explicitly exempts not-for-profit organiza­
tions or their subject matter precludes such applicability. (As noted in para­
graphs 1.32 and 1.33, not-for-profit organizations should follow the guidance 
in FASB Statements No. 116, Accounting for Contributions Received and 
Contributions Made, No. 117, and No. 124, Accounting for Certain Investments 
Held by Not-for-Profit Organizations,** and this Guide in applying the guid­
ance in pronouncements listed in appendixes C and D [paragraphs 1.44 and
1.45] of this chapter.)
1.28 The appendixes [paragraphs 1.42 through 1.48] of this chapter are 
aids to the implementation of the guidance in this chapter.
1.29 Pronouncements issued by the FASB subsequent to this Guide’s 
effective date apply to not-for-profit organizations unless those pronounce­
ments explicitly exempt not-for-profit organizations or their subject matter 
precludes such applicability.5
1.30 Not-for-profit organizations may follow and are not prohibited from 
following the guidance in effective provisions of the APB Opinions and the 
FASB Statements and Interpretations listed in appendix A [paragraph 1.42] of 
this chapter, which specifically exempt not-for-profit organizations from their 
application, unless FASB Statements No. 116 or No. 117 or this Guide provide 
different guidance. (However, the guidance included in the effective provisions 
of pronouncements listed in appendix A [paragraph 1.42] applies to all for- 
profit entities owned, whether owned all or in part, by not-for-profit entities.)
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, GASB Statement No. 34 amends GASB Statement No. 10. 
A brief summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this 
Guide. This chapter will be modified to conform to the requirements of GASB Statement No. 34 in a 
future edition of this Guide.
** Also, FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization or Charitable 
Trust That Raises or Holds Contributions for Others, was issued in June 1999. FASB Statement No. 136 
is effective for financial statements issued for fiscal periods beginning after December 15, 1999. Earlier 
application is encouraged. The provisions of paragraph 12 of FASB Statement No. 136, which are carried 
forward from FASB Interpretation No. 42, Accounting for Transfers of Assets in Which a Not-for-Profit 
Organization Is Granted Variance Power, continue to be effective for fiscal years ending after September
15, 1996. A summary of FASB Statement No. 136 is included in appendix F to this Guide.
5 The guidance in paragraphs 1.26 through 1.38 addresses only the pronouncements listed in 
paragraph 1.27. However, not-for-profit organizations are also subject to other pronouncements 
included in categories (b)-(d) of paragraph 5 of SAS No. 69 and should apply AICPA Audit and 
Accounting Guides, Statements of Position (SOPs), and Practice Bulletins and FASB Technical 
Bulletins and the consensus positions of the FASB Emerging Issues Task Force (EITF) that apply to 
them. (Appendix G [paragraph 1.48] of this chapter discusses SAS No. 69 and the GAAP hierarchy.)
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The discussion in paragraphs 1.32 through 1.38 should be considered in deter­
mining the hierarchy of such guidance and of guidance issued by the AICPA.
1.31 Certain financial reporting guidance listed in appendix B [para­
graph 1.43] of this chapter, such as that concerning common stock and convert­
ible debt, generally does not apply to the kinds of not-for-profit entities covered 
by this Guide, because such entities do not enter into the kinds of transactions 
covered by that guidance. (However, the guidance included in the effective 
provisions of pronouncements included in appendix B [paragraph 1.43] applies 
to all for-profit entities owned, whether owned all or in part, by not-for-profit 
entities. Also, not-for-profit organizations should follow the effective provisions 
of pronouncements in appendix B [paragraph 1.43] if they enter into the kinds 
of transactions covered by that guidance.)
1.32 Other pronouncements, which are listed in appendix C [paragraph
1.44] of this chapter (ARB No. 51, Consolidated Financial Statements, and APB 
Opinion No. 29, Accounting for Nonmonetary Transactions), do not exempt 
not-for-profit organizations from their scope, but the transactions they contem­
plate also are covered by FASB Statement No. 116 and this Guide. FASB 
Statement No. 116, No. 117, and No. 124* and this Guide provide guidance for 
applying the pronouncements to circumstances unique to not-for-profit organiza­
tions and not contemplated by the pronouncements and therefore should be 
followed to apply the guidance in those pronouncements to not-for-profit organiza­
tions. (However, the guidance included in the effective provisions of pronounce­
ments included in appendix C [paragraph 1.44] should be followed by all 
for-profit entities owned, whether owned all or in part, by not-for-profit entities.)
1.33 Some pronouncements (listed in appendix D [paragraph 1.45] of this 
chapter), which may include guidance concerning the recognition and measure­
ment of assets, liabilities, revenues, expenses, gains and losses, and financial 
statement display, state that their provisions apply only to entities operating 
in certain industries. Such entities generally are business enterprises. An 
example of such guidance is FASB Statement No. 63, Financial Reporting by 
Broadcasters. However, some not-for-profit organizations conduct activities6 in 
some of those industries and should apply the guidance in the pronouncements 
concerning the recognition and measurement of assets, liabilities, revenues, 
expenses, and gains and losses to the transactions unique to those industries. 
However, such not-for-profit organizations should follow the financial state­
ment display guidance in FASB Statement No. 117 and this Guide, even 
though it may conflict with display that would result from applying the 
guidance in the pronouncements listed in appendix D [paragraph 1.45].
1.34 Financial reporting pronouncements that have not been superseded 
and are not included in appendixes A through D [paragraphs 1.42 through
1.45] of this chapter are listed in appendix E [paragraph 1.46] of this chapter. 
Not-for-profit organizations should follow the effective provisions of the pro­
nouncements listed in appendix E [paragraph 1.46].7
* Also, FASB Statement No. 136, Transfers o f Assets to a Not-for-Profit Organization or Charitable 
Trust That Raises or Holds Contributions for Others, was issued in June 1999. FASB Statement No. 136 
is effective for financial statements issued for fiscal periods beginning after December 15 , 1999. Earlier 
application is encouraged. The provisions of paragraph 12 of FASB Statement No. 136, which are carried 
forward from FASB Interpretation No. 42, Accounting for Transfers of Assets in Which a Not-for-Profit 
Organization Is Granted Variance Power, continue to be effective for fiscal years ending after September
15, 1996. A summary of FASB Statement No. 136 is included in appendix F to this Guide.
6 Such activities may be conducted by (a) for-profit entities owned and consolidated by not-for-profit 
organizations, (b) divisions of not-for-profit organizations, or (c) entire not-for-profit organizations.
7 See footnote 5.
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1.35 Certain other pronouncements, although they do not exempt not-for- 
profit organizations and do cover transactions conducted by not-for-profit 
organizations, include some provisions whose application by not-for-profit 
organizations may be unclear. Nevertheless, not-for-profit organizations are 
required to follow the effective provisions of those pronouncements. These 
provisions and their applicability are discussed below.
APB Opinion No. 16, Business Combinations*
1.36 Because the conditions for applying the pooling of interests method 
of accounting for a business combination generally include an exchange of 
common stock of the combining entities, not-for-profit organizations generally 
would not meet the conditions for applying that method. The AICPA Account­
ing Standards Executive Committee (AcSEC) believes that circumstances exist 
under which reporting on the combination of two or more not-for-profit organi­
zations (or that of a not-for-profit organization with a formerly for-profit entity) 
by the pooling of interests method better reflects the substance of the transac­
tion than reporting by the purchase method. Therefore, not-for-profit organi­
zations are, under certain circumstances, permitted to report by the pooling of 
interests method, even though they generally do not issue common stock. Such 
circumstances include the combination of two or more entities to form a new 
entity without the exchange of consideration. See paragraph 11.28 for further 
guidance.
1.37 An example of acceptable practice, in some circumstances, for report­
ing business combinations by not-for-profit organizations if there has been no 
exchange of consideration is to report the (a) assets, (b) liabilities, and (c) net 
asset balances of the combined entities as of the beginning of the year and 
disclose the information that would be required to be disclosed for a pooling of 
interests under APB Opinion No. 16.
Provisions of Certain Pronouncements Concerning Financial 
Statement Display
1.38 The following pronouncements include provisions specifying the fi­
nancial statement display of certain financial statement elements or items 
such as gains and losses, extraordinary items, translation adjustments, income 
tax expense, and prepaid or deferred income taxes:
•  APB Opinion No. 9, Reporting the Results of Operations
•  APB Opinion No. 26, Early Extinguishment of Debt, as amended by 
APB Opinion No. 30, Reporting the Results of Operations—Reporting 
the Effects of Disposal of a Segment of a Business, and Extraordinary, 
Unusual and Infrequently Occurring Events and Transactions’, FASB 
Statement No. 4, Reporting Grains and Losses from Extinguishment of 
Debt’, and FASB Statement No. 125, Accounting for Transfers and 
Servicing of Financial Assets and Extinguishments of Liabilities
•  APB Opinion No. 30, as amended by FASB Statement No. 128, Earn­
ings per Share, and FASB Statement No. 135, Rescission of FASB 
Statement No. 75 and Technical Corrections
* In September 1999, the FASB released an exposure draft of a proposed FASB Statement, 
Business Combinations and Intangible Assets, that has two parts. The first part would apply only to 
business enterprises, and in addition to other matters, would amend APB Opinion No. 16. The FASB 
is addressing issues pertaining to not-for-profit combinations in a separate project.
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•  FASB Statement No. 52, Foreign Currency Translation
•  FASB Statement No. 109, Accounting for Income Taxes
None of the preceding pronouncements considers the net asset reporting 
model included in FASB Statement No. 117 and this Guide. Therefore, 
preparers of financial statements of not-for-profit organizations should 
consider the reporting objectives of these APB Opinions and FASB State­
ments when exercising judgment about how to best display elements, such 
as in which net asset class.
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GAAP Hierarchy for Governmental Organizations*
1.39 SAS No. 69 provides that, for state or local governmental entities, 
officially established accounting principles consist of GASB Statements and 
Interpretations as well as AICPA and FASB pronouncements specifically made 
applicable to state and local governmental entities by GASB Statements or 
Interpretations. (Appendix G [paragraph 1.48] of this chapter discusses SAS 
No. 69 and the hierarchy of sources of GAAP for governmental entities.) GASB 
Statements No. 20 and No. 29, The Use of Not-for-Profit Accounting and 
Financial Reporting Principles by Governmental Entities, provide guidance on 
the applicability of FASB and AICPA pronouncements to proprietary activities 
of government, such as governmental health care enterprises that use enter­
prise fund accounting and financial reporting. Footnote 1 of this chapter 
discusses the guidance in GASB Statement No. 20.
1.40 GASB Statement No. 29 provides that proprietary activities that 
apply the provisions of paragraph 7 of GASB Statement No. 20 should apply 
only those “new” FASB Statements and Interpretations that are developed for 
business enterprises, rather than those whose provisions are limited to not-for- 
profit organizations or address issues primarily concerning such organizations 
(such as FASB Statements No. 116, No. 117, and No. 124).
1.41 Paragraph 33 in the “Basis for Conclusions” of GASB Statement No. 
20 also provides that AICPA pronouncements issued after November 30 , 1989 
and not specifically made applicable to governmental entities should be applied 
using the same logic used in the application of FASB standards. That is, AICPA 
pronouncements that do not conflict with or contradict GASB pronouncements 
should be applied on an “all or none” basis and constitute level “b” in the GAAP 
hierarchy. (See appendix G [paragraph 1.48] of this chapter.) Many of the 
AICPA pronouncements issued after November 30, 1989 provide guidance on 
specialized industries, including this Guide. However, users of this Guide 
should note the provisions of SOP 94-6, Disclosure of Certain Significant Risks 
and Uncertainties, discussed in paragraph 8.30 of this Guide.
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement supersedes footnote 1 and amends 
paragraphs 7 through 9 of GASB Statement No. 20, and supersedes paragraphs 1, 3, 4, and 6 and 
amends paragraph 7 of GASB Statement No. 29. A brief summary of GASB Statement No. 34 is 
provided in paragraphs 1.09 through 1.11 in this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 in a future edition of this Guide.
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Appendix B— Financial Reporting Pronouncements 
That, by the Nature of Their Subject Matter, Generally 
Do Not Apply to Not-for-Profit Organizations
•  APB Opinion 14, Accounting for Convertible Debt and Debt Issued with 
Stock Purchase Warrants
•  APB Opinion 25, Accounting for Stock Issued to Employees, as 
amended by FASB Statement Nos. 109 and 123, and including FASB 
Interpretation Nos. 28, 38, and 44
•  FASB Statement No. 84, Induced Conversions of Convertible Debt
•  FASB Statement No. 123, Accounting for Stock-Based Compensation, 
as amended by FASB Statement Nos. 128 and 135
•  FASB Interpretation No. 28, Accounting for Stock Appreciation Rights 
and Other Variable Stock Option or Award Plans, as amended by 
FASB Statement Nos. 123 and 128
•  FASB Interpretation No. 38, Determining the Measurement Date for 
Stock Option, Purchase, and Award Plans Involving Junior Stock, as 
amended by FASB Statement Nos. 123 and 128
1.43
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Appendix C— Financial Reporting Pronouncements 
Whose Application to Not-for-Profit Organizations is 
Subject to Additional FASB or AICPA Guidance
Pronouncement
ARB No. 51, Consolidated Financial 
Statements, as amended by APB Opin­
ions 10, 16, 18, and 23, and FASB State­
ment Nos. 58, 71, 94, 111, and 131CON
APB Opinion 29, Accounting for Non­
monetary Transactions, as amended by 
FASB Statement Nos. 71, 109, and 123, and 
including FASB Interpretation No. 30
FASB Statement No. 94, Consolida­
tion of All Majority-Owned Subsidiar­
ies, as amended by FASB Statement 
No. 131 CON
FASB Statement No. 116, Accounting 
for Contributions Received and Con­
tributions Made, including FASB In­
terpretation No. 42AGT
FASB Statement No. 117, Financial 
Statements of Not-for-Profit Organiza­
tions, as amended by FASB Statement 
No. 124
FASB Statement No. 124, Accounting 
for Certain Investments Held by Not- 
for-Profit Organizations, as amended 
by FASB Statement No. 133, Account­
ing for Derivative Instruments and 
Hedging Activities*
Additional Guidance
This Guide
FASB Statement No. 116 and chap­
ters 5 and 10 of this Guide provide 
accounting guidance for contributions
See ARB No. 51
This Guide and the AICPA Audit 
and Accounting Guide Not-for- 
Profit Organizations
This Guide
This Guide
(continued)
AGT Among other matters, FASB Statement No. 136, Transfers o f Assets to a Not-for-Profit 
Organization or Charitable Trust That Raises or Holds Contributions for Others, incorporates 
without reconsideration the guidance in FASB Interpretation No. 42, and supersedes that 
Interpretation. FASB Statement No. 136 is effective for financial statements issued for fiscal periods 
beginning after December 15 , 1999, except for the provisions incorporated from FASB Interpretation 
No. 42, which continue to be effective for fiscal years ending after September 15 , 1996. A summary of 
FASB Statement No. 136 is included in appendix F to this Guide.
CON On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 16 , 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and paragraphs 1-3 and 5 of ARB No. 51, add a sentence to endnote 3 of ARB No. 51, and amend APB 
Opinions 16 and 18 and FASB Statement Nos. 15, 57, and 65.
* Note regarding effective dates, FASB Statement No. 133, Accounting for Derivative 
Instruments and Hedging Activities, as amended by FASB Statement No. 137, Accounting for 
Derivative Instruments and Hedging Activities—Deferral of the Effective Date o f FASB Statement No. 
133, is effective for all fiscal quarters of fiscal years beginning after June 15, 2000. Also, on March 3, 
2000, the FASB issued an exposure draft, Accounting for Certain Derivative Instruments and Certain 
Hedging Activities, that would amend FASB Statement No. 133. Readers should be alert for the 
issuance of a final standard.
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FASB Statement No. 136, Transfers of 
Assets to a Not-for-Profit Organization 
or Charitable Trust That Raises or 
Holds Contributions for OthersAGT
FASB Interpretation No. 30, Accounting 
for Involuntary Conversions of Non­
monetary Assets to Monetary Assets, as 
amended by FASB Statement No. 109
FASB Interpretation No. 42, Account­
ing for Transfers of Assets in Which a 
Not-for-Profit Organization Is Grant­
ed Variance Power
Pronouncement Additional Guidance
This Guide and the AICPA Audit 
and Accounting Guide Not-for- 
Profit Organizations
See APB Opinion 29
This Guide and the AICPA Audit 
and Accounting Guide Not-for- 
Profit Organizations
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Appendix D— Financial Reporting Pronouncements 
Pertaining to Specialized Industry Practices of 
Business Enterprises
Note regarding effective dates:
• FASB Statement No. 133, Accounting for Derivative Instruments and 
Hedging Activities, as amended by FASB Statement No. 137, Accounting 
for Derivative Instruments and Hedging Activities—Deferral of the 
Effective Date of FASB Statement No. 133, is effective for all fiscal 
quarters of fiscal years beginning after June 15, 2000. Also, on March 3, 
2000, the FASB issued an exposure draft, Accounting for Certain 
Derivative Instruments and Certain Hedging Activities, that would 
amend FASB Statement No. 133. Readers should be alert for the 
issuance of a final standard.
This appendix includes pronouncements that apply only to entities operating 
in certain industries, generally business enterprises. However, some not-for- 
profit organizations conduct activities in some of those industries and should 
apply the guidance concerning recognition and measurement of assets, liabili­
ties, revenues, expenses, and gains and losses in those pronouncements to the 
transactions unique to those industries. In addition, those not-for-profit organi­
zations should follow the financial statement display guidance in FASB State­
ment No. 117, Financial Statements of Not-for-Profit Organizations, and this 
Guide, although it may conflict with display that would result from applying 
the guidance in the pronouncements included in this appendix.
•  APB Opinion 12, Omnibus Opinion—1967 (guidance under the head­
ing “Capital Changes”)
•  APB Opinion 13, Amending Paragraph 6 of APB Opinion No. 9, 
Application to Commercial Banks
•  FASB Statement No. 7, Accounting and Reporting by Development 
Stage Enterprises, as amended by FASB Statement Nos. 71 and 95, 
and including FASB Interpretation No. 7
•  FASB Statement No. 19, Financial Accounting and Reporting by Oil and 
Gas Producing Companies, as amended by FASB Statement Nos. 25, 69, 
71, 109, and 121, and including FASB Interpretation Nos. 33 and 36
•  FASB Statement No. 25, Suspension of Certain Accounting Require­
ments for Oil and Gas Producing Companies (an amendment of FASB 
Statement No. 19), as amended by FASB Statement No. 111
•  FASB Statement No. 35, Accounting and Reporting by Defined Benefit 
Pension Plans, as amended by FASB Statement Nos. 75, 110, and 135
•  FASB Statement No. 44, Accounting for Intangible Assets of Motor 
Carriers (an amendment of Chapter 5 of ABB No. 43 and an Interpretation 
of APB Opinions 17 and 30), as amended by FASB Statement No. 109
•  FASB Statement No. 45, Accounting for Franchise Fee Revenue
•  FASB Statement No. 50, Financial Reporting in the Record and Music 
Industry
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•  FASB Statement No. 51, Financial Reporting by Cable Television 
Companies, as amended by FASB Statement Nos. 71, 121, and 131
•  FASB Statement No. 53, Financial Reporting by Producers and Dis­
tributors of Motion Picture Films
•  FASB Statement No. 60, Accounting and Reporting by Insurance Enter­
prises, as amended by FASB Statement Nos. 91, 97, 109, 113, 114, 115, 
120, 121, 124, 133, and 135, and including FASB Interpretation No. 40
•  FASB Statement No. 61, Accounting for Title Plant, as amended by 
FASB Statement No. 121
•  FASB Statement No. 63, Financial Reporting by Broadcasters
•  FASB Statement No. 65, Accounting for Certain Mortgage Banking 
Activities, as amended by FASB Statement Nos. 91, 115, 124, 125, 
133, and 134CON
•  FASB Statement No. 67, Accounting for Costs and Initial Rental 
Operations of Real Estate Projects, as amended by FASB Statement 
Nos. I l l  and 121
•  FASB Statement No. 69, Disclosures about Oil and Gas Producing 
Activities (an amendment of FASB Statements 19, 25, 33, and 39), as 
amended by FASB Statement Nos. 89, 95, 109, and 131
•  FASB Statement No. 71, Accounting for the Effects of Certain Types of 
Regulation, as amended by FASB Statement Nos. 90, 92, 109, 121, and 
135
•  FASB Statement No. 72, Accounting for Certain Acquisitions of Bank­
ing or Thrift Institutions (an amendment of APB Opinion No. 17, an 
interpretation of APB Opinions 16 and 17, and an amendment of FASB 
Interpretation No. 9)
•  FASB Statement No. 73, Reporting a Change in Accounting for Rail­
road Track Structures (an amendment of APB Opinion No. 20)
•  FASB Statement No. 90, Regulated Enterprises—Accounting for Aban­
donments and Disallowances of Plant Costs (an amendment of FASB 
Statement No. 71), as amended by FASB Statement Nos. 92 and 109
•  FASB Statement No. 91, Accounting for Nonrefundable Fees and Costs 
Associated with Originating or Acquiring Loans and Initial Direct 
Costs of Leases (an amendment of FASB Statements No. 13, 60, and 
65 and a rescission of FASB Statement No. 17), as amended by FASB 
Statement Nos. 98, 114, 115, and 124
•  FASB Statement No. 92, Regulated Enterprises—Accounting for 
Phase-in Plans (an amendment of FASB Statement No. 71)
•  FASB Statement No. 97, Accounting and Reporting by Insurance 
Enterprises for Certain Long-Duration Contracts and for Realized 
Gains and Losses from the Sale of Investments, as amended by FASB 
Statement Nos. 113, 115, and 120
•  FASB Statement No. 101, Regulated Enterprises—Accounting for the 
Discontinuation of Application of FASB Statement No. 71, as amended 
by FASB Statement Nos. 109 and 121
•  FASB Statement No. 110, Reporting by Defined Benefit Pension Plans 
of Investment Contracts (an amendment of FASB Statement No. 35)
•  FASB Statement No. 113, Accounting and Reporting for Reinsurance of 
Short-Duration and Long-Duration Contracts, as amended by FASB 
Statement Nos. 120 and 133, and including FASB Interpretation No. 40
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•  FASB Statement No. 120, Accounting and Reporting by Mutual Life 
Insurance Enterprises and by Insurance Enterprises for Certain Long- 
Duration Participating Contracts (an amendment of FASB Statement 
Nos. 60, 97, and 113 and Interpretation No. 40)
•  FASB Statement No. 134, Accounting for Mortgage-Backed Securities 
Retained after the Securitization of Mortgage Loans Held for Sale by a 
Mortgage Banking Enterprise (an amendment of FASB Statement No. 65)
•  FASB Interpretation No. 7, Applying FASB Statement No. 7 in Finan­
cial Statements of Established Operating Enterprises
•  FASB Interpretation No. 9, Applying APB Opinions No. 16 and 17 
When a Savings and Loan Association or a Similar Institution Is 
Acquired in a Business Combination Accounted for by the Purchase 
Method, as amended by FASB Statement No. 72
•  FASB Interpretation No. 33, Applying FASB Statement No. 34 to Oil 
and Gas Producing Operations Accounted for by the Full Cost Method
•  FASB Interpretation No. 36, Accounting for Exploratory Wells in 
Progress at the End of a Period
•  FASB Interpretation No. 40, Applicability of Generally Accepted Ac­
counting Principles to Mutual Life Insurance and Other Enterprises, 
as amended by FASB Statement Nos. 115, 120, and 135
CON On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 16, 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and paragraphs 1-3 and 5 of ARB No. 51, add a sentence to endnote 3 of ARB No. 51, and amend APB 
Opinions 16 and 18 and FASB Statement Nos. 15, 57, and 65.
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Appendix E— Financial Reporting Pronouncements 
Not Subsequently Superseded and Not Included 
in Appendixes A  through D of This Chapter
Note regarding effective dates:
• FASB Statement No. 133, Accounting for Derivative Instruments and 
Hedging Activities, as amended by FASB Statement No. 137, Accounting 
for Derivative Instruments and Hedging Activities—Deferral o f the 
Effective Date of FASB Statement No. 133, is effective for all fiscal 
quarters of fiscal years beginning after June 15, 2000. Also, on March 3, 
2000, the FASB issued an exposure draft, Accounting for Certain 
Derivative Instruments and Certain Hedging Activities, that would 
amend FASB Statement No. 133. Readers should be alert for the 
issuance of a final standard.
2 0  Health Care Organizations
As stated in paragraph 1.27 of this Guide, not-for-profit organizations should 
follow the guidance in effective provisions of ARBs, APB Opinions, and FASB 
Statements and Interpretations, except for specific pronouncements that ex­
plicitly exempt not-for-profit organizations and pronouncements for which this 
Guide provides guidance. This appendix includes pronouncements, not sub­
sequently superseded, that (a) do not exempt not-for-profit organizations from 
their application, (b) by the nature of their subject matter, apply to the kinds 
of transactions not-for-profit organizations engage in, (c) are subject to no 
additional FASB or AICPA guidance, and (d) do not pertain to specialized 
industry practices of business enterprises. Not-for-profit organizations should 
follow the guidance in the effective provisions of the pronouncements included 
in this appendix.
•  ARB No. 43, Restatement and Revision of Accounting Research 
Bulletins, as amended by APB Opinions 6, 9, 10, 16, 17, 20, 21, 25, 
and 26, and FASB Statement Nos. 5, 6,  44, 52, 78, 94 , 109, 111, 115, 
123, 131, 133, and 135
•  ARB No. 45, Long-Term Construction-Type Contracts
•  ARB No. 46, Discontinuance of Dating Earned Surplus
•  APB Opinion 2, Accounting for the “Investment Credit ” as amended 
by APB Opinion 4 and FASB Statement Nos. 71 and 109
•  APB Opinion 4 (amending Opinion 2), Accounting for the “Investment 
Credit”
•  APB Opinion 6, Status of Accounting Research Bulletins, as amended 
by APB Opinions 16, 17, and 26, and FASB Statement Nos. 52, 71, 
109, 111, and 135
•  APB Opinion 9, Reporting the Results of Operations (paragraph 1.38 
of this Guide discusses this pronouncement), as amended by APB 
Opinions 13, 15, 20, and 30, and FASB Statement No. 16
•  APB Opinion 10, Omnibus Opinion—1966, as amended by APB Opin­
ions 12, 14, 16, and 18, and FASB Statement Nos. 111 and 129, and 
including FASB Interpretation Nos. 39 and 41
•  APB Opinion 12, Omnibus Opinion—1967 (except guidance under the 
heading, “Capital Changes”), as amended by APB Opinion 14 and 
FASB Statement Nos. 87, 106, and 111
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•  APB Opinion 16, Business Combinations (paragraph 1.36 of this Guide 
discusses this pronouncement), as amended by FASB Statement Nos. 
10, 38, 71, 79, 87, 106, 109, 121, and 135, and including FASB 
Interpretation Nos. 4, 9, and 21CON, COM
•  APB Opinion 17, Intangible Assets, as amended by APB Opinion 30 and 
FASB Statement Nos. 2, 71, 72, 109, 121, and 135, and including FASB 
Interpretation No. 9COM
•  APB Opinion 20, Accounting Changes, as amended by FASB State­
ment Nos. 16, 58, 71, 73, 95, 111, and 128, and including FASB 
Interpretation Nos. 1 and 20
•  APB Opinion 21, Interest on Receivables and Payables, as amended by 
FASB Statement Nos. 34 and 109
•  APB Opinion 22, Disclosure of Accounting Policies, as amended by 
FASB Statement Nos. 2, 52, 95, and 111
•  APB Opinion 23, Accounting for Income Taxes—Special Areas, as 
amended by FASB Statement Nos. 60, 71, 94, and 109
•  APB Opinion 26, Early Extinguishment of Debt (paragraph 1.38 of this 
Guide discusses this pronouncement), as amended by APB Opinion 30 
and FASB Statement Nos. 4 ,  15, 71, 84, and 125
•  APB Opinion 30, Reporting the Results of Operations—Reporting the 
Effects of Disposal of a Segment of a Business, and Extraordinary, 
Unusual and Infrequently Occurring Events and Transactions (para­
graph 1.38 of this Guide discusses this pronouncement), as amended 
by FASB Statement Nos. 4 , 16, 60, 97, 101, 109, and 128, and including 
FASB Interpretation No. 27
•  FASB Statement No. 2, Accounting for Research and Development 
Costs, as amended by FASB Statement Nos. 71 and 86, and including 
FASB Interpretation Nos. 4 and 6
•  FASB Statement No. 4, Reporting Gains and Losses from Extinguish­
ment of Debt (an amendment of APB Opinion No. 30) (paragraph 1.38 
of this Guide discusses this pronouncement), as amended by FASB 
Statement Nos. 64 and 71
•  FASB Statement No. 5, Accounting for Contingencies, as amended by 
FASB Statement Nos. 11, 16, 60, 71, 87, 111, 112, 113, 114, and 123, 
and including FASB Interpretation Nos. 14 and 34
•  FASB Statement No. 6, Classification of Short-Term Obligations Ex­
pected to Be Refinanced (an amendment of ARB No. 43, Chapter 3A), 
and including FASB Interpretation No. 8
•  FASB Statement No. 10, Extension of “Grandfather” Provisions for 
Business Combinations (an amendment of APB Opinion No. 16)
•  FASB Statement No. 11, Accounting for Contingencies—Transition 
Method (an amendment of FASB Statement No. 5)
•  FASB Statement No. 13, Accounting for Leases, as amended by FASB 
Statement Nos. 22, 23, 27, 28, 29, 34, 71, 91, 94, 98,109, 125, and 135, 
and including FASB Interpretation Nos. 19, 21, 23, 24, 26, and 27
•  FASB Statement No. 15, Accounting by Debtors and Creditors for 
Troubled Debt Restructurings, as amended by FASB Statement Nos. 71, 
111, 114,121, and 135CON
•  FASB Statement No. 16, Prior Period Adjustments, as amended by 
FASB Statement Nos. 71 and 109
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•  FASB Statement No. 22, Changes in the Provisions of Lease Agreements 
Resulting from Refundings of Tax-Exempt Debt (an amendment of FASB 
Statement No. 13), as amended by FASB Statement Nos. 71 and 125
•  FASB Statement No. 23, Inception of the Lease (an amendment of 
FASB Statement No. 13)
•  FASB Statement No. 27, Classification of Renewals or Extensions of 
Existing Sales-Type or Direct Financing Leases (an amendment of 
FASB Statement No. 13)
•  FASB Statement No. 28, Accounting for Sales with Leasebacks (an 
amendment of FASB Statement No. 13), as amended by FASB State­
ment No. 66
•  FASB Statement No. 29, Determining Contingent Rentals (an amend­
ment of FASB Statement No. 13), as amended by FASB Statement No. 98
•  FASB Statement No. 34, Capitalization of Interest Cost, as amended 
by FASB Statement Nos. 42, 58, 62, 71, and 121, and including FASB 
Interpretation No. 33
•  FASB Statement No. 37, Balance Sheet Classification of Deferred 
Income Taxes (an amendment of APB Opinion No. 11), as amended by 
FASB Statement No. 109
•  FASB Statement No. 38, Accounting for Preacquisition Contingencies 
of Purchased Enterprises (an amendment of APB Opinion No. 16), as 
amended by FASB Statement No. 109
•  FASB Statement No. 42, Determining Materiality for Capitalization 
of Interest Cost (an amendment of FASB Statement No. 34)
•  FASB Statement No. 43, Accounting for Compensated Absences, as 
amended by FASB Statement Nos. 71 , 112, 123, and 135
•  FASB Statement No. 47, Disclosure of Long-Term Obligations
•  FASB Statement No. 48, Revenue Recognition When Right of Return Exists
•  FASB Statement No. 49, Accounting for Product Financing Arrange­
ments, as amended by FASB Statement No. 71
•  FASB Statement No. 52, Foreign Currency Translation (paragraph
1.38 of this Guide discusses this pronouncement), as amended by 
FASB Statement Nos. 95, 109, 130, 133, and 135, and including FASB 
Interpretation No. 37
•  FASB Statement No. 57, Related Party Disclosures, as amended by 
FASB Statement Nos. 95 and 109CON
•  FASB Statement No. 58, Capitalization of Interest in Financial State­
ments That Include Investments Accounted for by the Equity Method 
(an amendment of FASB Statement No. 34)
•  FASB Statement No. 62, Capitalization of Interest Cost in Situations 
Involving Certain Tax-Exempt Borrowings and Certain Gifts and 
Grants (an amendment of FASB Statement No. 34)
•  FASB Statement No. 64, Extinguishments of Debt Made to Satisfy 
Sinking-Fund Requirements (an amendment of FASB Statement No. 4)
•  FASB Statement No. 66, Accounting for Sales of Real Estate, as 
amended by FASB Statement Nos. 98 , 121, and 135
•  FASB Statement No. 68, Research and Development Arrangements
•  FASB Statement No. 78, Classification of Obligations That Are Call­
able by the Creditor (an amendment of ARB No. 43, Chapter 3A)
•  FASB Statement No. 79, Elimination of Certain Disclosures for Busi­
ness Combinations by Nonpublic Enterprises (an amendment of APB 
Opinion No. 16)
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•  FASB Statement No. 80, Accounting for Futures Contracts, as 
amended by FASB Statement Nos. 115 and 130 (Superseded by FASB 
Statement No. 133.)
•  FASB Statement No. 86, Accounting for the Costs of Computer Soft­
ware to Be Sold, Leased, or Otherwise Marketed
•  FASB Statement No. 87, Employers’ Accounting for Pensions, as 
amended by FASB Statement Nos. 106, 109, 130, 132, and 135
•  FASB Statement No. 88, Employers’ Accounting for Settlements and 
Curtailments of Defined Benefit Pension Plans and for Termination 
Benefits, as amended by FASB Statement No. 132
•  FASB Statement No. 93, Recognition of Depreciation by Not-for-Profit 
Organizations, as amended by FASB Statement Nos. 99 and 135
•  FASB Statement No. 95, Statement of Cash Flows, as amended by 
FASB Statement Nos. 102, 104, 117, and 133
•  FASB Statement No. 98, Accounting for Leases:
— Sale-Leaseback Transactions Involving Real Estate
— Sales-Type Leases of Real Estate
— Definition of the Lease Term
— Initial Direct Costs of Direct Financing Leases
(an amendment of FASB Statements No. 13, 66, and 91 and a rescis­
sion of FASB Statement No. 26 and Technical Bulletin No. 79-11)
•  FASB Statement No. 99, Deferral of the Effective Date of Recognition 
of Depreciation by Not-for-Profit Organizations (an amendment of 
FASB Statement No. 93)
•  FASB Statement No. 102, Statement o f Cash Flows—Exemption of 
Certain Enterprises and Classification of Cash Flows from Certain 
Securities Acquired for Resale (an amendment of FASB Statement No. 
95), as amended by FASB Statement Nos. 115 and 135
•  FASB Statement No. 104, Statement of Cash Flows—Net Reporting of 
Certain Cash Receipts and Cash Payments and Classification of Cash 
Flows from Hedging Transactions (an amendment of FASB Statement 
No. 95)
•  FASB Statement No. 105, Disclosure of Information about Financial 
Instruments with Off-Balance-Sheet Risk and Financial Instruments 
with Concentrations of Credit Risk, as amended by FASB Statement 
Nos. 107, 111, 119, 123, and 125, and including FASB Interpretation 
No. 39 (Superseded by FASB Statement No. 133.)
•  FASB Statement No. 106, Employers’ Accounting for Postretirement 
Benefits Other Than Pensions, as amended by FASB Statement Nos. 
132 and 135
•  FASB Statement No. 107, Disclosures about Fair Value of Financial 
Instruments, as amended by FASB Statement Nos. 112, 119, 123, 125, 
126, and 133
•  FASB Statement No. 109, Accounting for Income Taxes (paragraph
1.38 of this Guide discusses this pronouncement), as amended by 
FASB Statement Nos. 115, 123, 130, and 135
•  FASB Statement No. 111, Rescission of FASB Statement No. 32 and 
Technical Corrections
•  FASB Statement No. 112, Employers’ Accounting for Postemployment 
Benefits (an amendment of FASB Statements No. 5 and 43), as 
amended by FASB Statement No. 123
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•  FASB Statement No. 114, Accounting by Creditors for Impairment of 
a Loan (an amendment of FASB Statements No. 5 and 15), as amended 
by FASB Statement No. 118
•  FASB Statement No. 118, Accounting by Creditors for Impairment of 
a Loan—Income Recognition and Disclosures (an amendment of FASB 
Statement No. 114)
•  FASB Statement No. 119, Disclosure about Derivative Financial In­
struments and Fair Value of Financial Instruments (Superseded by 
FASB Statement No. 133.)
•  FASB Statement No. 121, Accounting for the Impairment of Long- 
Lived Assets and for Long-Lived Assets to Be Disposed Of
•  FASB Statement No. 125, Accounting for Transfers and Servicing of 
Financial Assets and Extinguishments of Liabilities, as amended by 
FASB Statement Nos. 127 and 133
•  FASB Statement No. 126, Exemption from Certain Required Disclo­
sures about Financial Instruments for Certain Nonpublic Entities, as 
amended by FASB Statement No. 133
•  FASB Statement No. 127, Deferral of the Effective Date of Certain 
Provisions of FASB Statement No. 125
•  FASB Statement No. 129, Disclosure of Information about Capital 
Structure
•  FASB Statement No. 132, Employers’ Disclosures about Pensions and 
Other Postretirement Benefits, as amended by FASB Statement No. 
135
•  FASB Statement No. 133, Accounting for Derivative Instruments and 
Hedging Activities
•  FASB Statement No. 135, Rescission of FASB Statement No. 75 and 
Technical Corrections
•  FASB Statement No. 137, Accounting for Derivative Instruments and 
Hedging Activities—Deferral of the Effective Date of FASB Statement 
No. 133
•  FASB Interpretation No. 1, Accounting Changes Related to the Cost of 
Inventory, as amended by FASB Statement No. 121
•  FASB Interpretation No. 4, Applicability of FASB Statement No. 2 to 
Business Combinations Accounted for by the Purchase Method
•  FASB Interpretation No. 6, Applicability of FASB Statement No. 2 to 
Computer Software, as amended by FASB Statement No. 86
•  FASB Interpretation No. 8, Classification of a Short-Term Obligation 
Repaid Prior to Being Replaced by a Long-Term Security
•  FASB Interpretation No. 14, Reasonable Estimation of the Amount of 
a Loss
•  FASB Interpretation No. 19, Lessee Guarantee of the Residual Value 
of Leased Property
•  FASB Interpretation No. 20, Reporting Accounting Changes under 
AICPA Statements of Position, as amended by FASB Statement No. 111
•  FASB Interpretation No. 21, Accounting for Leases in a Business 
Combination
•  FASB Interpretation No. 23, Leases of Certain Property Owned by a 
Governmental Unit or Authority
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•  FASB Interpretation No. 24, Leases Involving Only Part of a Building
•  FASB Interpretation No. 26, Accounting for Purchase of a Leased Asset 
by the Lessee during the Term of the Lease
•  FASB Interpretation No. 27, Accounting for a Loss on a Sublease, as 
amended by FASB Statement No. 135
•  FASB Interpretation No. 34, Disclosure of Indirect Guarantees of 
Indebtedness of Others
•  FASB Interpretation No. 37, Accounting for Translation Adjustments 
upon Sale of Part of an Investment in a Foreign Entity
•  FASB Interpretation No. 39, Offsetting of Amounts Related to Certain 
Contracts, as amended by FASB Statement Nos. 113 and 135 and 
FASB Interpretation No. 41
•  FASB Interpretation No. 41, Offsetting of Amounts Related to Certain 
Repurchase and Reverse Repurchase Agreements
•  FASB Interpretation No. 43, Real Estate Sales
COM In September 1999, the FASB released an exposure draft of a proposed FASB Statement, 
Business Combinations and Intangible Assets, that has two parts. The first part, which applies to 
only business enterprises would, in addition to other matters, amend APB Opinion No. 16. The 
second part, which applies to both business enterprises and not-for-profit organizations, would in 
addition to other matters, supersede APB Opinion No. 17. The FASB is addressing issues pertaining 
to not-for-profit combinations in a separate project.
CON On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 16 , 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and paragraphs 1-3 and 5 of ARB No. 51, add a sentence to endnote 3 of ARB No. 51, and amend APB 
Opinions 16 and 18 and FASB Statement Nos. 15, 57, and 65.
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Appendix F— All Financial Reporting Pronouncements, 
Cross-Referenced by Appendix
Pronouncement _____Appendix_____
1.47
ARB 1 to ARB 42 Superseded
ARB 43 E
ARB 44 Superseded
ARB 44 (Revised) Superseded
ARB 45 E
ARB 46 E
ARB 47 to ARB 50 Superseded
ARB 51 C
APB Opinion 1 Superseded
APB Opinion 2 E
APB Opinion 3 Superseded
APB Opinion 4 E
APB Opinion 5 Superseded
APB Opinion 6 E
APB Opinions 7 and 8 Superseded
APB Opinion 9 E
APB Opinion 10 E
APB Opinion 11 Superseded
APB Opinion 12 D, E
APB Opinion 13 D
APB Opinion 14 B
APB Opinion 15 Superseded
APB Opinion 16 E
APB Opinion 17 E
APB Opinion 18 A
APB Opinion 19 Superseded
APB Opinion 20 E
APB Opinion 21 E
APB Opinion 22 E
APB Opinion 23 E
APB Opinion 24 Superseded
APB Opinion 25 B
APB Opinion 26 E
APB Opinion 27 Superseded
APB Opinion 28 A
APB Opinion 29 C
APB Opinion 30 E
APB Opinion 31 Superseded
FASB Statement No. 1 Superseded
FASB Statement No. 2 E
FASB Statement No. 3 A
FASB Statement No. 4 E
FASB Statement No. 5 E
FASB Statement No. 6 E
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Pronouncement_______ ____ Appendix
FASB Statement No. 7 D
FASB Statement Nos. 8 and 9 Superseded
FASB Statement No. 10 E
FASB Statement No. 11 E
FASB Statement No. 12 Superseded
FASB Statement No. 13 E
FASB Statement No. 14 Superseded
FASB Statement No. 15 E
FASB Statement No. 16 E
FASB Statement No. 17 Superseded
FASB Statement No. 18 Superseded
FASB Statement No. 19 D
FASB Statement No. 20 Superseded
FASB Statement No. 21 Superseded
FASB Statement No. 22 E
FASB Statement No. 23 E
FASB Statement No. 24 Superseded
FASB Statement No. 25 D
FASB Statement No. 26 Superseded
FASB Statement No. 27 E
FASB Statement No. 28 E
FASB Statement No. 29 E
FASB Statement No. 30 Superseded
FASB Statement Nos. 31 to 33 Superseded
FASB Statement No. 34 E
FASB Statement No. 35 D
FASB Statement No. 36 Superseded
FASB Statement No. 37 E
FASB Statement No. 38 E
FASB Statement Nos. 39 to 41 Superseded
FASB Statement No. 42 E
FASB Statement No. 43 E
FASB Statement No. 44 D
FASB Statement No. 45 D
FASB Statement No. 46 Superseded
FASB Statement No. 47 E
FASB Statement No. 48 E
FASB Statement No. 49 E
FASB Statement No. 50 D
FASB Statement No. 51 D
FASB Statement No. 52 E
FASB Statement No. 53 D
FASB Statement Nos. 54 to 56 Superseded
FASB Statement No. 57 E
FASB Statement No. 58 E
FASB Statement No. 59 Superseded
FASB Statement No. 60 D
FASB Statement No. 61 D
FASB Statement No. 62 E
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FASB Statement No. 63 
FASB Statement No. 64 
FASB Statement No. 65 
FASB Statement No. 66 
FASB Statement No. 67 
FASB Statement No. 68 
FASB Statement No. 69 
FASB Statement No. 70 
FASB Statement No. 71 
FASB Statement No. 72 
FASB Statement No. 73 
FASB Statement No. 74 
FASB Statement No. 75 
FASB Statement No. 76 
FASB Statement No. 77 
FASB Statement No. 78 
FASB Statement No. 79 
FASB Statement No. 80 
FASB Statement Nos. 81 to 83 
FASB Statement No. 84 
FASB Statement No. 85 
FASB Statement No. 86 
FASB Statement No. 87 
FASB Statement No. 88 
FASB Statement No. 89 
FASB Statement No. 90 
FASB Statement No. 91 
FASB Statement No. 92 
FASB Statement No. 93 
FASB Statement No. 94 
FASB Statement No. 95 
FASB Statement No. 96 
FASB Statement No. 97 
FASB Statement No. 98 
FASB Statement No. 99 
FASB Statement No. 100 
FASB Statement No. 101 
FASB Statement No. 102 
FASB Statement No. 103 
FASB Statement No. 104 
FASB Statement No. 105 
FASB Statement No. 106 
FASB Statement No. 107 
FASB Statement No. 108 
FASB Statement No. 109 
FASB Statement No. 110 
FASB Statement No. 111 
FASB Statement No. 112 
FASB Statement No. 113
______ Pronouncement______
D
E
D
E
D
E
D
Superseded
D
D
D
Superseded
Superseded
Superseded
Superseded
E
E
E*
Superseded
B
Superseded
E
E
E
A
D
D
D
E
C
E
Superseded
D
E
E
Superseded
D
E
Superseded
E
E*
E
E
Superseded
E
D
E
E
D
____ Appendix
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Pronouncement________  ____ Appendix
FASB Statement No. 114 E
FASB Statement No. 115 A
FASB Statement No. 116 C
FASB Statement No. 117 C
FASB Statement No. 118 E
FASB Statement No. 119 E*
FASB Statement No. 120 D
FASB Statement No. 121 E
FASB Statement No. 122 Superseded
FASB Statement No. 123 B
FASB Statement No. 124 C
FASB Statement No. 125 E
FASB Statement No. 126 E
FASB Statement No. 127 E
FASB Statement No. 128 A
FASB Statement No. 129 E
FASB Statement No. 130 A
FASB Statement No. 131 A
FASB Statement No. 132 E
FASB Statement No. 133 E
FASB Statement No. 134 D
FASB Statement No. 135 E
FASB Statement No. 136 C
FASB Statement No. 137 E
FASB Interpretation No. 1 E
FASB Interpretation Nos. 2 and 3 Superseded
FASB Interpretation No. 4 E
FASB Interpretation No. 5 Superseded
FASB Interpretation No. 6 E
FASB Interpretation No. 7 D
FASB Interpretation No. 8 E
FASB Interpretation No. 9 D
FASB Interpretation Nos. 10 to 13 Superseded
FASB Interpretation No. 14 E
FASB Interpretation Nos. 15 to 17 Superseded
FASB Interpretation No. 18 A
FASB Interpretation No. 19 E
FASB Interpretation No. 20 E
FASB Interpretation No. 21 E
FASB Interpretation No. 22 Superseded
FASB Interpretation No. 23 E
FASB Interpretation No. 24 E
FASB Interpretation No. 25 Superseded
FASB Interpretation No. 26 E
FASB Interpretation No. 27 E
FASB Interpretation No. 28 B
FASB Interpretation No. 29 Superseded
FASB Interpretation No. 30 C
FASB Interpretation No. 31 Superseded
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Pronouncement
FASB
FASB
FASB
FASB
FASB
FASB
FASB
FASB
FASB
FASB
FASB
FASB
FASB
Interpretation
Interpretation
Interpretation
Interpretation
Interpretation
Interpretation
Interpretation
Interpretation
Interpretation
Interpretation
Interpretation
Interpretation
Interpretation
No. 32 
No. 33 
No. 34 
No. 35 
No. 36 
No. 37 
No. 38 
No. 39 
No. 40 
No. 41 
No. 42 
No. 43 
No. 44
Superseded
D
E
A
D
E
B
E
D
E
C**
E
B
Appendix
* FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities, as 
amended by FASB Statement No. 137, Accounting for Derivative Instruments and Hedging Activi­
ties—Deferral o f the Effective Date o f FASB Statement No. 133, is effective for all fiscal quarters of 
fiscal years beginning after June 15, 2000. FASB Statement No. 133 supersedes FASB Statement No. 
80, Accounting for Futures Contracts, FASB Statement No. 105, Disclosure of Information about 
Financial Instruments with Off-Balance-Sheet Risk and Financial Instruments with Concentrations 
o f Credit Risk, and FASB Statement No. 119, Disclosure about Derivative Financial Instruments and 
Fair Value o f Financial Instruments. Also, on March 3, 2000, the FASB issued an exposure draft, 
Accounting for Certain Derivative Instruments and Certain Hedging Activities, that would amend 
FASB Statement No. 133. Readers should be alert for the issuance of a final standard.
** Among other matters, FASB Statement No. 136, Transfers of Assets to a Not-for-Profit 
Organization or Charitable Trust That Raises or Holds Contributions for Others, incorporates with­
out reconsideration the guidance in FASB Interpretation No. 42, and supersedes that Interpretation. 
FASB Statement No. 136 is effective for financial statements issued for fiscal periods beginning after 
December 15, 1999, except for the provisions incorporated from FASB Interpretation No. 42, which 
continue to be effective for fiscal years ending after September 15, 1996. A summary of FASB 
Statement No. 136 is included in appendix F to this Guide.
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Appendix G— The Hierarchy of GAAP
SAS No. 69, The Meaning of Present Fairly in Conformity With Generally 
Accepted Accounting Principles in the Independent Auditor’s Report, estab­
lishes the hierarchy of GAAP.
For financial statements of entities other than  governmental entities, the 
hierarchy is summarized as follows:
Category (a). Rule 203 literature consists of officially established ac­
counting principles, which are FASB Statements and 
Interpretations, APB Opinions, and ARBs.
Category (b). This consists of FASB Technical Bulletins and, if clear­
ed by the FASB, AICPA Industry Audit and Account­
ing Guides, and AICPA SOPs.
Category (c). This consists of AICPA AcSEC Practice Bulletins that 
have been cleared by the FASB and consensus positions 
of the FASB EITF.
Cateory (d). This consists of AICPA accounting interpretations and 
implementation guides (“Qs and As”) published by the 
FASB staff, and practices that are widely recognized 
and prevalent either generally or in the industry.
If the accounting treatment of a transaction or event is not specified by Rule 
203 literature, the auditor should consider whether the accounting treatment 
is specified by another source of established accounting principles. If an 
established accounting principle from one or more sources in category (b), (c), 
or (d) is relevant to the circumstances, the auditor should be prepared to justify 
a conclusion that another treatment is generally accepted. If there is a conflict 
between accounting principles relevant to the circumstances from one or more 
sources in category (b), (c), or (d), the auditor should follow the treatment 
specified by the source in the higher category—for example, follow category (b) 
treatment over category (c)—or be prepared to justify a conclusion that a 
treatment specified by a source in the lower category better presents the 
substance of the transaction in the circumstances.
For financial statements of governmental entities,1 the hierarchy is summa­
rized as follows:
Category (a). Officially established accounting principles, consists 
of GASB Statements and Interpretations, as well as 
AICPA and FASB pronouncements specifically made 
applicable to state and local governmental entities by 
GASB Statements or Interpretations. GASB Statements 
and Interpretations are periodically incorporated in the 
Codification of Governmental Accounting and Finan­
cial Reporting Standards.
1 State and local governmental entities include public benefit corporations and authorities; 
public employee retirement systems; and governmental utilities, hospitals and other health care 
providers, and colleges and universities. SAS No. 91, Federal GAAP Hierarchy, amends SAS No. 69 
to establish a hierarchy for federal governmental entities. Federal health care organizations are not 
included in the scope of this Guide.
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Category (b). This consists of GASB Technical Bulletins and, if spe­
cifically made applicable to state and local governmen­
tal entities by the AICPA and cleared2 by the GASB, 
AICPA Industry Audit and Accounting Guides and 
AICPA SOPs.
Category (c). This consists of AICPA AcSEC Practice Bulletins if 
specifically made applicable to state and local govern­
mental entities and cleared3 by the GASB, as well as 
consensus positions of a group of accountants organ­
ized by the GASB that attempts to reach consensus 
positions on accounting issues applicable to state and 
local governmental entities.4
Category (d). Includes implementation guides (“Qs and As”) publish­
ed by the GASB staff, as well as practices that are widely 
recognized and prevalent in state and local government.
In the absence of a pronouncement covered by Rule 203 or another source of 
established accounting principles, the auditor of financial statements of state 
and local governmental entities may consider other accounting literature, 
depending on its relevance in the circumstances. Other accounting literature 
includes, for example, GASB Concepts Statements; the pronouncements re­
ferred to in categories (a) through (d) above that relate to other than govern­
mental entities when not specifically made applicable to state and local 
governmental entities either by the GASB or by the organization issuing them; 
FASB Concepts Statements; AICPA Issues Papers; International Accounting 
Standards of the International Accounting Standards Committee; pronounce­
ments of other professional associations or regulatory agencies; Technical 
Information Service Inquiries and Replies included in AICPA Technical Prac­
tice Aids', and accounting textbooks, handbooks, and articles. The appropriate­
ness of other accounting literature depends on its relevance to particular 
circumstances, the specificity of the guidance, and the general recognition of 
the issuer or author as an authority. For example, GASB Concepts Statements 
would normally be more influential than other sources in this category.
2 The auditor should assume that such pronouncements specifically made applicable to state and 
local governments have been cleared by the GASB unless the pronouncement indicates otherwise.
3 See footnote 2.
4 As of the date of this Guide, the GASB had not organized such a group.
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Chapter 2 
General Auditing Considerations
Scope of the Engagement
2.01 SAS No. 83, Establishing an Understanding With the Client* (AICPA, 
Professional Standards, vol. 1, AU sec. 310), provides that, for each audit 
engagement, the independent auditor and the health care organization 
should establish a clear understanding regarding the services to be per­
formed. The understanding should include the objectives of the engage­
ment, management’s responsibilities, the auditor’s responsibilities, and 
limitations of the engagement. Such an understanding should be docu­
mented in the working papers, preferably through a written communication 
with the client. If the auditor believes an understanding with the client has 
not been established, he or she should decline to accept or perform the 
engagement. In addition to reporting on the entity’s basic financial state­
ments, the independent auditor may be asked to report on the following 
special reports: (a) cost-reimbursement reports; (b) cost reports related to 
research grants; (c) reports for contributors; (d) reports for local, state, or 
federal authorities; (e) reports related to bond indentures and other debt 
instruments; and (f)  other special-purpose reports. The nature, timing, and 
extent of auditing procedures to be performed and the type of reports to be 
issued are based on the scope of services required by the entity.
Planning the Audit
2.02 The nature, timing, and extent of planning usually vary with the size 
and complexity of the entity, as well as with the independent auditor’s experience 
with the entity and with the industry. SAS No. 22, Planning and Supervision 
(AICPA, Professional Standards, vol. 1, AU sec. 311), contains guidance on plan­
ning an audit in accordance with generally accepted auditing standards (GAAS).
2.03 The independent auditor’s work in forming an opinion on financial 
statements consists of obtaining and evaluating evidential matter regarding 
management’s assertions. Assertions are representations by management that 
are embodied in the financial statements. They can be either explicit or implicit 
and can be classified according to the following broad categories: existence and 
occurrence, completeness, rights and obligations, valuation and allocation, and 
presentation and disclosure.
In December 1999 the AICPA Auditing Standards Board issued SAS No. 89, Audit Adjust­
ments, which, among other matters, amends SAS No. 83, to include in the understanding with the 
client, management’s responsibility for determining the appropriate disposition of financial state­
ment misstatements aggregated by the auditor. SAS No. 89 adds to the list of matters that are 
generally included in the understanding with the client a statement that management is responsible 
for adjusting the financial statements to correct material misstatements and for affirming to the 
auditor in the representation letter that the effects of any uncorrected misstatements aggregated by 
the auditor during the current engagement and pertaining to the latest period presented are 
immaterial, both individually and in the aggregate, to the financial statements taken as a whole. SAS 
No. 89 is effective for audits of financial statements for periods beginning on or after December 15,
1999, with earlier adoption permitted.
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2.04 The purpose of specific audit objectives and examples of control activi­
ties in the auditing sections of the following chapters is to illustrate how the 
independent auditor might obtain an understanding of internal control, assess 
control risk, and perform audit procedures. There is not necessarily a one-to-one 
relationship between audit objectives and procedures. Some procedures may 
relate to more than one objective. On the other hand, a combination of procedures 
may be needed to achieve a single objective. The illustrations are not intended to 
be all-inclusive or to suggest that specific audit objectives, control activities, and 
audit procedures should be applied. Some of the objectives may not be relevant to 
a particular entity because of the nature of its operations or the absence of certain 
types of transactions. The absence of one or more of the illustrative controls would 
not necessarily indicate a deficiency in internal control. The auditor performs 
procedures that are responsive to the auditor's risk assessment.
2.05 The illustrations are arranged by broad audit objectives. These 
classifications may be useful in the evaluation process, but the classifications 
are of secondary importance. Some specific objectives may serve to achieve 
more than one broad objective.
2.06 Many of the illustrative control activities are premised on the exist­
ence of certain essential characteristics of internal control (for example, 
authorization of transactions, segregation of duties, documentation, supervi­
sion and review, and timeliness of procedures). To avoid repetition, these 
characteristics have not been emphasized in the illustrations.
Inherent Risk
2.07 In determining the scope of audit procedures to be performed, the 
independent auditor should be aware of certain aspects of the health care 
organization’s operations that are usually subject to higher or lower levels of 
inherent risk. SAS No. 47, Audit Risk and Materiality in Conducting an Audit 
(AICPA, Professional Standards, vol. 1, AU sec. 312), provides guidance on the 
consideration of audit risk and materiality when planning and performing an 
audit of financial statements. SOP 00-1, Auditing Health Care Third-Party 
Revenues and Related Receivables, provides guidance to auditors regarding 
uncertainties inherent in health care third-party revenue recognition. SOP 
00-1 is effective for audits of periods ending on or after June 30, 2000. SOP 00-1 
is included as appendix E to this Guide.
2.08 In many health care organizations, certain accounts typically (a) will 
have a low volume of transactions, (b) will consist of transactions that are not 
complex, and (c) do not require the use of significant accounting estimates. 
Accounts such as inventories, marketable securities, assets whose use is lim­
ited, property and equipment, long-term debt, and equity frequently have 
these characteristics and may allow the auditor to assess inherent risk as being 
at a relatively low level. However, in certain circumstances, such as invest­
ments in complex derivative financial instruments, inherent risk may be 
higher. The auditor should use professional judgment in evaluating the factors 
relevant to assessments of inherent risk.
2.09 Because of the large monetary amounts and the complexity of deter­
mining health care service revenue and receivables, there are risks associated 
with health care service revenue recognition and the valuation of the related 
receivables. A significant portion of services usually is paid for by third parties 
such as Medicare, Medicaid, and various health insurance carriers under 
statutory provisions or other arrangements in amounts that can be signifi­
cantly different from, and frequently less than, the entity’s established rates.
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2.10 Risks are associated with recognizing the liability for costs incurred 
by providers of prepaid health care services (for example, HMOs) because such 
costs may have been incurred but not yet reported to the providers. It is 
therefore necessary to estimate the liability for those costs. These estimates 
often require a high degree of management judgment. Management must 
consider historical experience as well as the effects of any changes in conditions 
such as seasonality trends and changes in subscriber population and in the 
services and benefits provided.
2.11 Risks also are associated with contingencies for uninsured medical 
malpractice losses and obligations under continuing care contracts. A high 
degree of management judgment and complex analyses usually are involved in 
evaluating the related financial statement assertions.
2.12 The risk of material misstatements, whether caused by error or 
fraud, and illegal acts by clients is present in all audit engagements. SAS No. 
82, Consideration of Fraud in a Financial Statement Audit (AICPA, Profes­
sional Standards, vol. 1, AU sec. 316), and SAS No. 54, Illegal Acts by Clients 
(AICPA, Professional Standards, vol. 1, AU sec. 317), describe the auditor’s 
responsibilities for detecting these matters in an audit of financial statements. 
They also describe the auditor’s responsibilities for communicating detected er­
rors, fraudulent acts, and illegal acts to parties within and external to the entity.
2.13 SAS No. 82 states that, in auditing financial statements, the audi­
tor’s interest specifically relates to fraudulent acts that cause a material 
misstatement of the financial statements. Two types of misstatements are 
relevant to the auditor’s consideration of fraud in a financial statement audit: 
misstatements arising from fraudulent financial reporting and misstatements 
arising from misappropriation of assets.
2.14 SAS No. 82 does not change the auditor’s responsibilities for consid­
ering fraud, but it does establish new performance requirements for auditors 
to formally consider and explicitly document their consideration of fraud risk 
factors.* Specifically, SAS No. 82—
•  Requires the auditor to specifically assess the risk of material mis­
statement due to fraud on every audit and provides categories of fraud 
risk factors that the auditor should consider in making that assess­
ment. It provides examples of fraud risk factors that, when present, 
might indicate the presence of fraud.
•  Offers guidance on how the auditor may respond to the results of the 
assessment.
•  Reaffirms the requirement that the auditor communicate known in­
stances of fraud to an appropriate level of management and the audit 
committee and, under certain circumstances, appropriate regulators.
•  Provides guidance on the evaluation of test results as they relate to 
the risk of material misstatements due to fraud.
•  Requires the auditor to document evidence of the performance of the 
assessment including risk factors identified as present and the audi­
tor’s response thereto.
* The AICPA has published a practice aid entitled Considering Fraud in a Financial Statement 
Audit: Practical Guidance for Applying SAS No. 82 (product no. 008883), that provides nonauthorita­
tive guidance on applying the concepts of the SAS to various industries, including health care 
organizations. It also includes sample workpaper documentation, descriptions of common fraud 
schemes, and extended audit procedures. Copies may be obtained by calling the AICPA Order 
Department at (888) 777-7077 or faxing a request to (800) 362-5066.
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Internal Control[1]
2.15 SAS No. 55, Consideration of Internal Control in a Financial State­
ment Audit, as amended by SAS No. 78, Consideration of Internal Control in a 
Financial Statement Audit: An Amendment to SAS No. 55 (AICPA, Profes­
sional Standards, vol. 1, AU sec. 319), describes the components of internal 
control and explains how an independent auditor should consider internal 
control in planning and performing an audit. Internal control is a process—ef­
fected by an entity’s board of directors, management, and other personnel—de­
signed to provide reasonable assurance regarding the achievement of 
objectives in the following categories: (a) reliability of financial reporting, (b) 
effectiveness and efficiency of operations, and (c) compliance with applicable 
laws and regulations. Internal control consists of the following five interrelated 
components:
a. Control environment
b. Risk assessment
c. Control activities
d. Information and communication
e. Monitoring
2.16 The auditor should obtain an understanding of each of the five 
components of internal control sufficient to plan the audit by performing 
procedures to understand the design of controls relevant to an audit of finan­
cial statements and whether the controls have been placed in operation.
2.17 After obtaining an understanding of the components of internal 
control, the independent auditor assesses control risk for the assertions embod­
ied in the account balance, transaction class, and disclosure components of the 
financial statements. The independent auditor uses the knowledge provided by 
the understanding of internal control and the assessed level of control risk in 
determining the nature, timing, and extent of substantive tests for financial 
statement assertions.
Analytical Procedures
2.18 SAS No. 56, Analytical Procedures (AICPA, Professional Standards, 
vol. 1, AU sec. 329), provides guidance on the use of analytical procedures and 
requires their use in the planning and overall review stages of all audits. For 
planning purposes, these procedures should focus on (a) enhancing the inde­
pendent auditor’s understanding of the client’s business and the transactions 
and events that have occurred since the last audit date and (b) identifying 
areas that may represent specific risks relevant to the audit. Thus, the objec­
tive of the procedures is to identify such things as the existence of unusual 
transactions and events, as well as amounts, ratios, and trends that might 
indicate matters that have financial statement and audit planning ramifica­
tions. For overall review purposes, these procedures should focus on consider­
ing the adequacy of the evidence gathered in response to unusual or 
unexpected balances or relationships. The objective of the procedures is to 
assist the auditor in assessing the conclusions reached and evaluating the 
overall financial statement presentation. Analytical procedures also may be used 
as substantive tests to identify potential misstatements. These procedures focus 
on comparing actual balances with expected balances and investigating and 
evaluating significant differences from the balances expected.
[1] [Footnote deleted.]
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2.19 Examples of sources of information for developing expectations in­
clude prior-period financial information, budgets, and health care financial 
and statistical ratios. Additional information is available from the Center for 
Healthcare Industry Performance Studies’ (CHIPS) Financial Analysis Service, 
which is published annually, as well as other health care industry associations.
2.20 Following are examples of analytical procedures the independent 
auditor may find useful:
•  Comparison of account balances with budget and prior-period amounts
•  Analysis of changes in revenues during the current period based on 
statistical data (for example, admissions, patient days, visits, and 
professional service procedure counts for laboratory, radiology, and 
surgery) and information concerning price changes
•  Comparison between periods of the number of days of revenue in 
receivables
•  Relationship between periods of the allowance for uncollectible ac­
counts to the balance of patient accounts receivable in the aggregate, 
based on known changes in the accounts receivable’s aging and com­
position by payor
•  Relationship between periods of the liability for claims incurred but 
not reported (IBNR) to the related expense
Accounting Estimates
2.21 In determining the scope of audit procedures to be performed, the 
independent auditor should recognize that certain areas of health care organi­
zation operations require accounting estimates that may be material in the 
preparation and presentation of financial statements. SOP 94-6, Disclosure of 
Certain Significant Risks and Uncertainties,2 requires entities to include in 
their financial statements information about the use of estimates in the 
preparation of financial statements. In addition, if certain specified disclosure 
criteria are met, the SOP requires entities to include disclosures about certain 
significant estimates in their financial statements. (SOP 94-6 is effective for 
financial statements issued for fiscal years ending after December 15, 1995.) 
SAS No. 57, Auditing Accounting Estimates (AICPA, Professional Standards, 
vol. 1, AU sec. 342), provides guidance on obtaining and evaluating sufficient 
competent evidential matter to support significant accounting estimates in an 
audit of financial statements in accordance with GAAS. SOP 00-1 provides 
guidance for auditors regarding the sufficiency of evidential matter supporting 
accounting estimates recorded for the proper valuation of health care third- 
party revenues and related receivables. SOP 00-1 is included as appendix E to 
this Guide.
2.22 Although management is responsible for making estimates, the 
independent auditor is responsible for evaluating the reasonableness of esti­
mates and should consider appropriate procedures in planning and performing 
the audit. These procedures should include both subjective and objective 
factors.
2 SOP 94-6 does not pertain to governmental entities, unless the entity has elected to follow all 
FASB pronouncements under paragraph 7 of GASB Statement No. 20, Accounting and Financial 
Reporting for Proprietary Funds and Other Governmental Entities That Use Proprietary Fund 
Accounting. (See chapter 1, footnote 1.)
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2.23 The independent auditor should acquire an understanding of the 
relevance of internal control to the accumulation of data and the preparation 
of accounting estimates. Internal control should also provide for adequate 
review and approval of accounting estimates by appropriate levels of authority.
2.24 Although significant accounting estimates may affect many ele­
ments of a health care organization’s financial statements, they most often 
affect the following:
a. The provision for third-party payor contractual adjustments and 
allowances and the provision for estimated receivables and payables 
for final settlements with those payors
b. The provision for uncollectible accounts
c. Accruals for uninsured medical malpractice claims
d. Accruals for obligations under continuing care contracts
e. Accruals by providers of prepaid health care services for IBNR costs
Individual Practice Associations
2.25 In planning the audit of an individual practice association (IPA), the 
auditor usually considers the following matters:
•  The size of a typical IPA accounting department and business office 
often is not large enough to result in effective segregation of duties. 
However, most IPAs have an active office manager who can exercise 
a high degree of influence and control over the operations.
•  Physician compensation arrangements often use incentives or other 
features with complicated methodologies and formulas.
•  Contracts with managed care plans, often with capitated payment and 
risk pool settlement terms, frequently represent a significant amount 
of revenue for the IPA.
2.26 IPAs with capitated contracts accrue costs when the services are 
rendered, including cost estimates of IBNR claims. The IBNR accrual includes 
an estimate of the costs of services for which the IPA is responsible, including 
referrals outside the IPA. Risk pool settlements should be accrued during the 
contract period based on relevant factors, such as experience to date.
Other Planning Considerations
2.27 In planning the audit, the independent auditor also should consider—
•  Matters relating to the entity’s business and the health care industry.
•  Financial statement items likely to require adjustment.
•  Conditions that might require extension or modification of audit tests 
(such as the existence of related party transactions or the existence of 
uninsured malpractice risks).
•  The entity’s experience with payment denials and other matters 
subject to review by medical review organizations.
•  The nature of reports expected to be rendered. Examples include 
reports on consolidated or consolidating financial statements, reports 
on financial statements filed with the Securities and Exchange Com­
mission (SEC), reports filed with third-party payors or other regula­
tory bodies, and other special reports.
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2.28 Planning procedures usually include reviewing the independent 
auditor’s files relating to the entity and holding discussions with audit person­
nel and the personnel of the entity. Examples of these procedures include the 
following:
•  Review correspondence files, the prior year’s working papers, perma­
nent files, financial statements, and independent auditors’ reports.
•  Review the minutes of meetings of the governing board of directors 
and board committees.
•  Review the relationship of affiliated organizations to the health care 
organization and determine the extent to which their financial infor­
mation should be included in the financial statements of the entity. 
(See the related discussion in chapter 11.)
•  Review the status of unsettled cost (reimbursement) reports for prior 
periods filed with third-party payors.
•  Discuss matters that may affect the audit with the firm’s personnel 
responsible for any nonaudit services to the entity.
•  Identify situations for which accounting estimates are required and 
relevant factors that may affect those estimates.
•  Inquire about current business developments affecting the entity.
•  Read the current year’s interim financial statements and 10-Q forms.
•  Review periodic reports to third-party payors or other regulatory 
bodies.
•  Discuss the nature, scope, and timing of the engagement with the 
entity’s management, board of directors, or audit committee.
•  Consider the effects of all applicable accounting and auditing pro­
nouncements, particularly recent pronouncements.
•  Coordinate the assistance of entity personnel in data preparation.
•  Determine the extent of involvement, if any, of consultants, special­
ists, and internal auditors.
•  Establish the timing of the audit work.
2.29 The independent auditor may find it helpful to maintain a perma­
nent file that includes copies of the following documents relating to the health 
care organization:
a. Articles of incorporation
b. Bylaws
c. Chart of accounts
d. Organization chart
e. Specific documents concerning restrictions on donor gifts and bequests
f. Contracts and agreements, including leases, agreements with phy­
sicians, agreements with third-party payors, and agreements with 
affiliated organizations
g. Description of internal control
h. Loan agreements, bond indentures, and other debt instruments
2.30 The independent auditor should understand the specific cost-finding 
or other rate-setting methods used by third-party payors to determine final 
amounts reimbursable to the health care organization. These payment meth­
ods may require that a health care organization accumulate and report various 
statistical data, such as admissions, discharges, patient days, visits, beds, 
square footage, and pounds of laundry.
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2.31 The independent auditor intending to use audit-sampling proce­
dures should refer to SAS No. 39, Audit Sampling (AICPA, Professional 
Standards, vol. 1, AU sec. 350), when planning the work to be done.
2.32 If the health care organization has an internal audit function, the 
independent auditor should also refer to SAS No. 65, The Auditor’s Considera­
tion o f the Internal Audit Function in an Audit o f Financial Statements 
(AICPA, Professional Standards, vol. 1, AU sec. 322).
Transactions Processed by Service Organizations
2.33 Health care organizations may engage outside service organizations 
to perform services that are part of the health care provider’s information 
system. A service organization’s services are part of an entity’s information 
system if they affect—
a. How the entity’s transactions are initiated
b. The accounting records, supporting information, and specific ac­
counts in the financial statements involved in the processing and 
reporting of the entity’s transactions
c. The accounting processing involved from the initiation of the trans­
actions to their inclusion in the financial statements, including 
electronic means (such as computers and electronic data inter­
change) used to transmit, process, maintain, and access information
d. The financial reporting process used to prepare the entity’s financial 
statements, including significant accounting estimates and disclosures
Examples of service organizations used by health care organizations include 
the following:
•  Bank trust departments that invest and service assets for health care 
organizations
•  Electronic data processing (EDP) service centers that process payroll
•  Billing entities that prepare reimbursement claims to insurers and 
other third parties
•  Administrators of employee benefit plans who process and pay benefit 
claims and maintain participant records
2.34 SAS No. 55, as amended by SAS No. 78, states that the auditor 
should obtain an understanding of an entity’s internal control sufficient to plan 
the audit. This understanding may encompass controls placed in operation by 
the health care organization and service organizations whose services are part 
of the health care organization’s information system. In planning the audit, 
such information should be used to—
•  Identify types of potential misstatements.
•  Consider factors that affect the risk of material misstatement.
•  Design substantive tests.
2.35 SAS No. 70, Service Organizations, as amended (AICPA, Profes­
sional Standards, vol. 1, AU sec. 324), explains the considerations an auditor 
should make in obtaining an understanding of internal control and assessing 
control risk for entities that use a service organization to process transactions.
2.36 The auditor of a health care organization should determine whether 
the health care organization uses a service organization. Information about the
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nature of the services provided by the service organization and the service 
organization’s controls over those services may be available from sources such 
as user manuals, system overviews, technical manuals, the contract between 
the health care organization and the service organization, and reports by 
service auditors, internal auditors, or regulatory authorities on the service 
organization’s controls.
2.37 After considering the available information, the auditor of the health 
care organization may conclude that he or she has the means to obtain a 
sufficient understanding of internal control to plan the audit. If the auditor of 
the health care organization concludes that information is not available to 
obtain a sufficient understanding to plan the audit, he or she may consider 
contacting the service organization, through the health care organization, to 
obtain specific information or request that a service auditor be engaged to 
perform procedures that will supply the necessary information, or the auditor 
of the health care organization may visit the service organization and perform 
such procedures. If the auditor of the health care organization is unable to 
obtain sufficient evidence to achieve his or her audit objectives, the auditor of 
the health care organization should qualify his or her opinion or disclaim an 
opinion on the financial statements because of a scope limitation.
2.38 After obtaining an understanding of internal control, the auditor 
may assess control risk a t the maximum level for some or all financial state­
ment assertions related to the service organization’s processing because, he or 
she believes controls are unlikely to pertain to an assertion, are unlikely to be 
effective, or because evaluating their effectiveness would be inefficient, Proce­
dures to evaluate operating effectiveness include one or any combination of the 
following:
a. Performing tests of controls over the activities of the service organi­
zation a t the health care organization
b. Performing tests of controls a t the service organization
c. Obtaining a service auditor’s report that describes the results of tests 
of the operating effectiveness of controls performed by the service 
auditor
Other Audit Considerations 
Illegal Acts
2.39 The Social Security Act provides for criminal penalties for individu­
als or entities th a t offer, pay, solicit, or receive rem uneration to induce 
business th a t is reimbursed under Medicare or state health  care programs. 
The types of rem uneration covered by the Medicare Anti-Kickback S tatu te 
include, with certain exceptions, kickbacks, bribes, and rebates made di­
rectly or indirectly, overtly or covertly, and in cash or in kind. In  addition, 
prohibited conduct includes not only rem uneration intended to induce 
referrals or patients bu t also remuneration intended to induce the purchas­
ing, leasing, ordering, or arranging for any good, facility, service, or item 
paid for by Medicare or state health  care programs. In addition, fraudulent 
activities may exist th a t are unrelated to Medicare or state  programs, such 
as fraudulent billing and adm itting practices.
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2.40 The auditor’s procedures will vary based on his or her assessm ent 
of the risk of m aterial m isstatem ent resulting from such illegal acts. SAS 
No. 54 states th a t the auditor should plan and perform the audit to provide 
reasonable assurance of detecting illegal acts having a direct and m aterial 
effect on the determ ination of financial statem ent amounts. SAS No. 54 also 
notes th a t an audit in accordance with GAAS does not include audit proce­
dures specifically designed to detect illegal acts th a t have only an indirect 
effect on the financial statem ents (for example, illegal acts th a t have a 
m aterial effect as the result of fines or penalties th a t may be imposed on the 
entity) and provides guidance on the auditor’s responsibilities when specific 
information concerning the possible existence of this type of illegal act 
comes to the auditor’s attention.
2.41 Examples of laws and regulations that are generally recognized by 
auditors to have a direct and material effect on the determination of amounts 
in financial statements of health care organizations include tax laws affecting 
tax accruals and tax expense as well as Medicare and Medicaid laws directly 
affecting the amount of revenue recognized during the accounting period (such 
as those concerning the submission of bills for fictitious patients).
2.42 Health care organizations also may be affected by many other laws 
and regulations such as those related to Medicare and Medicaid fraud and 
abuse, securities trading, occupational safety and health, food and drug ad­
ministration, environmental protection, equal employment opportunities, and 
price-fixing or other antitrust violations. Generally, these laws and regulations 
relate more to an entity’s operating aspects than to its financial and accounting 
aspects, and their financial statement effect is only indirect. An auditor ordi­
narily does not have sufficient basis for recognizing possible violations of such 
laws and regulations. Their indirect effect is normally the result of the need to 
disclose a contingent liability because of the allegation or determination of 
illegality. For example, patients may be obtained based on illegal arrange­
ments with physicians or other providers. While the direct effects of the 
services rendered may be recorded appropriately, their indirect effects, the 
possible contingent liability for violating Medicare and Medicaid fraud and 
abuse statutes, may not be appropriately disclosed. Even when violations of 
such laws and regulations can have consequences material to the financial 
statements, auditors may not become aware of the existence of the illegal act 
unless he or she is informed by the client, or there is evidence of a governmental 
agency investigation or enforcement proceeding in the records, documents, or 
other information normally inspected in an audit of financial statements.
2.43 Whether an act is, in fact, illegal is a determination that is normally 
beyond the auditor’s professional competence. The auditor’s training, experi­
ence, and understanding of the client and the industry may provide a basis for 
recognizing that some acts coming to the auditor’s attention may be illegal. 
However, determining whether a particular client act is illegal generally would 
be based on the advice of an informed expert qualified to practice law or may 
have to await final determination by a court of law. For example, determining 
whether admitting a patient or providing a service is medically necessary or 
whether a particular procedure or device was properly approved is not within 
the auditor’s professional competence.
Use of a Specialist
2.44 SAS No. 73, Using the Work o f a Specialist (AICPA, Professional 
Standards, vol. 1, AU sec. 336), provides guidance to the auditor who uses the
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work of a specialist in performing the audit of a health care organization’s 
financial statements. Guidance is provided on deciding when to use a special­
ist, the auditor’s responsibilities for evaluating the qualifications and the work 
of the specialist, and using the findings of the specialist. The Statement 
requires the auditor to evaluate the relationship of the specialist to the client 
and states that the auditor should perform additional procedures if the auditor 
concludes that the objectivity of the specialist may be impaired by such a 
relationship.
Clinical Coding Validations
2.45 Typically, a number of clinicians (e.g., the attending physician, 
consulting physicians, radiologists, pathologists, therapists, and nurses) add 
documentation to a patient’s medical record. Provider personnel generally 
review the medical record and assign a code (ICD-9-CM or CPT-4 code) to the 
record. The provider prepares and submits a bill that includes, among other 
things, the assigned ICD-9-CM or CPT-4 code. The Medicare Fiscal Intermedi­
ary or other third-party payor typically reviews the bill and assigns it a specific 
payment code, such as a Diagnostic Related Group (DRG) number. Payment is 
based on the DRG or other payment code assigned. The provider may check the 
payment code assigned and follow up on any discrepancies identified. However, 
since the assignment of the payment code is made by the third-party payor, 
responsibility for correct assignment rests with that payor.
2.46 Errors can occur throughout this process. Physicians or other clini­
cians may not document the appropriate procedure. Coding personnel may not 
notice or interpret certain items in the medical record correctly. Accordingly, 
an incorrect code may be assigned and an erroneous amount may be paid.
2.47 An auditor ordinarily would not find it necessary to consider the 
process of assigning codes in planning and performing an audit of the 
provider’s financial statements. However, the auditor should be alert for 
indications of potential material misstatements of the financial statements 
resulting indirectly from such matters. For example, the auditor may become 
aware that a retrospective review has been performed or that an investigation 
has been completed or is in process. In such circumstances, the auditor should 
consider whether performance of additional substantive audit procedures is 
necessary to reduce audit risk to an acceptable level.
Going-Concern Considerations
2.48 SAS No. 59, The Auditor’s Consideration o f an Entity’s Ability to 
Continue as a Going Concern (AICPA, Professional Standards, vol. 1, AU sec. 341), 
provides guidance to the independent auditor conducting an audit on how to 
evaluate whether there is substantial doubt about the entity’s ability to con­
tinue as a going concern. Continuation of an entity as a going concern is 
assumed in financial reporting in the absence of significant information to the 
contrary. Ordinarily, information that significantly contradicts the going-con­
cern  assumption relates to the entity’s inability to continue to meet its obliga­
tions as they become due without substantial disposition of assets outside the 
ordinary course of business, restructuring of debt, externally forced revision of 
its operations, or similar actions. SAS No. 59 states that the independent 
auditor has a responsibility to evaluate whether there is substantial doubt 
about the entity’s ability to continue as a going concern for a reasonable period 
of time, not to exceed one year beyond the date of the financial statements 
being audited.
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2.49 Noncompliance with donor-imposed restrictions should be disclosed 
if there is a reasonable possibility that a material contingent liability has been 
incurred a t the date of the financial statements or there is at least a reasonable 
possibility that the noncompliance could lead to a material loss of revenue or 
could cause an entity to be unable to continue as a going concern. If the 
noncompliance results from an organization’s failure to maintain an appropri­
ate composition of assets in amounts needed to comply with all donor restric­
tions, the amounts and circumstances should be disclosed.
Communication
Communication of Matters Related to Internal Control
2.50 SAS No. 60, Communication o f Internal Control Related Matters 
Noted in an Audit (AICPA, Professional Standards, vol. 1, AU sec. 325), 
provides guidance in identifying and reporting conditions related to an entity’s 
internal control that are observed during an audit of the financial statements. 
It is contemplated that the communication generally would be to the audit 
committee or, in organizations that do not have an audit committee, to those 
with an equivalent level of authority and responsibility such as the board of 
directors, the owner in an owner-managed enterprise, or the individuals who 
engaged the independent auditor. Conditions noted by the independent auditor 
that are considered reportable under SAS No. 60 should be reported, preferably 
in writing. If information is communicated orally, the independent auditor 
should document the communication by appropriate memoranda or notations 
in the working papers.
Communication With Audit Committees
2.51 SAS No. 61, Communication With Audit Committees* (AICPA, Pro­
fessional Standards, vol. 1, AU sec. 380), establishes a requirement for the 
independent auditor to determine th a t certain m atters related to the con­
duct of an audit are communicated to those with responsibility for oversight 
of the financial reporting process. The communications required by SAS No. 
61 are applicable to (a) entities th a t either have an audit committee or 
otherwise have formally designated oversight of the financial reporting 
process to a group equivalent to an audit committee (such as a finance 
committee or a budget committee) and (b) all SEC engagements as defined 
in SAS No. 61. In addition, communication with the audit committee or its 
equivalent by the independent auditor on certain specified m atters when 
they arise in the conduct of an audit is required by other standards, 
including SAS No. 82 and SAS No. 54.
* In December 1999 the AICPA Auditing Standards Board issued SAS No. 89, Audit Adjust­
ments, and SAS No. 90, Audit Committee Communications. SAS No. 89 amends SAS No. 61 to require 
the auditor to inform the audit committee about uncorrected misstatements aggregated by the 
auditor during the current engagement and pertaining to the latest period presented, whose effects 
management believes are immaterial, both individually and in the aggregate, to the financial 
statements taken as a whole. SAS No. 89 is effective for audits of financial statements for periods 
beginning on or after December 15, 1999, with earlier adoption permitted. SAS No. 90 revises SAS 
No. 61, by adding a new paragraph requiring an auditor of SEC clients to discuss with audit 
committees the auditor’s judgments about the quality, not just the acceptability, of the company’s 
accounting principles and underlying estimates in its financial statements. This amendment is 
effective for audits of financial statements for periods ending on or after December 15, 2000, with 
earlier application permitted.
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2.52 SAS No. 85, Management Representations* (AICPA, Professional 
Standards, vol. 1, AU sec. 333), establishes a requirement that an auditor 
performing an audit in accordance with GAAS, obtain written representations 
from management for all financial statements and periods covered by the 
auditor’s report. The specific written representations to be obtained depend on 
the circumstances of the engagement and the nature and basis of presentation 
of the financial statements. Paragraph 6 of SAS No. 85 lists m atters ordinarily 
included in management’s representation letter. SAS No. 85 includes several 
examples as well. Appendix A of the SAS includes an illustrative management 
representation letter, Appendix B provides illustrative wording for additional 
representations that may be appropriate in certain situations, and Appendix 
C provides an illustrative updating management representation letter. Inde­
pendent auditors of health care organizations also might obtain repre­
sentations, if applicable, of the following:
•  The health care organization is in compliance with the provisions of 
Internal Revenue Code (IRC) sec. 501(c)(3) and is exempt from federal 
income tax under IRC sec. 501(a), as evidenced by a determination letter.
•  Information returns have been filed on a timely basis.
•  Provision has been made, when material, for estimated retroactive 
adjustments by third-party payors under reimbursement agreements.
•  The health care organization is in compliance with bond indentures or 
other debt instruments.
•  Pending changes in the organizational structure, financing arrange­
ments, or other matters that could have a material effect on the 
financial statements of the entity are properly disclosed.
•  The health care organization is in compliance with contractual agree­
ments, grants, and donor restrictions.
•  The health care organization has maintained an appropriate composition 
of assets in amounts needed to comply with all donor restrictions.
•  All assets and liabilities under the entity’s control have been included 
in the financial statements.
•  The internal controls over the receipt and recording of contributions 
received are adequate.
•  Reclassifications between net asset classes is proper.
2.53 SOP 00-1 provides the following examples of specific representations 
for receivables, cost reports filed with third parties, and contingencies related 
to health care third-party revenue recognition:
•  Receivables
— Adequate consideration has been given to, and appropriate provision 
made for, estimated adjustments to revenue, such as for denied 
claims and changes to diagnosis-related group (DRG) assignments.
Management Representations
* In December 1999 the AICPA Auditing Standards Board issued SAS No. 89, Audit Adjust­
ments, which, among other matters, amends SAS No. 85 to require that the management repre­
sentation letter include an acknowledgment by management that the effects of any uncorrected 
financial statement misstatements aggregated by the auditor during the current engagement and 
pertaining to the latest period presented are immaterial, both individually and in the aggregate, to 
the financial statements taken as a whole. It also requires that a summary of the uncorrected 
misstatements be included in or attached to the representation letter. This amendment is effective for 
audits of financial statements for periods beginning on or after December 15, 1999 with early 
adoption permitted.
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— Recorded valuation allowances are necessary, appropriate, and 
properly supported.
— All peer review organizations, fiscal intermediary, and third- 
party payor reports and information have been made available.
•  Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports have been 
properly filed.
— Management is responsible for the accuracy and propriety of all 
cost reports filed.
— All costs reflected on such reports are appropriate and allowable 
under applicable reimbursement rules and regulations and are 
patient-related and properly allocated to applicable payors.
— The reimbursement methodologies and principles employed are 
in accordance with applicable rules and regulations.
— Adequate consideration has been given to, and appropriate provi­
sion made for, audit adjustments by intermediaries, third-party 
payors, or other regulatory agencies.
— All items required to be disclosed, including disputed costs that 
are being claimed to establish a basis for a subsequent appeal, 
have been fully disclosed in the cost report.
— Recorded third-party settlements include differences between 
filed (and to be filed) cost reports and calculated settlements, 
which are necessary based on historical experience or new or 
ambiguous regulations that may be subject to differing interpre­
tations. While management believes the entity is entitled to all 
amounts claimed on the cost reports, management also believes 
the amounts of these differences are appropriate.
•  Contingencies
— There are no violations or possible violations of laws or regula­
tions, such as those related to the Medicare and Medicaid anti- 
fraud and abuse statutes, including but not limited to the 
Medicare and Medicaid Anti-Kickback Statute, Limitations on 
Certain Physician Referrals (the Stark law), and the False Claims 
Act, in any jurisdiction, whose effects should be considered for 
disclosure in the financial statements or as a basis for recording 
a loss contingency other than those disclosed or accrued in the 
financial statements.
— Billings to third-party payors comply in all m aterial respects 
with applicable coding guidelines (for example, ICD-9-CM and 
CPT-4) and laws and regulations (including those dealing with 
Medicare and Medicaid antifraud and abuse), and billings 
reflect only charges for goods and services that were medically 
necessary; properly approved by regulatory bodies (for example, 
the Food and Drug Administration), if required; and properly 
rendered.
— There have been no communications (oral or written) from regulatory 
agencies, governmental representatives, employees, or others con­
cerning investigations or allegations of noncompliance with laws and 
regulations in any jurisdiction (including those related to the Medi­
care and Medicaid antifraud and abuse statutes), deficiencies in 
financial reporting practices, or other matters that could have a 
material adverse effect on the financial statements.
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2.54 An independent auditor may be engaged to audit the financial 
statem ents of a health  care organization th a t expends federal awards from 
a governmental agency in accordance with the Single Audit Act Amend­
ments of 1996 and Office of Management and Budget (OMB) Circular 
A-133, Audits o f States, Local Governments, and Non-Profit Organizations. 
Federal awards may take the form of grants, contracts, loans, loan guaran­
tees, property, cooperative agreements, interest subsidies, and insurance or 
direct appropriations.
2.55 OMB Circular A-133 prescribes policies, procedures, and guidelines 
to implement the Single Audit Act Amendments of 1996 and requires state and 
local governments and not-for-profit organizations that expend total federal 
awards equal to or in excess of $300,000 in a fiscal year to have an audit 
performed in accordance with the Act and OMB Circular A-133.
2.56 Institutions covered by OMB Circular A-133 include both not-for- 
profit hospitals and institutions of higher education and public hospitals and 
institutions of higher education, and their affiliated hospitals, voluntary 
health and welfare organizations and other community-based organizations. 
Medicare payments to a non-federal entity for providing patient care services 
to Medicare eligible individuals are not considered federal awards expended 
under OMB Circular A-133. Medicaid payments to a subrecipient for providing 
patient care services to Medicaid eligible individuals are not considered federal 
awards expended under OMB Circular A-133 unless a state requires the funds 
to be treated as federal awards expended because reimbursement is on a 
cost-reimbursement basis.[3]
2.57 OMB Circular A-110 establishes standard requirements (such as 
insurance, record retention, and banking) for obtaining consistency and uni­
formity among federal agencies in the administration of grants to and agree­
ments with public and private hospitals and other entities. OMB Circular A-87, 
Cost Principles for State and Local Governments, establishes principles and 
standards for determining allowable costs incurred by state and local govern­
ments under grants, contracts, and other agreements. OMB Circular A-21, 
Cost Principles for Educational Institutions, and OMB Circular A-122, Cost 
Principles for Nonprofit Organizations, establish principles and standards for 
determining allowable costs incurred by educational institutions and not-for- 
profit organizations under grants, contracts, and other agreements.
2.58 SAS No. 74, Compliance Auditing Considerations in Audits of Govern­
mental Entities and Recipients o f Governmental Financial Assistance (AICPA, 
Professional Standards, vol. 1, AU sec. 801), provides general guidance for audits 
of governmental entities and entities that receive federal awards. The Statement 
explains the requirements of the financial audit standards contained in Govern­
ment Auditing Standards, as amended (the Yellow Book) issued by the Comp­
troller General of the United States and their relationship to GAAS. It also 
provides general guidance on testing compliance with requirements applicable to 
federal awards. The Statement clarifies that the entity, rather than the inde­
pendent auditor, is responsible for arranging for audits that meet all applicable 
requirements and provides guidance on communications the auditor should 
make upon becoming aware that the entity may be subject to an audit requirement 
that may not be satisfied by his or her engagement.
Single Audit Act and Related Audit Considerations
[3] [Footnote deleted.]
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2.59 SOP 98-3, Audits o f States, Local Governments, and Not-for-Profit 
Organizations Receiving Federal Awards, provides guidance on the auditor’s 
responsibilities when conducting a single audit or program-specific audit in 
accordance with the Single Audit Act Amendments of 1996 and OMB Circular 
A-133.* It discusses the auditor’s responsibility for considering internal control 
and for performing tests of compliance with applicable laws, regulations, and 
program compliance requirements. Further, it provides reporting guidance 
including examples of the reports required by Government Auditing Standards 
and OMB Circular A-133.
Statutory Reporting Considerations for Managed 
Care Organizations
Risk-based Capital Requirements
2.60 Many managed care organizations (MCO) that bear financial risk 
are regulated by state departments of insurance. The risk-based capital (RBC) 
formula is one of the tools used by regulators to evaluate the financial health 
of regulated entities.
2.61 The National Association of Insurance Commissioners (NAIC) for­
mula for the RBC of managed care organizations became effective in the filing 
of 1998 annual statements. Five principal risk elements to the MCO RBC 
formula are: affiliated investment risk, asset risk, underwriting risk, credit 
risk, and general business risk. Four action levels (in order of increasingly 
stringent level of regulatory response) are: company action level, regulatory 
action level, authorized control level, and mandatory control level. At a mini­
mum, the company action-level event requires the filing with the respective 
state insurance commissioner an RBC plan detailing conditions leading to the 
event and proposals of corrective action. State laws vary as to whether appli­
cable legislation pertaining to compliance with the RBC formula has been 
passed. Additional information can be found on the NAIC Web site a t 
http://www.naic.org.
Codification of Statutory Accounting Principles for Managed 
Care Entities
2.62 Generally speaking, regulated insurers have been required by their 
state of domicile to submit annually a set of audited financial statements that 
were prepared using that state’s prescribed or permitted regulatory accounting 
principles. These statutory accounting practices (SAP) are considered to be an 
“other comprehensive basis of accounting” (OCBOA) under SAS No. 62, Special 
Reports.
2.63 Recently, the NAIC completed a project to codify SAP for certain 
insurance enterprises, including regulated managed care organizations. The 
codification project was designed to streamline accounting guidelines for regu­
lators and insurers in one comprehensive source, and to provide uniform 
statutory guidance that will facilitate analysis of annual statem ents filed by
* SOP 98-3 superseded SOP 92-9, Audits of Not-for-Profit Organizations Receiving Federal 
Awards, and certain sections of the Audit and Accounting Guide Audits o f State and Local Govern­
mental Units.
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insurers. As a result of the codification project, the NAIC has issued a new 
Accounting Practices and Procedures Manual tha t is effective for years begin­
ning on or after January 1, 2001 (i.e., for quarterly and calendar year 2001 
financial statements).
2.64 Companies are not required to follow the codification guidance con­
tained in the revised Manual until it is adopted by the state of domicile. Until 
then, auditors of affected managed care organizations should continue to 
report on statutory financial statements prepared in conformity with the 
accounting practices prescribed or permitted by the insurance department of 
the state of domicile. Auditors should also understand the differences between 
the revised Manual and the previous guidance (primarily the HMO Accounting 
Manual), monitor the status of adoption of the revised Manual by the state of 
domicile, and monitor the organization’s adoption of the new accounting prac­
tices and procedures. Consideration should be given to disclosure in the finan­
cial statements prepared in conformity with generally accepted accounting 
principles (GAAP), if the effect of the adoption is expected to be material or in 
situations in which the client has not determined the effect. In addition, 
practitioners should consider whether going-concern  issues exist as a result of 
the financial statement effect of adoption. This includes consideration of the 
effect on RBC.
2.65 Eight of the Statements of Statutory Accounting Principles (SSAPs) 
included in the revised Manual have been specifically modified or written to 
address issues related to managed care. These include SSAP No. 25, Account­
ing for and Disclosures about Transactions with Affiliates and Other Related 
Parties, No. 35, Guaranty Fund and Other Assessments, No. 47, Uninsured 
Plans, No. 50, Classifications and Definitions o f Insurance or Managed Care 
Contracts in Force, No. 54, Individual and Group Accident and Health Con­
tracts, No. 55, Unpaid Claims, Losses and Loss Adjustment Expenses, No. 66, 
Retrospectively Rated Insurance Contracts, and No. 73, Health Care Delivery 
Assets—Supplies, Pharmaceuticals and Surgical Supplies, Durable Medical 
Equipment, Furniture, Medical Equipment and Fixtures, and Leasehold Im ­
provements in Health Care Facilities. All other SSAPs will apply if applicable 
to the entity. This could lead to significant changes in accounting for some 
companies, because statutory accounting guidance for managed care organiza­
tions was silent in many areas.
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Chapter 3
Cash and Cash Equivalents 
Accounting and Financial Reporting
3.01 Cash and cash equivalents should include all cash and highly liquid 
investments that are both (a) readily convertible to cash and (b ) so near to 
maturity that they present insignificant risk of changes in value because of 
changes in interest rates, in accordance with paragraph 8 of FASB Statement 
No. 95, Statement of Cash Flows, and paragraph 9 of GASB Statement No. 9, 
Reporting Cash Flows of Proprietary and Nonexpendable Trust Funds and 
Governmental Entities That Use Proprietary Fund Accounting.* For fiduciary 
purposes, separate checking or savings accounts may be maintained for re­
stricted donations. Such accounts, however, are not reported on a line separate 
from other cash and cash equivalents because donor restrictions generally 
relate to limitations on the use of net assets rather than on the use of specific 
assets.1 However, cash and claims to cash that (a) are restricted as to with­
drawal or use for other than current operations, (b) are designated for expenditure 
in the acquisition or construction of noncurrent assets, (c) are required to be 
segregated for the liquidation of long-term debts, or (d) are required by a donor- 
imposed restriction that limits their use to long-term purposes are reported 
separately and are excluded from current assets. (See paragraph 10.10.) Internally 
designated funds should be reported separately from externally designated funds 
either on the face of the balance sheet or in the notes to the financial statements. 
If the form of the assets is not evident from the description on the balance sheet, 
the form of the assets should be disclosed in the notes to the financial statements. 
GASB Statement No. 9, paragraph 8, provides that a governmental health care 
enterprise’s statement of cash flows should explain the change in all cash and cash 
equivalents, regardless of any restrictions on their use.
Agency Funds **
3.02 Health care organizations may receive and hold assets owned by 
others under agency relationships; for example, they may perform billing and
* GASB Statement No. 34, Basic Financial Statements—and Managements Discussion and Analy­
sis—for State and Local Governments, establishes financial reporting standards for state and local 
governments. Among other matters, this Statement amends GASB Statement No. 9. A  brief summary of 
GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. This chapter will be 
modified to conform to the requirements of GASB Statement No. 34 in a future edition of this Guide.
1 A columnar presentation that highlights the three classes of net assets (that is, permanently 
restricted, temporarily restricted, and unrestricted) is not precluded if the totals for the reporting 
entity as a whole are displayed.
** FASB Statement No. 136, Transfers of Assets to a Not-fbr-Profit Organization or Charitable Trust 
That Raises or Holds Contributions for Others, establishes standards for transactions in which an 
entity—the donor—makes a contribution by transferring assets to a not-for-profit organization or 
charitable trust—the recipient organization—that accepts the assets from the donor and agrees to use 
those assets on behalf of or transfer those assets, the return on investment of those assets, or both to 
another entity—the beneficiary—that is specified by the donor. FASB Statement No. 136 incorporates 
without reconsideration the guidance in FASB Interpretation No. 42, and supersedes that Interpretation. 
FASB Statement No. 136 is effective for financial statements issued for fiscal periods beginning after 
December 15, 1999 (earlier application is encouraged), except for the provisions incorporated from FASB 
Interpretation No. 42, which continue to be effective for fiscal years ending after September 15, 1996. A  
summary of FASB Statement No. 136 is included in appendix F to this Guide. This chapter will be 
modified to conform to the requirements of FASB Statement No. 136 in a future edition of this Guide.
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collection services for physicians. In accepting responsibility for those assets, 
an organization incurs a liability to the principal under the agency relationship 
to return the assets in the future or, if authorized, to disburse them to another 
party on behalf of the principal. Agency funds are reported as unrestricted 
assets. Transactions involving receipt and disbursement of agency funds are 
discussed in paragraph 11.23. In September 1996, the FASB issued Interpre­
tation No. 42, Accounting for Transfers o f Assets in Which a Not-for-Profit 
Organization Is Granted Variance Power (an interpretation of FASB State­
ment No. 116, Accounting for Contributions Made and Contributions Received), 
which provides guidance relating to situations where the recipient organiza­
tion has the unilateral power to redirect the use of the assets away from the 
specified beneficiary (see paragraph 11.23).
Disclosures
3.03 If the provider has concentrations of credit risk related to financial 
instruments such as certificates of deposit or money market mutual funds, the 
disclosure requirements of FASB Statement No. 105, Disclosure o f Information 
about Financial Instruments with Off-Balance-Sheet Risk and Financial In­
struments with Concentrations o f Credit Risk,2, * should be followed. Examples 
of potential exposure to credit risk include funds deposited with a single 
financial institution in excess of Federal Deposit Insurance Corporation 
(FDIC) limits and investments in obligations that are not insured or guaran­
teed by the government. For governmental health care enterprises, GASB 
Statement No. 3, Deposits with Financial Institutions, Investments (including 
Repurchase Agreements), and Reverse Repurchase Agreements, requires certain 
disclosures about deposits, including credit risk classification of bank balances 
that are not entirely insured.**
Auditing
3.04 There are no unique auditing considerations with respect to cash and 
cash equivalents recorded by health care organizations.
2 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See chapter 1, 
footnote 1.)
* FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities, 
supersedes FASB Statement No. 105, and amends FASB Statement No. 107, Disclosures about Fair 
Value o f Financial Instruments, to include in FASB Statement No. 107 the disclosure provisions about 
concentrations of credit risk from FASB Statement No. 105, with modifications. FASB Statement No. 
133, as amended by FASB Statement No. 137, Accounting for Derivative Instruments and Hedging 
Activities—Deferral of the Effective Date of FASB Statement No. 133, is effective for all fiscal quarters 
of fiscal years beginning after June 15, 2000. Also, on March 3, 2000, the FASB issued an exposure 
draft, Accounting for Certain Derivative Instruments and Certain Hedging Activities, that would 
amend FASB Statement No. 133. Readers should be alert for the issuance of a final standard.
The FASB has established the Derivatives Implementation Group (DIG) to assist the Board and its 
staff in providing implementation guidance regarding FASB Statement No. 133. Issues addressed by 
the DIG and the status of related guidance can be found at http://www.fa8b.org.
** GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement amends GASB Statement No. 3. A brief 
summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. This 
chapter will be modified to conform to the requirements of GASB Statement No. 34 in a future edition 
of this Guide.
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Chapter 4 
Investments
Accounting
4.01 This chapter discusses the accounting and reporting for investments 
of health care entities other than (a) equity investments accounted for under 
the equity method or (b) investments in consolidated subsidiaries. Discussions 
pertaining to those two types of investments are included in chapter 11.
4.02 The accounting for investments in equity securities that have readily 
determinable fair values and all investments in debt securities is discussed in 
paragraphs 4.03 through 4.13. Other types of investments (such as real estate 
or oil and gas interests) are reported at amortized cost and are subject to 
impairment considerations consistent with FASB Statement No. 121, Account­
ing for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be 
Disposed Of.1
Investments in Debt Securities and Certain 
Equity Securities
4.03 This section discusses the accounting and reporting for investments 
in equity securities that have readily determinable fair values and all invest­
ments in debt securities held by (a) investor-owned entities, (b) not-for-profit 
organizations, and (c) governmental entities.
Investor-Owned Entities*
4.04 Investor-owned providers are subject to the accounting and report­
ing requirements of FASB Statement No. 115, Accounting for Certain Invest­
ments in Debt and Equity Securities. FASB Statement No. 115 defines three 
categories into which an enterprise classifies investments. The accounting and 
reporting differ by category. Investments in debt securities that the enterprise 
has the positive intent and ability to hold to maturity are classified as held-to- 
maturity securities and are reported at amortized cost. Debt and equity securi­
ties that are bought and held principally for the purpose of selling them in the 
near term are classified as trading securities and reported at fair value, with 
unrealized holding gains and losses included in income. However, an enterprise
1 This pronouncement is not applicable to governmental health care enterprises that do 
not apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for 
Proprietary Funds and Other Governmental Entities That Use Proprietary Fund Accounting. 
(See chapter 1, footnote 1.)
* FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities, 
amends FASB Statement No. 115. FASB Statement No.133 establishes the accounting and reporting 
standards for derivative instruments and for hedging activities and, as amended by FASB Statement 
No. 137, Accounting for Derivative Instruments and Hedging Activities—Deferral of the Effective Date 
of FASB Statement No. 133, is effective for all fiscal quarters of fiscal years beginning after June 15, 
2000. Also, on March 3, 2000, the FASB issued an exposure draft, Accounting for Certain Derivative 
Instruments and Certain Hedging Activities, that would amend FASB Statement No. 133. Readers 
should be alert for the issuance of a final standard.
The FASB has established the Derivatives Implementation Group (DIG) to assist the Board and its 
staff in providing implementation guidance regarding FASB Statement No. 133. Issues addressed by 
the DIG and the status of related guidance can be found at http://www.fasb.org.
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is not precluded from classifying a t acquisition a security it plans to hold for a 
longer period as a trading security. Investments in debt securities that are not 
classified as held-to-maturity or trading and equity securities that are not 
classified as trading are classified as available-for-sale securities and reported 
a t fair value, with unrealized holding gains and losses excluded from income 
and reported in a separate component of other comprehensive income.
4.05 Investor-owned entities should follow the disclosure requirements of 
FASB Statement No. 115.
Not-for-Profit Organizations*
4.06 Not-for-profit organizations should report investments in equity 
securities with readily determinable fair values and all debt securities a t 
fair value on the balance sheet consistent with FASB Statem ent No. 124, 
Accounting for Certain Investments Held by Not-for-Profit Organizations. 
Investm ent return, including realized and unrealized gains and losses, 
should be included as changes in net assets consistent w ith paragraphs 4.07 
through 4.10.
4.07 Investment return (including realized and unrealized gains and 
losses) not restricted by donors or by law should be classified as changes in 
unrestricted net assets as follows:
a. Included in the performance indicator (see paragraphs 10.17 and
10.18):
•  Dividend, interest, and other similar investment income
•  Realized gains and losses
•  Unrealized gains and losses on trading securities2
•  Other than temporary impairment losses
b. Excluded from the performance indicator:
•  Unrealized gains and losses on other than trading securities
4.08 Except as described in paragraphs 4.09 and 4.10, investment return 
(including realized and unrealized gains and losses) restricted by donors or by 
law, should be classified as changes in temporarily or permanently restricted 
net assets consistent with the applicable restrictions.
4.09 Gains and investment income that are limited to specific uses by 
donor-imposed restrictions may be reported as increases in unrestricted net 
assets if the restrictions are met in the same reporting period as the gains and 
income are recognized, provided that the organization has a similar policy for 
reporting contributions received, applies the policy consistently from period to
FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities, 
amends FASB Statement No. 124. FASB Statement No. 133 establishes the accounting and reporting 
standards for derivative instruments and for hedging activities and, as amended by FASB Statement 
No. 137, Accounting for Derivative Instruments and Hedging Activities—Deferral of the Effective Date 
of FASB Statement No. 133, is effective for all fiscal quarters of fiscal years beginning after June 15, 
2000. Also, on March 3, 2000, the FASB issued an exposure draft, Accounting for Certain Derivative 
Instruments and Certain Hedging Activities, that would amend FASB Statement No. 133. Readers 
should be alert for the issuance of a final standard.
The FASB has established the Derivatives Implementation Group (DIG) to assist the Board and its 
staff in providing implementation guidance regarding FASB Statement No. 133. Issues addressed by 
the DIG and the status of related guidance can be found at http://www.fasb.org.
2 Trading securities are defined in FASB Statement No. 115, including any interpretations thereof.
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period, and discloses its accounting policy. The classification of these gains 
and investm ent income in unrestricted net assets should be consistent with 
paragraph 4.07.
4.10 In the absence of donor stipulations or law to the contrary, losses on 
the investments of a donor-restricted endowment fund3 shall reduce tempo­
rarily restricted net assets to the extent th a t donor-imposed temporary re­
strictions on net appreciation of the fund have not been met before the loss 
occurs. Any remaining loss shall reduce unrestricted net assets and shall be 
excluded from the determination of the performance indicator. If losses re­
duce the assets of a donor-restricted endowment fund below the level required 
by the donor stipulations or law, gains that restore the fair value of the assets 
of the endowment fund to the required level shall be classified as increases in 
unrestricted net assets and shall be excluded from the determination of the 
performance indicator.
4.11 Not-for-profit organizations should follow the disclosure require­
ments of FASB Statement No. 124.
Governmental Entities*
4.12 Governmental health care entities are subject to the accounting and 
reporting requirements of GASB Statement No. 31, Accounting and Financial 
Reporting for Certain Investments and for External Investment Pools. Governmen­
tal health care entities should report investments in (a) participating interest- 
earning investment contracts, (b) external investment pools, (c) open-ended 
mutual funds, (d) debt securities, and (e) equity securities, option contracts, stock 
warrants, and stock rights that have readily determinable fair values at fair value 
on the balance sheet. Governmental entities are permitted to report certain money 
market investments and participating interest-earning investment contracts at 
amortized cost, provided that the investment has a remaining maturity of one year 
or less at time of purchase. All investment income, including changes in the fair 
value of investments, shall be recognized as nonoperating revenue in the state­
ment of operations. Governmental health care entities should follow the disclo­
sure requirements of GASB Statement No. 31.
4.13 GASB Statements No. 3, Deposits with Financial Institutions, In­
vestments (Including Repurchase Agreements), and Reverse Repurchase Agree­
ments, No. 28, Accounting and Financial Reporting for Securities Lending 
Transactions, and GASB Interpretation No. 3, Financial Reporting for Reverse 
Repurchase Agreements, provide guidance on investment-related disclosures 
required by governmental entities as well as accounting for securities lending 
and reverse repurchase agreements.
3 Donors that create endowment funds can require that their gifts be invested in perpetuity or 
for a specified term. Some donors may require that a portion of income, gains, or both be added to the 
gift and invested subject to similar restrictions. It is generally understood that at least the amount of 
the original gift(s) and any required accumulations are not expendable, although the value of the 
investments purchased may occasionally fall below that amount. Future appreciation of the invest­
ments generally restores the value to the required level. In states that have enacted its provisions, 
the Uniform Management of Institutional Funds Act describes “historic dollar value” as the amount 
that is not expendable.
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement amends GASB Statement Nos. 3 , 28 and 31, 
and provides standards for the classification of revenues as operating and nonoperating. A brief 
summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. This 
chapter will be modified to conform to the requirements of GASB Statement No. 34 in a future edition 
of this Guide.
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Entities Subject to FASB Statement No. 115, FASB 
Statement No. 124, or GASB Statement No. 31*,**
4.14 Securities should be reported as either current or noncurrent, as 
appropriate, under the provisions of ARB No. 43, Restatement and Revision o f 
Accounting Research Bulletins, Chapter 3A.4
4.15 For cash flow reporting purposes by nongovernmental entities, 
purchases, sales, and m aturities of trading securities should be classified 
as cash flows from operating activities; governmental entities should class­
ify these items as investing activities. Cash flows from purchases, sales, 
and m aturities of all other securities should be classified as cash flows from 
investing activities. If  investm ents in  debt securities are reported as 
cash equivalents in accordance w ith FASB S tatem ent No. 95, Statem ent 
o f Cash Flows, or GASB Statem ent No. 9, Reporting Cash Flows o f Proprie­
tary and Nonexpendable Trust Funds and Governmental Entities That Use 
Proprietary Fund Accounting, the notes to the financial statem ents should 
reconcile the reporting classifications used in the statem ent of financial 
position.
Financial Statement Presentation
* FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities, 
supersedes FASB Statement No. 105, Disclosure of Information about Financial Instruments with 
Off-Balance-Sheet Risk and Financial Instruments with Concentrations of Credit Risk, and FASB 
Statement No. 119, Disclosure about Derivative Financial Instruments and Fair Value o f Financial 
Instruments. FASB Statement No. 133 amends FASB Statement No. 95, Statement o f Cash Flows, 
FASB Statement No. 115, Accounting for Certain Investments in Debt and Equity Securities, FASB 
Statement No. 124, Accounting for Certain Investments Held by Not-for-Profit Organizations, and 
FASB Statement No. 126, Exemption from Certain Required Disclosures about Financial Instruments 
for Certain Nonpublic Entities. FASB Statement No. 133 establishes the accounting and reporting 
standards for derivative instruments and for hedging activities, and amends FASB Statement No. 
107, Disclosures about Fair Value of Financial Instruments, to include in FASB Statement No. 107 the 
disclosure provisions about concentrations of credit risk from FASB Statement No. 105, with 
modifications. FASB Statement No. 133, as amended by FASB Statement No. 137, Accounting for 
Derivative Instruments and Hedging Activities—Deferral o f the Effective Date of FASB Statement No. 
133, is effective for all fiscal quarters of fiscal years beginning after June 15, 2000. Also, on March 3,
2000, the FASB issued an exposure draft, Accounting for Certain Derivative Instruments and Certain 
Hedging Activities, that would amend FASB Statement No. 133. Readers should be alert for the 
issuance of a final standard.
The FASB has established the Derivatives Implementation Group (DIG) to assist the Board and its 
staff in providing implementation guidance regarding FASB Statement No. 133. Issues addressed by 
the DIG and the status of related guidance can be found at www.fasb.org.
** GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement amends GASB Statement Nos. 3 ,  9, and 28. 
A brief summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this 
Guide. This chapter will be modified to conform to the requirements of GASB Statement No. 34 in a 
future edition of this Guide.
4 Chapter 3A of ARB No. 43 indicates in paragraph 4 that “the term current assets is used to 
designate cash and other assets or resources commonly identified as those which are reasonably 
expected to be realized in cash or sold or consumed during the normal operating cycle of the 
business.” That paragraph further indicates that the term also comprehends “marketable securities 
representing the investment of cash available for current operations.” Paragraph 5 indicates that “a 
one-year time period is to be used as a basis for the segregation of current assets in cases where there 
are several operating cycles occurring within a year.” Paragraph 6 says that the “concept of the 
nature of current assets contemplates the exclusion from that classification of . . .  cash and claims to 
cash which are restricted as to withdrawal or use for other than current operations, are designated 
for expenditure in the acquisition or construction of noncurrent assets, or are segregated for the 
liquidation of long-term debts.” Cash and cash equivalents of permanent endowment funds held 
temporarily until suitable long-term investment opportunities are identified are included in the 
classification “long-term investments.”
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4.16 All health care organizations with investments that meet the defini­
tion of financial instruments set forth in FASB Statement No. 105, Disclosure 
o f Information about Financial Instruments with Off-Balance-Sheet Risk and 
Financial Instruments with Concentrations of Credit Risk, are subject to the 
disclosure requirements of FASB Statements No. 105 and No. 107, Disclosures 
about Fair Value o f Financial Instruments.* Organizations with derivative 
financial investments (for example, futures, forward, swap, and option con­
tracts) are subject to the disclosure requirements in FASB Statement No. 119, 
Disclosure about Derivative Financial Instruments and Fair Value o f Financial 
Instruments.5 Governmental health care entities are also required to disclose 
information about their investments in accordance with GASB Statements No.
3 and No. 28, GASB Technical Bulletin No. 87-1, Applying Paragraph 68 of 
GASB Statement No. 3, No. 94-1, Disclosures about Derivatives and Similar 
Debt and Investment Transactions, No. 97-1, Classifications o f Deposits and 
Investments into Custodial Credit Risk Categories for Certain Bank Holding 
Company Transactions, and GASB Interpretation No. 3.
4.17 The following example illustrates the accounting treatm ent and 
financial statement presentation for other-than-trading securities of a not-for- 
profit health care organization:
Facts
Other than trading securities are purchased in year 1 a t a cost of $100. At the 
end of year 1, the fair value of the securities is $300. In year 2, the securities 
are sold for $400.
Journal Entries
•  Entry at the end o f year 1 to adjust the recorded value o f the securities 
to fair value:
Valuation allowance 200
Change in net unrealized gains and losses on investments 200
•  Entry at the end o f year 2 to record the sale o f the securities:
Cash 400
Realized gain 300
Investments 100
Change in net unrealized gains and losses on investments 200 
Valuation allowance 200
As discussed in paragraph 4.07, unrealized gains and losses on other than 
trading securities are reported in the statement of operations below the per­
formance indicator and realized gains and losses are reported in the statem ent 
of operations above the performance indicator.
Auditing
4.18 Auditing objectives and procedures for investments of health care 
organizations generally are similar to those of other organizations. SAS No. 81,
* Disclosures about the fair value of financial instruments prescribed in FASB Statement No. 
107 are optional for an entity that meets the criteria of FASB Statement No. 126, Exemption from 
Certain Required Disclosures about Financial Instruments for Certain Nonpublic Entities.
5 FASB Statements No. 105, No. 107, and No. 119 are not applicable to governmental health care 
enterprises that do not apply paragraph 7 of GASB Statement No. 20. (See chapter 1, footnote 1.)
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Auditing Investments* (AICPA, Professional Standards, vol. 1, AU sec.332), 
provides guidance to auditors in auditing investments in debt securities and 
equity securities as defined in FASB Statem ent No. 115, and investments 
accounted for under APB Opinion No. 18, The Equity Method o f Accounting 
for Investments in Common Stock. In addition, the independent auditor may 
need to consider the examples of specific auditing objectives, selected control 
activities, and auditing procedures that are presented in exhibit 4.1.
* The AICPA Auditing Standards Board has plans to release a new SAS that if adopted, would 
supersede SAS No. 81. Readers should be alert for the issuance of this SAS.
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Exhibit 4.1
Financial Statement 
Assertions
Existence and 
completeness; 
rights and 
obligations; and 
valuation
Valuation, rights, 
and obligations
Accuracy and 
completeness
Specific Auditing Selected Control 
Objectives Activities
Auditing Considerations
Marketable 
securities are 
fairly stated, 
properly 
classified, 
described, and 
disclosed.
An independent 
trustee manages 
the investments. 
The trustee’s 
reports are 
reviewed by a 
responsible 
employee.
Auditing
Procedures
Verify existence
through
confirmation.
Test the valuation 
of equity and debt 
securities not 
intended to be 
held to maturity 
by comparing the 
recorded values 
with the fair 
market values 
reported by the 
trustee or another 
independent 
source.
Endowment 
funds are 
properly stated at 
their required 
value and related 
gains and losses 
are properly 
classified.
Investment 
income and 
gains/losses are 
recorded in 
accordance with 
donor restrictions.
Value of 
endowment 
funds are 
reviewed 
periodically to 
ensure that the 
balance is a t its 
required level.
Review of 
investment 
transactions to 
ensure they are 
recorded in 
compliance with 
donor restrictions.
Verified that 
value of
endowments are 
a t required levels 
through 
confirmation.
Review treatm ent 
of gains and 
losses on
endowment funds 
to ensure that 
they are properly 
classified.
Test the recording 
of selected 
transactions to 
ensure amounts 
are properly 
classified in 
accordance with 
donor restrictions.
AAG-HCO 4.18
60 Health Care Organizations
Presentation and 
disclosure
Financial Statement
Assertions
Specific Auditing 
Objectives
Securities are
properly
classified.
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Selected Control 
Activities
Classification is 
monitored 
periodically and 
is based on 
management’s 
intent or ability 
to dispose of 
excess funds that 
are available for 
operations within 
an operating 
cycle.
Auditing
Procedures
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Chapter 5 
Receivables
5.01 Receivables may include amounts due for (a) health care services 
from patients, residents, third-party payors, and employers; (b) premiums and 
stop-loss insurance recoveries; (c) intercompany transactions; (d) promises to 
give in future periods (pledges); and (e) amounts due from employees, physicians, 
or others. All loans, such as loans to physicians, should be evaluated peri­
odically for impairment. Loans that are included in the scope of FASB State­
ment No. 114, Accounting by Creditors for Impairments o f a Loan,1 should be 
evaluated based on the provisions of that statement. A loan is impaired when, 
based on current information and events, it is probable that the provider will 
be unable to collect all amounts due, including principal and interest, according 
to the contractual terms of the loan agreement. If the provider measures an 
impaired loan using a present value amount, the creditor should calculate that 
present value based on an estimate of the expected future cash flows of the 
impaired loan, discounted at the loan’s effective interest rate.
5.02 Amounts realizable from third-party payors for health care services 
are usually less than the provider’s full established rates for those services. The 
realizable amounts may be determined by (a) contractual agreement with 
others (such as Blue Cross plans, Medicare, Medicaid, or HMOs), (b) legislation 
or regulation (such as workers’ compensation or no-fault insurance), or (c) 
provider policy or practice (such as courtesy discounts to medical staff mem­
bers and employees or other administrative adjustments).
5.03 Revenue and the related receivables for health care services usually 
are recorded in the accounting records on an accrual basis a t the provider’s full 
established rates. The provision for contractual adjustments (that is, the differ­
ence between established rates and third-party payor payments) and discounts 
(that is, the difference between established rates and the amount collectible) are 
recognized on an accrual basis and deducted from gross service revenue to 
determine net service revenue. Contractual adjustments, discounts, and an 
allowance for uncollectibles are recorded to report the receivables for health care 
services a t net realizable value. Estimates of contractual adjustments, other 
adjustments, and the allowance for uncollectibles are reported in the period 
during which the services are provided even though the actual amounts may 
become known at a later date. This later date may be (a) when the person is 
discharged, (b) subsequent to discharge or completion of service, (c) when the 
third party is billed, or (d) when payment or partial payment is received. As 
discussed in paragraph 10.03, the provision of charity care does not qualify for 
recognition as receivables or revenue in the financial statements.
Rate Setting
5.04 The independent auditor should be familiar with the rate-setting 
environment in which the entity operates and the regulations and contractual
1 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See chapter 1, 
footnote 1.)
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agreements that determine payments to be received for health  care services. 
Paym ent ra tes established by regulations or contractual agreem ents may 
be determ ined either prospectively or retrospectively.
5.05 Prospective rate setting is a method used to set payment rates in 
advance of the delivery of health care services. Such payment rates determine 
what third parties will pay for health care services during the rate period 
(generally one year). Prospective rate setting may result from a contractual 
agreement with a third party, such as a Blue Cross plan, or it may be mandated 
through legislation. The intent of prospective rate setting is to establish 
payment rates before the period to which they will apply and that are not 
subject to change. The independent auditor should be aware, however, that 
some rate-setting methods described as prospective may include provision for 
retrospective adjustments and that some third parties pay prospective rates 
for certain services and retrospective rates for other services.
5.06 Under retrospective rate setting, third parties usually determine an 
interim payment rate and, during the rate period (generally one year), pay the 
health care organization for services rendered using that rate. After the rate 
period has ended, a final settlement is made in accordance with federal or state 
regulations or contractual agreements.
Estimated Final Settlements
5.07 Under a retrospective system, an entity may be entitled to receive 
additional payments or may be required to refund amounts received in excess 
of amounts earned under the system. Although final settlements are not made 
until a subsequent period, they are usually subject to reasonable estimations 
and are reported in the financial statements in the period in which services are 
rendered. Differences between original estimates and subsequent revisions 
(including final settlements) are included in the statement of operations in the 
period in which the revisions are made and disclosed, if material. Those 
differences are not treated as prior period adjustments unless they meet the 
criteria for prior period adjustments as set forth in FASB Statement No. 16, 
Prior Period Adjustments.2
5.08 Rate-setting methods that are described as prospective but provide 
for retrospective adjustments are accounted for as retrospective rate-setting 
systems for the services to which they apply (see paragraph 5.07).
State Waiver Contingencies Under Medicare
5.09 Certain states (referred to as waiver states) have received permis­
sion to determine rates of payment for Medicare patients in accordance with a 
statewide rate-setting method different from the method used by the federal 
program. A condition for Medicare participation in a state waiver program 
typically requires that Medicare expenditures in that state not exceed pre­
scribed limits. If Medicare expenditures exceed prescribed limits, the excess, 
depending on the conditions of the waiver, may be recoverable by the federal 
government. FASB Statem ent No. 5, Accounting for Contingencies, provides 
guidance w ith respect to accounting for loss contingencies, such as those
2 Paragraph 37 of SOP 00-1, Auditing Health Care Third-Party Revenues and Related Receiv­
ables, provides a sample disclosure for material differences between an original estimate and 
subsequent revisions. SOP 00-1 is effective for audits of periods ending on or after June 30, 2000. SOP 
00-1 is included in appendix E to this Guide.
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arising under state Medicare waivers. GASB Statement No. 10, Accounting and 
Financial Reporting for Risk Financing and Related Insurance Issues, provides 
guidance with respect to accounting for contingencies by governmental entities.
Premiums and Stop-Loss Insurance Receivables
5.10 Some health care organizations contract to provide comprehensive 
health  care services for a fixed period in re tu rn  for fixed periodic premiums. 
Many of those organizations may transfer a portion of their financial risks 
under the contract to another organization by purchasing stop-loss insurance. 
Receivables of those organizations may include uncollected premiums and 
amounts recoverable from stop-loss insurers reduced by appropriate valuation 
allowances. Chapter 13 provides guidance on applying GAAP for stop-loss 
insurance costs of providers of prepaid health care services. FASB Statement 
No. 113, Accounting and Reporting for Reinsurance o f Short-Duration and 
Long-Duration Contracts, also provides guidance on accounting for reinsur­
ance contracts. Governmental entities should comply with the provisions of 
GASB Statement No. 10 which provides different guidance on accounting for 
reinsurance contracts than FASB Statement No. 113.*
Promises to Give in Future Periods (Pledges)* *,***
5.11 Providers involved in fund-raising campaigns frequently are the recipi­
ents of promises to give3 with payments due in future periods; pledge drives 
are a common example. FASB Statement No. 116, Accounting for Contributions 
Received and Contributions Made,4 establishes the accounting and financial 
reporting guidance for pledges and similar promises to pay; a general summary
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, GASB Statement No. 34 amends GASB Statement No. 10. 
A brief summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this 
Guide. This chapter will be modified to conform to the requirements of GASB Statement No. 34 in a 
future edition of this Guide.
** GASB Statement No. 33, Accounting and Financial Reporting for Nonexchange Transactions, 
which establishes accounting and reporting standards for nonexchange transactions involving 
financial or capital resources, is effective for financial statements for periods beginning after June 15, 
2000, with earlier implementation encouraged. A brief summary of GASB Statement No. 33 is 
provided in paragraph 10.24 of this Guide. Also, refer to the footnote to paragraph 10.24 for a 
discussion of GASB Statement No. 34, which will amend paragraph 11 of GASB Statement No. 33.
*** FASB Statement No. 136, Transfers o f Assets to a Not-for-Profit Organization or Charitable 
Trust That Raises or Holds Contributions for Others, establishes standards for transactions in which 
an entity—the donor—makes a contribution by transferring assets to a not-for-profit organization or 
charitable trust—the recipient organization—that accepts the assets from the donor and agrees to 
use those assets on behalf of or transfer those assets, the return on investment of those assets, or 
both to another entity—the beneficiary—that is specified by the donor, including standards for a 
beneficiary’s recognition of its rights to the assets held by an agent or other recipient organization. 
FASB Statement No. 136 incorporates without reconsideration the guidance in FASB Interpretation 
No. 42, and supersedes that Interpretation. FASB Statement No. 136 is effective for financial 
statements issued for fiscal periods beginning after December 15, 1999 (earlier application is 
encouraged), except for the provisions incorporated from FASB Interpretation No. 42, which continue 
to be effective for fiscal years ending after September 1 5 , 1996. A summary of FASB Statement No. 
136 is included in appendix F to this Guide. This chapter will be modified to conform to the 
requirements of FASB Statement No. 136 in a future edition of this Guide.
3 lb  be recognized in financial statements there must be sufficient evidence in the form of verifiable 
documentation that a promise was made and received (FASB Statement No. 116, paragraph 6).
4 This pronouncement is not applicable to governmental health care enterprises. (See chapter 1, 
footnote 1.)
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of th a t guidance is presented below. Specific guidance is provided in chapter 5 
of the AICPA Audit and Accounting Guide Not-for-Profit Organizations. By 
specifying that they will adhere to future payment dates, donors implicitly 
indicate that their gift is to support activities in each period in which a 
payment is scheduled. Therefore, in any promise to give with payments due in 
future periods, a time restriction is implicit unless the donor explicitly states 
that the gift is to support current activities or other circumstances clearly point 
to th a t intent.
5.12 Promises to give fall into two broad categories: conditional and 
unconditional. Conditional promises to give depend on the occurrence of a 
specified future and uncertain event (for example, a stipulation that the 
provider must meet a matching requirement) whose occurrence or failure of 
occurrence gives the donor the right of return of the assets or releases the donor 
from the obligation to transfer assets in the future. Conditional promises to 
give are not recognized in financial statements until the conditions on which 
they depend are substantially met (that is, until the period in which the 
conditional promise becomes an unconditional promise). A transfer of assets in 
partial fulfillment of a conditional promise shall be accounted for as a refund­
able advance (that is, as a liability) until such time as the conditional promise 
becomes unconditional.5
5.13 Unconditional promises to give with payments due in future periods 
should be reported as receivables and as restricted support in the period the 
promise is received (unless explicit donor stipulations or circumstances sur­
rounding the receipt of the promise make clear that the donor intended the 
promise to be used to support activities of the current period). The expiration 
of those restrictions (or the expiration of a portion of the restriction) is recog­
nized as the donor makes the future payment or payments. If the promise is to 
be paid in one future payment, the related temporarily restricted net assets 
will be transferred to unrestricted net assets in the period in which the 
payment is received. If the donor sets forth a schedule of future payments, a 
transfer from temporarily restricted net assets to unrestricted net assets is 
made in each period a payment is received. If other explicit donor restrictions 
are attached to the promise, such as that the gift be used for a specific purpose, 
the expiration of the restriction is recognized in the time period(s) when the 
donor makes the future payment(s) and when the stipulated purpose for which 
the assets were restricted has been fulfilled. In the period (or periods) that the 
restrictions expire, the temporarily restricted net assets (or the portion of the 
temporarily restricted net assets th a t relate to the particular payment install­
ment) are reclassified as unrestricted net assets and reported in the statement 
of operations as net assets released from restriction.
5.14 In the year that unconditional promises to give cash are received, 
they should be measured at the present value6 of their estimated future cash 
flows. (Unconditional promises to give cash th a t are expected to be collected 
within one year of the financial statement date may be measured a t their net 
realizable value.) In determining the estim ated future cash flows of uncon­
ditional promises to give cash, not-for-profit organizations should consider
5 For accounting purposes, a conditional promise to give is considered unconditional if the 
possibility that the condition will not be met is remote. In the case of ambiguous donor stipulations, 
if a promise contains stipulations that are not clearly unconditional (that is, if the donor's stipula­
tions are ambiguous), the promise is presumed to be a conditional promise. Additional guidance on 
distinguishing conditional promises from unconditional promises is provided in FASB Statement No. 
116, paragraphs 22 and 23.
6 FASB Statement No. 116 states that present value should be calculated using a discount rate 
commensurate with the risks involved.
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when the receivable is expected to be collected, the creditworthiness of the 
other parties, the organization’s past collection experience and its policies 
concerning the enforcement of promises to give, and other factors concerning 
the receivable’s collectibility. If the fair value of unconditional promises to give 
cash decreases after initial measurement because of decreases in estimated 
future cash flows, the decrease should be recognized in the period(s) in which 
the expectation changes. Such decreases should be reported as expenses or losses 
(bad debt) in the net asset class in which the net assets are represented.7 
Accretion of the discount element of the unconditional promise to give is 
accounted for as contribution income, which increases unrestricted, temporar­
ily, or permanently restricted net assets, as appropriate.
5.15 With regard to pledges and other promises to pay in future periods, if a 
provider routinely conducts fund drives, an estimate of the future cash flows of a 
portfolio of short-term promises resulting from a mass fund-raising appeal may be 
made based on experience gained from similar appeals in prior years.
5.16 Chapter 5 of the Audit and Accounting Guide Not-for-Profit Organi­
zations provides farther guidance regarding accounting for promises to give in 
future periods.
Financial Statement Presentation 
Accounts Receivable*
5.17 Receivables are reported net of an allowance for doubtful accounts. 
Although the aggregate amount of receivables may include balances due from 
patients and third-party payors (including final settlements and appeals), the 
amounts due from third-party payors for retroactive adjustments of items such 
as final settlements or appeals shall be reported separately in the financial 
statements.
5.18 Accounts receivable of health care organizations generally are sub­
ject to the same financial disclosure requirements as other business organiza­
tions.8 FASB Statem ent No. 107, Disclosures about Fair Value o f Financial
7 As discussed in FASB Statement No. 116, all expenses should be reported as decreases in 
unrestricted net assets. Therefore, decreases in contributions because of changes in the estimated 
future cash flows should be reported as losses if they are decreases in temporarily restricted net 
assets or permanently restricted net assets.
* FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities, 
supersedes FASB Statement No. 105, Disclosure of Information about Financial Instruments with 
Off-Balance-Sheet Risk and Financial Instruments with Concentrations o f Credit Risk, and FASB 
Statement No. 119, Disclosure about Derivative Financial Instruments and Fair Value o f Financial 
Instruments. FASB Statement No. 133 amends FASB Statement No. 107, Disclosures about Fair 
Value of Financial Instruments, to include in FASB Statement No. 107 the disclosure provisions about 
concentrations of credit risk from FASB Statement No. 105, with modifications. FASB Statement No. 
133, as amended by FASB Statement No. 137, Accounting for Derivative Instruments and Hedging 
Activities—Deferral o f the Effective Date o f FASB Statement No. 133, is effective for all fiscal quarters 
of fiscal years beginning after June 15, 2000. Also, on March 3, 2000, the FASB issued an exposure 
draft, Accounting for Certain Derivative Instruments and Certain Hedging Activities, that would 
amend FASB Statement No. 133. Readers should be alert for the issuance of a final standard.
The FASB has established the Derivatives Implementation Group (DIG) to assist the Board and its 
staff in providing implementation guidance regarding FASB Statement No. 133. Issues addressed by 
the DIG and the status of related guidance can be found at www.fasb.org.
8 See discussion of SOP 00-1 in paragraph 5.28. SOP 00-1 is effective for audits of periods ending 
on or after June 15, 2000, and is included as appendix E to this Guide.
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Instruments,8a sets forth disclosure requirements regarding the carrying 
amount of patient accounts receivable.
5.19 FASB Statement No. 105, Disclosure o f Information about Financial 
Instruments with Off-Balance-Sheet Risk and Financial Instruments with 
Concentrations o f Credit Risk,9 requires disclosure of information about sig­
nificant concentrations of credit risk from third parties and off-balance-sheet 
risk of accounting losses for all financial instruments, including trade accounts 
receivable. Concentration of credit risk frequently is an issue because most 
health care organizations generally tend to treat patients from their local or 
surrounding communities. Accordingly, disclosure should be made of the pri­
mary geographic sources of patients. It should be noted that concentration of 
credit risk may be a significant issue in stand-alone financial statements 
issued for a member hospital of a large national multi hospital system but may 
not be an issue for financial statements prepared for the hospital system. When 
the individual facilities’ financial statements are consolidated into statements 
prepared for the entire system, the credit risk is dispersed over a much 
larger base of health plans, patients, and geographies and, therefore, is not 
as concentrated. Health care organizations with significant concentrations of 
credit risk should comply w ith the disclosure provisions of FASB S ta te­
m ent No. 105.
5.20 OfF-balance-sheet risk exists when the possible accounting loss from 
a financial instrum ent is not reflected on the balance sheet. Health care 
organizations (most notably hospitals) may enter into arrangements where 
they will finance their patient accounts receivable as a cash flow management 
strategy. Organizations that enter into certain types of receivable financing 
arrangements should disclose their off-balance-sheet risk, in accordance with 
FASB Statement No. 105.
5.21 FASB Statement No. 119, Disclosure about Derivative Financial 
Instruments and Fair Value o f Financial Instruments,10 requires disclosures 
about derivative financial instruments—futures, forward, swap, and option 
contracts; and other financial instruments with similar characteristics. It also 
amends existing requirements of FASB Statements No. 105 and No. 107. GASB 
Technical Bulletin 94-1, Disclosures about Derivatives and Similar Debt and 
Investment Transactions, also applies to governmental health care enterprises.
5.22 FASB Statement No. 119 requires disclosures about amounts, na­
ture, and terms of derivative financial instruments that are not subject to 
FASB Statement No. 105 because they do not result in off-balance-sheet risk 
of accounting loss. It requires that a distinction be made between financial 
instruments held or issued for trading purposes (including dealing and other 
trading activities measured a t fair value with gains and losses recognized in 
earnings)11 and financial instruments held or issued for purposes other than 
trading. FASB Statement No. 119 requires additional disclosures about those 
derivative financial instruments held for trading purposes, those held for 
purposes other than trading, and those accounted for as hedges of anticipated 
transactions.
8a This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20. (See chapter 1, footnote 1.)
9 See footnote 8a.
10 See footnote 8a.
11 See chapter 4 for further guidance relating to accounting for investments by not-for-profit 
entities.
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Interfund Receivables
5.23 Interfund receivables (or payables) may exist in internal records. 
However, since general-purpose financial statements of not-for-profit health 
care organizations do not classify assets and liabilities into fund groups, 
interfund receivables (or payables) are eliminated. Such interfund balances 
and transactions are different from interfund transactions between a govern­
mental health care enterprise fund and another fund, such as the general fund 
or a special revenue fund of a primary government, when the two funds are 
included in the same financial reporting entity. Governmental health care 
enterprises that are a part of a larger financial reporting entity, such as a city 
or a county, are required to report amounts that are receivable (or payable) to 
other funds or component units of the same financial reporting entity in their 
external financial reports.*
Promises to Give in Future Periods (Pledges)
5.24 Contributions receivable should be reported net of an allowance for 
uncollectible amounts. That allowance may be based on the receivable’s age, 
the creditworthiness of the parties, the organization’s past collection experi­
ence and its policies concerning the enforcement of promises to give, and other 
factors concerning the receivable’s collectibility. After the date of initial meas­
urement, bad debt expense should be reported for the amount of promises to 
give that are expected to be uncollectible (see paragraph 5.12).
5.25 Recipients of unconditional pledges (promises to give in future peri­
ods) shall disclose—
a. The amounts of promises receivable in less than one year, in one to 
five years, and in more than five years.
b . The amount of the allowance for uncollectible promises receivable.
5.26 Recipients of conditional pledges (promises to give in future periods) 
shall disclose—
a. The total of the amounts promised.
b . A description and amount for each group of promises having similar 
characteristics, such as amounts of promises conditioned on estab­
lishing new programs, completing a new building, or raising match­
ing gifts by a specified date.
Auditing
5.27 In general, receivables, particularly those arising from health care 
services, are material to the financial position of health care organizations. 
Examples of specific auditing objectives, selected control activities, and audit­
ing procedures that may be considered by the independent auditor as they 
relate to the major components of receivables of health care organizations are 
presented in exhibit 5.1 a t the end of this chapter.
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement provides guidance regarding the reporting 
of interfund and intraentity activities and balances. A brief summary of GASB Statement No. 34 is 
provided in paragraphs 1.09 through 1.11 in this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 in a future edition of this Guide.
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5.28 SOP 00-1, Auditing Health Care Third-Party Revenues and Related 
Receivables, provides guidance to auditors in evaluating the reasonableness of 
management’s estimates regarding the proper valuation of health care third- 
party revenues and receivables embodied in the financial statements. SOP 
00-1 is effective for audits of periods ending on or after June 30, 2000 and is 
included as appendix E to this Guide.
Accounts Receivable Confirmations
5.29 Direct confirmation of amounts due from discharged patients and 
third-party payors may be an appropriate audit procedure for obtaining evi­
dence about the existence and accuracy of amounts due. However, many 
patients whose accounts are expected to be paid by a third-party payor may not 
have received bills, and many third-party payors may be unable to respond to 
confirmation requests on specific account balances. In addition, obtaining 
confirmation of receivables from patients who are not discharged may be 
impracticable because those patients may not know the amount of their 
indebtedness until they are discharged.
5.30 If confirmation of amounts due from patients and third-party payors 
is impracticable or determined not to be effective, the independent auditor 
should document this decision in accordance with SAS No. 67, The Confirma­
tion Process (AICPA, Professional Standards, vol. 1, AU sec. 330), and should 
use alternate procedures such as—
•  Performing an analytical procedure or testing the details of sub­
sequent receipts.
•  Reviewing third-party contracts or payment agreements.
•  Comparing billings with documentation in medical records.
•  Reviewing the results of third-party payor audits and, if available, 
peer review organization (PRO) reports.
•  Examining or confirming interim payments with third-party payors.
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Exhibit 5.1
Auditing Considerations
Financial Statement Specific Auditing 
Assertions________ Objectives
Receivables for Health Care Services
Existence Amounts reported 
in the financial 
statements 
represent valid 
receivables, which 
do not include 
charity care 
balances.
Selected Control 
Activities
Charges are 
generated 
automatically 
when services are 
performed.
A medical record 
is prepared.
Auditing
Procedures
Review and test
subsequent
receipts.
Compare billing 
information to the 
documentation 
contained in the 
medical records.
Procedures 
ensure that 
amounts due 
from third-party 
payors for 
individual 
accounts are 
supported 
properly.
Review the 
results of PRO, if 
available, and 
insurance 
company reviews 
for evidence that 
might indicate 
receivables may 
not be realized.
Procedures 
ensure the 
proper recording 
of cash receipts.
Trace the receipts 
applicable to 
patient accounts 
to the accounts 
receivable records.
Completeness
Procedures 
ensure charity 
care balances are 
identified and 
excluded from 
gross receivables.
Amounts reported 
in the financial 
statements are 
complete and are
Procedures 
ensure that (a) 
detailed accounts 
receivable
Review the 
management 
policy for 
determining 
charity care.
Review policy and 
reasonableness of 
charity care 
measurement. 
Compare detailed 
accounts
receivable records 
with control
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Financial Statement
Assertions
Valuation
Specific Auditing Selected Control 
Objectives Activities
calculated and
accumulated
properly.
records are 
compared 
routinely with 
control accounts 
and third-party 
payor logs, (b) 
differences are 
investigated and 
reconciled, and
(c) adjustments, 
if necessary, are 
made promptly.
Auditing
Procedures
accounts and 
third-party payor 
logs, and 
investigate 
reconciling items.
Receivables are 
reported in the 
financial
statements a t net 
realizable value.
Allowances for 
uncollectibles 
and contractual 
adjustments are 
reviewed 
periodically by 
management to 
ensure that 
receivables are 
reported at 
estimated net 
realizable value.
Review 
third-party 
contracts and 
recompute patient 
receivables.
Examine 
contracts or 
confirm interim 
third-party 
payments with 
third-party payors,
Write-offs and 
allowances for 
uncollectibles are 
identified and 
approved in 
accordance with 
the entity’s 
established policy.
Review and test 
the method used 
to determine the 
allowances for 
uncollectible 
accounts.
Determine that 
patient accounts 
are classified 
appropriately by 
payor (for 
example, 
Medicare or 
self-pay) to 
evaluate 
collectibility.
Test Medicare 
logs for accuracy 
and completeness.
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Financial Statement Specific Auditing
Assertions________ Objectives
Presentation and Significant 
disclosure contractual
arrangements 
with third parties 
are disclosed.
Estimated Third-Party Settlements
Existence
Completeness and 
valuation
Amounts reported 
in the financial 
statements 
represent valid 
receivables and/or 
payables.
Amounts included 
in the financial 
statements are 
accurate and 
complete.
Selected Control 
Activities
Procedures 
ensure that 
estimated 
third-party 
settlements 
are determined 
in accordance 
with the 
reimbursement 
and rate-setting 
methodologies 
applicable to the 
entity.
Procedures 
ensure that 
estimated 
third-party 
settlements are 
accurately
Auditing
Procedures
Test and analyze 
aged accounts 
receivable trial 
balances, 
collection trends, 
delinquent 
accounts, 
subsequent period 
write-offs and 
economic or other 
factors used to 
determine 
allowance for 
uncollectible 
accounts.
Review pledges 
and other 
receivables for 
collectibility.
Determine that 
significant 
contractual 
arrangements 
with third parties 
are disclosed.
Review
correspondence 
from significant 
third-party payors 
related to (a) 
interim payment 
rates applicable to 
periods for which 
final settlements 
have not been 
made and (b) the 
amount of interim 
or final
settlements made 
during the period. 
Test the
reasonableness of 
settlement 
amounts, 
including specific 
and unallocated
AAG-HCO 5.30
72 Health Care Organizations
Financial Statement
Assertions
Presentation and 
disclosure
Specific Auditing Selected Control 
Objectives Activities
calculated and 
reported.
Amounts reported 
in the financial 
statements are 
presented 
properly and all
Auditing
Procedures
reserves, in light 
of the payors 
involved, the 
nature of the 
payment 
mechanism, the 
risks associated 
with future 
audits, and other 
relevant factors.
Review
third-party payor 
audit reports and 
adjustments for 
prior years’ cost 
reports or 
settlements to 
consider whether
(а) the effect of 
such adjustments 
has been reported 
properly in the 
financial 
statements and
(b) adjustments of 
a similar nature 
apply to the 
current period.
Obtain a 
representation 
from management 
that provisions for 
estimated 
retroactive 
adjustments by 
third-party payors 
under
reimbursement 
agreements for 
open years are 
adequate.
Determine that 
the tentative 
nature of 
third-party 
settlement
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required 
disclosures are 
made.
Financial Statement Specific Auditing
Assertions Objectives
Selected Control 
Activities
amounts is 
disclosed properly.
Determine that 
differences 
between original 
estimates and 
subsequent 
revisions 
(including final 
settlements) are 
included in the 
statement of 
operations in the 
period in which 
the revisions are 
made and 
disclosed, if 
material.
Auditing
Procedures
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Chapter 6 
Property and Equipment, Supplies, and 
Other Assets*
Overview
6.01 Health care organizations use various types of property and equip­
ment. Those assets may be material to the financial position of institutional 
health care organizations, such as hospitals and nursing homes. Typical ac­
counts used to record property and equipment transactions are land, land 
improvements, buildings and improvements, leasehold improvements, equip­
ment (fixed and movable), leased property and equipment, accumulated depre­
ciation and amortization, and construction in progress.
6.02 Supplies usually are not material to the financial position of health 
care organizations. However, because of the volume of supply transactions, 
they may materially affect operations. Supplies typically include medical and 
surgical supplies; pharmaceuticals; linens, uniforms, and garments; food and 
other commodities; and housekeeping, maintenance, and office supplies.
6.03 Other assets may include prepaid expenses, deposits, and deferred 
expenses. Prepaid costs, such as amounts paid to physicians for future services 
(for example, administering a hospital department or providing community 
services that further the organization’s mission) may be deferred and amor­
tized over the period benefited. Such assets are classified as current or noncur­
rent as appropriate.
Accounting
6.04 Accounting for property and equipment, supplies, and other assets of 
health care organizations is similar to that vised by other business organizations.
6.05 Depreciation and amortization of property and equipment are re­
corded in conformity with GAAP. Useful lives assigned to depreciable assets 
should be reasonable, based on the circumstances. The American Hospital 
Association publishes useful guidelines for classifications and estimated useful 
lives for property and equipment used by hospitals. Those guidelines also may 
be useful to other health care organizations. If there is a potential that an asset 
is impaired, health care organizations should consider the guidance in FASB 
Statement No. 121, Accounting for the Impairment o f Long-Lived Assets and  
for Long-Lived Assets to Be Disposed O f.1
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement provide guidance regarding the 
capitalization and reporting of capital assets of proprietary funds. A brief summary of GASB 
Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. This chapter will be 
modified to conform to the requirements of GASB Statement No. 34 in a future edition of this Guide.
1 This pronouncement is not applicable to governmental health care enterprises that do not apply 
paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and 
Other Governmental Entities That Use Proprietary Fund Accounting. (See chapter 1, footnote 1.)
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6.06 The recognition of contribution income related to donated long-lived 
assets (or assets recognized to be acquired with donated funds) is discussed in 
chapter 10 of this Guide.
Financial Statement Presentation
6.07 Financial statement presentation of property and equipment of 
health care organizations is similar to that of other business organizations. 
Property held for investment purposes should be presented as part of invest­
ments. Donor or legal restrictions on the proceeds from the disposition of 
donated property and equipment (or of property and equipment purchased 
with cash restricted for acquisition of long-lived assets) are disclosed.
6.08 Financial statement presentation of supplies and other assets of 
health care organizations is similar to that of other business organizations.
Auditing
6.09 Auditing objectives for property and equipment, supplies, and other 
assets of health care organizations are similar to those in audits of other 
business organizations. The auditor may be able to assess inherent risk for 
these accounts as being relatively low because the transactions therein are 
generally small in number, relatively simple in nature, and do not involve the 
use of complex estimates. The auditor should consider the characteristics of the 
entity and of the transactions occurring during the period when assessing 
inherent risk for these accounts.
6.10 A health care organization may have access to the use of property 
and equipment under a variety of arrangements. It may (a) own property and 
equipment, (b) rent property and equipment from an independent or related 
organization, (c) use property and equipment provided by a related organiza­
tion (such as a religious order) or by an unrelated organization under an 
affiliation program, or (d) use property and equipment provided by a govern­
ment agency or unit or a government-related hospital district. The inde­
pendent auditor should inquire into (and the financial statements should 
disclose) the nature of any relationship between the health care organization 
and lessors, bailors, or other owners of property. With respect to leases, FASB 
Statement No. 13, Accounting for Leases, as amended and interpreted, pro­
vides accounting guidance.2 GASB Statement No. 13, Accounting for Operat­
ing Leases with Scheduled Rent Increases, provides additional guidance for 
operating leases of governmental health care enterprises.
6.11 In evaluating capitalization policies, the independent auditor should 
consider whether interest has been capitalized in accordance with the provisions 
of FASB Statement No. 34, Capitalization o f Interest Cost, and related amend­
ments and FASB Statement No. 62, Capitalization o f Interest Cost in Situations 
Involving Certain Tax-Exempt Borrowings and Certain Gifts and Grants.
2 For governmental health care enterprises, National Council on Governmental Accounting 
(NCGA) Statement No. 5, Accounting and Financial Reporting Principles for Lease Agreements of 
State and Local Governments, requires the application of FASB Statement No. 13 for proprietary 
activities and provides additional guidance on specific matters unique to governmental entities.
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement amends GASB Statement No. 13 and NCGA 
Statement No. 5. A brief summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 
1.11 in this Guide. This chapter will be modified to conform to the requirements of GASB Statement 
No. 34 in a future edition of this Guide.
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6.12 In evaluating the entity’s depreciation policies, the auditor may wish 
to refer to the American Hospital Association’s Estimated Useful Lives of 
Depreciable Hospital Assets, which is revised periodically and sets forth plant 
asset classifications and the estimated useful lives of depreciable assets. The 
auditor also should be aware that social, economic, and scientific advances in 
the health care industry make obsolescence an important factor to be consid­
ered when evaluating depreciation policies and methods.
6.13 FASB Statement No. 121 requires that health care organizations 
review long-lived assets for impairment whenever events or changes in circum­
stances indicate that the carrying amount of the asset may not be recoverable. 
In considering a health care organization’s application of FASB Statement No. 
121, auditors should obtain an understanding of the policies and procedures 
used by management to determine whether all impaired assets have been 
properly identified. In addition to evaluating the entity’s procedures for iden­
tifying indicators of impairment, the auditor should consider information 
obtained during the audit in determining whether the health care organization 
has identified appropriate indicators of impairment. For example, a change in 
the use of a facility from an acute-care hospital to an ambulatory surgery 
center may require that the asset be reviewed for impairment using the 
method prescribed by FASB Statement No. 121.
6.14 The independent auditor may need to consider the examples of 
specific auditing objectives, selected control activities, and auditing procedures 
relating to property and equipment that are presented in exhibit 6.1.
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Exhibit 6.1
Auditing Considerations
Financial Statement Specific Auditing 
Assertions Objectives
Donated Property Equipment
Valuation Donated property 
and equipment is 
reported a t fair 
market value at 
the date of 
donation.
Selected Control 
Activities
Procedures 
ensure that the 
donation of 
property and 
equipment is 
known and 
recorded and 
that
documentation 
supports the 
determination of 
the fair market 
value.
Presentation and The receipt of 
disclosure donated property
and equipment is 
properly reported.
Property and Equipment Not Held for Use in Operations
Presentation and 
disclosure
Property and 
equipment not 
used for 
operations is 
reported 
separately.
Property records 
segregate 
property and 
equipment not 
used for 
operating 
purposes.
Property and Equipment Additions
Rights and 
obligations
The appropriate 
health care 
planning agency 
or other
regulatory agency 
approvals, if 
required, have 
been obtained for 
property and 
equipment 
additions.
Management 
regularly 
monitors 
compliance with 
health care 
planning agency 
regulations 
related to 
additions of 
property and 
equipment.
Auditing
Procedures
Review the 
documentation 
supporting the 
determination of 
the fair market 
value.
Review material 
donated property 
and equipment 
transactions to 
ensure the 
propriety of the 
reporting.
Determine that 
property held for 
nonoperating 
purposes is 
reported 
separately.
For material new 
construction, 
determine 
compliance with 
health care 
planning agency 
or other
regulatory agency 
requirements.
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Financial Statement Specific Auditing 
Assertions________ Objectives
Selected Control 
Activities
Additions are 
authorized in the 
capital budget.
Auditing
Procedures
Existence and 
valuation
Recorded 
property and 
equipment are 
owned by the 
entity and are 
carried a t the 
appropriate 
amounts.
Inventory of fixed 
assets is taken 
periodically. 
Detailed property 
records
periodically are 
reconciled to the 
recorded 
amounts.
Review a 
summary of 
property and 
equipment (cost 
and accumulated 
depreciation) 
including 
additions, 
deletions, and 
transfers.
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Chapter 7 
Current Liabilities, Tax Considerations, and 
Long-Term Obligations
Overview
7.01 Current liabilities may include notes payable to banks; the current 
portion of long-term debt; accounts payable; advances from and amounts 
payable to third-party payors for estimated and final reimbursement settle­
ments; refunds to and deposits from patients and others; deferred revenue; 
accrued salaries and payroll taxes; and other accruals such as pension or 
profit-sharing contributions, compensated absences, and income and other 
taxes. In addition, there may be a current portion of estimated malpractice 
costs and risk-contract recognized losses (see chapter 8).
7.02 Long-term obligations may include notes, mortgages, capital leases, 
bonds, and obligations under continuing care contracts. They also may include 
estimated malpractice cost and risk-contract recognized losses.
Accounting for Current Liabilities*
7.03 Accounting for current liabilities of health care organizations is similar 
to that of other business enterprises. Health care organizations are usually 
labor-intensive and provide employees with compensated absences, such as for 
holidays, vacations, and illnesses. Liabilities related to such absences are ac­
counted for in accordance with FASB Statement No. 43, Accounting for Compen­
sated Absences. Governmental health care entities should follow the guidance in 
GASB Statement No. 16, Accounting for Compensated Absences.
7.04 Liabilities related to postretirement benefits other than pensions 
should be accounted for in accordance with FASB Statement No. 106, Employ­
ers’ Accounting for Postretirement Benefits Other Than Pensions, and postem­
ployment benefits should be accounted for in accordance with FASB Statement 
No. 112, Employers’ Accounting for Postemployment Benefits. These two pro­
nouncements are not required to be applied by governmental health care enter­
prises. GASB Statement No. 12, Disclosure of Information on Postemployment 
Benefits Other Than Pension Benefits by State and Local Governmental Employ­
ers, however, does require certain disclosures about postemployment benefits.
Tax Considerations for Not-for-Profit Health 
Care Organizations
7.05 Health care organizations that are owned and operated by a state or 
local government are exempt from federal income tax pursuant to IRC sec. 115 
and also are exempt from the federal income tax filing requirements. Such 
organizations are exempt not only from regular federal income tax  but also
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement amends GASB Statement Nos. 12 and 16. A 
brief summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. 
This chapter will be modified to conform to the requirements of GASB Statement No. 34 in a future 
edition of this Guide.
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from the tax on unrelated business income. If  a health care entity is owned and 
operated by a separately constituted authority or other legal entity, the entity’s 
management should consider whether such authority or other legal entity is 
organized properly to preserve qualification of the tax exemption pursuant to 
IRC sec. 115. In some cases, state or local governmental entities will secure 
tax-exempt status as an IRC sec. 501(c)(3) organization. If such an exemption 
is secured, the entity may become subject to federal income tax and the related 
filing requirements on the same basis as other tax-exempt entities.
Tax-Exempt Entities
7.06 Nongovernmental not-for-profit health care organizations usually seek 
exemption from federal income tax under IRC sec. 501(a). Under IRC sec. 501(a), 
entities organized and operated exclusively for religious, charitable, or educational 
purposes, as described in IRC sec. 501(c)(3), are exempt from federal income taxes. 
The following are additional requirements for such entities:
a. No part of the entity’s net earnings, either directly or indirectly, 
inures to any private shareholder or individual.
b. No substantial part of the entity’s activities consists of carrying on 
propaganda or otherwise attempting to influence legislation. (IRC 
sec. 501(h) provides a limited exception to the general rule that public 
charities may not incur expenditures to influence legislation.)
c. The entity does not participate in, or intervene in, any political 
campaign on behalf of any candidate for public office.
7.07 The term charitable is used in IRC sec. 501(c)(3) in its generally 
accepted legal sense. Providing health care to the community is considered a 
charitable activity. Therefore, provided a health care entity is not organized or 
operated for the benefit of private interests (such as designated individuals, 
the founder or the founder’s family, shareholders of the entity, or persons 
controlled directly or indirectly by such private interests), it generally would 
qualify as an IRC sec. 501(c)(3) organization.
7.08 The Internal Revenue Service (IRS) has ruled that in order for a 
nursing home to establish its exemption as a public charitable organization 
under IRC sec. 501(c)(3), it must be operated to meet the primary needs of the 
elderly for housing, health care, and financial security. Operating for financial 
security generally means that an individual will be maintained in residence 
even if such individual can no longer pay residence fees.
Private Inurement
7.09 Under IRC sec. 501(c)(3) no part of the net earnings of the charitable 
organization shall inure to the benefit of any private shareholder or individual. 
A private shareholder or individual refers to a person or persons having a 
private or personal interest in the activities of the organization. The IRS has 
stated that physicians have a personal or private interest in the activities of a 
hospital and could be subject to the private inurement proscription.
Unrelated Business Income Tax
7.10 Although not-for-profit organizations may be exempt from federal 
income tax, they nevertheless may be subject to tax on unrelated business 
income. The objective of the tax on unrelated business is to place such activities
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on the same basis as that of taxable entities. Unrelated business income is the 
income from any regularly carried-on trade or business, the conduct of which 
is not substantially related to the exercise or performance of the organization’s 
tax-exempt purpose or function. The fact that proceeds from an activity are 
used exclusively for the entity’s tax-exempt purpose does not make the activity 
substantially related to its tax-exempt purpose or function. As is the case with 
most tax-related definitions, there are qualifications and exceptions. Some of 
the more significant exclusions from this tax include—
•  An annual specific deduction for certain limited activities.
•  Income from activities of which substantially all the work is performed 
by unpaid volunteers.
•  Income from activities carried on for the convenience of the entity’s 
patients, officers, or employees.
•  Dividends, interest, annuities, royalties, capital gains and losses, and 
rents from real property—with two major exceptions. The first excep­
tion is that income from investments that are debt-financed and 
otherwise not functionally related to the tax-exempt purpose is tax­
able. The second major exception makes taxable the interest, annui­
ties, royalties, and rents received from a controlled (80-percent-owned) 
taxable corporation or partnership unless this entity is engaged in an 
activity th a t would have been exempt if it were carried on directly by 
the not-for-profit organization.
Financial Statement Presentation
7.11 Financial reporting and disclosure requirements for current liabili­
ties and long-term obligations of health care organizations are the same as for 
other business organizations. In addition, with respect to CCRCs, the method 
of accounting for advance fees, the method of calculating the obligation to 
provide future services and use of facilities, and the refund policy for refund­
able fees are disclosed in the financial statements. Chapter 14 describes other 
disclosure requirements applicable to CCRCs. Taxable entities have the same 
financial reporting and disclosure requirements as other commercial enter­
prises. Tax-exempt entities should disclose their tax-exempt status.
Long-Term Debt
7.12 Significant sums of money are required to replace and upgrade 
buildings and expand the facilities of health care organizations. As a result, 
health care organizations are dependent on external sources of funds to satisfy 
their capital needs. Many health care organizations finance acquisitions, addi­
tions, and renovations with long-term debt.
7.13 In addition to serving as a financing source for government opera­
tions, tax-exempt debt frequently is issued by state and local governments on 
behalf of nongovernmental organizations (for example, not-for-profit organiza­
tions) to foster private-sector participation in certain desirable community 
activities such as the provision of health care services. Tax-exempt bonds 
usually can be issued to obtain a higher ratio of project financing (up to 100 
percent), a longer maturity period (up to thirty years), and a lower interest cost 
than  taxable bonds. The majority of tax-exempt bonds issued by health  care 
organizations are revenue bonds, which are bonds secured by a pledge of the 
entity’s revenues. General obligation bonds are secured by the revenues of 
the issuing authority.
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Financing Authorities
7.14 Because most providers legally cannot issue tax-exempt revenue 
bonds directly, a significant number of states have enacted legislation permit­
ting health care organizations to borrow funds for capital projects by issuing 
bonds through financing authorities. Financing authorities are authorized to 
issue tax-exempt bonds or other obligations and use the proceeds for the 
benefit of the health care organization. To obtain project financing, a health 
care organization sometimes is required by a financing authority to enter into 
a lease arrangement, a sublease arrangement, or both. At other times, a lease 
or sublease arrangement is not required.
7.15 When a financing authority issues tax-exempt bonds or similar debt 
instruments and uses the proceeds for the benefit of a health care organization, 
the obligation is reported as a liability in the organization’s balance sheet if the 
health care organization is responsible for repayment. In some cases, this 
obligation may take the form of a liability arising from a capital lease. If a 
health care organization has no obligation to make payments of principal and 
interest on the debt or capital or operating lease payments on related buildings 
or equipment, the organization should not reflect the liability on its balance 
sheet. In such circumstances, proceeds from the bond issue are reported as 
contributions from the sponsoring organization.
Assets Whose Use is Limited
7.16 Among the many provisions normally included in the bond inden­
tures of tax-exempt issues are the requirements to set aside funds annually 
from operations to ensure that bond principal, interest payments, and other 
requirements are met. The treatm ent of funds established under the terms of 
debt-financing instruments is discussed in paragraphs 1.16 and 1.17.
Advance Refundings
7.17 In an advance refunding, new debt is issued for the purpose of replacing 
an existing debt issue. Advance refundings enable providers to restructure their 
long-term liabilities, take advantage of reduced interest rates, or terminate restric­
tive bond covenants. The terms by which the debt may be satisfied legally and the 
related lien released without the debt necessarily being retired are spelled out in 
the debt instrument. Under the Tax Reform Act of 1986, bonds issued before 
January 1, 1986, may be advance refunded only twice. Bonds issued on or after 
that date may be advance refunded only once.
7.18 The accounting, financial reporting, and disclosure requirements for 
advance refundings entered into by health care organizations other than 
governmental entities are described in FASB Statements No. 4, Reporting 
Gains and Losses from Extinguishment of Debt (as amended), No. 125, Account­
ing for Transfers and Servicing of Financial Assets and Extinguishments o f 
Liabilities* and FASB Interpretation No. 39, Offsetting o f Amounts Related to
* The FASB has issued a Special Report, A  Guide to Implementation of Statement 125 on 
Accounting for Transfers and Servicing o f Financial Assets and Extinguishments o f Liabilities, Third 
Edition, to aid in understanding and implementing FASB Statement No. 125. The FASB currently 
has a project on its agenda to amend FASB Statement No. 125, which could also affect several of the 
questions and answers in this Special Report.
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Certain Contracts.1 Generally speaking, these entities are required to report 
any gain or loss resulting from an advance refunding as an extraordinary item 
in the financial statements of the period in which the refunding occurred. The 
accounting, financial reporting, and disclosure requirements for advance re­
fundings (and for current refundings) entered into by governmental health 
care entities are set forth in GASB Statements No. 23, Accounting and Finan­
cial Reporting for Refundings o f Debt Reported by Proprietary Activities, and 
No. 7, Advance Refundings Resulting in Defeasance o f D ebt.* Generally speak­
ing, governmental entities are required to amortize any gain or loss resulting 
from a current or advance refunding to interest expense over the shorter of the 
life of the new bonds or the remaining life of the old bonds.
7.19 There are several types of advance refundings, including net ad­
vance refundings, full cash advance refundings, and crossover refundings (see 
the Glossary). In a crossover refunding, because the old bonds are not defeased 
until the crossover date, no immediate gain or loss should be recognized. If the 
retirement dates of the old debt have been established, the call premium, 
unamortized premium or discount, and initial issue costs should be recognized 
systematically in the income statement over the remaining life of the old debt 
as an adjustment of the cost of borrowing related to the old debt. In addition, 
the income earned on the funds used to consummate the advance refunding 
and the interest expense on both the old and new debts should be recognized 
in the statement of operations. The funds used to consummate the advance 
refunding should be reported as an asset and both the old and new debts should 
be reported as liabilities. The assets and liabilities should not be offset.
7.20 FASB Statement No. 125** provides accounting and reporting stand­
ards for extinguishments of liabilities. Paragraph 16 of FASB Statement No. 
125 says a debtor should derecognize a liability if and only if it has been 
extinguished. Paragraph 16 says a liability has been extinguished if either of 
the following conditions is met:
a. The debtor pays the creditor and is relieved of its obligation for the 
liability. Paying the creditor includes delivery of cash, other financial 
assets, goods, or services or reacquisition by the debtor of its out­
standing debt securities whether the securities are canceled or held 
as so-called treasury bonds.
b. The debtor is legally released from being the primary obligor under 
the liability, either judicially or by the creditor [footnote omitted].
1 Emerging Issues Task Force (EITF) Issue No. 96-19, Debtor’s Accounting for a Modification or 
Exchange o f Debt Instruments, addresses accounting for modifications or exchanges of debt instru­
ments. EITF Issue 96-19 requires that (1) an exchange of debt instruments with substantially 
different terms is a debt extinguishment and should be accounted for in accordance with paragraph 
16 of FASB Statement No. 125; and (2) a substantial modification of terms should be accounted for 
like, and reported in the same manner as an extinguishment. Also, transactions involving the 
modification or exchange of debt instruments can only result in gain or loss recognition by the debtor 
if the conditions for extinguishment of debt described in paragraph 16 of FASB Statement No. 125 are 
satisfied or if the consensus in Issue No. 96-19 requires that accounting.
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement amends GASB Statement Nos. 7 and 23. A 
brief summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. 
This chapter will be modified to conform to the requirements of GASB Statement No. 34 in a future 
edition of this Guide.
** The FASB has issued a Special Report, A  Guide to Implementation of Statement 125 on 
Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities, Third 
Edition, to aid in understanding and implementing FASB Statement No. 125. The FASB currently 
has a project on its agenda to amend FASB Statement No. 125, which could also affect several of the 
questions and answers in this Special Report.
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7.21 Paragraph 17b of FASB Statement No. 125 requires that, if an entity 
had debt that was considered to be extinguished by an in-substance defeasance 
under the provisions of FASB Statement No. 76 prior to the effective date of 
FASB Statement No. 125, the entity should provide a general description of the 
transaction and the amount of debt that is considered extinguished at the end 
of the period so long as that debt remains outstanding.
Arbitrage Rebate Liabilities
7.22 Advance refundings involving tax-exempt debt are subject to arbi­
trage rules under the IRC sec. 103(c) and related regulations that, in general, 
prohibit the yield realized from the investment of the proceeds of the new debt 
from exceeding the yield on the debt itself. Compliance with those rules is 
necessary for the interest on the debt to be exempt from federal income tax and, 
possibly, from state and local tax.
7.23 Whenever a provider invests tax-exempt bond proceeds and the 
ultim ate yield is higher than the interest rate on the bonds, the provider may 
be subject to an arbitrage rebate liability. The arbitrage determination is made 
as of the date of the issue; however, intentional acts undertaken after the date 
of the issue can disqualify the issue retroactively. The earnings in excess of 
interest expense represent a liability that must be paid to the U.S. Treasury in 
order for the bonds to maintain their tax-exempt status. The arbitrage rebate 
liability may be a substantial amount if the bond proceeds are not spent as 
quickly as planned. For example, this may occur if a provider encounters a 
delay in a major construction project.
Auditing
7.24 Auditing objectives and procedures for long-term debt issued by 
health care organizations generally are similar to those of other organizations. 
In addition, the independent auditor may need to consider the examples of 
specific auditing objectives, selected control activities, and auditing procedures 
th a t are presented in exhibit 7.1.
Paragraph 84 of FASB Statement No. 125 provides related guidance.
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Exhibit 7.1
Auditing Considerations
Financial Statement Specific Auditing 
Assertions________ Objectives
Tax-Exempt Debt
Presentation and 
disclosure
Amounts related 
to tax-exempt 
debt are properly 
classified in the 
financial 
statements and 
related
disclosures are 
adequate.
Selected Control 
Activities
Procedures 
ensure that the 
providers 
monitor their 
compliance with 
restrictive debt 
covenants.
Auditing
Procedures
Review the debt 
instruments for 
the presence of 
any restrictive 
debt covenants.
Test compliance 
with restrictive 
debt covenants.
Income Taxes
Rights and 
obligations
The not-for-profit 
organization has 
obtained a 
qualifying income 
tax exemption 
from the 
governmental 
authority.
Management 
monitors 
compliance with 
applicable tax 
regulations.
Transactions are 
reviewed for 
their effect on tax 
status and tax 
liabilities.
Determine that 
the not-for-profit 
organization has 
obtained a 
determination of 
its tax-exempt 
status.
Inquire if tax 
returns have been 
filed on a timely 
basis.
Determine the 
status of the tax 
returns under 
examination.
Read the prior 
years’ tax returns.
Read the minutes 
and the 
accounting for 
evidence of 
significant 
unrelated 
business activities.
Review for 
reasonableness
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Financial Statement
Assertions
Presentation and 
disclosure
Specific Auditing Selected Control 
Objectives Activities
The entity’s 
tax-exempt status 
and its tax 
contingencies are 
disclosed in the 
notes to the 
financial 
statements.
Auditing
Procedures
the unrelated 
business income 
tax liability.
Determine that 
the entity’s 
tax-exempt status 
is disclosed in the 
notes to the 
financial 
statements.
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Chapter 8 
Commitments and Contingencies
Overview
8.01 Commitments and contingencies may include (a) losses arising from 
litigation, including malpractice and other claims; (b) contingencies related to 
risk contracting; (c) third-party payment and rate-setting programs; (d) con­
struction contract commitments; (e) the Hill-Burton Act obligation to provide 
uncompensated care; (f) commitments and guarantees that include contractual 
agreements with physicians, specialists, and others who perform services by 
arrangement with health care organizations; and (g) commitments and contin­
gent liabilities related to pension plans, operating leases, purchase commit­
ments, and loan guarantees.
8.02 FASB Statement No. 5, Accounting for Contingencies, as amended 
and interpreted, and FASB Interpretation No. 14, Reasonable Estimation o f 
the Amount o f a Loss, provide guidance on accounting for contingencies. FASB 
Statement No. 60, Accounting and Reporting by Insurance Enterprises, dis­
cusses accounting for claims costs, including estimates of costs relating to 
IBNR claims. Governmental health care entities should consider the account­
ing and disclosure requirements of GASB Statement No. 10, Accounting and 
Financial Reporting for Risk Financing and Related Insurance Issues, as 
amended by GASB Statement No. 30, Risk Financing Omnibus, and Interpre­
tation No. 4, Accounting and Financial Reporting for Capitalization Contribu­
tions to Public Entity Risk Pools.*
Medical Malpractice Claims
8.03 The extent of risk transfer is key in determining whether a liability 
should be recognized in a provider’s financial statements pertaining to mal­
practice claims. The existence of an insurance policy, by itself, is no assurance 
that the risk of financial loss is transferred.
8.04 If the entity has purchased a claims-made insurance policy (see 
paragraph 8.13), there is no transfer of risk for claims not reported to the 
insurance carrier within the policy term. With regard to retrospectively rated 
insurance policies (see paragraphs 8.14 and 8.15) and policies by captive 
insurance companies (see paragraphs 8.16 through 8.19), the economic sub­
stance of the terms of the insurance policy may more closely resemble a claims 
funding mechanism than an instrument th a t transfers risk of loss to an 
external third party. If the health care organization has not transferred risk to 
an external third party, it should evaluate its exposure to losses arising from 
malpractice claims and record a liability, if appropriate.
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, GASB Statement No. 34 amends GASB Statement No. 10. 
A brief summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this 
Guide. This chapter will be modified to conform to the requirements of GASB Statement No. 34 in a 
future edition of this Guide.
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Accruing Malpractice Liabilities
8.05 The ultimate costs of malpractice claims, which include costs associ­
ated with litigating or settling claims, are accrued when the incidents th a t give 
rise to the claims occur. Estimated losses from asserted and unasserted claims 
are accrued either individually or on a group basis, based on the best estimates 
of the ultimate costs of the claims and the relationship of past reported 
incidents to eventual claims payments. All relevant information, including 
industry experience, the entity’s own historical experience, the entity’s existing 
asserted claims, and reported incidents, is used in estimating the expected 
amount of claims. The accrual includes an estimate of the losses that will result 
from unreported incidents, which are probable of having occurred before the 
end of the reporting period.
8.06 In estimating the probability that unreported incidents have oc­
curred, some health care organizations may develop a range of possible esti­
mates of the number of unreported incidents, including zero. However, the 
greater the volume of a health care organization’s operations, the greater the 
likelihood that the organization’s minimum estimate of the number of probable 
unreported incidents will be greater than zero.
8.07 If it is probable that a loss has been incurred and the information 
available indicates the loss is within a range of amounts, the most likely 
amount of loss in the range is accrued. If no amount in the range is more likely 
than any other, the minimum amount in the range is accrued. The potential 
additional loss is disclosed if there is at least a reasonable possibility of a loss 
in excess of the amount accrued.
8.08 In estimating losses from malpractice claims, a health care organi­
zation may need to modify data drawn from industry experience so it is 
relevant to developing an estimate that is specific to the organization. Various 
factors (such as the nature of operations, size, and the provider’s past experi­
ence) are considered in assessing comparability. Further, industry data that 
are not current may not be relevant.
8.09 Estimated losses are reviewed and changed, if necessary, a t each 
reporting date. The amounts of the changes are recognized currently as addi­
tional expense or as a reduction of expense.
8.10 Accrued unpaid claims and expenses that are expected to be paid 
during the normal operating cycle (generally within one year of the date of the 
financial statements) are classified as current liabilities. All other accrued 
unpaid claims and expenses are classified as noncurrent liabilities.
8.11 A health care organization discloses its program of medical malprac­
tice insurance coverages and the basis for any related loss accruals. If the 
organization cannot estimate losses relating to a particular category of mal­
practice claims (for example, asserted claims, reported incidents, or unreported 
incidents) in accordance with paragraphs 8.03 through 8.10, the potential 
losses related to that category of claims are not accrued. However, the contin­
gency is disclosed in the notes to the financial statements, as required by FASB 
Statement No. 5.
8.12 Health care organizations that discount accrued malpractice claims 
should disclose in the notes to the financial statements the carrying amount of 
accrued malpractice claims that are discounted in the financial statements and 
the interest rate or rates used to discount those claims. Also, the FASB has 
issued FASB Concepts Statement No. 7, Using Cash Flow Information and 
Present Value in Accounting Measurements. This Concepts Statement provides
AAG-HCO 8.05
Commitments and Contingencies 91
useful discussion of general principles governing the use of present value, and 
of the objective of present value in accounting measurements. Statements of 
Financial Accounting Concepts are not sources of established accounting prin­
ciples as described in SAS No. 69, The Meaning o f Present Fairly in Conformity 
with Generally Accepted Accounting Principles in the Independent Auditor’s 
Report, and, thus, do not amend, modify, or justify a change from generally 
accepted accounting principles currently in effect.
Accounting for Claims-Made Insurance Policies and 
Tail Coverage
8.13 A claims-made insurance policy represents a transfer of risk within 
the policy limits to the insurance carrier for asserted claims and incidents 
reported to the insurance carrier. The policy, however, does not represent a 
transfer of risk for claims and incidents not reported to the insurance carrier 
during the policy period. Consequently, a health care organization th a t is 
insured under a claims-made insurance policy recognizes the estimated cost of 
those claims and incidents not reported to the insurance carrier, in accordance 
with paragraphs 8.03 through 8.10. This estimation is done unless the health 
care organization has bought tail coverage (see the Glossary) and included the 
cost of the premium as an expense in the financial statements for that period.
Accounting for Retrospectively Rated Premiums
8.14 A health care organization with a retrospectively rated insurance 
policy whose ultimate premium is based primarily on the health care organi­
zation’s loss experience accounts for the minimum premium as an expense over 
the period of coverage under the policy and accrues estimated losses from 
asserted and unasserted claims in excess of the minimum premium, as indi­
cated in paragraphs 8.03 through 8.10. Such estimated losses, however, are not 
accrued in excess of a stipulated maximum premium. If the health care 
organization cannot estimate losses from asserted or unasserted malpractice 
claims, as indicated in paragraphs 8.03 through 8.10, the health care organi­
zation should disclose the existing contingency in the notes to the financial 
statements, as required by FASB Statement No. 5.
8.15 A health care organization insured under a retrospectively rated 
policy whose ultimate premium is based primarily on the experience of a group 
of health care organizations amortizes the initial premium to expense on a pro 
ra ta  basis over the policy term. The organization also accrues additional 
premiums or refunds on the basis of the group’s experience to date, which 
includes a provision for the ultimate cost of asserted and unasserted claims 
before the financial statement date, whether reported or unreported. The 
health care organization discloses that (a) it is insured under a retrospectively 
rated policy and (b) premiums are accrued based on the ultimate cost of the 
experience to date of a group of organizations. If the health care organization 
cannot estimate losses from asserted or unasserted malpractice claims, as 
indicated in paragraphs 8.03 through 8.10, it should disclose the existing 
contingency in the notes to the financial statements, as required by FASB 
Statement No. 5.
Accounting for Medical Malpractice Claims Insured by 
Captive Insurance Companies
8.16 A majority-owned captive insurance company (for example, a wholly 
owned captive) is consolidated in accordance with FASB Statem ent No. 94,
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Consolidation o f All Majority-Owned Subsidiaries.* Multi provider captives, in 
which the ownership percentage is 50 percent or less, are accounted for in 
accordance with APB Opinion No. 18, The Equity Method o f Accounting for 
Investments in Common Stock.
 
8.17 A health care organization insured by an unconsolidated multi 
provider captive insurance company for medical malpractice claims under a 
retrospectively rated insurance policy whose ultimate premium is based pri­
marily on the health care organization’s experience up to a maximum pre­
mium, if any, accounts for such insurance as indicated in paragraph 8.14.
8.18 A health care organization insured by an unconsolidated multi 
provider captive insurance company for medical malpractice claims under a 
retrospectively rated policy based primarily on the experience of a group of 
health care organizations accounts for such insurance as indicated in para­
graph 8.15. However, the health care organization considers whether the 
economic substance of the multi provider captive insurance company is suffi­
cient to relieve the health care organization from further liability. The health 
care organization should disclose that (a) it is insured under a retrospectively 
rated policy of a multi provider captive insurance company and (b) the premi­
ums are accrued based on the captive insurance company’s experience to date.
8.19 A health care organization that is insured by a multi provider captive 
insurance company discloses in its financial statements that it is insured by 
such a company, and it should disclose its ownership percentage, if significant, 
in the captive company as well as the method of accounting for its investment 
in, and the operations of, the captive company. In addition, if the health care 
organization cannot make the necessary estimates of losses from asserted or 
unasserted claims, as indicated in paragraphs 8.03 through 8.10, the health 
care organization discloses the existing contingency in the notes to the finan­
cial statements, as required by FASB Statement No. 5.
Accounting for Trust Funds
8.20 In general, a trust fund, whether legally revocable or irrevocable, is 
included in the financial statements of the health care organization. A portion 
of the fund equal to the amount of assets expected to be liquidated to pay 
malpractice claims classified as current liabilities is classified as a current 
asset; the balance of the fund, if any, is classified as a noncurrent asset. 
Revenues and administrative expenses of the trust fund are included in the 
statem ent of operations (see chapter 10). In some circumstances, the foregoing 
may not be possible (for example, if a common trust fund exists for a group of 
health care organizations; if the health care organization is part of a common 
municipality risk-financing internal service fund; or if the legal, regulatory, or 
indenture restrictions prevent the inclusion of a trust fund in a health care 
organization’s financial statements). In those circumstances, the provisions of 
paragraphs 8.21 and 8.22 apply.
8.21 In general, estimated losses from asserted and unasserted claims are 
accrued and reported, as indicated in paragraphs 8.03 through 8.12. The 
estimated losses are not based on payments to the trust fund. However, 
accounting for a health  care organization th a t participates in a pooled fund
* On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 15 , 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and amend APB Opinion 18.
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depends on the extent to which the associated risks and rewards have been 
transferred to another party. An organization that transfers its risk of loss to 
the common trust fund and forfeits its rights to any excess funding should 
expense its contributions and account for its participation in the trust fund 
based on the type of coverage obtained (for example, occurrence basis, claims- 
made, or retrospectively rated). Governmental health care entities that are 
component units of a state or local government reporting entity and that 
participate in th a t entity’s risk-financing internal service fund should report 
claims expenses equal to the charges from the internal service fund if those 
charges meet the requirements of paragraphs 65 through 68 of GASB State­
ment No. 10.*
8.22 The existence of the trust fund and whether it is irrevocable is 
disclosed in the financial statements.
Governmental Health Care Enterprises*
8.23 Governmental health care enterprises that are component units of a 
state or local governmental reporting entity and that participate in that 
entity’s risk-financing internal service fund should report claims expenses 
equal to the charges from the internal service fund if those charges meet the 
requirements of paragraphs 65 through 68 of GASB Statement No. 10. A 
governmental health care enterprise that participates in a public entity risk 
pool with transfer or pooling of risk should present its premium or required 
contribution as insurance expense, as discussed in GASB Statement No. 10, 
paragraphs 69 and 70. Enterprises participating in public entity risk pools 
without transfer or pooling of risk should report payments to pools as deposits 
and recognize and measure claims liabilities in accordance with GASB State­
ment No. 10, paragraphs 53 through 58.
Auditing Commitments and Contingencies
8.24 Auditing objectives and procedures for commitments and contingen­
cies generally are similar to those of other organizations. The independent 
auditor may need to consider the specific auditing objectives, selected control 
activities, and auditing procedures presented in exhibit 8.1 at the end of this 
chapter.
Auditing Medical Malpractice Loss Contingencies
8.25 The existence of an insurance policy, by itself, is no assurance that 
malpractice contingencies are assumed by others. The auditor should review 
the insurance contracts and determine the extent of the risk retained by the 
provider. Specific auditing procedures to consider include the following:
•  Determine the type (such as occurrence basis or claims-made) and 
level (per occurrence or in the aggregate) of insurance protection the 
provider has obtained.
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, GASB Statement No. 34 amends GASB Statement No. 10. 
A brief summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this 
Guide. This chapter will be modified to conform to the requirements of GASB Statement No. 34 in a 
future edition of this Guide.
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•  Determine i f  the coverage actually transfers the malpractice risks. Is 
the insurance with a related party (for example, a captive insurance 
company)? Does it  provide for retrospective premiums or similar 
adjustments?
Once the extent of the risk retained is understood, the auditor will be able to 
determine the nature, extent, and timing of other auditing procedures.
8.26 I f  a health care organization has transferred the risk of loss to a 
financially viable third party by purchasing insurance coverage of sufficient 
limits on an occurrence basis, no additional auditing procedures are necessary. 
I f  the organization retains all or a portion of the risk through self-insurance or 
has purchased a claims-made policy, the independent auditor should perform 
additional auditing procedures to obtain reasonable assurance that the organi­
zation’s accounting for medical malpractice losses is in accordance with GAAP.
8.27 The independent auditor should consider the extent to which the 
renewal of a claims-made policy or the purchase of tail coverage after the 
balance-sheet date but before the auditor’s report is issued limits the entity’s 
liability exposure as of the balance-sheet date. I f  an entity either renews a 
claims-made policy or purchases tail coverage, and the new policy covers claims 
asserted during the new policy term (regardless of when the incident occurred), 
the entity has transferred to the insurer the risk for that portion of the entity’s 
claims that is expected to be reported during the new policy term (up to the new 
policy limits). Accordingly, the entity’s liability for the IBNR claims transferred 
would not exceed the premium on the new policy, except for anticipated claims 
in excess of the new policy limits.
8.28 Management’s intent to renew a claims-made policy is not sufficient 
to constitute a lim it on IBNR claims as of the balance-sheet date unless 
management contractually obligates itself for renewal before the issuance date 
of the financial statements and the cost is expensed in the period covered by 
the financial statements. The requirement to renew a claims-made policy or to 
purchase and expense tail coverage applies even i f  state regulations require 
that renewal of claims-made coverage be offered continually.
8.29 I f  the insured has the unilateral option to purchase tail coverage at 
a premium that may not exceed a stipulated maximum, and the provider 
intends to purchase that coverage, the amount of IBNR loss to be accrued may 
effectively be limited to the maximum tail-coverage premium stated in the 
policy. However, providers in these circumstances that do not intend to pur­
chase tail coverage may not accrue the cost of obtaining that coverage as a 
substitute for the IBNR accrual.
Auditing Accounting Estimates
8.30 Management is responsible for making the accounting estimates 
that are included in the financial statements. Management is also responsible 
for providing proper disclosure of (1) the use of estimates in the preparation of 
financial statements and (2) certain significant estimates (SOP 94-6, Disclo­
sure o f Certain Significant Risks and Uncertainties).1 The auditor is responsi­
ble for evaluating the reasonableness of management’s estimates and the 
adequacy of the related disclosures. The auditor does this using one or more of 
the following approaches:
1 See paragraphs 8.40 through 8.43. SOP 94-6 does not pertain to governmental entities unless 
the entity has elected to follow all FASB pronouncements under paragraph 7 of GASB Statement No.
20, Accounting an d  Financial Reporting fo r  Proprietary Funds an d  Other Governmental Entities That 
Use Proprietary Fund Accounting. (See chapter 1, footnote 1.)
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a. Test the process used by management to develop the estimate.
b. Develop an independent expectation of the estimate to corroborate 
the reasonableness of management’s estimate.
c. Review subsequent events or transactions occurring prior to comple­
tion of fieldwork.
8.31 In evaluating management’s estimates of asserted and unasserted 
claims, the auditor should consider factors such as management’s description 
and evaluation of asserted claims and unasserted claims arising from reported 
incidents; the lawyer’s (and, if appropriate, the outside risk manager’s) assess­
ment of asserted claims and reported incidents not covered by insurers; and 
the actuary’s evaluations of the aggregate liability covering asserted claims 
and unasserted claims arising from reported and unreported incidents.
8.32 Written assurances should be obtained from management that it has 
disclosed all such matters required to be disclosed by FASB Statement No. 5.
8.33 In evaluating the information provided by legal counsel, it may be 
necessary to supplement the written representations with inquiries if the 
representations are not clear regarding the probability of the litigation out­
come or the potential range of loss.2
8.34 The auditor should consider the frequency of losses due to unre­
ported incidents and the magnitude of prior losses and underlying causes for 
the IBNR claims. If there is a basis for an accrual, the auditor should then 
determine whether the entity’s prior history supports the estimation of the 
number of claims and the probable settlement value.
Use of Actuaries and Actuarial Methods
8.35 An actuary may be engaged to provide or review the estimate of the 
medical malpractice loss amount or range of amounts or to assist in developing 
certain factors and assumptions used in estimating the malpractice liability. 
The decision to use an actuary should be based on a consideration of whether 
(a) the estimated claim liability is potentially material to the fair presentation 
of financial statements in conformity with GAAP and (b) special knowledge is 
required to estimate the claim liability.
8.36 If an actuary is involved in a substantial way in determining the 
amount of a provider’s malpractice self-insurance liability, the independent 
auditor should follow the requirements of SAS No. 73, Using the Work o f a 
Specialist (AICPA, Professional Standards, vol. 1, AU sec. 336). The inde­
pendent auditor should consider the actuary’s professional qualifications, 
reputation, prior experience in estimating malpractice claim losses, and rela­
tionship to the client. There should be an understanding among the auditor, 
the client, and the actuary of the objectives and scope of the analysis and the 
methods and assumptions used. The independent auditor should be aware of 
(a) the limitations of assurances in actuarial calculations due to uncertainties
2 According to SAS No. 12, Inquiry o f a Client’s Lawyer Concerning Litigation, Claims, and 
Assessments (AICPA, Professional Standards, vol. 1, AU sec. 337), a letter of audit inquiry to the 
lawyer handling the claims is the auditor’s primary means of obtaining corroboration of the informa­
tion furnished by management concerning claims made and known incidents for which claims have 
not been made that are either uninsured or in excess of the insurance coverage. Audit inquiry letters 
generally would not be required with respect to reported contingencies that were not considered to 
have a material potential loss. The inability or unwillingness of counsel to evaluate asserted claims 
and or reported incidents would give rise to a modification of the auditor’s opinion.
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and (b) restrictions as to the use of the actuarial reports. The independent 
auditor is responsible for determining the adequacy of the actuary’s report for 
purposes of corroborating the representations in the financial statements. The 
independent auditor should perform an appropriate test of the accounting data 
provided by the client to the actuary. Such accounting data may include 
historical claim experience, policy terms (such as coverage, expiration, deduct­
ibles, presence of retrospectively determined premiums, and indemnity limita­
tions), exposure data (such as the number of beds, high-risk medical 
specialties, outpatient visits, and emergency room visits), and information 
about risk management systems, personnel, and procedures.
8.37 An accrual for malpractice losses should be based on estimated 
ultimate losses and costs associated with settling claims. Accruals should not 
be based on recommended funding amounts, which in addition to a provision 
for the actuarially determined liability also includes a provision for (a) credit 
for investment income and (b ) a margin for risk of adverse deviation. The 
following are examples of factors to consider and adjustments that may be 
required to convert actuarially determined malpractice funding amounts to an 
appropriate loss accrual to be reported in the financial statements:
•  The risk of adverse deviation is an additional cost factor applied to 
bring a funding requirement to a selected confidence level. This factor 
does not meet the criteria for recognition as a liability in accordance 
with FASB Statement No. 5.
•  An evaluation should be made of the extent and validity of industry 
data when the credibility factor actuarial technique is used. The lower 
the credibility factor, the greater the blending of industry data. This 
may create an unacceptable level of industry data at lower confidence 
levels. Further, a low credibility factor may indicate that provider-spe­
cific data is not sufficient to support the claims liability estimation 
process.
•  A review of the discounting approach used is necessary to develop the 
required disclosure. The impact on the discounting calculation of any 
other adjustment made to the actuarially determined amounts (such 
as risk of adverse deviation or the credibility of the risk management 
system) has to be evaluated.
•  A review of the expenses included in the loss estimation process should 
be made. Such expenses include the expense of settlement and litiga­
tion (that is, allocated loss adjustment expenses).
8.38 Limitations on the availability of provider-specific data, lack of a suffi­
cient patient population for claims projection purposes, a very low credibility 
factor, and a variety of other factors may cause the actuary’s estimate of loss to be 
of limited value in developing an estimate of the liability under GAAP.
Risks and Uncertainties
8.39 Uncertainties arise when the evidence available is insufficient for a 
reasonable estimation of the effects of the outcome of a particular future event 
on the current financial statements. Normally, the resolution of the uncer­
tainty is prospective, and sufficient evidence cannot be expected to exist at the 
time of the audit. In these situations, it cannot be determined what adjust­
ments, if any, to the financial statements may be appropriate. The existence of 
such an uncertainty, if material, ordinarily should result in the inclusion of an 
explanatory paragraph in the auditor’s report. In certain circumstances, the
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possible effects of the uncertainty on the financial statements may be so 
pervasive that the balance of the financial statements has little meaning. In 
these cases, a disclaimer of opinion may be appropriate.
8.40 SOP 94-6 requires entities to include in their financial statements 
information about—
a. The nature of their operations.
b. Use of estimates in the preparation of financial estimates.
In addition, if certain specified disclosure criteria are met, it requires entities 
to include in their financial statements disclosures about—
a. Certain significant estimates.
b. Current vulnerability due to certain concentrations.
8.41 Paragraph 18 of SOP 94-6 gives examples of items that may be based 
on estimates that are particularly sensitive to changes in the near term. 
Examples of similar estimates that may be included in financial statements of 
health care organizations include, but are not limited to, the following:
•  Third-party revenue and related receivables
•  Assets subject to impairment, for example, goodwill
•  Environmental remediation-related obligations
•  Litigation-related contingencies, for example, fraud and abuse actions 
by regulators
•  Estimated risk pool settlements arising from managed care contracting
•  Amounts reported for long-term obligations such as amount reported 
for pensions and postemployment benefits
•  Estimated net proceeds recoverable, the provisions for expected loss 
to be incurred, or both, on disposition of a business or assets
8.42 SOP 00-1 provides guidance to auditors regarding uncertainties 
inherent in health care revenue recognition. Examples of risks unique to the 
government-contracting environment are presented in paragraph 7 of the SOP. 
SOP 00-1 is effective for audits of periods ending on or after June 30, 2000. 
Also, in the health care environment, it is almost always at least reasonably 
possible that estimates regarding third-party payments could change in the 
near term as a result of one or more future confirming events (for example, 
regulatory action reflecting local or national audit or enforcement initiatives). 
For most entities with significant third-party revenues, the effect of the change 
could be material to the financial statements. Where material exposure exists, 
the uncertainty regarding revenue realization is disclosed in the notes to the 
financial statements.3
8.43 Examples of concentrations that may meet the criteria that require 
disclosure in the financial statements of health care organizations in accord­
ance with paragraph 21 of the SOP include the following:
•  Concentrations in the volume of business transacted with a particular 
payor, supplier, lender, grantor, or contributor
•  Concentrations in revenue from particular products, services, or fund­
raising events
3 A sample disclosure is provided in SOP 00-1 that among other things indicates laws and 
regulations governing the Medicare and Medicaid programs are extremely complex and subject to 
interpretation. As a result, there is at least a reasonable possibility that recorded estimates will 
change by a material amount in the near term. SOP 00-1 is included as appendix E to this Guide.
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•  Concentrations in the available sources of supply of material, labor, or 
services, or of licenses or other rights used in the entity’s operations
•  Concentrations in the market or geographic area in which an entity 
conducts its operations
Evaluating Lawyers' Responses
8.44 Determining the outcome of pending or threatened litigation, claims 
and assessments (including unasserted claims and assessments) normally is 
beyond the auditor’s professional competence. Accordingly, the auditor’s evalu­
ation of the need for disclosures or report modifications is based primarily on 
the opinion of the lawyer handling the matter. The American Bar Association 
(ABA) has adopted a Statement of Policy Regarding Lawyers’ Responses to 
Auditors’  Requests for Information under which lawyers accept certain respon­
sibility for responses to auditors’ inquiries. However, the ABA Statement of 
Policy is not enforceable by the ABA in the same way the AICPA is able to 
enforce its standards under the accounting profession’s Code of Professional 
Conduct. As a result, lawyers’ responses may vary widely.
8.45 Interpretation No. 7 of SAS No. 12, entitled “Assessment of a Law­
yer’s Evaluation of the Outcome of Litigation” (AICPA, Professional Stand­
ards, vol. 1, AU sec. 9337.18-.22) includes the following examples of 
evaluations of litigation, which may be considered to communicate in a suffi­
ciently clear manner a remote likelihood of an unfavorable outcome:
•  “We are of the opinion that this action will not result in any liability 
to the company.”
•  “It is our opinion that the possible liability to the company in this 
proceeding is nominal in amount.”
•  “We believe the company will be able to defend this action successfully.”
•  “We believe that the plaintiffs case against the company is without 
merit.”
•  “Based on the facts known to us, after a full investigation, it is our 
opinion that no liability will be established against the company in 
these suits.”
8.46 On the other hand, the lawyer may use terms, such as meritorious 
defenses, that have different meanings to different lawyers. The Interpretation 
includes the following examples of lawyers’ evaluations that are unclear re­
garding the likelihood of an unfavorable outcome:
•  “This action involves unique characteristics wherein authoritative 
legal precedents do not seem to exist. We believe that the plaintiff will 
have serious problems establishing the company’s liability under the 
act; nevertheless, if the plaintiff is successful, the award may be 
substantial.”
•  “It is our opinion that the company will be able to assert meritorious 
defenses to this action.” (The term “meritorious defenses” indicates 
that the company’s defenses will not be summarily dismissed by the 
court; it does not necessarily indicate the lawyer’s opinion that the 
company will prevail.)
•  “We believe the action can be settled for less than the damages 
claimed.”
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•  “We are unable to express an opinion as to the merits of the litigation 
at this time. The company believes there is absolutely no merit to the 
litigation.” (If the company’s lawyer, with the benefit of all relevant 
information, is unable to conclude that the likelihood of an unfavorable 
outcome is “remote”, it is unlikely that management would be able to 
form a judgment to that effect.)
•  “In our opinion, the company has a substantial chance of prevailing in 
this action.” (A “substantial chance”, a “reasonable opportunity”, or 
similar terms indicate more uncertainty than an opinion that the 
company will prevail.)
8.47 When the lawyer’s response is unclear, the auditor may request a 
conference to clarify the lawyer’s opinion. If the response is still unclear or the 
materiality of the uncertainty cannot be determined, the auditor should con­
sider the guidance in paragraphs 29 through 32 of SAS No. 58, Reports on 
Audited Financial Statements, as amended by SAS No. 79, Amendment to 
Statement on Auditing Standards No. 58, Reports on Audited Financial State­
ments (AICPA, Professional Standards, vol. 1, AU sec. 508).
Auditing
8.48 The independent auditor may need to consider the examples of 
specific auditing objectives, selected control activities, and auditing procedures 
for commitments and contingencies that are presented in exhibit 8.1.
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Exhibit 8.1
Financial Statement 
Assertions
Auditing Considerations
Specific Auditing 
Objectives
Malpractice Loss Contingencies
Existence and 
occurrence, 
completeness, 
rights and 
obligations, and 
valuation
The liability for 
malpractice 
claims is reported 
properly in the 
balance sheet.
Selected Control 
Activities
Insurance 
coverage is 
reviewed 
regularly, 
including the 
financial viability 
of the insurer.
The risk 
management 
system identifies 
and monitors 
malpractice 
incidents and 
evaluates 
associated losses.
Outside legal 
counsel and 
insurance 
carriers review 
and monitor all 
claims.
The adequacy of
malpractice
accruals is
reviewed
regularly by
management,
including
information
obtained from
qualified
specialists.
Information
supplied to
specialists is
reviewed for
accuracy and
completeness.
Actuarial
assumptions are
Auditing
Procedures
Review the 
amount of 
insurance 
coverage, the type 
of coverage 
(claims-made or 
occurrence), the 
deductible 
provisions, and so 
forth, to 
determine the 
level of risk that 
is retained by the 
entity. Consider 
the financial 
viability of the 
insurance carrier.
Send letters of 
inquiry to 
malpractice 
insurance carriers 
and legal counsel 
(in accordance 
with SAS No. 12).
Review and test 
the method of 
estimating 
accruals (for 
example, review 
actuarial reports 
and prior 
historical loss 
experience).
Determine that 
additional 
premiums 
charged by 
insurers for 
retrospectively 
related policies
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Assertions
Presentation and 
disclosure
Specific Auditing Selected Control 
Objectives Activities
reviewed for 
compliance with 
GAAP.
Changes in the 
risk management 
system are 
communicated on 
a timely basis.
Commitments and Contingencies
The program of
medical
malpractice
insurance
coverage and the
basis for any loss
accruals are
disclosed
adequately in the
financial
statements.
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Auditing
Procedures
are reported as a 
liability.
Review prior 
estimates and 
historical loss 
experience.
Determine 
whether 
uncertainties 
related to medical 
malpractice 
claims need to be 
disclosed in the 
auditor’s report.
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Chapter 9 
Net Assets (Equity)
Investor-Owned Health Care Organizations
9.01 The equity accounts of investor-owned health care entities are simi­
lar to those of other investor-owned businesses.
Not-for-Profit and Governmental Health 
Care Organizations*
9.02 The balance sheets of not-for-profit health care organizations should 
report separate amounts for each of three classes of net assets:1 (a) perma­
nently restricted net assets, (b) temporarily restricted net assets, and (c) 
unrestricted net assets. This is based on the existence or absence of donor-im­
posed restrictions.
9.03 Unrestricted net assets generally result from revenues from provid­
ing or agreeing to provide health care services, receiving unrestricted contribu­
tions and grants, or receiving dividends or interest from investing in 
income-producing assets minus expenses incurred in providing or agreeing to 
provide health care services, providing other community benefits, and perform­
ing administrative functions. The only limits on the use of unrestricted net 
assets are the broad limits resulting from the nature of the provider’s organi­
zation; the environment in which the organization operates; the purposes 
specified in its articles of incorporation or in its bylaws; or limits resulting from 
contractual agreements with suppliers, creditors, and others entered into in 
the course of business. Information about significant contractual limits, includ­
ing the existence of restrictive debt covenants, generally is provided in the 
notes to the financial statements. Similarly, information about self-imposed 
limits may be provided either on the face of the balance sheet or in the notes to 
the financial statements. Such specifics include information about voluntary 
resolutions by the entity’s governing board to designate a portion of its unre­
stricted net assets for identified purposes (for example, funded depreciation).
9.04 Information about the nature and amounts of different types of 
permanent restrictions or temporary restrictions should be provided either by 
reporting their amounts on the face of the financial statements or by including
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, paragraph 98 of GASB Statement No. 34 discusses the 
statement of net assets, noting that either a net assets format—assets less liabilities equal net 
assets—or a balance sheet format—assets equal liabilities plus net assets may be used to report 
proprietary funds. In addition, this paragraph states that net assets should be displayed in three 
broad components—invested in capital assets, net of related debt; restricted (distinguishing between 
major categories of restrictions), and unrestricted. A  brief summary of GASB Statement No. 34 is 
provided in paragraphs 1.09 through 1.11 in this Guide. This chapter will be modified to conform to 
the requirements of GASB Statement No. 34 in a future edition of this Guide.
1 Though some health care organizations may use other terms, such as equity, this Guide uses 
the term net assets to describe residual interest.
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relevant details in the notes to the financial statements. Separate line items 
may be reported within permanently restricted net assets (or in the notes to 
the financial statements) to distinguish between permanent restrictions for 
holdings of (a) assets, such as land or works of art, donated with stipulations 
that they be used for a specified purpose, be preserved, and not be sold, or (b) 
assets donated with stipulations that they be invested to provide a permanent 
source of income (that is, permanent endowment funds).
9.05 Similarly, separate line items may be reported within temporarily 
restricted net assets (or in the notes to the financial statements) to distinguish 
between temporary restrictions for (a) support of particular operating activi­
ties, (b) investment for a specified term, (c) use in a specified future period, or
(d ) acquisition of long-lived assets. Donors’ temporary restrictions may require 
that resources be used in a later period or after a specified date (time restric­
tions) or that resources be used for a specified purpose (purpose restrictions) or 
both. For example, gifts of cash and other assets with stipulations that they be 
invested to provide a source of income for a specified term and that the income 
be used for a specified purpose are restricted both as to time and purpose.
9.06 Governmental health care entities either report (1) the three classes 
of fund balance or (2) unrestricted (general) and restricted fund balances.[2]
9.07 The nature of the restrictions on donor-restricted resources should 
be disclosed in the financial statements.
Auditing
9.08 The independent auditor may need to consider the examples of 
specific auditing objectives, selected control activities, and auditing procedures 
relating to net assets (equity) that are presented in exhibit 9.1.
[2] [Deleted.]
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Exhibit 9.1
Auditing Considerations
Financial Statement Specific Auditing 
Assertions Objectives
Net Assets (Equity)
Rights and 
obligations
Resources are 
used and 
accounted for in 
accordance with 
donor and grantor 
restrictions.
Selected Control 
Activities
Management 
monitors 
compliance with 
these restrictions.
Auditing
Procedures
Review the 
minutes of board 
and board 
committee 
meetings for 
evidence of donor 
restrictions.
Determine 
compliance with 
donor and grantor 
restrictions.
Presentation and 
disclosure
Net assets are 
presented and 
disclosed properly 
in the financial 
statements.
Procedures 
ensure proper 
authorization, 
recording, and 
presentation.
Test significant 
net asset 
transactions to 
determine that 
they are properly 
authorized and 
recorded.
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Chapter 10 
Revenue, Expenses, Gains, and Losses
Conceptual Framework for Reporting Revenue, 
Expenses, Gains, and Losses
10.01 FASB Concepts Statement No. 6, Elements of Financial State­
ments, provides a useful conceptual framework for preparers of financial 
statements to distinguish among elements of financial statements for purposes 
of display. Additionally, not-for-profit organizations are subject to the require­
ments of FASB Statement No. 117, Financial Statements of Not-for-Profit 
Organizations.1 This chapter draws on the concepts contained in FASB 
Concepts Statement No. 6 and FASB Statement No. 117 in discussing 
revenue, expenses, gains, and losses with respect to health care organiza­
tions. Expenses are not generally netted against revenues, whereas gains 
and losses may be displayed as net amounts. The application of these 
concepts to the classification of revenue, expenses, gains, and losses in the 
statement of operations of health care organizations is discussed in para­
graphs 10.02 through 10.10.
10.02 FASB Concepts Statement No. 6, paragraph 78, defines reve­
nues as “inflows or other enhancements of assets of an entity or settlements 
of its liabilities (or a combination of both) from delivering or producing 
goods, rendering services, or other activities that constitute the entity’s 
ongoing major or central operations.” Similarly, paragraph 80 defines ex­
penses as “outflows or other using up of assets or incurrences of liabilities 
(or a combination of both) from delivering or producing goods, rendering 
services, or carrying out other activities that constitute the entity’s ongoing 
major or central operations.”
Distinguishing Charity Care From Bad Debt Expense
10.03 Charity care represents health care services that are provided 
but are never expected to result in cash flows. As a result, charity care does 
not qualify for recognition as receivables or revenue in the financial state­
ments. Distinguishing charity care from bad-debt expense requires the 
exercise of judgment. Charity care is provided to a patient with demon­
strated inability to pay. Each organization establishes its own criteria for 
charity care consistent with its mission statement and financial ability. 
Only the portion of a patient’s account that meets the organization’s charity 
care criteria is recognized as charity. Although it is not necessary for the 
entity to make this determination upon admission or registration of an 
individual, at some point the entity must determine that the individual 
meets the established criteria for charity care. (See paragraph 10.21 for 
disclosure requirements relating to charity care.)
1 This pronouncement is not applicable to governmental health care enterprises. (See chapter 1, 
footnote 1.)
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Revenue*
10.04 Revenue usually is recorded when coverage is provided to an en­
rollee or the service is provided to a patient or resident. Revenue is classified 
based on the type of service rendered or contracted to be rendered. Examples 
of revenue include—
• Patient service revenue, which is derived from fees charged for patient 
care. This may be based on diagnosis related group (DRG) payments, 
resource-based relative value scales (RBRVS) payments, per diems, 
discounts, or other fee-for-service arrangements.
•  Premium revenue, which is derived from capitation arrangements.
•  Resident service revenue, which may be related to maintenance fees, 
rental fees, or amortization of advance fees.
10.05 Some not-for-profit or governmental health care enterprises may re­
ceive relatively small amounts of contributions, grants, or tax support. Such 
amounts, whether temporarily restricted, permanently restricted, or unrestricted, 
are recognized as revenue or gains when they are received. Special considerations 
pertaining to revenue recognition of promises to give in future periods (pledges) 
are discussed in chapter 5 and in paragraphs 10.07 through 10.10.
10.06 Other revenue, gains, or losses are derived from services other than 
providing health care services or coverage to patients, residents, or enrollees. 
These typically include—
• Interest and dividends from all funds held by a trustee, malpractice 
funds, or other miscellaneous investment activities.
•  Certain realized changes in market values of marketable securities 
(see chapter 4).
•  Fees from educational programs, which include tuition for schools 
(such as nursing) or laboratory and X-ray technology.
•  Rental of health care facility space.
•  Sales of medical and pharmaceutical supplies to employees, physi­
cians, and others.
•  Fees charged for transcripts for lawyers, insurance companies, and 
others.
•  Proceeds from sale of cafeteria meals and guest trays to employees, 
medical staff, and visitors.
•  Proceeds from sale of scrap, used X-ray film, etc.
•  Proceeds from sales at gift shops, snack bars, newsstands, parking 
lots, vending machines, or other service facilities operated by the 
health care organization.
10.07 Interest earned and gains and losses on investments and other 
assets (or liabilities) are reported by not-for-profit organizations as increases 
or decreases in unrestricted net assets, unless their use is temporarily or
* GASB Statement No. 33, Accounting and Financial Reporting for Nonexchange Tr ansactions, 
establishes accounting and reporting standards for nonexchange transactions involving financial or 
capital resources, and is effective for financial statements for periods beginning after June 15, 2000, 
with earlier implementation encouraged. Among other things, GASB Statement No. 33 supersedes 
paragraphs 1 through 14, 17, 19, and 20 of NCGA Statement No. 2, Grant, Entitlement, and Shared 
Revenue Accounting by State and Local Governments, and paragraphs 14, 15, and 23 of GASB 
Statement No. 6, Accounting and Financial Reporting for Special Assessments. This chapter will be 
modified to conform to the requirements of GASB Statement No. 33 in a future edition of this Guide. 
A brief summary of GASB Statement No. 33 is provided in paragraph 10.24 of this Guide. Also, refer 
to the footnote to paragraph 10.24 for a discussion of GASB Statement No. 34, which will amend 
paragraph 11 of GASB Statement No. 33.
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permanently restricted by explicit donor stipulation or by law. Occasionally, 
not-for-profit organizations may transfer funds to, or receive transfers from, 
other related not-for-profit organizations.* Unless repayment is expected or 
the funds are restricted by an independent party, such transfers (referred to as 
equity transfers) are reported as separate items that increase or decrease 
unrestricted net assets. Net assets released from restriction, such as those 
related to the fulfillment of time or purpose restrictions, should be reported 
separately in the financial statements or disclosed in the notes. Additional 
guidance on accounting for investments can be found in chapter 4.
10.08 Contributions of noncash assets that are not long-lived assets are 
recognized as revenue or gains in the period received and as assets or a 
reduction of liabilities or expenses, depending on the form of the benefits 
received. (For example, a donation of supplies would be reflected as revenue or 
gains and as an increase in inventory or supply expense.) The donations are 
measured at fair value.2 Donations received with no restrictions attached are 
reported as unrestricted support in the statement of operations. Donations with 
explicit donor restrictions attached (other than permanent restrictions) are re­
ported as temporarily restricted support. The expiration of these restrictions is 
recognized in the period when the time stipulated by the donor has elapsed, when 
the stipulated purpose for which the asset was restricted has been fulfilled, or both. 
When the restriction expires, the temporarily restricted net assets are reclassified 
to unrestricted net assets and reported in the statement of operations as “net 
assets released from restriction.” Donor-restricted contributions whose restric­
tions are met in the same reporting period may be reported as unrestricted support 
provided that an organization discloses its accounting policy and applies the policy 
consistently from period to period. Donations with explicit donor restrictions 
attached that permanently limit the health care organization’s use of the contrib­
uted assets (for example, permanent endowments) are reported as increases in 
permanently restricted net assets.
10.09 Contributions of long-lived assets, including the use of long-lived 
assets such as land, buildings, and equipment, are reported as support or gains 
in the period received. The donation is measured at its fair value. If the donor 
places no restrictions on the use of the asset, the contribution is reported as 
unrestricted support. Contributions of long-lived assets with explicit donor 
restrictions are reported as temporarily or permanently restricted support. 
The provider reports expirations of donor restrictions when the stipulation is 
fulfilled and the assets are placed in service. At that time, temporarily re­
stricted net assets are reclassified to unrestricted net assets and reported in 
the statement of operations as “net assets released from restriction.”
* FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization or Charitable 
Trust That Raises or Holds Contributions for Others, establishes standards for transactions in which 
an entity—the donor—makes a contribution by transferring assets to a not-for-profit organization or 
charitable trust—the recipient organization—that accepts the assets from the donor and agrees to 
use those assets on behalf of or transfer those assets, the return on investment of those assets, or 
both to another entity—the beneficiary—that is specified by the donor. FASB Statement No. 136 
incorporates without reconsideration the guidance in FASB Interpretation No. 42, and supersedes 
that Interpretation. FASB Statement No. 136 is effective for financial statements issued for fiscal 
periods beginning after December 15, 1999 (earlier application is encouraged), except for the provi­
sions incorporated from FASB Interpretation No. 42, which continue to be effective for fiscal years 
ending after September 15, 1996. A summary of FASB Statement No. 136 is included in appendix F 
to this Guide. This chapter will be modified to conform to the requirements of FASB Statement No. 
136 in a future edition of this Guide.
2 Information necessary to estimate the fair value of a donated asset may be obtained from 
various sources as described in FASB Statement No. 116, Accounting for Contributions Received and 
Contributions Made, paragraph 19.
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10.10 Donations of cash or other assets that must be used to acquire 
long-lived assets are reported as temporarily restricted support in the period 
received. Expirations of donor restrictions are reported when the acquired 
long-lived assets are placed in service and donor-imposed restrictions are 
satisfied. The temporarily restricted net assets are reclassified to unrestricted 
net assets and reported in the statement of operations as “net assets released 
from restriction.” For providers that prepare classified balance sheets, assets 
that are restricted by donors for acquisition of long-lived assets (such as cash 
or contributions receivable) are not included in “cash and cash equivalents” or 
with other “contributions receivable.” Rather, those assets are reported in a 
separate section, such as “assets restricted to investment in property and 
equipment,” and are sequenced near the “property and equipment” section of 
the balance sheet (see paragraph 3.01).
10.11 The nature and extent of donated services received by health care 
organizations varies and can range from the limited participation of many 
people in fund-raising activities to active participation in the entity’s service 
programs; their values usually are not recorded. Contributed services should 
be reported as contribution revenue and as assets or expenses if the services 
create or enhance a nonfinancial (that is, nonmonetary) asset (for example, 
property and equipment) or meet all of the following criteria:
a. Require specialized skills
b. Are provided by individuals with those skills (such as accounting, 
financial, construction, educational, electrical, legal, medical, and 
other services provided by accountants, investment advisers, con­
tractors, teachers, electricians, lawyers, doctors, and other profes­
sionals and craftspeople)
c. Would typically need to be purchased by the organization if they had 
not been provided by contribution
Additional guidance with regard to the accounting for and the reporting of 
donated services is provided in FASB Statement No. 116.
10.12 For governmental health care enterprises, contributions from one 
governmental entity to another governmental health care enterprise are ac­
counted for in accordance with NCGA Statement No. 2, Grant, Entitlement, 
and Shared Revenue Accounting by State and Local Governments. FASB 
Statement No. 116 is not applicable to contributions and transfers among 
governmental entities. Contributions from one governmental entity to another 
governmental health care enterprise are accounted for in accordance with 
NCGA Statement No. 2 and GASB Statement No. 6, Accounting and Financial 
Reporting for Special Assessments. Furthermore, certain interfund transac­
tions with other funds in the same financial reporting entity are to be ac­
counted for as residual equity transfers or operating transfers, in accordance 
with paragraph 105 of NCGA Statement No. 1, Governmental Accounting and 
Financial Reporting Principles*
10.13 Additional guidance regarding accounting for contributions dis­
cussed above can be found in chapters 5 and 6 of the Audit and Accounting 
Guide Not-for-Profit Organizations, which also addresses the following:
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement amends GASB Statement No. 6 and NCGA 
Statement Nos. 1 and 2. Also, paragraph 18 of GASB Statement No. 34 discusses accounting for 
donated capital assets. A  brief summary of GASB Statement No. 34 is provided in paragraphs 1.09 
through 1.11 in this Guide. This chapter will be modified to conform to the requirements of GASB 
Statement No. 34 in a future edition of this Guide.
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•  Permanent endowments
•  Split-interest agreements
•  Gifts in kind
•  Contributed utilities, facilities, or use of long-lived assets
10.14 Foundations, business organizations, and other types of entities 
may provide resources to health care organizations under programs referred to 
as grants, awards, or sponsorships. Those asset transfers are contributions if 
the resource providers receive no value in exchange for the assets transferred 
or if the value received by the resource provider is incidental to the potential 
public benefit from using the assets transferred. The asset transfers are 
exchange transactions if the potential public benefit is secondary to the re­
source providers’ potential direct benefits. For example, a research grant made 
by a foundation to a hospital would likely be a contribution if  the research 
program is to be planned and carried out by the hospital and the hospital has 
the right to publish the results. If, however, the grant is made by a pharmaceu­
tical manufacturer that provides potential new medications to be tested in the 
hospital’s research facilities and retains the right to any patents or other 
results, the grant would likely be an exchange transaction.
10.15 The basis and timing of the recognition of expenses for health care 
organizations generally are the same as for other business enterprises. Not-for- 
profit organizations report expenses as decreases in unrestricted net assets.
10.16 Statement of Position (SOP) 98-2, Accounting for Costs of Activities 
of Not-for-Profit Organizations and Local Governmental Entities That Include 
Fund Raising, provides guidance for not-for-profit and state and local govern­
mental entities (including health care organizations) that conduct fund-raising 
activities with activities related to other functions, such as program activities 
or supporting services (joint activities). This SOP establishes financial ac­
counting standards for accounting for costs of joint activities, and requires 
financial statement disclosures about the nature of the activities for which 
joint costs have been allocated and the amounts of joint costs. SOP 98-2 is 
included as appendix C to this Guide.
10.17 The statement of operations for not-for-profit organizations should 
include a performance indicator that reports results of operations. Because of 
the importance of the performance indicator, it should be clearly labeled with 
a descriptive term such as revenues over expenses, revenues and gains over 
expenses and losses, earned income, or performance earnings. The notes to the 
financial statements should include a description of the nature and composi­
tion of the performance indicator. Not-for-profit organizations should report 
the performance indicator in a statement that also presents the total changes 
in unrestricted net assets. Other changes in net assets may be presented 
separately or in the same statement.
* GASB Statement No. 33, Accounting and Financial Reporting for Nonexchange Transactions, 
establishes accounting and reporting standards for nonexchange transactions involving financial or 
capital resources, and is effective for financial statements for periods beginning after June 15, 2000, 
with earlier implementation encouraged. This chapter will be modified to conform to the 
requirements of GASB Statement No. 33 in a future edition of this Guide. A  brief summary of GASB 
Statement No. 33 is provided in paragraph 10.24 of this Guide. Also, refer to the footnote to 
paragraph 10.24 for a discussion of GASB Statement No. 34, which will amend paragraph 11 of GASB 
Statement No. 33.
Expenses*
Financial Statement Presentation
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10.18 Health care organizations should report the following items sepa­
rately from the performance indicator*—
a. Transactions with owners acting in that capacity.
b. Equity transfers involving other entities that control the reporting 
entity, are controlled by the reporting entity, or are under common 
control with the reporting entity.
c. Receipt of restricted contributions, including temporary restrictions 
(such as time or purpose) or permanent restrictions.
d. Contributions of (and assets released from donor restrictions related 
to) long-lived assets.
e. Unrealized gains and losses on investments not restricted by donors 
or by law, except for those investments classified as trading securities 
(see paragraph 4.07).
f. Investment returns restricted by donors or by law (see paragraphs
4.08 through 4.10).
g. Other items that are required by GAAP to be reported separately 
(such as extraordinary items, the effect of discontinued operations, 
the cumulative effect of accounting changes, minimum pension li­
abilities in accordance with paragraph 37 of FASB Statement No. 87, 
Employers' Accounting for Pensions, or foreign currency translation 
adjustments).3
10.19 Classifying revenues, expenses, gains, and losses within classes of 
net assets does not preclude incorporating additional classifications within the 
performance indicator. For example, within a class or classes of changes in net 
assets, a not-for-profit organization may classify items as operating and non­
operating, expendable and nonexpendable, earned and unearned, recurring 
and nonrecurring, or in other ways. This Guide neither requires nor precludes 
reporting such intermediate measures or subtotals. However, because terms 
such as operating income are used with different meanings, if an intermediate 
measure of operations is reported and its use is not apparent from the details 
provided on the face of the statement, a note to the financial statements should 
describe the nature of the reported measure of operations or the items excluded 
from operations.
* Not-for-profit health care organizations that have early-adopted FASB Statement No. 133, 
Accounting for Derivative Instruments and Hedging Activities, should also report unrealized gains 
and losses on derivatives that do not qualify as a fair value hedge under FASB Statement No. 133, 
except for the effect of changes in interest accruals, separate from the performance indicator. FASB 
Statement No. 133, as amended, is effective for all fiscal quarters of fiscal years beginning after June 
15, 2000. Also, on March 3, 2000, the FASB issued an exposure draft, Accounting for Certain 
Derivative Instruments and Certain Hedging Activities, that would amend FASB Statement No. 133. 
Readers should be alert for the issuance of a final standard.
3 Governmental enterprises should report extraordinary items and the effect of discontinued 
operations in the statement of operations immediately preceding net income; the cumulative effect of 
an accounting change should be reported as an adjustment to beginning fund balance in the period of 
the change. GASB Statement No. 34, Basic Financial Statements—and Management's Discussion 
and Analysis—for State and Local Governments, establishes financial reporting standards for state 
and local governments. Among other matters, paragraph 100 of this Statement discusses the report­
ing of special and extraordinary items in the operating statement for proprietary funds. A brief 
summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. This 
chapter will be modified to conform to the requirements of GASB Statement No. 34 in a future edition 
of this Guide. Investor-owned enterprises should report extraordinary items, the effect of discontin­
ued operations and the cumulative effect of an accounting change in the statement of operations 
immediately preceding net income.
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10.20 For financial reporting purposes, patient service revenue is re­
ported net of provisions for contractual and other adjustments in the operating 
statement. Significant revenue earned under capitation arrangements is re­
ported separately. The notes to the financial statements disclose the methods 
of revenue recognition (for example, policies related to capitation revenue, 
patient service revenue, or contributions). In addition, with regard to contrac­
tual adjustments and third-party settlements, identification and explanation 
of the estimated amounts that are payable or receivable by the entity are 
disclosed.
10.21 As discussed in paragraph 10.03, patient service revenue does not 
include charity care. Management’s policy for providing charity care, as well as 
the level of charity care provided, should be disclosed in the financial state­
ments. Such disclosure generally is made in the notes to the financial state­
ments and is measured based on the provider’s rates, costs, units of service, or 
other statistical measure.
10.22 Expenses may be reported on the face of the financial statements 
using either a natural classification or a functional presentation. Public com­
panies (that is, registrants with the SEC) are required to disclose segment 
information in accordance with FASB Statement No. 131, Disclosure about 
Segments of an Enterprise and Related Information.4 Not-for-profit organiza­
tions that report using a natural classification of expenses are required to 
disclose expenses by functional classification.
10.23 The extent of classification and subclassification of expenses de­
pends on many factors, such as the nature and complexity of the health care 
organization. For example, some entities may present only two categories: (a) 
health services (including inpatient services, outpatient procedures, home 
health services, etc.) and (b) general and administrative. Others may present 
additional distinctions such as physician services, research, and teaching. 
Functional allocations should be based on full cost allocations.
Accounting and Financial Reporting for 
Nonexchange Transactions
10.24 GASB Statement No. 33, Accounting and Financial Reporting for 
Nonexchange Transactions,* establishes accounting and financial reporting 
standards for nonexchange transactions involving financial or capital re­
sources. The principal issue addressed is the timing of recognition of nonex­
change transactions. It identifies four classes of nonexchange transactions 
based on shared characteristics that affect the timing of recognition, and 
distinguishes between two kinds of stipulations on the use of resources: time
4 The segment reporting requirements of NCGA Interpretation No. 2, Segment Information for 
Enterprise Funds, apply to governmental health care enterprises. GASB Statement No. 34, Basic 
Financial Statements—and Management’s Discussion and Analysis—for State and Local Govern­
ments, establishes financial reporting standards for state and local governments. Among other 
matters, this Statement supersedes NCGA Interpretation No. 2. A  brief summary of GASB State­
ment No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. This chapter will be modified 
to conform to the requirements of GASB Statement No. 34 in a future edition of this Guide.
* GASB Statement No. 34, Basic Financial Statements—and Management’s Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement amends GASB Statement No. 33. A  brief 
summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. This 
chapter will be modified to conform to the requirements of GASB Statement No. 34 in a future edition 
of this Guide. Also, governments that elect early implementation of GASB Statement No. 34 should 
also implement GASB Statement No. 33 at the same time.
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requirements and purpose restrictions. Different standards apply to each kind 
of stipulation. GASB Statement No. 33 also provides guidance on recognizing 
promises made by private donors, contraventions of provider stipulations, and 
nonexchange revenues administered or collected by another government. The 
provisions of GASB Statement No. 33 are effective for financial statements for 
periods beginning after June 15, 2000, with earlier implementation encour­
aged. Readers should refer to the full text of this Statement when considering 
accounting and reporting issues related to nonexchange transactions.
Auditing5
10.25 The independent auditor may need to consider the examples of 
specific auditing objectives, selected control activities, and auditing procedures 
to audit revenue, expenses, gains, and losses that are presented in exhibit 10.1.
5 SOP 00-1, Auditing Health Care Third-Party Revenues an d  Related Receivables, discusses 
matters for auditors to consider in testing third-party revenues and related receivables, and provides 
guidance to auditors regarding the sufficiency of evidential matter and reporting on financial 
statements of health care entities exposed to material uncertainties. SOP 00-1 is effective for audits 
of periods ending on or after June 3 0 , 2000 and is included as appendix E to this Guide.
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Exhibit 10.1
Auditing Considerations
F inancia l Statement Specific A u d itin g  
Assertions Objectives
Selected Control 
A ctiv ities
Revenue and Gains fo r H ealth Care Services
Existence and 
occurrence, 
completeness, and 
presentation and 
disclosure
Revenue and 
gains are 
reported in the 
proper period 
using the accrual 
basis of 
accounting and 
are classified 
properly by the 
type of service 
rendered.
Procedures help 
ensure that 
revenue is 
accrued as 
services are 
performed or as 
contractual 
obligations are 
satisfied.
A u d itin g
Procedures
Perform a 
walk-through of 
the revenue 
system.
Compare the 
current period’s 
revenue with 
prior periods’ 
revenue and/or 
budgets and 
obtain
explanations for 
large or unusual 
variances.
In the statement 
of operations, 
revenue from 
health care 
services is 
reported, net of 
contractual 
adjustments and 
other
adjustments, in 
the proper period 
and is classified 
properly.
Management 
establishes and 
monitors controls 
over the 
recognition of 
revenue.
Controls ensure 
that deductions 
from revenue are 
recorded in the 
proper period 
and are classified 
properly.
Contractual and 
other
adjustments are 
authorized, 
controlled, and 
recorded properly.
Consider the 
adequacy of the 
controls over the 
revenue 
recognition 
process.
Review the 
financial 
statements to 
determine that 
revenue is 
reported net of 
contractual 
adjustments and 
other adjustments.
Test contractual
adjustments,
other
adjustments, and 
bad debts to 
determine that 
they are
accounted for both 
in  accordance 
with the 
respective 
contracts and the
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Financial Statement
Assertions
Specific Auditing 
Objectives
Selected Control 
Activities
Charity care, 
bad-debt 
writeoffs, and 
courtesy and 
policy discounts 
are authorized, 
controlled, and 
recorded properly.
entity’s policy. 
Determine that 
specific and 
unallocated 
reserves appear 
reasonable and 
comparable to 
prior year.
Auditing
Procedures
Review
third-party payor 
contracts and 
methods of 
payment and test 
the entity’s 
computation of 
estimated 
adjustments to 
revenue as 
required under 
such contracts.
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Chapter 11 
The Reporting Entity and 
Related Organizations
Overview
11.01 The FASB is presently studying the concept of the reporting entity 
and issues related to consolidations, application of the equity method of ac­
counting, and accounting for various types of joint ventures. On October 14, 
1995, the FASB released an exposure draft entitled Consolidated Financial 
Statements: Policy and Procedures as part of its project on consolidations and 
related matters.* The conclusions in this chapter will be reconsidered when the 
FASB completes this project, which may affect the definition of control and 
other related matters. The GASB has issued Statement No. 14, The Financial 
Reporting Entity, which addresses these issues for governmental entities. 
GASB Statement No. 14 establishes standards for defining and reporting for 
the financial reporting entity and for reporting its participation in joint ven­
tures.** The GASB also has on its agenda a project on the reporting of affiliated 
organizations, such as foundations, and has issued an exposure draft of a 
proposed Statement entitled The Financial Reporting Entity—Affiliated Or­
ganizations. Accordingly, these matters may require reconsideration pending 
resolution by the FASB and the GASB.
11.02 Networks among health care organizations, both vertical and hori­
zontal, are being formed continually and new organizational structures are 
being developed. The dynamics of change in the health care industry and their 
impact on evolving organizational structures must be considered in defining 
the reporting entity.
11.03 An integrated health care system typically consists of multiple 
related entities, operating both for-profit and not-for-profit organizations. A 
not-for-profit parent corporation may be the sole corporate member or, through 
other means, it may control other entities such as a not-for-profit hospital, a 
not-for-profit medical foundation that contracts with a for-profit physician 
group, or other not-for-profit providers such as a long-term care center, a 
substance abuse center, a surgery center, or an outpatient clinic. The system 
also may own stock in various for-profit ventures such as HMOs or insurance 
companies that may or may not provide patient care. Fund-raising typically is 
accomplished through a separate foundation. Foundations, auxiliaries, guilds,
* On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 16, 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and paragraphs 1-3 and 5 of ARB No. 51, add a sentence to endnote 3 of ARB No. 51, and amend APB 
Opinions 16 and 18 and FASB Statement Nos. 15, 57, and 65.
** GASB Statement No. 34, Basic Financial Statements—and Management's Discussion and 
Analysis—for State and Local Governments, establishes financial reporting standards for state and 
local governments. Among other matters, this Statement amends GASB Statement No. 14. A  brief 
summary of GASB Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. This 
chapter will be modified to conform to the requirements of GASB Statement No. 34 in a future edition 
of this Guide.
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and similar organizations frequently assist and, in many instances, are related 
to the health care organization.
11.04 The guidance in this chapter relates to for-profit and not-for-profit 
consolidations of parent-subsidiary relationships, whether through stock own­
ership or other means of control. Other circumstances may exist in the health 
care industry where combined financial statements involving commonly con­
trolled entities are more meaningful than their separate financial statements. 
More specific guidance related to combined financial statements can be found 
in ARB No. 51, Consolidated Financial Statements, paragraphs 22 and 23.1
Financial Reporting*
11.05 Whether the financial statements of a reporting health care organi­
zation and those of one or more other for-profit or not-for-profit entities should 
be consolidated, whether those other entities should be reported using the 
equity method, and the extent of disclosure that should be required (if any) if 
consolidated financial statements are not presented, should be based on the 
nature of the relationship between the entities.
11.06 Health care organizations may be related to one or more other 
entities in numerous ways, including ownership, control, and/or economic 
interest.
11.07 As discussed in paragraphs 11.10 through 11.16, the existence of 
various forms of control and economic interests result in various financial 
reporting. Certain kinds of control result in consolidation (see paragraph 
11.10). Other kinds of control result in consolidation only if coupled with an 
economic interest (see paragraph 11.11). Still other kinds of control result in 
consolidation being permitted but not required, if coupled with an economic 
interest (see paragraph 11.12). The existence of either control or an economic 
interest, but not both, is discussed in paragraph 11.13; disclosures concerning 
restrictions on distributions are discussed in paragraph 11.14; and reporting 
under the equity method of accounting is discussed in paragraph 11.16.
11.08 Control is the direct or indirect ability to determine the direction of 
management and policies through ownership, contract, or otherwise. However, 
the rights and powers of the controlling entity may vary depending on the legal 
structure of the controlled entity and the nature of control. The majority owner 
of a for-profit entity’s voting stock or the sole corporate member of a not-for- 
profit entity may not only have the ability to determine the direction of the 
controlled entity but also have the proportionate right to (or the responsibility 
for) operating results and a residual interest in the net assets upon dissolution. 
However, in other situations, the rights of the controlling party may be more
1 In some situations, debt agreements may require combined financial statements of affiliated 
entities, the assets or revenues of which serve as collateral for the related debt (sometimes called an 
“obligated group”). ARB No. 51 applies to those situations. However, if debt or other agreements 
prescribe a financial presentation that varies from GAAP (for example, exclusion of entities otherwise 
required to be consolidated), the auditor should consider SAS No. 62, Special Reports (AICPA, 
Professional Standards, vol. 1, AU sec. 623), for reporting guidance.
* On February 23, 1999, the FASB released an exposure draft (revised) of a proposed FASB 
Statement, Consolidated Financial Statements: Purpose and Policy—Revision of Exposure Draft 
issued October 16, 1995, that, in addition to other matters, would supersede FASB Statement No. 94 
and paragraphs 1-3 and 5 of ARB No. 51, add a sentence to endnote three of ARB 51, and amend APB 
Opinions 16 and 18 and FASB Statement Nos. 15, 57, and 65.
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limited. For example, in the case of a sole general partner in a limited 
partnership, the limited partners—and not the general partner—may be enti­
tled to the net assets upon dissolution. Further, the existence of “super-majority” 
voting rights can entitle the holder to disproportionate voting powers, and 
could affect the determination of the “controlling entity.” As a result, whether 
the financial statements of a controlled entity should be consolidated with 
the reporting entity depends on the nature of control and whether an economic 
interest exists.2
11.09 An economic interest in another entity exists if (a) the other entity 
holds or utilizes significant resources that must be used for the unrestricted or 
restricted purposes of the reporting entity—either directly or indirectly—for 
producing income or providing services or (b) the reporting entity is responsible 
for the liabilities of the other entity. The following are examples of economic 
interests:
•  Other entities solicit funds in the name of, and with the expressed or 
implied approval of, the reporting entity. In addition, substantially all 
of the funds solicited are intended by the contributor or are otherwise 
required to be transferred to the reporting entity or used at its 
discretion or direction.
•  The reporting entity transfers significant resources to another entity 
whose resources are held for the benefit of the reporting entity.
•  The reporting entity assigns certain significant functions to another 
entity.
•  The reporting entity provides or is committed to provide funds for 
another entity or the reporting entity guarantees significant debt of 
another entity.
•  The reporting entity has a right to, or the responsibility for, the 
operating results of another entity. Or, upon dissolution, the reporting 
entity is entitled to the net assets, or is responsible for any deficit, of 
another entity.
11.10 Health care organizations with a controlling financial interest in 
other entities through direct or indirect ownership of a majority voting inter­
est3 in those other entities should consolidate those other entities, unless 
control is likely to be temporary or does not rest directly or indirectly with the 
majority owner or sole corporate member (for example, if  the subsidiary is in 
legal reorganization or in bankruptcy).4 In such situations consolidation is 
prohibited, as discussed in paragraph 13 of FASB Statement No. 94, Consoli­
dation of All Majority-Owned Subsidiaries.
2 Emerging Issues Task Force (EITF) Issue No. 97-2, Application of FASB Statement No. 94 and 
APB Opinion No. 16 to Physician Practice Management Entities and Certain Other Entities with 
Contractual Management Arrangements, addresses the issue of consolidation and business combina­
tions among physician practice management entities, and other situations in which one entity 
manages another under similar circumstances and arrangements.
3 Because not-for-profit organizations may exist in various legal forms, ownership of not-for- 
profit organizations may be evidenced in various ways. Examples include corporations issuing stock, 
corporations issuing ownership certificates, membership corporations issuing membership certifi­
cates, joint ventures, and partnerships. A  parent corporation typically owns stock in a for-profit 
entity, whereas a sole corporate member holds membership rights in a not-for-profit entity. As it 
relates to health care consolidations, sole corporate membership in a not-for-profit entity is consid­
ered to be equivalent to ownership of a majority voting interest in a for-profit entity, unless the sole 
corporate member’s economic interest in the controlled entity is limited by state law or contractual 
agreement.
4 See footnote 2 of this chapter.
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11.11 In the case of (a) control through a majority voting interest in the 
board of another entity by means other than ownership or sole corporate 
membership5 and (b) an economic interest in such entities, consolidation is 
required, unless control is likely to be temporary or does not rest with the 
majority owner. In this situation consolidation is prohibited, as discussed in 
paragraph 13 of FASB Statement No. 94.
11.12 Control of a separate not-for-profit organization in which the re­
porting entity has an economic interest may take forms other than majority 
ownership or voting interest; for example, control may be through contract or 
affiliation agreement.6 In circumstances such as these, consolidation is permit­
ted but not required, unless control is likely to be temporary.7 In this situation 
consolidation is prohibited, as discussed in paragraph 13 of FASB Statement 
No. 94. If the reporting entity controls a separate not-for-profit entity through 
a form other than majority ownership (paragraph 11.10) or voting interest 
(paragraph 11.11), has an economic interest in that other entity, and consoli­
dated financial statements are not presented, the notes to the financial state­
ments should include the following disclosures:
a. Identification of the other entity and the nature of its relationship 
with the reporting entity that results in control
b. Summarized financial data of the other entity, including total assets, 
liabilities, net assets, revenue, and expenses; and resources that are 
held for the benefit of the reporting entity or that are under its control
c. The disclosures set forth in FASB Statement No. 57, Related Party 
Disclosures
11.13 In some cases, one entity may have an economic interest in another 
entity without controlling it (for example, a noncontrolled entity may solicit 
funds in the name of, and with the expressed or implied approval of, the 
reporting entity and substantially all of the funds solicited are intended by the 
contributor to benefit the reporting entity). The existence of control (other than 
through ownership or sole corporate membership) or an economic interest, but 
not both, precludes consolidation but requires the disclosures set forth in FASB 
Statement No. 57.8
11.14 If consolidated financial statements are presented and they include 
a controlled not-for-profit organization, they should disclose any restrictions 
made by entities outside of the reporting entity on distributions from the 
controlled not-for-profit organization to the reporting entity and any resulting 
unavailability of the net assets of the controlled not-for-profit organization for 
use by the reporting entity.
5 For purposes of this Guide, a majority voting interest in the board of another entity by means 
other than ownership or sole corporate membership is illustrated by the following example. Entity B 
has a five-member board, and a simple voting majority is required to approve board actions. Entity A  
will have a majority voting interest in the board of entity B if three or more of its board members, 
officers, or employees serve on (or may be appointed at entity A’s discretion to) the board of entity B. 
However, if three of entity A’s board members serve on the board of entity B but entity A  does not have 
the ability to require that those members serve on entity B’s board, entity A does not have a majority 
voting interest in the board of entity B.
6 Evidence of control may include authority to amend articles of incorporation and bylaws or 
authority to approve operating, capital, and construction budgets; capital acquisitions; strategic 
plans, goals, and objectives; and mergers or dissolutions.
7 See footnote 2 of this chapter.
8 The existence of an economic interest does not necessarily cause the entities to be related 
parties, as defined in FASB Statement No. 57. However, the disclosures required by that statement 
are required under this Guide if an economic interest exists.
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11.15 When consolidated financial statements are required or permitted, 
a minority interest should be provided if such interest is represented by an 
economic interest whereby the minority interest would share in the operating 
results or residual interest upon dissolution.
11.16 Investments in common stock of for-profit entities in which the 
reporting entity has 50 percent or less of the voting stock in the investee should 
be reported under the equity method in conformity with APB Opinion No. 18, 
The Equity Method of Accounting for Investments in Common Stock, if the 
guidance in that opinion requires use of the equity method. The equity method 
should be followed by an investor whose investment in voting stock gives it the 
ability to exercise significant influence over operating and financial policies of 
an investee. Determining the ability of an investor to exercise significant 
influence is not always clear, and applying judgment is necessary to assess the 
status of each investment. However, to achieve a reasonable degree of uniform­
ity, the ownership of 20 percent or more of the voting stock leads to a presump­
tion that the investor can exercise significant influence and, therefore, the 
investment should be accounted for under the equity method in accordance 
with APB Opinion No. 18. However, this presumption can be overcome in 
certain instances. FASB Interpretation No. 35, Criteria for Applying the Equity 
Method of Accounting for Investments in Common Stock, paragraph 4, provides 
examples of indications that an investor may be unable to exercise significant 
influence. Health care organizations that report investments on the equity 
method should make the financial statement disclosures required by APB 
Opinion No. 18.
11.17 This Guide provides guidance concerning consolidated financial 
statements. Consolidation of a parent or subsidiary organization requires the 
presentation of a single set of amounts for the entire reporting entity. Combi­
nation, as discussed in paragraphs 22 and 23 of ARB No. 51, refers to financial 
statements prepared for organizations between which common control exists 
but for which the parent-subsidiary relationship does not exist. Both consoli­
dation and combination require elimination of interorganization transactions 
and balances. Paragraph 22 of ARB No. 51 states that “there are circum­
stances, however, where combined financial statements (as distinguished from 
consolidated statements) of commonly controlled companies are likely to be 
more meaningful than their separate statements.” This Guide prohibits con­
solidated financial statements in certain circumstances. However, it provides 
no guidance concerning combined financial statements of commonly controlled 
entities, which may be presented in certain circumstances in conformity with 
the guidance in ARB No. 51.
11.18 Paragraph 15 of FASB Statement No. 94 precludes the use of the 
parent company’s financial statements as the general-purpose financial state­
ments of the primary reporting entity. Similarly, where consolidation is re­
quired, this Guide precludes the issuance of parent company financial 
statements as the general-purpose financial statements of the primary report­
ing entity. However, neither FASB Statement No. 94 nor this Guide discuss 
the use of the parent company’s financial statements as other than the general- 
purpose financial statements for the primary reporting entity.9 GAAP does not 
preclude the issuance of financial statements for the subsidiary only. However, 
care should be taken to include all disclosures required by FASB Statement 
No. 57 and other relevant pronouncements.
9 Contractual agreements or regulatory provisions may require parent company only financial 
statements. SAS No. 62 provides guidance for reporting on financial presentations to comply with 
contractual agreements or regulatory provisions.
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Transfers*
11.19 Equity transfers are similar to ownership transactions between a 
for-profit parent and its owned subsidiary (for example, additional paid-in 
capital or dividends).10 However, equity transfers can occur only between 
related not-for-profit entities when one controls the other or both are under 
common control. An equity transfer embodies no expectation of repayment, 
nor does the transferor receive anything of immediate economic value 
(such as a financial interest or ownership). Equity transfers are reported 
separately as changes in net assets, are excluded from the performance 
indicator, and do not result in any step-up in basis of the underlying assets 
transferred.
11.20 Other transfers may occur among related entities. If  the entities are 
consolidated or combined, such transfers are eliminated in consolidation 
and/or combination. If the entities are not consolidated or combined (for 
example, in separate subsidiaries or obligated group financial statements),11 the 
method of accounting for such transfers is dictated by the substance of the 
transaction as well as the legal form. For example, transfers by a founda­
tion to a hospital under common control, when the foundation is acting 
other than as an owner, should be accounted for as contributions received 
by the hospital, consistent with FASB Statement No. 116, Accounting for 
Contributions Received and Contributions Made, and chapter 10 of this 
Guide. In other situations, payments may be made for services provided 
between not-for-profit entities under common control, which should be 
accounted for as revenues and expenses depending on the types of services 
provided.
11.21 A health care organization may loan or advance resources to a 
related entity. I f  repayment is reasonably assured, a receivable or payable 
should be recorded by the entities. Subsequent to the time a receivable is 
recorded, the ability of the receiving entity to repay the receivable should be 
considered. If  the receivable is not to be repaid, or if the receiving entity is 
perceived as unable to repay, it may be accounted for as an equity transfer with 
the transferor reducing net assets and the transferee increasing net assets at 
the date such determination is made (see paragraph 11.19).
* FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization or Charitable 
Trust That Raises or Holds Contributions for Others, establishes standards for transactions in which 
an entity—the donor—makes a contribution by transferring assets to a not-for-profit organization or 
charitable trust—the recipient organization—that accepts the assets from the donor and agrees to 
use those assets on behalf of or transfer those assets, the return on investment of those assets, or 
both to another entity—the beneficiary—that is specified by the donor. Among other matters, FASB 
Statement No. 136 incorporates without reconsideration the guidance in FASB Interpretation No. 42, 
and supersedes that Interpretation. FASB Statement No. 136 is effective for financial statements 
issued for fiscal periods beginning after December 15, 1999 (earlier application is encouraged), except 
for the provisions incorporated from FASB Interpretation No. 42, which continue to be effective for 
fiscal years ending after September 15, 1996. A summary of FASB Statement No. 136 is included in 
appendix F to this Guide. This chapter will be modified to conform to the requirements of FASB 
Statement No. 136 in a future edition of this Guide.
10 Transfers, including residual equity transfers, reported by governmental health care enter­
prises should be reported in accordance with NCGA Statement No. 1, Governmental Accounting and 
Financial Reporting Principles, paragraphs 105 and 106. GASB Statement No. 34, Basic Financial 
Statements— and Management’s Discussion and Analysis—for State and Local Governments, estab­
lishes financial reporting standards for state and local governments. Among other matters, this 
Statement supersedes paragraphs 105 and 106 of NCGA Statement No. 1. A brief summary of GASB 
Statement No. 34 is provided in paragraphs 1.09 through 1.11 in this Guide. This chapter will be 
modified to conform to the requirements of GASB Statement No. 34 in a future edition of this Guide.
11 See paragraph 12.06 for additional discussion regarding obligated group financial statements.
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11.22 Transfers that result in changes in ownership interest are ac­
counted for as investments in accordance with APB Opinion No. 18 and FASB 
Statement No. 94.
11.23 A related entity may act as an agent for the reporting entity. 
Resources transferred by a related fund-raising organization to an affiliated 
health care entity that were solicited in the name of the health care entity may 
represent transfers under an agency arrangement. The reporting entity (and 
not the agent) records the contribution received in accordance with FASB 
Statement No. 116. If  a contribution is transferable to the ultimate recipient 
through an agent acting as an intermediary, the ultimate recipient should 
report the contribution when adequate evidence that the agent has received 
the promise to give or the contribution becomes available. FASB Interpretation 
No. 42, Accounting for Transfers of Assets in Which a Not-for-Profit Organiza­
tion Is Granted Variance Power (an interpretation of FASB Statement No. 
116),[12] clarifies that not-for-profit organizations that receive assets act as 
donees or donors, rather than as agents, trustees, or intermediaries, if  the 
resource provider specifies a third-party beneficiary or beneficiaries and ex­
plicitly grants the recipient organization the unilateral power to redirect the 
use of the assets away from the specified beneficiary or beneficiaries. Such 
unilateral power is often referred to as variance power.
11.24 Assets transferred from one commonly controlled entity to another 
should be recorded by the transferee at the carrying value of the transferring 
entity. This treatment is consistent with the guidance prescribed by AICPA 
Accounting Interpretation No. 39, Transfers and Exchanges Between Compa­
nies Under Common Control, of APB Opinion No. 16, Business Combinations.*
Disclosure
11.25 Significant relationships and transactions not in the ordinary course 
of business with directors, management, medical staff, or other related parties 
(including unconsolidated related organizations) should be disclosed in accordance 
with FASB Statement No. 57. SAS No. 45, Omnibus Statement on Auditing 
Standards—1983, “Related Parties” (AICPA, Professional Standards, vol. 1, AU 
sec. 334), sets forth procedures for the auditor to consider in determining the 
existence of transactions with related parties and identifying them.
11.26 Hospital boards may contract with management companies to op­
erate their facilities. Frequently, the management company will employ the 
administrator as well as other key personnel. Further, services may be ac­
quired from entities related to the management company.13 The auditor 
should evaluate the impact of these arrangements on the hospital’s internal 
controls and disclose related party transactions as required by FASB State­
ment No. 57.
11.27 The reporting and disclosure requirements of the nongovernmental 
health care organization under the circumstances noted in paragraphs 11.10 
through 11.18 are summarized as follows:
[12] [Renumbered and deleted.]
* In September 1999, the FASB released an exposure draft of a proposed FASB Statement, 
Business Combinations and Intangible Assets that has two parts. The first part, which applies only to 
business enterprises would, in addition to other matters, supersede AICPA Accounting Interpretation 
No. 39 of APB Opinion No. 16.
13 See footnote 2 of this chapter.
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The entity owns a majority of a 
for-profit entity’s voting stock.
The entity is the sole corporate 
member of a not-for-profit entity. 
(See paragraph 11.10, footnote 2.)
The entity controls another 
through a majority voting interest 
in the board and an economic 
interest exists.
The reporting entity owns 50 
percent or less of the common 
voting stock of an investee and can 
exercise significant influence over 
operating and financial policies.
There have been material 
transactions between the health 
care entity and the related 
organization. (This could be present 
in any of the foregoing 
circumstances.)
An entity has control over another 
not-for-profit organization or has 
an economic interest in the other, 
but not both.
The reporting entity controls a 
separate not-for-profit entity 
through a form other than majority 
ownership or voting interest and 
has an economic interest in that 
other entity.
Consolidate unless control is likely 
to be temporary or does not rest 
with the majority owner or the 
interest is limited by state law or 
contractual agreement.
Consolidate unless control is likely 
to be temporary or does not rest 
with the majority owner or the sole 
corporate member’s interest is 
limited by state law or contractual 
agreement.
Consolidate unless control is likely 
to be temporary or does not rest 
with the majority owner or the sole 
corporate member; or the interest 
is limited by state law or 
contractual agreement.
The investment should be 
accounted for under the equity 
method in accordance with APB 
Opinion No. 18.
In the notes to the financial 
statements (a) disclose the 
existence and nature of the 
relationship and (b) describe and 
quantify the transactions.
In the notes to the financial 
statements (a) disclose the 
existence and nature of the 
relationship and (b) describe and 
quantify the transactions. 
Consolidation is prohibited. 
Consolidation permitted but not 
required. If  consolidated 
statements are not presented, the 
notes to the financial statements 
should disclose (a) the 
identification of the other entity 
and the nature of its relationship 
with the reporting entity, (b) 
summarized financial data of the 
other entity, and (c) the disclosures 
set forth in FASB Statement No. 57.
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Business Combinations*
11.28 As discussed in paragraph 11.02, the dynamics of change in the 
health care industry have resulted in increased business combinations as new 
organizational structures are being formed. APB Opinion No. 16 provides 
guidance regarding business combinations concerning for-profit business en­
terprises and may provide a useful framework when evaluating similar trans­
actions entered into by not-for-profit health care business organizations. A list 
of possible factors to be considered when evaluating these transactions in 
relation to APB Opinion No. 16 is summarized as follows:
Circumstances
Monetary consideration received or 
paid, change in legal title to assets, 
and/or assumption of liabilities.
Change in control (for example, 
change in sole corporate member).
Accounting and Disclosure Guidance
This is similar to a purchase under 
APB Opinion No. 16.14
This is similar to a pooling of 
interests transaction under APB 
Opinion No. 16. No step-up in basis.
See paragraphs 1.36 and 1.37 for additional guidance regarding the application 
of APB Opinion No. 16 to not-for-profit organizations.
Auditing
11.29 The independent auditor may need to consider the examples of 
specific auditing objectives, control activities, and auditing procedures for 
related party organizations, balances, and transactions that are presented in 
exhibit 11.1.
* In September 1999, the FASB released an exposure draft of a proposed FASB Statement, 
Business Combinations and Intangible Assets that has two parts. The first part, which applies only to 
business enterprises would, in addition to other matters, supersede AICPA Accounting 
Interpretations 1 through 32 and 34 through 39 of APB Opinion No. 16, and would amend APB 
Opinion No. 16 and AICPA Accounting Interpretation 33 of Opinion 16. The FASB is addressing 
issues pertaining to not-for-profit combinations in a separate project.
14 See AICPA Accounting Interpretation No. 39 of APB Opinion No. 16 for treatment of transfers 
and exchanges between companies under common control.
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Exhibit 11.1
Auditing Considerations
Financial Statement Specific Auditing 
Assertions_________ Objectives
Selected Control 
Activities
Reporting Entity and Related Organizations 
Existence and The reporting 
occurrence, entity is
completeness, and appropriate, 
presentation and 
disclosure
Procedures 
ensure that 
investees, 
affiliates, and 
other related 
entities are 
accounted for 
appropriately.
Auditing
Procedures
Review the 
articles of 
incorporation, 
bylaws, and 
minutes of 
directors’ 
meetings, 
shareholder lists, 
and filings with 
regulatory 
authorities to 
determine the 
existence of 
related parties.
Obtain
representations 
from management 
as to whether all 
investees, 
affiliates, and 
related entities 
have been 
accounted for 
properly or 
disclosed.
Review
transactions with 
investees, 
affiliates, and 
other related 
entities to 
determine that 
they are reported 
properly.
Relationships and 
transactions with 
related
organizations are 
identified and 
disclosed, if 
appropriate, 
because of 
economic
Procedures 
ensure that 
conflict-of-interest 
policies, 
procedures, and 
disclosure 
requirements are 
met.
Test significant 
related party 
transactions as 
follows:
•  Determine 
substance.
•  Examine
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Financial Statement Specific Auditing 
Assertions Objectives
dependence of the 
entity.
Selected Control 
Activities
documents 
(invoices, 
contracts, and 
agreements).
•  Determine the 
basis of pricing.
•  Determine the 
collectibility of 
receivables and 
advances.
Review related
party transactions
for completeness
by—
• Considering 
previously 
identified 
transactions or 
relationships.
•  Reviewing the 
minutes of 
directors’ and 
other meetings.
•  Discussing 
related-party 
transactions 
with entity 
personnel.
•  Reviewing 
unusual 
transactions.
•  Reviewing the 
responses to 
related party 
(conflict-of- 
interest) 
questionnaires.
Auditing
Procedures
Presentation and 
disclosure
Related party 
transactions and 
organizations are 
reported properly.
Review the 
presentation and 
disclosure of 
related party 
information for 
completeness.
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Chapter 12 
Independent Auditor's Reports*
Overview
12.01 The guidance in SAS No. 58, Reports on Audited Financial State­
ments (AICPA, Professional Standards, vol. 1, AU sec. 508), applies to audit 
reports on the financial statements of health care organizations. Such a report 
may contain an unqualified opinion, an unqualified opinion with an explana­
tory paragraph, a qualified opinion, a disclaimer of opinion, or an adverse 
opinion. The facts and circumstances of each particular audit govern the 
appropriate form of the report.1 Report examples appearing in this chapter 
illustrate the form of certain auditor’s reports issued by the independent 
auditor in auditing the financial statements of a health care organization.
Unqualified Opinion
12.02 The independent auditor’s standard report states that the financial 
statements present fairly, in all material respects, an entity’s financial posi­
tion, results of operations, changes in net assets, and cash flows in conformity 
with GAAP. This conclusion may be expressed only when the independent 
auditor has formed such an opinion on the basis of an audit performed in 
accordance with GAAS. An example of the independent auditor’s standard 
report is presented in exhibit 12.1 at the end of this chapter.
Qualified Opinion
12.03 SAS No. 58 states that certain circumstances may require a quali­
fied opinion. A qualified opinion states that except for the effects of the matter 
to which the qualification relates, the financial statements present fairly, in all 
material respects, the financial position, results of operations, and cash flows 
in conformity with GAAP. Such an opinion is expressed when—
a. There is a lack of sufficient competent evidential matter or there are 
restrictions on the scope of the audit that have led the independent 
auditor to conclude that an unqualified opinion cannot be expressed 
and the independent auditor has concluded not to disclaim an opinion 
(see exhibit 12.2).
b. The independent auditor believes, on the basis of the audit, that the 
financial statements contain a departure from GAAP, the effect of 
which is material, and has concluded not to express an adverse 
opinion (see exhibit 12.3).
* GASB Technical Bulletin (TB) 2000-1, Disclosures about Year 2000 Issues—a rescission of 
Technical Bulletins 98-1 and 99-1, rescinds the provisions of GASB TB 98-1, Disclosures about Year 
2000 Issues, and GASB TB 99-1, Disclosures about Year 2000 Issues—an amendment of Technical 
Bulletin 98-1, for financial statements issued after February 22, 2000. However, TB 2000-1 indicates 
that other disclosure requirements continue to apply for year 2000-related events should they occur.
1 SAS No. 79, Amendment to Statement on Auditing Standards No. 58, Reports on Audited 
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 508), amends SAS No. 58 to 
eliminate the requirement that when certain criteria are met, the auditor add an uncertainties 
explanatory paragraph to the auditor’s report. It also clarifies and reorganizes the guidance in SAS 
No. 58 concerning emphasis paragraphs, uncertainties, and disclaimers of opinion.
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Additional Information
12.04 SAS No. 29, Reporting on Information Accompanying the Basic Finan­
cial Statements in Auditor-Submitted Documents (AICPA, Professional Stand­
ards, vol. 1, AU sec. 551), contains useful guidance on reporting on additional 
information. The information covered by SAS No. 29 is presented to accompany 
the basic financial statements in an independent auditor-submitted document and 
is not considered necessary for a fair presentation of financial position, results of 
operations, changes in net assets, and cash flows in conformity with GAAP. Such 
information includes additional details or explanations of items in, or related to, 
the basic financial statements, consolidating/combining information, historical 
summaries of items extracted from the basic financial statements, statistical data, 
and other material, some of which may be from sources outside the accounting 
system or outside the health care organization.
12.05 With respect to supplementary  and other information, guidance is 
contained in SAS No. 8, Other Information in Documents Containing Audited 
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 550), 
and SAS No. 52, Omnibus Statement on Auditing Standards—1987, “Required 
Supplementary Information” (AICPA, Professional Standards, vol. 1, AU sec. 
558). Among other changes, SAS No. 52 amends SAS No. 29 regarding required 
supplementary information. In addition, SAS No. 42, Reporting on Condensed 
Financial Statements and Selected Financial Data (AICPA, Professional 
Standards, vol. 1, AU sec. 552), contains guidance on reporting in a client-pre­
pared document when condensed financial statements or selected financial 
data are presented by a public entity.
Special Reports
12.06 If a health care organization is required to follow reporting require­
ments of a regulatory agency, to report under a cash receipts and disburse­
ments basis of accounting, or to report on another comprehensive basis of 
accounting other than GAAP, the auditor should follow the guidance in SAS 
No. 62, Special Reports (AICPA, Professional Standards, vol. 1, AU sec. 623). 
SAS No. 62 also provides reporting guidance when reporting on specified 
elements, accounts, or items of a financial statement; compliance with aspects 
of contractual agreements or regulatory requirements related to audited finan­
cial statements; financial presentations to comply with contractual agree­
ments or regulatory provisions; and financial information presented in 
prescribed forms (see exhibit 12.4). Accountants’ reports on regulatory basis 
financial statements generally are prescribed by professional standards as 
restricted-use reports as described in SAS No. 87, Restricting the Use of an 
Auditor’s Report (AICPA, Professional Standards, vol. 1, AU sec. 532). Where 
obligated group financial statements exclude entities that are required under 
GAAP to be consolidated in order to comply with loan agreements, the account­
ants’ report should restrict the use to specified parties (see exhibit 12.4).2 Use 
should be restricted to the company and other parties to the agreement. Guidance 
may also be found in SAS No. 75, Engagements to Apply Agreed-Upon Procedures 
to Specified Elements, Accounts, or Items of a Financial Statement (AICPA, 
Professional Standards, vol. 1, AU sec. 622). Health care providers that receive 
federal financial assistance should also refer to SOP 98-3, Audits of States, Local 
Governments, and Not-for-Profit Organizations Receiving Federal Awards.
2 Obligated group is a term used to denote a group of entities, sometimes a parent corporation and 
several of its subsidiaries, that is liable for the repayment of obligations, such as tax-exempt bonds.
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Unqualified Opinion—Comparative Financial Statements
Independent Auditor’s Report
To the Board of Trustees 
XYZ Health Care Organization
We have audited the accompanying balance sheets of XYZ Health Care Organi­
zation as of September 30, 20X2, and 20X1, and the related statements of 
operations, changes in net assets, and cash flows for the years then ended. 
These financial statements are the responsibility of XYZ Health Care Organi­
zation’s management. Our responsibility is to express an opinion on these 
financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing 
standards. These standards require that we plan and perform the audit to 
obtain reasonable assurance about whether the financial statements are free 
of material misstatement. An audit includes examining, on a test basis, evi­
dence supporting the amounts and disclosures in the financial statements. An 
audit also includes assessing the accounting principles used and significant 
estimates made by management, as well as evaluating the overall financial 
statement presentation. We believe that our audits provide a reasonable basis 
for our opinion.
In our opinion, the financial statements referred to above present fairly, in all 
material respects, the financial position of XYZ Health Care Organization as 
of September 30, 20X2, and 20X1, and the results of its operations, changes in 
net assets, and cash flows for the years then ended in conformity with generally 
accepted accounting principles.
[Signature]
[Date]
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Qualified Opinion—Scope Limitation
Independent Auditor’s Report
To the Board of Trustees 
XYZ Health Care Organization
[Include same first paragraph as the standard report—see exhibit 12.1]
Except as discussed in the following paragraph, we conducted our audits in 
accordance with generally accepted auditing standards. Those standards re­
quire that we plan and perform the audit to obtain reasonable assurance about 
whether the financial statements are free of material misstatement. An audit 
includes examining, on a test basis, evidence supporting the amounts and 
disclosures in the financial statements. An audit also includes assessing the 
accounting principles used and significant estimates made by management, as 
well as evaluating the overall financial statement presentation. We believe that 
our audits provide a reasonable basis for our opinion.
We were unable to obtain audited financial statements supporting XYZ’s 
investment in an affiliate stated at $XXX,XXX and $XXX,XXX at September
30, 20X2, and 20X1, respectively, or its equity in earnings of that affiliate of 
$XXX,XXX and $XXX,XXX, which is included in the statement of operations 
for the years then ended as described in Note X to the financial statements; nor 
were we able to satisfy ourselves as to the carrying value of the investment in 
the affiliate or the equity in its earnings by other auditing procedures.
In our opinion, except for the effects of such adjustments, if any, as might have 
been determined to be necessary had we been able to examine evidence 
regarding the affiliate investment and earnings, the financial statements 
referred to in the first paragraph present fairly, in all material respects, the 
financial position of XYZ Health Care Organization as of September 30, 20X2, 
and 20X1, and the results of its operations, changes in net assets, and cash 
flows for the years then ended in conformity with generally accepted accounting 
principles.
[Signature]
[Date]
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Qualified Opinion—Departure From 
Generally Accepted Accounting Principles 
That Have a Material Effect on the Financial Statements
Independent Auditor’s Report
To the Board of Trustees 
XYZ Health Care Organization
[Include same first and second paragraphs as the 
standard report—see exhibit 12.1]
XYZ Health Care Organization has excluded, from property and debt in the 
accompanying balance sheets, certain lease obligations that, in our opinion, 
should be capitalized to conform with generally accepted accounting principles. 
If  these lease obligations were capitalized, property would be increased by 
$XXX,XXX and $XXX,XXX, long-term debt would be increased by $XXX,XXX 
and $XXX,XXX, and unrestricted net assets would be increased by $XXX,XXX 
and $XXX,XXX as of September 31, 20X2, and 20X1, respectively. In addition, 
earnings would be increased by $XXX,XXX and $XXX,XXX, respectively, for 
the years then ended.
In our opinion, except for the effects of not capitalizing certain lease obligations 
as discussed in the preceding paragraph, the financial statements referred to 
in the first paragraph present fairly, in all material respects, the financial 
position of XYZ Health Care Organization as of September 30, 20X2, and 20X1, 
and the results of its operations, changes in net assets, and cash flows for the 
years then ended in conformity with generally accepted accounting principles.
[Signature]
[Date]
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Report on Financial Statements Prepared Pursuant to a 
Master Trust Indenture That Results in a Presentation Not 
in Conformity With Generally Accepted Accounting Principles 
or Other Comprehensive Basis of Accounting
Independent Auditor’s Report
To the Board of Directors 
Sample Health Care Corporation
We have audited the accompanying special-purpose combined balance sheets 
of the Obligated Group (as defined in the Master Trust Indenture dated 
December X, 20X0, between Sample Health Care Corporation and Any Bank 
as Trustee) of Sample Health Care Corporation and Affiliates as of December
31, 20X2, and 20X1, and the related special-purpose combined statements of 
operations, changes in net assets, and cash flows for the years then ended. 
These financial statements are the responsibility of management. Our respon­
sibility is to express an opinion on these financial statements based on our 
audits.
We conducted our audits in accordance with generally accepted auditing 
standards. Those standards require that we plan and perform the audit to 
obtain reasonable assurance about whether the financial statements are free 
of material misstatement. An audit includes examining, on a test basis, evi­
dence supporting the amounts and disclosures in the financial statements. An 
audit also includes assessing the accounting principles used and significant 
estimates made by management, as well as evaluating the overall financial 
statement presentation. We believe that our audits provide a reasonable basis 
for our opinion.
As described in Note 1, these special-purpose financial statements were pre­
pared in accordance with the accounting requirements set forth in the Master 
Trust Indenture and are not intended to be a presentation in conformity with 
generally accepted accounting principles.
In our opinion, the special-purpose financial statements of the Obligated Group 
as of and for the years ended December 31, 20X2, and 20X1, are fairly presented, 
in all material respects, on the basis of accounting described in Note 1.
This report is intended solely for the information and use of the board of 
directors and management of Sample Health Care Corporation, the Trustee 
under the Master Trust Indenture, and bondholders, and is not intended to be 
and should not be used by anyone other than these specified parties.
[Signature]
[Date]
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12.07 SOP 99-1, Guidance to Practitioners in Conducting and Reporting 
on an Agreed-Upon Procedures Engagement to Assist Management in Evaluat­
ing the Effectiveness of Its Corporate Compliance Program, provides guidance 
to practitioners in conducting and reporting on an agreed-upon procedures 
engagement performed pursuant to the AICPA Statements on Standards for 
Attestation Engagements to assist a health care provider in evaluating the 
effectiveness of its corporate compliance program consistent with the require­
ments of a Corporate Integrity Agreement entered into with the Office of the 
Inspector General of the U.S. Department of Health and Human Services. SOP 
99-1 is included as appendix D to this Guide.
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Chapter 13 
Financial Accounting and Reporting by 
Providers of Prepaid Health Care Services
Overview
13.01 This chapter provides guidance on applying GAAP to providers of 
prepaid health care services for the accounting and reporting of health care 
costs, contract losses (premium deficiencies), stop-loss insurance (reinsur­
ance), and contract acquisition costs.
Accounting for Health Care Costs
13.02 Health care costs should be accrued as services are rendered, 
including estimates of the costs of services rendered but not yet reported. 
Furthermore, if a provider of prepaid health care services is obligated to render 
services to specific members beyond the premium period due to provisions in 
the contract or regulatory requirements, the costs of such services to be 
incurred also should be accrued currently. Costs that will be incurred after a 
contract is terminated, such as guaranteed salaries, rent, and depreciation, net 
of any anticipated revenues, should be accrued when it is determined that a 
contract with a sponsoring employer or other group will be terminated.
13.03 Amounts payable to hospitals, physicians, or other health care 
providers under risk-retention, bonus, or similar programs should be accrued 
during the contract period based on relevant factors, such as experience to 
date.
13.04 The basis for accruing health care costs and significant business 
and contractual arrangements with hospitals, physicians, or other associated 
entities should be disclosed in the notes to the financial statements.
Accounting for Loss Contracts
13.05 A prepaid health care provider enters into contracts to provide 
members with specified health care services for specified periods in return for 
fixed periodic premiums. The premium revenue is expected to cover health care 
costs and other costs over the terms of the contracts. Only in unusual circum­
stances would a provider be able to increase premiums on contracts in force to 
cover expected losses. A provider may be able to control or reduce future health 
care delivery costs to avoid anticipated losses, but the ability to avoid losses 
under existing contracts may be difficult to measure or to demonstrate. Asso­
ciated entities such as hospitals, medical groups, and individual practice 
associations (IPAs) may enter into similar contracts with prepaid health care 
providers in which they agree to deliver identified health care services to the 
providers’ members for specified periods in return for fixed fees.
13.06 FASB Statement No. 5, Accounting for Contingencies, states that a 
loss should be accrued in financial statements when it is probable that a loss 
has been incurred and the amount of the loss can be reasonably estimated. 
Accordingly, losses should be recognized when it is probable that expected fu-
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ture health care costs and maintenance costs under a group of existing con­
tracts will exceed anticipated future premiums and stop-loss insurance recov­
eries on those contracts. The estimated future health care costs and 
maintenance costs to be considered in determining whether a loss has been 
incurred should include fixed and variable, direct and allocable indirect costs. 
Contracts should be grouped in a manner consistent with the provider’s 
method of establishing premium rates, for example, by community rating 
practices, geographical area, or statutory requirements, to determine whether 
a loss has been incurred.
Accounting for Stop-Loss Insurance
13.07 In stop-loss insurance, prepaid health care providers or associated 
entities transfer portions of their financial risks to other companies. A provider 
typically contracts to recover health care costs in excess of stated amounts 
during the contract periods.
13.08 Stop-loss insurance premiums should be included in reported 
health care costs. Stop-loss insurance recoveries should be reported as reduc­
tions of related health care costs. Receivables representing amounts recover­
able from insurers should be reported as assets, reduced by appropriate 
valuation allowances. In addition, the nature, amounts, and effects of signifi­
cant stop-loss insurance contracts should be disclosed.
Accounting for Contract Acquisition Costs
13.09 Many prepaid health care providers incur costs that vary with, and 
are primarily related to, the marketing of subscriber contracts and member 
enrollment. These costs, sometimes referred to as acquisition costs, consist 
mainly of commissions paid to agents or brokers and incentive compensation 
based on new enrollments. Commissions and incentive compensation may be 
paid when the contracts are written, at later dates, or over the terms of the 
contracts as premiums are received. Some providers incur additional costs 
directly related to the acquisition of specific contracts, such as the costs of 
specialized brochures, marketing, and advertising. Providers also incur costs 
that are related to the acquisition of new members but that do not relate to 
specific contracts and are not considered acquisition costs. These costs include 
salaries of the marketing director and staff, general marketing brochures, and 
general advertising and promotion expenses.
13.10 Although there is theoretical support for deferring certain acquisi­
tion costs, acquisition costs of providers of prepaid health care services—other 
than costs of advertising—should be expensed as incurred.1 Advertising costs 
should be accounted for in conformity with the guidance in SOP 93-7, Reporting 
on Advertising Costs.2
1 In accordance with existing practice, as mandated by SOP 89-5, Financial Accounting and 
Reporting by Providers of Prepaid Health Care Services. Although SOP 89-5 has been superseded 
with the issuance of this Audit and Accounting Guide, its provisions have been adopted in this 
chapter.
2 This pronouncement is not applicable to governmental health care enterprises that do not 
apply paragraph 7 of GASB Statement No. 20, Accounting and Financial Reporting for Proprietary 
Funds and Other Governmental Entities That Use Proprietary Fund Accounting. (See chapter 1, 
footnote 1.)
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Chapter 14 
Financial Accounting and Reporting by 
Continuing Care Retirement Communities
Overview
14.01 This chapter provides guidance on applying GAAP to continuing 
care retirement communities (CCRCs) for refundable and nonrefundable ad­
vance fees, for obligations to provide future services and the use of facilities to 
current residents, and for the costs of acquiring initial care contracts.1
14.02 The United States has over one thousand CCRCs. Most CCRCs are 
operated by not-for-profit organizations, and many are affiliated with religious 
organizations.
14.03 CCRC facilities may be independent or they may be affiliated with 
other health care facilities. They usually provide less intensive care than do 
hospitals. They generally supply required continuous nursing service or appro­
priate assistance to residents who have a wide range of medical conditions and 
needs.
14.04 Some states regulate CCRCs, although most states currently do 
not. There is, however, a growing trend toward regulation in this rapidly 
developing industry. States that do require some form of regulation specify 
that the CCRCs be certified by a state authority, such as a department of 
insurance or a department of social services. In addition, some states mandate 
that escrow or reserve funds be maintained for the protection of residents.
Types of Contracts
14.05 CCRCs use three basic types of contracts. They include all-inclusive 
(type A), modified (type B), and fee-for-service (type C) contracts.
Type A  Contracts
14.06 An all-inclusive continuing-care contract includes residential facili­
ties, meals, and other amenities. It also provides long-term nursing care for 
little or no increase in periodic fees, except to cover normal operating costs and 
inflation.
Type B Contracts
14.07 A modified continuing-care contract also includes residential facili­
ties, meals, and other amenities. However, only a specified amount of long­
term nursing care is provided for little or no increase in periodic fees, except to
1 The provisions of this chapter do not apply to governmental health care enterprises, unless the 
entity has elected to follow all FASB pronouncements under paragraph 7 of GASB Statement No. 20, 
Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities That 
Use Proprietary Fund Accounting. (See chapter 1, footnote 1.)
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cover normal operating costs and inflation. After the specified amount of 
nursing care is used, residents pay either a discounted rate or the full per diem 
rates for required nursing care.
Type C Contracts
14.08 A fee-for-service continuing-care contract includes residential fa­
cilities, meals, and other amenities as well as emergency and infirmary nurs­
ing care. Access to long-term nursing care is guaranteed, but it may be required 
at full per diem rates.
Types of Living Accommodations
14.09 CCRCs offer different types of living accommodations to residents, 
such as single or shared apartment units or individual homes. They also 
provide a variety of amenities, including social, recreational, dining, and 
laundry services.
14.10 CCRCs may provide long-term nursing-care services, either at the 
same location or, by agreement, with another facility. Residents are trans­
ferred to or from a nursing center as medical care is required. As the health of 
a resident declines, he or she may be transferred permanently to a nursing 
center.
Fees and Payment Methods
14.11 Continuing-care contracts contain a number of different ap­
proaches to providing delivery of services. Contract provisions, for example, 
may stipulate the amount of the advance fee, whether periodic fees will be 
required, and, if so, whether they can be adjusted. In addition, contracts 
generally do the following: detail the future services that will be provided to 
residents; explain how a resident will be charged for services; describe the 
CCRC’s refund policies and the formula for calculating the amount of the 
refund, which may be simple or complex; and describe the obligations of the 
CCRC and the resident if a contract is terminated or a residential unit is 
reoccupied.
14.12 A CCRC may require several different payment methods for serv­
ices and the use of facilities. Paragraphs 14.13 through 14.19 discuss three of 
the most prevalent methods.
Advance Fee Only
14.13 Under this method, a resident pays an advance fee in return for 
future services and the use of facilities. Such services generally include CCRC 
housing-related services (for example, meals, laundry, housekeeping, and so­
cial services) and health care. These services usually are provided to the 
resident for the remainder of his or her life or until the contract is terminated. 
Additional periodic fees are not paid, regardless of how long a resident lives or 
if the resident requires more services than anticipated. Generally, the resident 
receives no ownership interest in the facility.
Advance Fee With Periodic Fees
14.14 Under this method, a resident pays an advance fee and periodic fees 
for services and the use of facilities. Such periodic fees may be fixed, or they 
may be subject to adjustment for increases in operating costs or inflation or for 
other economic reasons.
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Periodic Fees Only
14.15 Under this method, a resident pays a fee at periodic intervals for 
services and the use of the facilities provided by the CCRC. Such fees may be 
either fixed or adjustable.
14.16 An advance fee may be met by transferring a resident’s personal 
assets (which may include rights to future income) or by paying a lump sum of 
cash to the CCRC.
14.17 Advance fees received for future services may be refunded at the 
occurrence of some future event, such as death, withdrawal from the CCRC, 
termination of the contract, or reoccupancy of a residential unit. The amount 
of the refund generally is based on contractual provisions or statutory require­
ments.
14.18 Many continuing-care contracts are similar to annuity contracts. 
Under those contracts, the CCRC assumes the risks associated with (a) esti­
mating the amount of the advance fee and other fees to be paid by a resident 
and (b) determining whether such fees will be sufficient to cover the cost of 
providing a resident’s required services and the use of facilities. For some 
contracts, residents may share the future costs without limit.
14.19 The CCRC has an obligation to provide future services for the 
length of the contract or the life of the resident. In certain circumstances, this 
obligation continues regardless of whether advance fees or periodic fees are 
sufficient to meet the costs of providing services to a resident.
Accounting for Refundable Advance Fees
14.20 Payment of an advance fee generally is required before a resident 
acquires a right to reside in an apartment or residential unit for life. A portion 
of advance fees may be refundable by rescission within a legally set time period 
or if a certain future event occurs, such as the death or withdrawal of a resident 
or termination of the contract. Some refunds are paid only if a residential unit 
is reoccupied.
14.21 CCRC refund policies vary either by region or according to statu­
tory requirements, but generally the amount of the refund is based on provi­
sions specified in a contract. For example, some contracts require a refund of 
the advance fee, less a reasonable processing fee. Amounts refunded may be 
based on a fixed amount or percentage, an amount that declines to a fixed 
amount over time, an amount that declines to zero, or an amount based on the 
resale amount. Refunds may be contingent on vacating the unit, resale of the 
unit, or passage of a fixed period of time if the unit is not resold.
14.22 The estimated amount of advance fees that is expected to be re­
funded to current residents under the terms of the contracts should be ac­
counted for and reported as a liability. The estimated amount should be based 
on the individual facility’s own experience or, if records are not available, on 
the experience of comparable facilities. The remaining amount of advance fees 
should be accounted for as deferred revenue within the liability section of the 
balance sheet. Adjustments to the estimated liability should be accounted for 
as deferred revenue and amortized together with nonrefundable advance fees 
as discussed in paragraph 14.23. The gross amount of contractual refund 
obligations under existing contracts and the CCRC’s refund policy should be 
disclosed in the notes to the financial statements. Amounts refunded should be 
disclosed in the statement of cash flows as a financing transaction.
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14.23 The deferred revenue should be amortized to income over future 
periods based on the estimated life of the resident or on the contract term, if 
shorter. The period of amortization should be adjusted annually based on the 
actuarially determined, estimated, remaining life expectancy of each individ­
ual or on the joint and last survivor life expectancy of each pair of residents 
occupying the same unit. The straight-line method should be used to amortize 
deferred revenue except in certain circumstances when costs are expected to 
increase at a significantly higher rate than future revenues in the later years 
of residence. In those situations, deferred revenue may be amortized to income 
using a method that reflects the disproportionate ratio between the costs of the 
expected services and the expected revenues. The amortized amount should 
not exceed the amount available to the CCRC under state regulations, contract 
provisions, or management policy. Unamortized deferred revenue from nonre­
fundable advance fees should be recorded as revenue upon a resident’s death 
or the termination of the contract. The method of amortization should be 
disclosed in the notes to the financial statements.
Accounting for Fees Refundable to Residents 
Only From Reoccupancy Proceeds of a Contract 
Holder's Unit
14.24 Some contracts between a CCRC and a resident stipulate that all 
or a portion of the advance fee may be refundable if the contract holder’s unit 
is reoccupied by another person. The source of money for the payment is from 
the proceeds of the advance fees collected by the CCRC from the next resident 
of the reoccupied unit. The terms governing how the proceeds from the next 
resident are to be paid to the previous resident vary from contract to contract. 
In effect, the CCRC acts as if it were an agent for present and future residents.
14.25 The portion of the fees that will be paid to current residents or their 
designees, only to the extent of the proceeds of reoccupancy of a contract 
holder’s unit, should be accounted for as deferred revenue, provided that legal 
and management policy and practice support the withholding of refunds under 
this condition. Similar amounts received from new residents in excess of the 
amount to be paid to previous residents or their designees also should be 
deferred. The deferred revenue should be amortized to income over future 
periods based on the remaining useful life of the facility. The basis and method 
of amortization should be consistent with the method for calculating deprecia­
tion and should be disclosed in the notes to the financial statements.
Accounting for Nonrefundable Advance Fees
14.26 Under provisions of continuing-care contracts entered into by a 
CCRC and residents, nonrefundable advance fees represent payment for fu­
ture services and should be accounted for as deferred revenue. If a CCRC has 
sufficient historical experience and relevant statistical data about life expec­
tancies, it should consider that information when determining the remaining 
life of residents. A CCRC with insufficient historical experience or reliable 
actuarial data may use relevant data of similar communities within that area, 
relevant national industry statistics, or other appropriate data. Nonrefundable 
advance fees should be amortized in the manner discussed in paragraph 14.23.
14.27 The application of the conclusions in paragraphs 14.25 and 14.26 is 
presented in exhibit 14.1 at the end of this chapter.
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Accounting for the Obligation to Provide Future 
Services and the Use of Facilities to Current Residents
14.28 A CCRC expects to provide services and the use of facilities to 
individuals over their remaining lives under continuing-care contract agree­
ments. The nature and extent of such services depend on such variables as the 
individual’s age, health, sex, and economic status upon entering the CCRC. 
Thus, the CCRC assumes a risk in estimating the cost of future services and 
the use of facilities. Although many CCRCs are allowed contractually to 
increase periodic fees, some contracts may restrict increases in periodic fees 
and require continuing services without additional compensation. I f  the ad­
vance fees and periodic fees charged are insufficient to meet the costs of 
providing future services and the use of facilities, the CCRC has a liability to 
provide future services and the use of facilities that is equal to the estimated 
cost of providing future services and the use of facilities (defined as amounts 
that are expected to be incurred to provide services and the use of facilities to 
individuals over their remaining lives under continuing care contracts, includ­
ing resident-care, dietary, health care, facility, interest, depreciation, and 
amortization costs) in excess of the related anticipated revenues. The liability 
is based on actuarial assumptions (such as mortality and morbidity rates), on 
estimates of future costs and revenues, and on the specific CCRC’s historical 
experience and statistical data.
14.29 The obligation to provide future services and the use of facilities to 
current residents should be calculated annually in order to determine whether 
a liability should be reported in the financial statements. The liability related 
to continuing-care contracts is the present value of future net cash flows, minus 
the balance of unamortized deferred revenue, plus depreciation of facilities to 
be charged related to the contracts, plus unamortized costs of acquiring the 
related initial continuing-care contracts, if  applicable. The calculation should 
be made by grouping contracts by type, such as all contracts with a limit on 
annual increases in fees, contracts with unlimited fee increases, and so forth.
14.30 Cash inflows include revenue contractually committed to support 
the residents and inflows resulting from monthly fees including anticipated 
increases in accordance with contract terms. This includes third-party pay­
ments, contractually or statutorily committed investment income from services 
related to CCRC activities, contributions pledged by donors to support CCRC 
activities, and the volume of deferred nonrefundable advance fees. Cash out­
flows are composed of operating expenses, including interest expense and 
excluding selling, and general and administrative expenses. Anticipated cost 
increases affecting these operating expenses should be considered in determin­
ing cash outflows. The expected inflation rate as well as other factors should 
be considered in determining the discount rate. In calculating the liability, the 
specific CCRC’s historical experience or statistical data relating to the residents’ 
life spans should be used. The life spans used should be the same as those used 
to amortize deferred revenue (see paragraph 14.23). For a new CCRC, either 
relevant data of similar communities in the area or relevant national industry 
statistics may be used if they are deemed to be representative.
14.31 A CCRC should disclose in its notes to the financial statements (1) 
the carrying amount of the liability to provide future services and the use of 
facilities related to continuing-care contracts that is presented at present value 
in the financial statements (if not separately disclosed in the balance sheet) 
and (2) the interest rate used to discount that liability. Also, the FASB has
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issued FASB Concepts Statement No. 7, Using Cash Flow Information and 
Present Value in Accounting Measurements. This Concepts Statement provides 
useful discussion of general principles governing the use of present value, and 
of the objective of present value in accounting measurements. Statements of 
Financial Accounting Concepts are not sources of established accounting prin­
ciples as described in SAS No. 69, The Meaning of Present Fairly in Conformity 
with Generally Accepted Accounting Principles in the Independent Auditor’s 
Report, and, thus, do not amend, modify, or justify a change from generally 
accepted accounting principles currently in effect.
14.32 The application of the conclusions in paragraph 14.30 is presented 
in exhibit 14.2 at the end of this chapter.
Accounting for the Costs of Acquiring Initial 
Continuing-Care Contracts
14.33 Advertising costs incurred in connection with acquiring initial con­
tinuing-care contracts should be accounted for in conformity with the guidance 
in SOP 93-7, Reporting on Advertising Costs. Start-up costs should be expensed 
as incurred in accordance with SOP 98-5, Reporting on the Costs of Start-Up 
Activities. However, costs of acquiring initial continuing-care contracts that are 
within the scope of FASB Statement No. 67, Accounting for Costs and Initial 
Rental Operations of Real Estate Projects, should be expensed or capitalized in 
accordance with that Statement. Capitalized costs should be amortized to 
expenses on a straight-line basis over the average expected remaining lives of 
the residents under the contract or the contract term, if shorter. The costs of 
acquiring continuing-care contracts after a CCRC is substantially occupied or 
one year following completion should be expensed when incurred.2
Financial Statements
14.34 A complete set of illustrative financial statements for a CCRC is 
included in appendix A.
14.35 The notes to the financial statements for each year presented 
should include—
• A description of the CCRC and the nature of the related continuing- 
care contracts entered into by the CCRC.
•  The statutory escrow or similar requirements.
•  The refund policy of the CCRC and the general amount of refund 
obligation under the existing contracts.
•  The interest rate used to discount the liability to provide future 
services.
Auditing
14.36 When auditing a CCRC, the independent auditor may need to 
consider the examples of specific auditing objectives, selected control activities, 
and auditing procedures that are presented in exhibit 14.3 at the end of this 
chapter.
2 In accordance with existing practice, as mandated by SOP 90-8, Financial Accounting and 
Reporting by Continuing Care Retirement Communities. Although SOP 90-8 is superseded with the 
issuance of this Audit and Accounting Guide, its provisions have been adopted in this chapter.
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Accounting for Refundable and Nonrefundable Advance Fees
Assumptions:
a. The unit is occupied for twenty years.
b. The facility has an estimated thirty-year life.
c. The resident is admitted on the first day of the year indicated and 
dies on the last day of year indicated.
d. The estimated remaining life expectancy is taken from an appropri­
ate actuarial table.
e. The cost of providing future services is expected to be incurred 
equally over the remaining life.
Example:
___________ Advance Fees___________
Refunded to
Year Entry Nonrefundable Refundable the Previous
Admitted Dies Resident Age Total 25% 75% Occupant*
1 4 A 68 $100,000 $25,000 $ 75,000 _
5 8 B 82 120,000 30,000 90,000 $75,000
9 13 C 79 150,000 37,500 112,500 90,000
14 — D 80 130,000 32,500 97,500 97,500
Amortization of Nonrefundable Advance Fees:
Resident A
Unamortized
Deferred
Revenue
Estimated 
Remaining 
Life (in Years) Income
Year 1 $25,000 12.1 = $ 2,066
2 22,934 11.5 = 1,994
3 20,940 11.1 = 1,886
4 19,054 10.6 = 1,798
Unamortized deferred revenue
recognized upon the death of the resident 17,256
Total $25,000
Per contact, the amount is limited to 75% of proceeds of reoccupancy up to amount originally 
paid by previous occupant.
Amortization of Advance Fees Refundable to Residents 
$75,000/30 years = $2,500 per year for years 1 through 4 
15,000/26 years = $577 additional or $3,077 per year for years 5 through 8
22,500/22 years = $1,023 additional or $4,100 per year for years 9 through next change in occupancy
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Unamortized 
Deferred 
Resident B  Revenue
Year 5 
6
7
8
$30,000
25,082
20,758
16,984
Estimated 
Remaining 
Life (in Years)
6.1 =
5.8 =
5.5 =
5.3 =
Income
$ 4,918
4,324 
3,774 
3,205
Unamortized deferred revenue
recognized upon the death of the resident 13,779
Total $30,000
Unamortized Estimated 
Deferred Remaining 
Resident C Revenue Life (in Years) Income
Year 9 
10 
11 
12 
13
$37,500
32,143
27,346
23,073
19,290
7.0 =
6.7 = 
6.4 =
6.1 =
5.8 =
$ 5,357 
4,797 
4,273 
3,783
3,324
Unamortized deferred revenue
recognized upon the death of the resident 15,966
Total $37,500
Resident D
Unamortized
Deferred
Revenue
Estimated 
Remaining 
Life (in Years) Income
Year 14 $32,500 6.7 = $4,851
15 27,649 6.4 = 4,321
16 23,328 6.1 = 3,824
17 19,504 5.8 = 3,363
18 16,141 5.5 = 2,935
19 13,206 5.3 = 2,492
20 10,714 5.1 = 2,100
Amortization continues until the death of the resident.
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Exhibit 14.2
Accounting for the Obligation to Provide Future Services 
and the Use of Facilities to Current Residents
Assumptions:
a. All residents pay a $ 50,000 fee, which is refundable less 2 percent 
per month for the first 36 months. After that period, none of the fee 
is refundable. The CCRC opened on 1/1/X4. (See exhibit 14.1 for an 
illustration of how to compute refundable and deferred revenue.)
b. An additional periodic fee of $1,000 is payable monthly with a 5 
percent increase annually.
c. The unamortized (deferred) costs of acquiring related initial con­
tracts on 12/31/X6 are assumed to be $17,000.
d. The unamortized deferred revenue on 12/31/X6 is assumed to be 
$27,027.
Present value of net cash flow on 12/31/X6:
Cash inflows:
Estimated
Remaining Life Estimated Cash Inflows
Resident
(in Months) 
on 12131/X6 19X7 19X8 19X9 20X0
A 36 $12,000 $12,600 $13,230 —
B 22 12,000 10,500 — —
C 27 12,000 12,600 3,308 —
D 38 12,000 12,600 13,230 $2,315
Estimated cash inflows $48,000 $48,300 $29,768 $2,315
Cash outflows:
Estimated 
Remaining Life Estimated Cash Outflows
Resident
(in Months) 
on 12/31/X6 19X7 19X8 19X9 20X0
A 36 $10,000 $12,000 $15,000 —
B 22 15,000 11,000 — —
C 27 14,000 17,000 5,000 —
D 38 8,000 12,000 14,000 $4,000
Estimated cash outflows $47,000 $52,000 $34,000 $4,000
Recapitulation 19X7 19X8 19X9 20X0
Cash inflows $ 48,000 $ 48,300 $ 29,768 $ 2,315
Cash outflows (47,000) (52,000) (34,000) (4,000)
$ 1,000 $ (3,700) $ (4,232) $(1,685)
Present value of net cash flows discounted at 10 percent $(7,137)
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Depreciation o f  facilities to be charged to current residents:
Original cost of facility $17,000,000
Cost of facility allocable to revenue-producing service 
areas $(2,000,000)
Cost of facility to be allocated to residents (including 
common areas) $15,000,000
Useful life 40 years
Annual depreciation using straight-line method $ 375,000
Number of residents expected to occupy the facility 200
Annual depreciation per resident $ 1,875
Monthly depreciation per resident $ 156
Estimated 
Remaining Life 
(in Months)
Resident on 12/ 31 /X6 19X7 19X8 19X9 20X0
A 36 $1,875 $1,875 $1,875 —
B 22 1,875 1,560 — —
C 27 1,875 1,875 468 —
D 38 1,875 1,875 1,875 $ 312
Yearly estimated depreciation of 
facilities to be charged to current 
residents $7,500 $7,185 $4,218 $ 312
Total estimated depreciation of the use of facilities to be
charged to the current residents $19,215
Liability fo r  providing future services and the use o f  facilities to current resi­
dents:
Present value of future net cash outflows 
Minus:
Unamortized deferred revenue on 12/31/X6 
Plus:
Depreciation to be charged to current residents
Unamortized costs of acquiring initial 
contracts—see assumption c above
Liability for providing future services and the use of 
facilities to current residents on 12/31/X6
$ 7,137 
(27,027) 
19,215 
17,000* 
$16,325
* These numbers are for illustrative purposes only and no inference has been made as to the 
recoverability of the $17,000.
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Exhibit 14.3
Auditing Considerations
Financial Statement Specific Auditing 
Assertions_________Objectives
Selected Control 
Activities
Continuing Care Retirement Communities
Existence, 
completeness, and 
presentation and 
maturity
Liabilities 
relating to 
refundable fee 
arrangements are 
accounted for and 
reported properly.
Written
documentation is 
prepared for 
refundable fee 
arrangements.
Auditing
Procedures
Review the 
refundable fee 
arrangements 
regarding 
stipulations for 
repayments and 
determine that 
such
arrangements are 
classified and 
disclosed properly 
in the financial 
statements.
Liabilities are 
accounted for and 
reported properly.
All liabilities are
classified,
described, and
disclosed
properly in the
financial
statements.
Management 
monitors 
compliance with 
restrictive 
covenants.
Compare the 
account balances 
with the prior 
periods’ balance 
and the 
amortization 
schedules.
Confirm any 
significant new 
obligations.
Deferred Revenue
Completeness, 
rights and 
obligations, and 
presentation and 
disclosure
Deferred revenue 
and the obligation 
to provide future 
services to, and 
the use of 
facilities by, 
current residents 
of CCRCs are 
recognized and 
reported properly.
Procedures 
ensure that 
amounts received 
as advance fees 
are recognized in 
the proper period 
and that the 
obligation to 
provide future 
services and the 
use of facilities is 
reported.
Test the 
procedures 
related to the 
recognition of 
advance fees and 
determine that 
the obligation to 
provide future 
services and the 
use of facilities is 
properly reported.
Long-Term Obligations
Existence, 
completeness, and
AAG-HCO 14.36
Liabilities 
relating to
Written
documentation is
Review the 
refundable fee
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Assertions
presentation and 
maturity
Specific Auditing 
Objectives
refundable fee 
arrangements are 
accounted for and 
reported properly.
Selected Control 
Activities
prepared for 
refundable fee 
arrangements.
Auditing
Procedures
arrangements 
regarding 
stipulations for 
repayments and 
determine that 
such
arrangements are 
classified and 
disclosed properly 
in the financial 
statements.
AAG-HCO 14.36
Illustrative Financial Statements 151
Appendix A 
Illustrative Financial Statements
The following illustrative financial statements illustrate the applications of 
the reporting practices discussed in this guide. Specific types of health care 
organizations have been selected to illustrate a wide diversity of reporting 
practices. It is not intended that these illustrations represent either the only 
types of disclosure nor the only statement formats that would be appropriate.
For example, the reporting of revenue, expenses, gains, and losses vary depend­
ing on the relationship of the underlying transaction to the entity’s operations. 
More or less detail should appear either in the financial statements or in the 
notes to the financial statements, depending on the circumstances.
Governmental health care entities are required to follow the accounting and 
reporting requirements of the GASB. GASB pronouncements may require 
governmental health care entities to present information beyond or different 
from that presented by not-for-profit and investor-owned entities. For example, 
GASB Statement No. 3, Deposits with Financial Institutions, Investments 
(including Repurchase Agreements), and Reverse Repurchase Agreements, re­
quires governmental entities to make certain disclosures about the credit and 
market risks of their investments. GASB Statement No. 27, Accounting for 
Pensions by State and Local Governmental Employers, requires certain ac­
counting for and disclosures about pension benefits provided to employees of 
governmental health care entities. GASB Statement No. 9, Reporting Cash 
Flows of Proprietary and Nonexpendable Trust Funds and Governmental 
Entities That Use Proprietary Fund Accounting, requires governmental health 
care entities to present a statement of cash flows using a format that differs in 
some respects from that required by FASB Statement No. 95, Statement of Cash 
Flows, and that requires the reporting of cash flow information on both 
restricted and unrestricted funds. GASB Statement No. 12, Disclosure of 
Information on Postemployment Benefits Other Than Pension Benefits by State 
and Local Governmental Employers, requires certain disclosures about other 
postemployment benefits (OPEB) provided to employees of governmental 
health care entities. GASB Statement No. 12 also provides that governmental 
health care entities are not required to change their recognition and measure­
ment of OPEB to comply with FASB Statement No. 106, Accounting for 
Postretirement Benefits Other Than Pensions, or FASB Statement No. 112, 
Employer’s Accounting for Postemployment Benefits. In June 1999, the GASB 
issued Statement No. 34, Basic Financial Statements—and Management’s 
Discussion and Analysis—for State and Local Governments, as part of its 
governmental financial reporting model project. GASB Statement No. 34 es­
tablishes new financial reporting requirements for state and local govern­
ments, and amends or supersedes various existing GASB and NCGA 
Statements and Interpretations. The requirements of GASB Statement No. 34 
are effective in three phases based on a government’s total annual revenues in 
the first fiscal year ending after June 15, 1999.
Other GASB pronouncements may also have implications for governmental 
health care entities. For example, GASB Statement No. 13, Accounting for 
Operating Leases with Scheduled Rent Increases (paragraph 6.10), may affect 
the accounting for and financial reporting of certain lease transactions. Dis­
cussed elsewhere in this Audit and Accounting Guide are GASB Statement No. 6,
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Accounting and Financial Reporting for Special Assessments (paragraph 
10.12), GASB Statement No. 7, Advance Refundings Resulting in Defeasance 
of Debt (paragraph 7.18), GASB Statement No. 10, Accounting and Financial 
Reporting for Risk Financing and Related Insurance Issues (paragraph 8.02), 
GASB Statement No. 14, The Financial Reporting Entity (paragraph 11.01), 
GASB Statement No. 16, Accounting for Compensated Absences (paragraph 
7.03), GASB Statement No. 20, Accounting and Financial Reporting for Pro­
prietary Funds and Other Governmental Entities That Use Proprietary Fund 
Accounting (chapter 1, footnote 1), GASB Statement No. 23, Accounting and 
Financial Reporting for Refundings of Debt Reported by Proprietary Activities 
(paragraph 7.18), GASB Statement No. 28, Accounting and Financial Report­
ing for Securities Lending Transactions (paragraph 4.13), GASB Statement No. 
29, The Use of Not-for-Profit Accounting and Financial Reporting Principles by 
Governmental Entities (chapter 1, footnote 1), GASB Statement No. 30, Risk 
Financing Omnibus (paragraph 8.02), GASB Statement No. 31, Accounting and 
Financial Reporting for Certain Investments and for External Investment Pools 
(paragraph 4.12), GASB Interpretation No. 3, Financial Reporting for Reverse 
Repurchase Agreements (paragraph 4.13), GASB Interpretation No. 4, Accounting 
and Financial Reporting for Capitalization Contributions to Public Entity Risk 
Pools (paragraph 8.02), and GASB Technical Bulletin 94-1, Disclosures about 
Derivatives and Similar Debt and Investment Transactions (paragraph 4.16).*
This appendix contains illustrative financial statements for the following types 
of health care organizations:
152 Health Care Organizations
1. Not-for-profit hospital
2. Governmental hospital authority
3. Nursing home
4. Continuing care retirement community (CCRC)
5. Home health agency
6. Health maintenance organization (HMO)
7. Ambulatory care organization
* GASB Statement No. 33, Accounting and Financial Reporting for Nonexchange Transactions, 
establishes accounting and reporting standards for nonexchange transactions involving financial or 
capital resources, and is effective for financial statements for periods beginning after June 15, 2000, 
with earlier implementation encouraged. A brief summary of GASB Statement No. 33 is provided in 
paragraph 10.24 of this Guide. Also, refer to the footnote to paragraph 10.24 for a discussion of GASB 
Statement No. 34, which will amend paragraph 11 of GASB Statement No. 33.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NOT-FOR-PROFIT HOSPITAL*
Sample Not-for-Profit Hospital 
Balance Sheets 
December 31, 20X7 and 20X6 
(in thousands)
20X7 20X6
Assets
Current assets:
Cash and cash equivalents $ 4,758 $ 5,877
Short-term investments 15,836 10,740
Assets limited as to use 970 1,300
Patient accounts receivable, net of 
allowance for doubtful accounts of $2,500
in 20X7 and $2,400 in 20X6 15,100 14,194
Other current assets 2,670 2,856
Total current assets 39,334 34,967
Assets limited as to use:
Internally designated for capital acquisition 12,000 12,500
Held by trustee 6,949 7,341
18,949 19,841
Less amount required to meet current
obligations (970) (1,300)
17,979 18,541
Long-term investments 4,680 4,680
Long-term investments restricted for capital
acquisition 320 520
Property and equipment, net 51,038 50,492
Other assets 1,695 1,370
Total assets $115,046 $110,570
(continued)
* FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization or Charitable 
Trust That Raises or Holds Contributions for Others, establishes standards for transactions in which 
an entity—the donor—makes a contribution by transferring assets to a not-for-profit organization or 
charitable trust—the recipient organization—that accepts the assets from the donor and agrees to 
use those assets on behalf of or transfer those assets, the return on investment of those assets, or 
both to another entity—the beneficiary—that is specified by the donor. FASB Statement No. 136 
incorporates without reconsideration the guidance in FASB Interpretation No. 42, and supersedes 
that Interpretation. A  summary of FASB Statement No. 136 is included in appendix F to this Guide. 
These illustrative financial statements will be modified to conform to the requirements of FASB 
Statement No. 136 in a future edition of this Guide.
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Sample Not-for-Profit Hospital 
Balance Sheets 
(continued) 
December 31, 20X7 and 20X6 
(in thousands)
20X7
Liabilities and Net Assets 
Current liabilities:
Current portion of long-term debt $ 1,470
Accounts payable and accrued expenses 5,818
Estimated third-party payor settlements 2,143
Other current liabilities 1,969
Total current liabilities 11,400
Long-term debt, net of current portion 23,144
Other liabilities 3,953
Total liabilities 38,497
Net assets:
Unrestricted 70,846
Temporarily restricted 2,115
Permanently restricted 3,588
Total net assets 76,549
Total liabilities and net assets $115,046
See accompanying notes to financial statements.
20X6
$ 1,750 
5,382 
1,942 
2,114
11,188
24,014
3,166
38,368
66,199
2,470
3,533
72,202
$110,570
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FORMAT A
Sample Not-for-Profit Hospital 
Statements of Operations 
Years Ended December 3 1 , 20X7 and 20X6 
(in thousands)
20X7 20X6
Unrestricted revenues, gains and other 
support:
Net patient service revenue $85,156 $78,942
Premium revenue 11,150 10,950
Other revenue 2,601 5,212
Net assets released from restrictions used
for operations 
Total revenues, gains and other support
300
99,207 95,104
Expenses:
Operating expenses 88,521 80,585
Depreciation and amortization 4,782 4,280
Interest 1,752 1,825
Provision for bad debts 1,000 1,300
Other 2,000 1,300
Total expenses 98,055 89,290
Operating income 1,152 5,814
Other income:
Investment income 3,900 3,025
Excess of revenues over expenses 5,052 8,839
Change in net unrealized gains and losses on
other than trading securities 300 375
Net assets released from restrictions used for
purchase of property and equipment 200
Contributions from Sample Hospital
Foundation for property acquisitions 235 485
Transfers to parent (640) (3,000)
Increase in unrestricted net assets, before
extraordinary item 5,147 6,699
Extraordinary loss from extinguishment
of debt
Increase in unrestricted net assets
(500) 
$ 4,647 $ 6,699
See accompanying notes to financial statements.
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FORMAT B
Sample Not-for-Profit Hospital 
Statements of Operations 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
20X7 20X6
Unrestricted revenues, gains and other 
support:
Net patient service revenue $ 85,156 $78,942
Premium revenue 11,150 10,950
Other, primarily investment income 6,501 8,237
Net assets released from restrictions used
for operations 300
Total revenues, gains and other support 103,107 98,129
Expenses:
Salaries and benefits 53,900 49,938
Medical supplies and drugs 26,532 22,121
Insurance 8,089 8,526
Depreciation and amortization 4,782 4,280
Interest 1,752 1,825
Provision for bad debts 1,000 1,300
Other 2,000 1,300
Total expenses 98,055 89,290
Excess of revenues, gains, and other support
over expenses 5,052 8,839
Change in net unrealized gains and losses on
other than trading securities 300 375
Net assets released from restrictions used for
purchase of property and equipment 200
Contributions from Sample Hospital
Foundation for property acquisitions 235 485
Transfers to parent (640) (3,000)
Increase in unrestricted net assets, before
extraordinary item 5,147 6,699
Extraordinary loss from extinguishment of
debt (500)
Increase in unrestricted net assets $ 4,647 $ 6,699
See accompanying notes to financial statements.
AAG-HCO APP A
Illustrative Financial Statements 1 5 7
Sample Not-for-Profit Hospital 
Statements of Changes in Net Assets 
Years Ended December 3 1 , 20X7 and 20X6 
(in thousands)
20X7 20X6
Unrestricted net assets:
Excess of revenues over expenses $ 5,052 $ 8,839
Net unrealized gains on investments, other
than trading securities 300 375
Contributions from Sample Hospital
Foundation for property acquisitions 235 485
Transfers to parent (640) (3,000)
Net assets released from restrictions used
for purchase of property and equipment 200
Increase in unrestricted net assets before
extraordinary item 5,147 6,699
Extraordinary loss from extinguishment of
debt (500)
Increase in unrestricted net assets 4,647 6,699
Temporarily restricted net assets:
Contributions for charity care 140 996
Net realized and unrealized gains on
investments 5 8
Net assets released from restrictions (500)
Increase (decrease) in temporarily
restricted net assets (355) 1,004
Permanently restricted net assets:
Contributions for endowment funds 50 411
Net realized and unrealized gains on
investments 5 2
Increase in permanently restricted net
assets 55 413
Increase in net assets 4,347 8,116
Net assets, beginning of year 72,202 64,086
Net assets, end of year $76,549 $72,202
See accompanying notes to financial statements.
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Sample Not-for-Profit Hospital 
Statements of Cash Flows (Indirect Method) 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
20X7 20X6
Cash flows from operating activities:
Change in net assets $ 4,347 $ 8,116
Adjustments to reconcile change in net 
assets to net cash provided by operating 
activities:
Extraordinary loss from extinguishment
of debt 500
Depreciation and amortization 4,782 4,280
Net realized and unrealized gains on
investments, other than trading (450) (575)
Transfers to parent 640 3,000
Provision for bad debts 1,000 1,300
Restricted contributions and investment
income received (290) (413)
(Increase) decrease in:
Patient accounts receivable (1,906) (2,036)
Trading securities 215
Other current assets 186 (2,481)
Other assets (325) (241)
Increase (decrease) in:
Accounts payable and accrued expenses 436 679
Estimated third-party payor settlements 201 305
Other current liabilities (145) (257)
Other liabilities 787 (128)
Net cash provided by operating
activities 9,978 11,549
Cash flows from investing activities:
Purchase of investments (3,769) (2,150)
Capital expenditures (4,728) (5,860)
Net cash used in investing activities (8,497) (8,010)
Cash flows from financing activities:
Transfers to parent (640) (3,000)
Proceeds from restricted contributions and
restricted investment income 290 413
Payments on long-term debt (24,700) (804)
Payments on capital lease obligations (150) (100)
Proceeds from issuance of long-term debt 22,600 500
Net cash used in financing activities (2,600) (2,991)
Net (decrease) increase in cash and cash
equivalents (1,119) 548
Cash and cash equivalents, beginning of year 5,877 5,329
Cash and cash equivalents, end of year $ 4,758 $ 5,877
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Supplemental Disclosures of Cash Flow Information:
The Hospital entered into capital lease obligations in the amount of $600,000 
for new equipment in 20X7.
Cash paid for interest (net of amount capitalized) in 20X7 and 20X6 was 
$1,780,000 and $1,856,000, respectively.
See accompanying notes to financial statements.
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Sample Not-for-Profit Hospital 
Notes to Financial Statements1 
December 31, 20X7 and 20X6
1. Description of Organization and Summary of Significant Accounting 
Policies
Organization. The Sample Not-for-Profit Hospital (the Hospital), located in Tulsa, 
Oklahoma, is a not-for-profit acute care hospital. The Hospital provides inpatient, 
outpatient and emergency care services for residents of northeastern Oklahoma. 
Admitting physicians are primarily practitioners in the local area. The Hospital was 
incorporated in Oklahoma in 20X1 and is affiliated with the Sample Health System.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include certain in­
vestments in highly liquid debt instruments with original maturities of three 
months or less.
The Hospital routinely invests its surplus operating funds in money market 
mutual funds. These funds generally invest in highly liquid U.S. government 
and agency obligations.
Investments. Investments in equity securities with readily determinable fair 
values and all investments in debt securities are measured at fair value in the 
balance sheet. Investment income or loss (including realized gains and losses 
on investments, interest and dividends) is included in the excess of revenues 
over expenses unless the income or loss is restricted by donor or law. Unrealized 
gains and losses on investments are excluded from the excess of revenues over 
expenses unless the investments are trading securities.
Assets limited as to use. Assets limited as to use primarily include assets held 
by trustees under indenture agreements and designated assets set aside by the 
Board of Trustees for future capital improvements, over which the Board 
retains control and may at its discretion subsequently use for other purposes. 
Amounts required to meet current liabilities of the Hospital have been reclas­
sified in the balance sheet at December 31, 20X7 and 20X6.
Property and equipment. Property and equipment acquisitions are recorded at 
cost. Depreciation is provided over the estimated useful life of each class of 
depreciable asset and is computed using the straight-line method. Equipment 
under capital lease obligations is amortized on the straight-line method over the 
shorter period of the lease term or the estimated useful life of the equipment. Such 
amortization is included in depreciation and amortization in the financial state­
ments. Interest cost incurred on borrowed funds during the period of construction 
of capital assets is capitalized as a component of the cost of acquiring those assets.
Gifts of long-lived assets such as land, buildings, or equipment are reported 
as unrestricted support, and are excluded from the excess of revenues over 
expenses, unless explicit donor stipulations specify how the donated assets
1 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue 
recognition and includes a sample disclosure in paragraph 37 of the SOP for material differences between 
an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is effective for 
audits of periods ending on or after June 3 0 , 2000. SOP 00-1 is included in appendix E to this Guide.
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must be used. Gifts of long-lived assets with explicit restrictions that specify 
how the assets are to be used and gifts of cash or other assets that must be used 
to acquire long-lived assets are reported as restricted support. Absent explicit 
donor stipulations about how long those long-lived assets must be maintained, 
expirations of donor restrictions are reported when the donated or acquired 
long-lived assets are placed in service.
Temporarily and permanently restricted net assets. Temporarily restricted 
net assets are those whose use by the Hospital has been limited by donors to a 
specific time period or purpose. Permanently restricted net assets have been 
restricted by donors to be maintained by the Hospital in perpetuity.
Excess of revenues over expenses. The statement of operations includes excess 
of revenues over expenses. Changes in unrestricted net assets which are excluded 
from excess of revenues over expenses, consistent with industry practice, include 
unrealized gains and losses on investments other than trading securities, perma­
nent transfers of assets to and from affiliates for other than goods and services, and 
contributions of long-lived assets (including assets acquired using contributions 
which by donor restriction were to be used for the purposes of acquiring such assets).
Net patient service revenue. The Hospital has agreements with third-party 
payors that provide for payments to the Hospital at amounts different from its 
established rates. Payment arrangements include prospectively determined 
rates per discharge, reimbursed costs, discounted charges, and per diem pay­
ments. Net patient service revenue is reported at the estimated net realizable 
amounts from patients, third-party payors, and others for services rendered, 
including estimated retroactive adjustments under reimbursement agree­
ments with third-party payors. Retroactive adjustments are accrued on an 
estimated basis in the period the related services are rendered and adjusted in 
future periods as final settlements are determined.
Premium revenue. The Hospital has agreements with various Health Main­
tenance Organizations (HMOs) to provide medical services to subscribing par­
ticipants. Under these agreements, the Hospital receives monthly capitation 
payments based on the number of each HMO’s participants, regardless of 
services actually performed by the Hospital. In addition, the HMOs make 
fee-for-service payments to the Hospital for certain covered services based upon 
discounted fee schedules.
Charity care. The Hospital provides care to patients who meet certain 
criteria under its charity care policy without charge or at amounts less than its 
established rates. Because the Hospital does not pursue collection of amounts 
determined to qualify as charity care, they are not reported as revenue.
Donor-restricted gifts. Unconditional promises to give cash and other assets 
to the Hospital are reported at fair value at the date the promise is received. 
Conditional promises to give and indications of intentions to give are reported 
at fair value at the date the gift is received. The gifts are reported as either 
temporarily or permanently restricted support if they are received with donor 
stipulations that limit the use of the donated assets. When a donor restriction 
expires, that is, when a stipulated time restriction ends or purpose restriction 
is accomplished, temporarily restricted net assets are reclassified as unre­
stricted net assets and reported in the statement of operations as net assets 
released from restrictions. Donor-restricted contributions whose restrictions 
are met within the same year as received are reported as unrestricted contri­
butions in the accompanying financial statements.
Estimated malpractice costs. The provision for estimated medical malprac­
tice claims includes estimates of the ultimate costs for both reported claims and 
claims incurred but not reported.
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Income taxes. The Hospital is a not-for-profit corporation and has been 
recognized as tax-exempt pursuant to Sec. 501(c)(3) of the Internal Revenue Code.
2. Net Patient Service Revenue
The Hospital has agreements with third-party payors that provide for pay­
ments to the Hospital at amounts different from its established rates. A 
summary of the payment arrangements with major third-party payors follows:
• Medicare. Inpatient acute care services rendered to Medicare program 
beneficiaries are paid at prospectively determined rates per discharge. 
These rates vary according to a patient classification system that is based 
on clinical, diagnostic, and other factors. Inpatient nonacute services, 
certain outpatient services, and defined capital and medical education 
costs related to Medicare beneficiaries are paid based on a cost reimburse­
ment methodology. The Hospital is reimbursed for cost reimbursable 
items at a tentative rate with final settlement determined after submis­
sion of annual cost reports by the Hospital and audits thereof by the 
Medicare fiscal intermediary. Beginning in 20X3, the Hospital claimed 
Medicare payments based on an interpretation of certain "disproportion­
ate share” rules. The intermediary disagreed and declined to pay the 
excess reimbursement claimed under that interpretation. Through 1996, 
the Hospital has not included the claimed excess in net patient revenues 
pending resolution of the matter. In 20X7, the intermediary accepted the 
claims and paid the outstanding claims, including $950,000 applicable to 
20X6 and $300,000 applicable to 20X5 and prior, which has been included 
in 20X7 net revenues.
• Medicaid. Inpatient and outpatient services rendered to Medicaid 
program beneficiaries are reimbursed under a cost reimbursement 
methodology. The Hospital is reimbursed at a tentative rate with final 
settlement determined after submission of annual cost reports by the 
Hospital and audits thereof by the Medicaid fiscal intermediary.
The Hospital also has entered into payment agreements with certain com­
mercial insurance carriers, health maintenance organizations, and preferred 
provider organizations. The basis for payment to the Hospital under these 
agreements includes prospectively determined rates per discharge, discounts 
from established charges, and prospectively determined daily rates.
3. Investments
Assets Limited as to Use
The composition of assets limited as to use at December 31, 20X7 and 20X6, 
is set forth in the following table. Investments are stated at fair value.
20X7 20X6
Internally designated for capital acquisition:
Cash $ 545,000 $ 350,000
U.S. Treasury obligations 11,435,000 12,115,000
Interest receivable 20,000 35,000
12,000,000 12,500,000
Held by trustee under indenture agreement:
Cash and short-term investments 352,000 260,000
U.S. Treasury obligation 6,505,000 7,007,000
Interest receivable 92,000 74,000
6,949,000 7,341,000
$18,949,000 $19,841,000
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Other investments, stated at fair value, at December 31, 20X7 and 20X6, 
include:
Other Investments
20X7 20X6
Trading:
U.S. Corporate Bonds $ 1,260,000 $ 1,475,000
Other:
U.S. Treasury obligations $19,266,000 $14,233,000
Interest receivable 310,000 232,000
20,836,000 15,940,000
Less:
Long-term investments 4,680,000 4,680,000
Long-term investments restricted for capital
acquisitions 320,000 520,000
Short-term investments $15,836,000 $10,740,000
Investment income and gains for assets limited as to use, cash equivalents,
and other investments are comprised of the following for the years ending
December 31, 20X7 and 20X6:
20X7 20X6
Income:
Interest income $3,585,000 $2,725,000
Realized gains on sales of securities 150,000 200,000
Unrealized gains on trading securities 165,000 100,000
$3,900,000 $3,025,000
Other Changes in Unrestricted Net Assets: 
Unrealized gains on other than trading 
securities $ 300,000 $ 375,000
4. Property and Equipment
A summary of property and equipment at December 31, 20X7 and 20X6,
follows:
20X7 20X6
Land $ 3,000,000 $ 3,000,000
Land improvements 472,000 472,000
Buildings and improvements 46,852,000 46,636,000
Equipment 29,190,000 26,260,000
Equipment under capital lease obligations 2,851,000 2,752,000
82,365,000 79,120,000
Less accumulated depreciation and 
amortization 34,928,000 30,661,000
47,437,000 48,459,000
Construction in progress 3,601,000 2,033,000
Property and equipment, net $51,038,000 $50,492,000
Depreciation expense for the years ended December 31, 20X7 and 20X6 
amounted to approximately $4,782,000 and $4,280,000. Accumulated amorti­
zation for equipment under capital lease obligations was $689,000 and $453,000
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at December 31, 20X7 and 20X6, respectively. Construction contracts of ap­
proximately $7,885,000 exist for the remodeling of Hospital facilities. At 
December 31, 20X7, the remaining commitment on these contracts approxi­
mated $4,625,000.
5. Long-Term Debt 
A summary of long-term debt and capital lease obligations at December 31, 
20X7 and 20X6, follows:
20X7 20X6
7.25 percent 20X7 Tax-Exempt Revenue 
Bonds, principal maturing in varying annual 
amounts, due November 1, 20XX, 
collateralized by a pledge of the Hospital’s 
gross receipts $21,479,000
8.50 percent 20X2 Tax-Exempt Revenue 
Bonds, principal maturing in varying annual
amounts, due June 1, 20XX $22,016,000
7.75 percent mortgage loan, principal 
maturing in varying annual amounts, due 
January 20XX, collateralized by a mortgage 
on certain property and equipment
7.75 percent note payable, payable in monthly 
installments of $12,000, including interest, 
due March 20XX, unsecured
Capital lease obligations, at varying rates of 
imputed interest from 6.8 percent to 9.3 
percent collateralized by leased equipment
Less current portion
2,010,000 2,127,000
125,000 671,000
1,000,000 950,000
24,614,000 25,764,000
1,470,000 1,750,000
$23,144,000 $24,014,000
Under the terms of the 20X7 and 20X2 revenue bond indentures, the Hospital 
is required to maintain certain deposits with a trustee. Such deposits are 
included with assets limited as to use. The revenue note indenture also places 
limits on the incurrence of additional borrowings and requires that the Hospital 
satisfy certain measures of financial performance as long as the notes are 
outstanding.
Scheduled principal repayments on long-term debt and payments on capital 
lease obligations are as follows:
Year Ending Long-Term Capital Leases
December 31, Debt Obligations
20X8 $ 970,000 $ 550,000
20X9 912,000 260,000
20Y0 983,000 260,000
20Y1 1,060,000 45,000
20Y2 1,143,000 —
Thereafter 18,546,000 —
Less amount representing interest 
under capital leases obligations 115,000
$23,614,000 1,115,000
 
$1,000,000
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A summary of interest cost and investment income on borrowed funds held 
by the trustee under the 20X7 and 20X2 revenue bond indentures during the 
years ended December 31, 20X7 and 20X6, follows:
20X7 20X6
Interest cost: 
Capitalized 
Charged to operations
$ 740,000 
1,752,000
$ 700,000 
1,825,000
Total $2,492,000 $2,525,000
Investment income: 
Capitalized
Credited to other revenue
$ 505,000 
330,000
$ 663,000 
386,000
Total $ 835,000 $1,049,000
6. Temporarily and Permanently Restricted Net Assets
Temporarily restricted net assets are available for the following purposes or 
periods at December 31, 20X7 and 20X6:
20X7 20X6
Health care services 
Purchase of equipment 
Indigent care 
Health education 
For periods after December 31, 20X9
$ 320,000
840,000
350,000
605,000
$ 520,000
950,000
400,000
600,000
$2,115,000 $2,470,000
Permanently restricted net assets at December 31, 20X7 and 20X6, are 
restricted to:
20X7 20X6
Investments to be held in perpetuity, the 
income from which is expendable to support 
health care services (reported as operating 
income)
Endowment requiring income to be added to 
original gift until fund value is $1,500,000
$2,973,000
615,000
$2,923,000
610,000
$3,588,000 $3,533,000
During 20X7, net assets were released from donor restrictions by incurring 
expenses satisfying the restricted purposes of indigent care and health care 
education in the amounts of $250,000 and $50,000, respectively.
7. Medical Malpractice Claims
The Hospital purchases professional and general liability insurance to cover 
medical malpractice claims. There are known claims and incidents that may 
result in the assertion of additional claims, as well as claims from unknown
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incidents that may be asserted arising from services provided to patients. The 
Hospital has employed independent actuaries to estimate the ultimate costs, if 
any, of the settlement of such claims. Accrued malpractice losses have been 
discounted at 7 percent and in management’s opinion provide an adequate 
reserve for loss contingencies.
On March 15, 20X7, a patient filed a suit against the Hospital for malpractice 
during care received as an inpatient. The Hospital believes it has meritorious 
defenses against the suit; however, the ultimate resolution of the matter could 
result in a loss. The patient has claimed $16 million in actual damages. Under 
state law, punitive damages are determined at trial. The Hospital maintains 
insurance coverage for malpractice claims. The coverage does not include 
punitive damages awards. Trial is scheduled to occur within the next year.
8. Pension and Other Postretirement Benefit Plans1
The Hospital has a defined benefit pension plan covering substantially all of 
its employees. The plan benefits are based on years of service and the employ­
ees’ compensation during the last five years of covered employment. Contribu­
tions are intended to provide not only for benefits attributed to service to date 
but also for those expected to be earned in the future.
[The following paragraph is encouraged but not required.]
The Hospital also sponsors two defined benefit postretirement plans that 
cover both salaried and nonsalaried employees. One plan provides medical and 
dental benefits, and the other provides for the payment of life insurance 
premiums. The postretirement health care plan is contributory, with retiree 
contributions adjusted annually; the life insurance plan is noncontributory. 
The accounting for the health care plan anticipates future cost-sharing changes 
to the written plan that are consistent with the Hospital’s expressed intent to 
increase retiree contributions each year to 50 percent of the excess of the 
expected general inflation rate over 6 percent. Beginning in 20X7, the Hospital 
adopted a funding policy for its postretirement health care plan similar to its 
funding policy for its life insurance plan—an amount equal to a level percentage 
of the employees’ salaries is contributed to the plan annually. For 20X7, that 
percentage was 4.25, and the aggregate contribution for both plans was 
$34,000.
The following table sets forth the changes in benefit obligations, changes in 
plan assets and components of net periodic benefit cost for both the pension 
plan and the other postretirement benefit plans:
1 FASB Statement No. 132, Employers’ Disclosures about Pensions and Other Postretirement 
Benefits, an amendment of FASB Statement Nos. 87, 88, and 106, permits reduced disclosures for 
nonpublic entities. This note to the financial statements illustrates the financial statement disclo­
sures about pension and postretirement benefit plans for a public entity. Readers should refer to 
FASB Statement No. 132 when considering disclosure requirements for nonpublic entities.
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Change in benefit obligation:
Benefit obligation at beginning 
of year 
Service cost 
Interest cost
Plan participants’ contributions 
Actuarial gain 
Benefits paid
Benefit obligation at end of year
Change in plan assets:
Fair value of plan assets at 
beginning of year 
Actual return on plan assets 
Employer contribution 
Plan participants’ contributions 
Benefits paid 
Fair value of plan assets at end 
of year
Funded status
Unrecognized net actuarial gain 
Unrecognized prior service cost 
Unrecognized transition obligation 
Unrecognized transition asset
Prepaid (accrued) benefit cost
Weighted-average assumptions as of 
December 31:
Discount rate
Expected return on plan assets 
Rate of compensation increase
Pension Benefits Other Benefits
20X7 20X6 20X7 20X6
$ 9,710 $ 9,700 $585 $500
905 770 14 15
700 650 50 44
34 34
(20) (7)
(375) (1,410) (66) (8)
10,920 9,710 610 585
9,800 9,610 89 40
759 810 4 4
866 790 39 19
34 34
(375) (1,410) (66) (8)
11,050 9,800 100 89
130 90 (510) (496)
(30) (40) (30) (40)
50 55 16 19
445 470
(15) (20)
$ 135 $___85 $ (79) $ (47)
7.00% 7.00% 7.00% 7.00%
8.00% 8.00% 6.60% 6.60%
6.00% 6.00%
For measurement purposes, a 7 percent annual rate of increase in the per capita 
cost of covered health care benefits was assumed for 20X8. The rate was 
assumed to decrease gradually to 5 percent over the next five years.
Pension Benefits Other Benefits
20X7 20X6 20X7 20X6
Components of net periodic
benefit cost:
Service cost $905 $770 $14 $15
Interest cost 700 650 50 44
Expected return on plan assets (784) (769) (6) (3)
Amortization of prior service cost 5 7 3 2
Recognized net actuarial (gain) (5) (2) (15) (1)
Amortization of transition
obligation 25 25
Amortization of transition asset (5) (1)
Net periodic benefit cost $816 $655 $71 $82
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Assumed health care cost trend rates have a significant effect on the amounts 
reported for the health care plans. A one-percentage-point change in assumed 
health care cost trend rates would have the following effects:
1-Percentage- 1-Percentage- 
Point Increase Point Decrease
Effect on total of service and interest 
cost components 
Effect on postretirement benefit obligation
$13
73
$ (11)
(67)
9. Concentrations of Credit Risk
The Hospital grants credit without collateral to its patients, most of whom 
are local residents and are insured under third-party payor agreements. The 
mix of receivables from patients and third-party payors at December 31, 20X7 
and 20X6, was as follows:
20X7 20X6
Medicare 51% 53%
Medicaid 17 14
Blue Cross 18 17
Other third-party payors 7 9
Patients 7
100%
7
100%
10. Commitments and Contingencies
Operating leases. The Hospital leases various equipment and facilities under 
operating leases expiring at various dates through April 20Y2. Total rental 
expense in 20X7 and 20X6 for all operating leases was approximately $859,000 
and $770,000, respectively.
The following is a schedule by year of future minimum lease payments under 
operating leases as of December 31, 20X7, that have initial or remaining lease 
terms in excess of one year.
Year Ending 
December 31,
20X8
20X9
20Y0
20Y1
20Y2
Amount
$517,000
506,000
459,000
375,000
343,000
Litigation. The Hospital is involved in litigation and regulatory investigations 
arising in the course of business. After consultation with legal counsel, manage­
ment estimates that these matters will be resolved without material adverse effect 
on the Hospital’s future financial position or results from operations.
Allowance for doubtful accounts. Beginning in 20X5, the Hospital has provided 
care under an agreement with Associated HMO. The HMO currently owes the 
Hospital $950,000, substantially all of which is overdue. The Hospital has notified 
the HMO that further services under the contract cannot be provided without 
payment on the outstanding balance. The HMO has assured the Hospital that 
additional funds are being obtained in order to pay the overdue balance and 
continue service under the agreement, however, if the HMO is unable to make 
payments, additional allowances for bad debts would need to be accrued.
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11. Extraordinary Loss
In 20X7, the Hospital advance refunded its 20X2 Revenue Bonds in the 
amount of $22 million by issuing 20X7 Revenue Bonds. As a result of this 
in-substance defeasance transaction, an extraordinary loss totaling $500,000 
was recorded. As of December 31, 20X7, $21 million of advance refunded bonds, 
which are considered extinguished, remain outstanding.
12. Related Party Transactions
During the years ended December 31, 20X7 and 20X6, the Hospital contrib­
uted capital to Sample Health System, an affiliate with some board members 
in common with the Hospital, in the amounts of $640,000 and $3 million, 
respectively.
The Sample Hospital Foundation (the Foundation), which is controlled by 
Sample Health System, was established to solicit contributions from the gen­
eral public and to support the Hospital. Funds are distributed to the Hospital 
as determined by the Foundation’s Board of Directors. A summary of the 
foundation’s assets, liabilities, net assets, results of operations, and changes in 
net assets follows.
At December 31, 
20X7 20X6
Assets, principally cash and cash equivalents $521,000 $472,000
Liabilities 11,000 10,000
Net assets 510,000 462,000
Total liabilities and net assets $521,000 $472,000
Support and revenue $269,000 $535,000
Expenses
Distributions to Sample Hospital for property
acquisitions 235,000 485,000
Other 13,000 16,000
Total expenses 248,000 501,000
Excess of support and revenue over expenses 21,000 34,000
Other changes in net assets 27,000 17,000
Net assets, beginning of year 462,000 411,000
Net assets, end of year $510,000 $462,000
Liabilities include $10,000 payable at the end of each year to Sample Hospital. 
These amounts were paid after the end of each year.
13. Functional Expenses
The Hospital provides general health care services to residents within its 
geographic location. Expenses related to providing these services are as follows 
(in thousands):
At December 31, 
20X7 20X6
Health care services $86,000 $78,647
General and administrative 12,055 10,643
$98,055 $89,290
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The following methods and assumptions were used by the Hospital in esti­
mating the fair value of its financial instruments:
Cash and cash equivalents: The carrying amount reported in the 
balance sheet for cash and cash equivalents approximates its fair value.
Investments: Fair values, which are the amounts reported in the 
balance sheet, are based on quoted market prices, if available, or 
estimated using quoted market prices for similar securities.
Assets limited as to use: These assets consist primarily of cash and 
short-term investments and interest receivable. The carrying 
amount reported in the balance sheet is fair value.
Accounts payable and accrued expenses: The carrying amount re­
ported in the balance sheet for accounts payable and accrued ex­
penses approximates its fair value.
Estimated third-party payor settlements: The carrying amount re­
ported in the balance sheet for estimated third-party payor settle­
ments approximates its fair value.
Long-term debt: Fair values of the Hospital’s revenue notes are 
based on current traded value. The fair value of the Hospital’s 
remaining long-term debt is estimated using discounted cash flow 
analyses, based on the Hospital’s current incremental borrowing 
rates for similar types of borrowing arrangements.
The carrying amounts and fair values of the Hospital’s financial instru­
ments at December 31, 20X7 and 20X6, are as follows (In thousands):
14. Fair Value of Financial Instruments
20X7 20X6
Carrying Carrying
Amount Fair Value Amount Fair Value
Cash and cash
equivalents $ 4,758 $ 4,758 $ 5,877 $ 5,877
Short-term investments 15,836 15,836 10,740 10,740
Assets limited as to use 18,949 18,949 19,841 19,841
Long-term investments 4,680 4,680 4,680 4,680
Long-term investments
restricted for capital
acquisition 320 320 520 520
Accounts payable and
accrued expenses 5,818 5,818 5,382 5,382
Estimated third-party
payor settlements 2,143 2,143 1,942 1,942
Long-term debt 24,614 23,980 25,764 24,918
15. Promises to Contribute
At December 31, 20X7, the Hospital had received $1,500,000 of conditional 
promises to contribute to the building of a new facility for outpatient services. 
These contributions will be recorded as temporarily restricted support when 
received. The Hospital had no material outstanding unconditional promises of 
support at December 31, 20X7.
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The amount of charges foregone for services and supplies furnished under the 
Hospital’s charity care policy aggregated approximately $4,500,000 and 
$4,100,000 in 20X7 and 20X6, respectively.
17. Subsequent Event
On February 9, 20X8, the Hospital signed a contract in the amount of 
$1,050,000 for the purchase of certain real estate.
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ILLUSTRATIVE FINANCIAL STATEMENTS 
FOR A GOVERNMENTAL HOSPITAL AUTHORITY*
Sample Governmental Hospital Authority 
Balance Sheets—Restricted and Unrestricted Funds 
December 3 1 , 20X7 and 20X6 
(in thousands)
20X7 20X6
Assets
Current assets:
Cash and cash equivalents 
Short-term investments 
Assets limited as to use 
Patient accounts receivable, net of 
estimated uncollectibles of $2,125 in 20X7 
and $2,040 in 20X6 
Supplies and other current assets
Total current assets
Assets limited as to use:
Internally designated 
Held by trustees
Less amount required to meet current obligations
Property and equipment, net 
Other assets
Total assets
Liabilities and Fund Balance
Current liabilities:
Current maturities of long-term debt 
Accounts payable and accrued expenses 
Estimated third-party payor settlements 
Other current liabilities
Total current liabilities
Long-term debt, net of current maturities 
Other liabilities
Total liabilities
Fund balance:
Unrestricted 
Restricted
Total fund balance
Total liabilities and fund balance 
See accompanying notes to financial statements.
* In June 1999, the GASB issued Statement No. 34, Basic Financial Statements—and 
Management's Discussion and Analysis—for State and Local Governments. GASB Statement No. 34 
establishes new financial reporting requirements for state and local governments, and amends or 
supersedes various existing GASB and NCGA Statements and Interpretations. A brief summary of GASB 
Statement No. 34 is provided in paragraphs 1.09 through 1.11. These illustrative financial statements will 
be modified to conform to the requirements of GASB Statement No. 34 in a future edition of this Guide.
$ 1,250 $ 1,488
4,945 4,575
1,822 1,651
1,673 1,797
9,690 9,511
19,672 20,412
3,361 2,690
32,723 32,613
63,311 58,831
4,848 5,103
68,159 63,934
$100,882 $96,547
$ 7,136 $ 7,557 
1,961 2,049 
825 1,105
19,834 16,727
2,270 2,428
32,026 29,866
21,000 20,600
3,858 3,103
24,858 23,703
(825) (1,105)
24,033 22,598
43,382 42,918
1,441 1,165
$100,882 $96,547
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Sample Governmental Hospital Authority 
Statements of Operations—Unrestricted Funds
Years Ended December 3 1 , 20X7 and 20X6
(in thousands)
20X7 20X6
Revenue:
Net patient service revenue 
Ad valorem taxes 
Other
$54,864
23,895
3,416
$60,292
15,309
3,248
Total revenue 82,175 78,849
Expenses:
Salaries and benefits
Medical supplies and drugs
Insurance
Other supplies
Provision for bad debts
Depreciation and amortization
Interest
46,845
12,746
7,030
10,314
859
4,065
1,489
43,235
7,986
7,382
11,166
938
3,638
1,552
Total expenses 83,348 75,897
Operating income (loss) (1,173) 2,952
Nonoperating income 
Investment income 5,653 5,304
Excess of revenues over expenses $ 4,480 $ 8,256
See accompanying notes to financial statements.
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Sample Governmental Hospital Authority 
Statements of Changes in Fund Balances 
Years Ended December 31, 20X7 and 20X6 
(in thousands)
Unrestricted Restricted
Fund balance, January 1 , 20X6 $50,575 $3,899
Excess of revenues over expenses 8,256
Unexpended research grants 853
Endowment funds ______  351
8,256 1,204
Fund balance, December 31 , 20X6 58,831 5,103
Excess of revenues over expenses 4,480
Unexpended research grants 170
Amounts released from restrictions ______  (425)
4,480 (255)
Fund balance, December 3 1 , 20X7 $63,311 $4,848
See accompanying notes to financial statements.
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Sample Governmental Hospital Authority 
Statements of Cash Flows—Restricted and 
Unrestricted Funds (Indirect Method) 
Years Ended December 3 1 , 20X7 and 20X6 
(in thousands)
20X7 20X6
Cash flows from operating activities:
Operating income (loss) $ (1,173) $ 2,952
Interest expense considered capital
financing activity 1,489 1,552
Ad valorem taxes considered financing
activity (23,895) (15,309)
Adjustments to reconcile operating income 
to net cash provided by operating activities:
Depreciation and amortization 4,065 3,638
Provision for bad debts 859 938
Changes in:
Patient accounts receivable (3,966) (2,909)
Supplies and other current assets 158 100
Other assets (276)
Accounts payable, accrued expenses, and
other current liabilities 246 (225)
Estimated third-party payor settlements 171 (235)
Other liabilities 671 241
Net cash provided by operating activities (21,651) (9,257)
Cash flows from noncapital financing 
activities:
Net proceeds from contributions restricted
for specific expenditure 170 853
Ad valorem taxes 23,895 15,309
Other (425) 266
Net cash provided by noncapital financing
activities 23,640 16,428 
(continued)
AAG-HCO APP A
1 7 6 Health Care Organizations
Sample Governmental Hospital Authority 
Statements of Cash Flows—Restricted and 
Unrestricted Funds (Indirect Method) 
(continued)
December 31, 20X7 and 20X6 
(in thousands)
Cash flows from capital and related financing 
activities:
Principal paid on long-term debt 
Interest paid on long-term debt 
Purchase of property and equipment
Net cash used by capital and related 
financing activities
Cash flows from investing activities:
Interest and dividends on investments 
Purchases of investments 
Proceeds from sale of investments
Net cash provided by investing activities
Net increase (decrease) in cash and cash 
equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Reconciliation of cash and cash equivalents to 
the balance sheets:
Cash and cash equivalents in current assets 
Cash and cash equivalents in assets limited 
as to use
Held by trustee for self-insurance 
Held by trustee under debt indenture
Total cash and cash equivalents
20X7
(1,488)
(1,489) 
(4,019)
(6,996)
2,737
(1,045)
2,327
4,019
(988)
9,101
$8,113
7,136
474
503
$8,113
Supplemental Disclosures of Cash Flow Information:
20X6
(1,896)
(1,552)
(4,111)
(7,559)
2,124
(289)
683
2,518
2,130
6,971
$9,101
7,557
473
1,071
$9,101
The Authority entered into capital lease obligations of $510,000 for new 
equipment in 20X7.
See accompanying notes to financial statements.
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Sample Governmental Hospital Authority 
Notes to Financial Statements *, 
December 31, 20X7 and 20X6
1. Description of Reporting Entity and Summary of Significant Ac­
counting Policies
Reporting entity. The Sample Hospital Authority (the Authority) is a public 
corporation. It was created on January 1, 20XX, by the Board of County 
Commissioners of Feeling County, Illinois, to operate, control, and manage all 
matters concerning the county’s health care functions. The Board of County 
Commissioners appoints the Board of Trustee members of the Authority, and 
the Authority may not issue debt without the county's approval. For this reason, 
the Authority is considered to be a component unit of Feeling County, Illinois, 
and is included as a discretely presented component unit in the general purpose 
financial statements of the county.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Proprietary fund accounting. The Authority utilizes the proprietary fund 
method of accounting whereby revenue and expenses are recognized on 
the accrual basis. Substantially all revenues and expenses are subject to 
accrual.
Costs of borrowing. Interest cost incurred on borrowed funds during the 
period of construction of capital assets is capitalized as a component of the cost 
of acquiring those assets.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instruments with an original maturity of three months 
or less.
* Includes only disclosures unique to a governmental hospital.
** GASB Technical Bulletin (TB) 2000-1, Disclosures about Year 2000 Issues—a rescission of 
Technical Bulletins 98-1 and 99-1, rescinds the provisions of GASB TB 98-1, Disclosures about Year 
2000 Issues, and GASB TB 99-1, Disclosures about Year 2000 Issues—an amendment of Technical 
Bulletin 98-1, for financial statements issued after February 2 2 , 2000. However, TB 2000-1 indicates 
that other disclosure requirements continue to apply for year 2000-related events should they occur.
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Ad valorem taxes. The Authority received approximately 29 percent in 20X7 
and 19 percent in 20X6 of its financial support from ad valorem taxes. These 
funds were used as follows:
20X7 20X6
Percentage used to support operations 26% 16%
Percentage used for debt service on general 
obligation bonds 3% 3%
Current taxes are received beginning in October of each year and become 
delinquent after January 31 of the following year.
Accounting standards. Pursuant to Governmental Accounting Standards 
Board (GASB) Statement No. 20, Accounting and Financial Reporting for 
Proprietary Funds and Other Governmental Entities That Use Proprietary Fund 
Accounting, the Authority has elected to apply the provisions of all relevant 
pronouncements of the Financial Accounting Standards Board (FASB), includ­
ing those issued after November 30 , 1989, that do not conflict with or contradict 
GASB pronouncements.
Risk management. The Authority is exposed to various risks of loss from torts; 
theft of, damage to, and destruction of assets; business interruption; errors and 
omissions; employee injuries and illnesses; natural disasters; and employee health, 
dental, and accident benefits. Commercial insurance coverage is purchased for 
claims arising from such matters. Settled claims have not exceeded this commercial 
coverage in any of the three preceding years. The Authority is self-insured for 
medical malpractice claims and judgments, as discussed in Note 14.
Investments in debt and equity securities. Investments in debt and equity 
securities are carried at fair value except for investments in debt securities with 
maturities of less than one year at the time of purchase. These investments are 
reported at amortized cost, which approximates fair value. Interest, dividends, 
and gains and losses, both realized and unrealized, on investments in debt and 
equity securities are included in nonoperating income when earned.
2. Restricted Fund Balance
Temporarily restricted fund balance is available for the following purposes:
20X7 20X6
Program A activities:
Purchase of equipment $ 404 $ 321
Research 553 683
General 46 63
Program B activities:
Purchase of equipment 235 235
General 79 110
Program C activities:
General 206 400
Buildings and equipment 94 72
Annuity trust agreements 44 65
For periods after December 31, 20X7 and
20X6 184 151
Total temporarily restricted fund balance $1,845 $2,100
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Permanently restricted fund balance as of December 31, 20X7 and 20X6, is 
restricted to investment in perpetuity, the income from which is expendable to 
support:
20X7 20X6
Program A activities $ 158 $ 158
Program B activities 176 176
Program C activities 423 423
Any activities of the Authority 854 854
1,611 1,611
Endowment requiring income to be added to
original gift until fund’s value is $2,125 1,392 1,392
Total permanently restricted fund balance 3,003 3,003
Total temporarily and permanently
restricted fund balance $4,848 $5,103
3. Donor Restrictions Released
Fund balance was released from donor restrictions by incurring expenses 
satisfying the restricted purposes or by occurrence of other events specified by 
donors:
20X7
Purpose restrictions accomplished:
Program A expenses $168
Program B expenses 31
Program C expenses 206
405
Time restrictions expired:
Passage of specified time 20
Total restrictions released $425
4. Charity Care
Charges excluded from revenue under the Authority’s charity care policy were 
$5,100 and $4,845 for 20X7 and 20X6, respectively.
5. Assets Limited as to Use
Assets limited as to use that are required for obligations classified as 
current liabilities are reported in current assets. The composition of assets 
limited as to use at December 31 , 20X7 and 20X6, is set forth in the following 
table.
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20X7 20X6
Internally designated for capital acquisitions $21,000 $20,600
Held by trustees 1,245 923
Under indenture agreement 2,613 2,180
Total $24,858 $23,703
6. Bank Deposits and Investments
Statutes authorize the Authority to invest in obligations of the U.S. Treasury, 
agencies, and instrumentalities, commercial paper rated A-1 by Standard & 
Poor’s Corporation or P-1 by Moody’s Commercial Paper Record, bankers’ 
acceptances. At December 31, 20X7 and 20X6, the Authority had bank balances 
as follows:
20X7 20X6
Insured (FDIC) or collateralized with 
securities held by the Authority $3,687 $5,677
Collateralized by securities held by the 
pledging financial institution’s trust
department in the Authority’s name 1,153 300
Total $4,840 $5,977
Carrying Value $5,021 $6,539
As discussed in Note 1, the Authority’s investments generally are carried at 
fair value. All securities are held in the Authority’s name by a custodial bank 
that is the agent of the Authority. At December 31, 20X7 and 20X6, the 
Authority’s investments consisted of the following:
20X7 20X6
U.S. Treasury Obligations $21,771 $20,039
U.S. Government Agency Securities 5,048 5,713
$26,819 $25,752
The Authority’s bylaws require that investments be made only in U.S. 
government obligations and that all bank balances be insured or collateral­
ized by U.S. government securities held by the Authority’s third-party agent 
or the pledging financial institution’s trust department in the name of the 
Authority.
7. Long-Term Debt
A summary of long-term debt, including capital lease obligations, at Decem­
ber 31, 20X7 and 20X6, follows:
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7.25 percent Revenue Notes, due November
1, 20YY, collateralized by a pledge of the
Authority’s gross receipts $18,257 $18,714
9.25 percent mortgage loan, due January 
20XX, collateralized by a mortgage on 
property and equipment with a depreciated
cost of $1,530 at December 31 , 20X7 1,709 1,808
9.75 percent note payable, due March 20XX, 
unsecured 106 570
Total long-term debt 20,072 21,092
Less current maturities of long-term debt 825 1,020
Long-term debt net of current maturities $19,247 $20,072
Capital lease obligations, at varying rates of 
imputed interest from 9.8 percent to 12.3 
percent collateralized by leased equipment
with cost of $1,275 at December 31, 20X7 $ 850 $ 808
Less current portion of capital lease 
obligations 425 468
Capital lease obligations, excluding current 
portion $ 425 $ 340
Under the terms of the Revenue Note Indenture, the Authority is required to 
maintain certain deposits with a trustee. Such deposits are included with assets 
limited as to use in the financial statements. The Revenue Note Indenture also 
places limits on the incurrence of additional borrowings and requires that the 
Authority satisfy certain measures of financial performance as long as the notes 
are outstanding.
Scheduled principal repayments on long-term debt and payments on capital 
lease obligations for the next five years are as follows:
Year Ending Long-Term Capital Lease
December 31, Debt Obligations
20X8 $ 825 $506
20X9 775 221
20Y0 836 221
20Y1 900 —
20Y2 972 —
Thereafter 15,764 —
$20,072 948
Less amount representing interest on
capital lease obligations 98
Total $850
20X7 20X6
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A summary of interest cost and investment income on borrowed funds held 
by the trustee under the Revenue Note Indenture during the years ended 20X7 
and 20X6 follows:
20X7 20X6
Interest cost:
Capitalized $ 629 $ 628
Charged to operations 1,489 1,552
Total $2,118 $2,180
Investment income:
Capitalized $ 429 $ 564
Credited to other revenue" 280 328
Total $ 709 $ 892
8. Pension Plan
Plan description. Sample Hospital Pension Plan (SHPP) provides retirement 
and disability benefits, annual cost-of-living adjustments, and death benefits 
to plan members and beneficiaries. SHPP is affiliated with County Employees 
Pension Plan (CEPP), an agent multiple-employer pension plan administered 
by the Illinois Retirement System. Article 39 of the Regulations of the State of 
Illinois assigns the authority to establish and amend the benefit provisions of 
the plans that participate in CEPP to the respective employer entities; for 
CEPP, that authority rests with the County of Feeling, Illinois. The Illinois 
Retirement System issues a publicly available financial report that includes 
financial statements and required supplementary information for SHPP. That 
report may be obtained by writing to Illinois Retirement System, State Gov­
ernment Lane, Anytown, USA 01000 or by calling 1-800-555-PLAN.
Funding policy. The contribution requirements of plan members and the 
Authority are established and may be amended by the CEPP Board of Trustees. 
Plan members are required to contribute 7.8 percent of their annual covered 
salary. The Authority is required to contribute at an actuarially determined 
rate; the current rate is 11.9 percent of annual covered payroll.
Annual pension cost and net pension obligation. The Authority’s annual 
pension cost and net pension obligation to SHPP for the current year were as follows:
20X7
Annual required contribution $ 26 
Interest on net pension obligation 3 
Adjustment to annual required contribution _(3)
Annual pension cost 26
Contributions made (12)
Increase (decrease) in net pension obligation 14
Net pension obligation beginning of year 66
Net pension obligation, end of year $ 80
The annual required contribution for the current year was determined as part 
of the December 31, 20X6, actuarial valuation using the entry age actuarial 
cost method. The actuarial assumptions included (a) 7.5% investment rate of
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return (net of administrative expenses) and (b) projected salary increases 
ranging from 5.5% to 9.5% per year. Both (a) and (b) included an inflation 
component of 5.5%. The actuarial assumptions also include a 2% per year 
cost-of-living adjustment. The actuarial value of assets was determined using 
techniques that smooth the effects of short-term volatility in the market value 
of investments over a four-year period. The unfunded actuarial accrued liability 
is being amortized as a level percentage of projected payroll on an open basis. 
The remaining amortization period at December 31, 20X6, was 23 years.
Three-Year Trend Information
Fiscal Annual Percentage Net
Year Pension of APC Pension
Ending Cost (APC) Contributed Obligation
12/31/X5 $20 94% $49
12/31/X6 23 68 65
12/31/X7 26 46 80
(The preparer of the financial statements should consider the need for 
required supplementary information (RSI) as required by GASB Statement No. 
27, Accounting for Pensions by State and Local Governmental Employers, 
paragraph 22.)
9. Postretirement Plan
In addition to the pension benefits described above, the Authority provides 
postretirement health care benefits, in accordance with the Authority’s bylaws, 
to all employees who retire from the Authority on or after attaining age 60 with 
at least 15 years of service. Currently 250 retirees meet these eligibility 
requirements. The Authority reimburses 75 percent of the amount of validated 
claims for medical, dental, and hospitalization costs incurred by pre-Medicare 
retirees and their dependents. The Authority also reimburses a fixed amount 
of $25 per month for a Medicare supplement for each retiree eligible for 
Medicare. Expenditures for postretirement health care benefits are recognized 
as retirees report claims and include a provision for estimated claims incurred 
but not yet reported to the Authority. During the year, expenditures of $764 
were recognized for postretirement health care. Approximately $64 of the $128 
increase in expenditures over the previous year was caused by the addition of 
dental benefits, effective July 1, 20X7.
Other disclosures that may be required include the following:
10. Property, Plant, and Equipment*
11. Off-Balance-Sheet Risk and Concentration of Credit Risk*
12. Fair Value of Financial Instruments*
13. Commitments and Contingencies*,#
14. Operating Leases*
15. Subsequent Events*
* The disclosures contained in these notes would be similar to the disclosures contained in the 
notes to the financial statements for a not-for-profit hospital and, therefore, are not repeated here.
# Requirements for disclosures about claims and judgments and risk financing by governmental 
health care enterprises are provided in GASB Statement No. 10, Accounting and Financial Report­
ing for Risk Financing and Related Insurance Issues, and are not illustrated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NURSING HOME 
Sample For-Profit Nursing Home, Inc. 
Balance Sheets 
December 3 1 , 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash and cash equivalents $ 95,000 $ 129,000
Investments 150,000
Assets limited as to use 50,000 50,000
Patient accounts receivable, net of allowance 
for doubtful accounts of $6,700 in 20X5 and
$5,300 in 20X4 162,000 152,000
Estimated third-party payor settlements 71,000 62,000
Interest receivable 7,000
Supplies 47,000 43,000
Prepaid expenses 3,000 2,000
Deferred tax asset 12,000 14,000
Total current assets 597,000 452,000
Assets limited as to use, net of amount required
for current liabilities 173,000 150,000
Property and equipment:
Land 205,000 205,000
Land improvements 37,000 32,000
Buildings 1,399,000 1,399,000
Furniture, fixtures, and equipment 228,000 189,000
1,869,000 1,825,000
Less accumulated depreciation 210,000 141,000
Property and equipment, net 1,659,000 1,684,000
Other assets 150,000 127,000
Total assets $2,579,000 $2,413,000 
(continued)
AAG-HCO APP A
Illustrative Financial Statements 1 8 5
Sample For-Profit Nursing Home, Inc. 
Balance Sheets
(continued) 
December 3 1 , 20X5 and 20X4
20X5 20X4
Liabilities and Shareholders’ Equity
Current liabilities:
Current maturities of long-term debt $ 50,000 $ 50,000
Accounts payable 78,000 52,000
Accrued expenses 175,000 188,000
Deposits from patients 50,000 45,000
Other current liabilities 74,000 15,000
Total current liabilities 427,000 350,000
Deferred tax liability 6,000 14,000
Long-term debt, net of current maturities 1,700,000 1,750,000
Shareholders’ equity:
Common stock, $20 par value; authorized 
5,000 shares; issued and outstanding
3,500 shares 70,000 70,000
Retained earnings 376,000 229,000
Total shareholders’ equity 446,000 299,000
Total liabilities and shareholders’ equity $2,579,000 $2,413,000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc. 
Statements of Income and Retained Earnings 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue:
Net patient service revenue $2,163,000 $1,949,000
Other revenue 67,000 22,000
Interest on investments held by trustee 13,000 7,000
Total revenue 2,243,000 1,978,000
Expenses:
Salaries and benefits 969,000 919,000
Medical supplies and drugs 511,000 499,000
Insurance and other 216,000 176,000
Provision for bad debts 92,000 83,000
Depreciation 69,000 57,000
Interest 164,000 172,000
Total expenses 2,021,000 1,906,000
Operating income 222,000 72,000
Nonoperating income:
Other interest income 5,000
Income before provision for income taxes 227,000 72,000
Provision for income taxes 80,000 29,000
Net income 147,000 43,000
Retained earnings, beginning of year 229,000 186,000
Retained earnings, end of year $ 376,000 $ 229,000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc. 
Statements of Cash Flows 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities: 
Cash received from residents and
third-party payors $2,019,000 $1,796,000
Cash received from others 67,000 22,000
Cash paid to employees and suppliers (1,679,000) (1,495,000)
Interest and dividends received 10,000 10,000
Interest paid (160,000) (170,000)
Taxes paid (29,000) (30,000)
Deposits received from patients 35,000 15,000
Deposits refunded to patients (30,000) (20,000)
Net cash provided by operating activities 233,000 128,000
Cash flows from investing activities:
Purchase of investments (150,000)
Proceeds from sale of property 2,000
Capital expenditures (44,000) (79,000)
Purchase of assets limited as to use (23,000)
Net cash used in investing activities (217,000) (77,000)
Cash flows from financing activities:
Repayment of long-term debt (50,000) (50,000)
Net cash used in financing activities (50,000) (50,000)
Net increase (decrease) in cash and cash
equivalents (34,000) 1,000
Cash and cash equivalents, beginning of year 129,000 128,000
Cash and cash equivalents, end of year $ 95,000 $ 129,000
(continued)
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Sample For-Profit Nursing Home, Inc. 
Statements of Cash Flows 
(continued) 
Years Ended December 3 1 , 20X5 and 20X4
20X5 20X4
Reconciliation of net income to net cash 
provided by operating activities:
Net income $147,000 $43,000
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation 69,000 57,000
Provision for bad debts 92,000 83,000
Loss on sale of property — 11,000
Change in deferred income taxes (6,000) (14,000)
(Increase) decrease in:
Patient accounts receivable (102,000) (41,000)
Other current assets (21,000) (15,000)
Estimated third-party payor settlements (9,000) (10,000)
Interest receivable (7,000) (3,000)
Other assets (7,000) (10,000)
Increase (decrease) in:
Accounts payable and accrued expenses 13,000 43,000
Deposits from patients 5,000 (5,000)
Other current liabilities 59,000 (11,000)
Net cash provided by operating activities $233,000 $128,000
See accompanying notes to financial statements.
AAG-HCO APP A
Illustrative Financial Statements 1 8 9
Sample For-Profit Nursing Home,  Inc. 
Notes to Financial Statements2 
December 3 1 , 20X5 and 20X4
1. Description of Organization and Summary of Significant Account­
ing Policies
Organization. The Sample Nursing Home, Inc. (the Company) was incorpo­
rated in New State in 20X1 and operates a 128-bed nursing home in Abacus, 
New State. A summary of the Company’s significant accounting policies follows:
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments 
in highly liquid debt instruments with an original maturity of three months or 
less, excluding amounts whose use is limited by note indenture.
Investments. Investments in debt instruments, including assets limited as 
to use, are classified as held-to-maturity because the Company has the positive 
intent and ability to hold the securities until maturity. Held-to-maturity 
securities are carried at cost adjusted for amortization of premiums and 
accretion of discounts.
Assets limited as to use. Assets deposited with a trustee under terms of the 
note indenture and assets set aside by the Board of Directors for capital 
improvements are classified as assets limited as to use. Amounts required to 
meet current liabilities have been reclassified in the balance sheet.
Property and equipment. Property and equipment are recorded at cost. 
Depreciation is calculated on the straight-line method over the estimated useful 
lives of depreciable assets.
Bond issuance costs. Costs incurred in issuing the Series 20X1 bonds are 
being amortized based on the effective interest method.
Net patient service revenue. Net patient service revenue is reported at the 
estimated net realizable amounts from residents, third-party payors, and 
others for service rendered.
Revenue under third-party payor agreements is subject to audit and retroac­
tive adjustment. Provisions for estimated third-party payor settlements are 
provided in the period the related services are rendered. Differences between 
the estimated amounts accrued and interim and final settlements are reported 
in operations in the year of settlement.
Income taxes. The provisions for income taxes are based on amounts esti­
mated to be currently payable and those deferred because of temporary differ­
ences between the financial statement and tax bases of assets and liabilities. 
These differences consist principally of bad debts and depreciation.
2. Assets Limited as to Use
Assets limited as to use include:
2 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue 
recognition and includes a sample disclosure in paragraph 37 of the SOP for material differences between 
an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is effective for 
audits of periods ending on or after June 3 0 , 2000. SOP 00-1 is included in appendix E to this Guide.
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Assets held by trustee under the Series 20X1 note indenture 
agreement at December 31, 20X5 and 20X4.
U.S. Government obligations 
Cash
Accrued interest income
Internally designated by the Board of 
Directors for capital improvements
Certificate of deposit 
Accrued interest
20X5
$150,000
24,000
2,000
176,000
$ 45,000 
2,000
47,000
$130,000
21,000
2,000
153,000
20X4
$ 45,000 
2,000
47,000
$223,000 $200,000
3. Investments
The amortized cost and approximate fair value of held-to-maturity securities 
at December 31, 20X5 and 20X4, are as follows:
December 31, 20X5
U.S. Treasury obligations 
U.S. Government agency 
obligations 
Other debt securities
U.S. Treasury obligations 
U.S. Government agency 
obligations
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
(Losses)
Approximate 
Fair Value
$150,000 $11,000 $(16,000) $145,000
83,000
67,000
(7,000)
(18,000)
76,000
49,000
$300,000 $11,000 $(41,000) $270,000
December 31, 20X4
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
(Losses)
Approximate 
Fair Value
$103,000 $ $(10,000) $ 93,000
27,000 2,000 29,000
$130,000 $2,000 $(10,000) $122,000
Maturities of held-to-maturity securities at December 31, 20X5, are as fol­
lows:
One year or less 
After one through five years 
After five through ten years 
After ten years
Amortized
Cost
$131,000
31,000
68,000 
70,000
Approximate 
Fair Value
$126,000
29,000
62,000 
53,000
$300,000 $270,000
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4. Long-Term Debt
Long-term debt at December 31, 20X5 and 20X4, was as follows:
20X5 20X4
9.5 percent bonds payable to the City of 
Abacus, maturing $50,000 annually through 
November 1, 20YY, with a final maturity of 
$1 million on November 1, 20YY $1,750,000 $1,800,000
Less current maturities 50,000 50,000
$1,700,000 $1,750,000
The notes are collateralized by a first-mortgage lien on all property and 
equipment of the Company and a security interest in all of its receipts. The note 
indenture requires the maintenance of certain deposits with a trustee, which 
are included in assets limited as to use.
Future maturities of long-term debt as of December 31, 20X5, follow:
Year Ending December 31, Amount
20X6 $ 50,000
20X7 50,000
20X8 50,000
20X9 50,000
20Y0 50,000
Thereafter 1,500,000
Total $1,750,000
5. Income Taxes
The provisions for income taxes are as follows:
20X5 20X4
Current:
Federal $72,000 $15,000
State 2,000 ____________
Total current 74,000 15,000
Deferred:
Federal 6,000 13,000
State ______  1,000
Total deferred 6,000 14,000
Total provision for income taxes $80,000 $29,000
Deferred income taxes are provided for the temporary differences between 
the financial reporting basis and the tax basis of the Company’s assets and 
liabilities.
For the years ended December 31, 20X5 and 20X4, the effective tax rate 
approximated the statutory rate of 34 percent and 40 percent, respectively.
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The net current and noncurrent components of deferred income taxes recog­
nized in the balance sheet at December 31, 20X5 and 20X4, follows:
20X5 20X4
Net current assets $12,000 $14,000
Net noncurrent liabilities 6,000 14,000
$ 6,000 $____ 0
Management has determined that no valuation allowance related to deferred 
tax assets is necessary at December 31, 20X5 and 20X4, respectively.
6. Concentration in State Medicaid Program
The Company has 100 of its 128 beds designated for care of patients under 
the state’s Medicaid program. The current funding of that program is 90 days 
behind filed claims. The current state budget has no provision for reducing that 
lag and, while the proposed budget for 20X6 includes additional funding, there 
is no assurance that the final budget will include the needed additional funds.
7. Risks and Uncertainties Disclosures*
8. Pension Plan*
9. Postretirement Benefits*
10. Fair Values of Financial Instruments*
11. Concentrations of Credit Risk*
* The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A CONTINUING 
CARE RETIREMENT COMMUNITY
Sample Not-for-Profit Continuing Care Retirement Community 
Balance Sheets 
December 31, 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash $ 375,000 $ 330,000
Assets limited as to use 265,000 170,000
Accounts receivable, net of allowance for 
doubtful accounts of $4,000 in 20X5 and
$5,000 in 20X4 187,000 197,000
Supplies 40,000 21,000
Prepaid expenses 115,000 73,000
Total current assets 982,000 791,000
Assets limited as to use, net of amount
required for current liabilities 1,865,000 1,583,000
Property and equipment, net 14,893,000 15,280,000
Deferred financing costs, net of accumulated 
amortization of $28,000 in 20X5 and $21,000
in 20X4 83,000 90,000
Total assets $17,823,000 $17,744,000
Liabilities and Net Assets
Liabilities:
Current maturities of long-term debt $ 90,000 $ 77,000
Accounts payable 180,000 174,000
Accrued expenses 161,000 178,000
Deposits on unoccupied units 22,000 40,000
Total current liabilities 453,000 469,000
Long-term debt, less current maturities 8,871,000 8,935,000
Refundable fees 59,000 144,000
Estimated obligation to provide future 
services, in excess of amounts received or to
be received 88,000 100,000
Deferred revenue from advance fees 6,304,000 6,585,000
Total liabilities 15,775,000 16,233,000
Net assets:
Unrestricted 1,286,000 833,000
Temporarily restricted 311,000 294,000
Permanently restricted 451,000 384,000
Total net assets 2,048,000 1,511,000
Total liabilities and net assets $17,823,000 $17,744,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community 
Statements of Operations 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Resident services, including amortization of
advance fees of $935,000 in 20X5 and
$915,000 in 20X4 $3,946,000 $3,152,000
Patient revenue from nonresidents 249,000 275,000
Change in obligation to provide future
services 12,000 (82,000)
Contributions 54,000 39,000
Net assets released from restrictions used for
operations 24,000 50,000
Investment income 29,000 30,000
Other 75,000 68,000
Total revenue, gains, and other support 4,389,000 3,532,000
Expenses:
Salaries and benefits 1,708,000 1,250,000
Medical supplies and drugs 543,000 742,000
Insurance 291,000 311,000
Depreciation 452,000 447,000
Interest 967,000 955,000
Total expenses 3,961,000 3,705,000
Operating income (loss) 428,000 (173,000)
Net assets released from restriction—purchase
of equipment 25,000 45,000
Increase (decrease) in unrestricted net
assets $ 453,000 $ (128,000)
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community 
Statements of Changes in Net Assets 
Years Ended December 3 1 , 20X5 and 20X4
20X5 20X4
Unrestricted net assets:
Operating income (loss) $ 428,000 $ (173,000)
Net assets released from
restriction—purchase of equipment 25,000 45,000
Increase (decrease) in unrestricted net
assets 453,000 (128,000)
Temporarily restricted net assets:
Contributions 40,000 15,000
Net assets released from restrictions used
for operations (24,000) (50,000)
Net assets released from
restriction—purchase of equipment (25,000) (45,000)
Investment income 26,000 15,000
Increase (decrease) in temporarily
restricted net assets 17,000 (65,000)
Permanently restricted net assets:
Contributions 67,000 52,000
Increase in permanently restricted net
assets 67,000 52,000
Increase (decrease) in net assets 537,000 (141,000)
Net assets, beginning of year 1,511,000 1,652,000
Net assets, end of year $2,048,000 $1,511,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community 
Statements of Cash Flows
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities: 
Cash received from residents and 
third-party payors 
Advance fees received 
Other receipts from operations 
Investment income received 
Contributions received 
Cash paid to employees and suppliers 
Interest paid
$ 3,252,000 
654,000
75,000
68,000 
51,000
(2,576,000)
(950,000)
$ 2,341,000 
857,000 
68,000
53,000
44,000 
(2,040,000)
(945,000)
Net cash provided by operating activities 574,000 378,000
Cash flows from investing activities: 
Purchase of property and equipment 
Purchase of assets limited as to use
(65,000)
(377,000)
(250,000)
229,000
Net cash used in investing activities (442,000) (21,000)
Cash flows from financing activities: 
Permanently restricted funds received 
Refunds of deposits and refundable fees 
Proceeds from issuance of long-term debt 
Principal payments of long-term debt
67,000 
(103,000)
26,000 
(77,000)
52,000
(52,000)
(307,000)
Net cash used in financing activities (87,000) (307,000)
Net increase in cash 45,000 50,000
Cash, beginning of year 330,000 280,000
Cash, end of year $ 375,000 $ 330,000
(continued)
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Sample Not-for-Profit Continuing Care Retirement Community 
Statements of Cash Flows 
(continued) 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Reconciliation of change in net assets to net 
cash provided by operating activities:
Change in net assets $ 537,000 $(141,000)
Adjustments to reconcile change in net assets
to net cash provided by operating activities:
Advance fees received 654,000 857,000
Restricted net assets received (67,000) (52,000)
Amortization of advance fees (935,000) (915,000)
Loss (gain) on obligation to provide future
services (12,000) 82,000
Depreciation 452,000 447,000
Amortization of deferred financing costs 7,000 34,000
Provision for bad debts 3,000 3,000
(Increase) decrease in:
Accounts receivable 7,000 (33,000)
Other assets (61,000) (4,000)
Increase (decrease) in:
Accounts payable and accrued expenses (11,000) 100,000
Net cash provided by operating
activities $ 574,000 $ 378,000
See accompanying notes to financial statements.
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Notes to Financial Statements3 
December 3 1 , 20X5 and 20X4
1. Description of Organization and Summary of Significant Accounting 
Policies*
Organization. The Sample Continuing Care Retirement Community (the 
CCRC) is a nonprofit organization that principally provides housing, health 
care, and other related services to residents through the operation of a retire­
ment facility containing 249 apartments and a 78-bed health care facility 
located in Evergreen Park, Illinois. The CCRC was incorporated in Illinois in 
20X1. A summary of significant accounting policies follows.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Investments. Investments, which consist of U.S. Treasury obligations, are 
measured at fair value in the balance sheet. Investment income (including 
realized gains and losses on investments, interest, and dividends) is included 
in operating income (loss) unless restricted by donor or law. Unrealized gains 
and losses on investments, if any, are excluded from operating income (loss).
Deferred financing costs. Deferred financing costs are amortized using the 
effective interest method over the term of the related financing agreement.
Advance fees. Fees paid by a resident upon entering into a continuing care 
contract, net of the portion thereof that is refundable to the resident, are 
recorded as deferred revenue and are amortized to income using the straight- 
line method over the estimated remaining life expectancy of the resident.
Obligation to provide future services. The CCRC annually calculates the 
present value of the net cost of future services and the use of facilities to be provided 
to current residents and compares that amount with the balance of deferred 
revenue from advance fees. If the present value of the net cost of future services 
and the use of facilities exceeds the deferred revenue from advance fees, a liability 
is recorded (obligation to provide future services and use of facilities) with the 
corresponding charge to income. The obligation is discounted at 9 percent, based 
on the expected long-term rate of return on government obligations.
Donor restrictions. The CCRC reports gifts of cash and other assets as restricted 
support if they are received with donor stipulations that limit the use of the donated 
assets. When a donor restriction expires (that is, when a stipulated time restriction 
ends or a purpose restriction is accomplished), temporarily restricted net assets 
are reclassified as unrestricted net assets and reported in the statement of 
operations as net assets released from restrictions. Donor-restricted contributions 
whose restrictions are met within the same year as received are reflected as 
unrestricted contributions in the accompanying financial statements.
Sample Not-for-Profit Continuing Care Retirement Community
3 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue 
recognition and includes a sample disclosure in paragraph 37 of the SOP for material differences 
between an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is 
effective for audits of periods ending on or after June 3 0 , 2000. SOP 00-1 is included in appendix E to 
this Guide.
* Does not include all disclosures common to all health care entities.
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The CCRC reports gifts of property and equipment (or other long-lived assets) 
as unrestricted support unless explicit donor stipulations specify how the 
donated assets must be used. Gifts of long-lived assets with explicit restrictions 
that specify how the assets are to be used and gifts of cash or other assets that 
must be used to acquire long-lived assets are reported as restricted support. 
Absent explicit donor stipulations about how long those long-lived assets must 
be maintained, the CCRC reports expirations of donor restrictions when the 
donated or acquired long-lived assets are placed in service.
Income taxes. The CCRC has been recognized by the Internal Revenue 
Service as a not-for-profit corporation as described in Sec. 501(c)(3) of the 
Internal Revenue Code (IRC) and is exempt from federal income taxes pursuant 
to Sec. 501(a) of the IRC.
Property and equipment. Property and equipment are stated at cost. Donated 
property is recorded at its estimated fair value at the date of receipt. Deprecia­
tion is computed on the straight-line method based on the following estimated 
useful lives:
Land improvements 20 years
Buildings and improvements 40 years
Furniture and equipment 5—15 years
Operating income (loss). The statement of operations includes operating 
income (loss). Changes in unrestricted net assets which are excluded from 
operating income (loss), consistent with industry practice, include unrealized 
gains and losses on investments other than trading securities, permanent 
transfers of assets to and from affiliates for other than goods and services, and 
contributions of long-lived assets (including assets acquired using contribu­
tions which by donor restriction were to be used for the purposes of acquiring 
such assets).
2. Property and Equipment
A summary of property and equipment at December 31, 20X5 and 20X4, 
follows:
20X5 20X4
Land $ 557,000 $ 557,000
Land improvements 205,000 203,000
Buildings and improvements 14,573,000 14,564,000
Furniture and equipment 752,000 698,000
16,087,000 16,022,000
Less: accumulated depreciation (1,194,000) (742,000)
$14,893,000 $15,280,000
3. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes:
20X5 20X4
Purchase of equipment $169,000 $152,000
Charity care 142,000 142,000
$311,000 $294,000
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Net assets were released from donor restrictions by incurring expenses 
satisfying the restricted purposes or by occurrence of other events specified by 
donors:
20X5
Charity care $24,000
Purchase of equipment $25,000
4. Permanently Restricted Net Assets
Permanently restricted net assets are restricted to investment in perpetuity, 
the income from which is expendable to support:
2 0 0  Health Care Organizations
20X4
$50,000
$45,000
20X5 20X4
Charity care $168,000 $168,000
Community activities 283,000 216,000
$451,000 $384,000
5. Long-Term Debt
Long-term debt at December 31, 20X5 and 20X4, is as follows:
20X5 20X4
10.75 percent mortgage note payable $8,901,000 $8,965,000
Notes payable to bank—unsecured 34,000 14,000
Other 26,000 33,000
8,961,000 9,012,000
Less current maturities 90,000 77,000
$8,871,000 $8,935,000
The mortgage note is payable in consecutive monthly installments of principal 
and interest of $85,425 to May 20XX. The note is collateralized by a first 
mortgage on property and equipment with a depreciated cost at December 31, 
20X5, of $14,893,000 and by a pledge of all operating revenue.
As required by the mortgage note agreement, the CCRC established an initial 
debt service reserve fund of $1,000,000 at April 15, 20X3. All resident fees 
received thereafter, net of resident fee refunds and debt service payments not 
to exceed $300,000 annually in the first four years and $200,000 annually 
thereafter, are to be added to the debt service reserve fund until the total sum 
of $2,050,000 is accumulated. Since June 1 , 20X4, the CCRC has been required 
to deliver to the trustee $5,500 per month to establish maintenance reserves 
until the aggregate of such payments equals a residential unit reserve and a 
health care center reserve of $240,000 and $90,000, respectively. At December 
31, 20X5 and 20X4, the trustee held investments aggregating $2,130,000 and 
$1,753,000, respectively. Such amount has been classified as assets limited as 
to use.
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Scheduled annual principal maturities of long-term debt for the next five 
years are as follows:
Year Ending December 31,
20X6 
20X7 
20X8 
20X9 
20Y0
6. Classification of Expenses
Amount
$ 90,000
90,000
95,000
105,000
105,000
20X5 20X4
Program activities 3,368,000 3,135,000
General and administrative 593,000 570,000
$3,961,000 $3,705,000
7. Assets Limited as to Use*
8. Risks and Uncertainties Disclosures*
9. Pension Plan*
10. Postretirement Benefits*
11. Fair Values of Financial Instruments*
12. Concentrations of Credit Risk*
13. Investments*
* The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A HOME HEALTH AGENCY 
Sample Not-for-Profit Home Health Agency 
Balance Sheets 
December 31, 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash and cash equivalents $ 74,000 $ 41,000
Investments 147,000 137,000
Accounts receivable, net of allowance for 
doubtful accounts of $61,000 in 20X5 and 
$30,000 in 20X4 752,000 476,000
Other receivables 27,000 22,000
Total current assets 1,000,000 676,000
Investments 100,000 100,000
Equipment:
Medical and office equipment 56,000 39,000
Vehicles 50,000 37,000
106,000 76,000
Less accumulated depreciation (45,000) (24,000)
Equipment, net 61,000 52,000
Deferred finance charges, net of accumulated 
amortization of $15,000 in 20X5 and $10,000 
in 20X4 20,000 25,000
Total assets $1,181,000 $853,000
Liabilities and Net Assets
Current liabilities:
Current maturities of long-term debt $ 13,000 $ 13,000
Accounts payable 40,000 21,000
Accrued payroll and vacation costs 496,000 352,000
Estimated third-party payor settlements 28,000 31,000
Advances from third-party payors 70,000 66,000
Total current liabilities 647,000 483,000
Long-term debt, less current maturities 105,000 118,000
Total liabilities 752,000 601,000
Net assets:
Unrestricted 330,000 167,000
Temporarily restricted 9,000 5,000
Permanently restricted 90,000 80,000
Total net assets 429,000 252,000
Total liabilities and net assets $1,181,000 $853,000
See accompanying notes to financial statements.
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FORMAT A 
Sample Not-for-Profit Home Health Agency 
Statements of Operations 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Net patient service revenue $4,042,000 $2,687,000
Contributions 5,000 22,000
Net assets released from restrictions 5,000 —
Investment income 13,000 6,000
Other revenue 27,000 32,000
Total revenue, gains, and other support 4,092,000 2,747,000
Expenses:
Salaries and benefits 2,714,000 1,835,000
Medical supplies and drugs 1,042,000 675,000
Insurance and other 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest 16,000 19,000
Total expenses 3,929,000 2,648,000
Excess of revenue over expenses and change in
unrestricted net assets $ 163,000 $ 99,000
See accompanying notes to financial statements.
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FORMAT B
Sample Not-for-Profit Home Health Agency 
Statements of Operations 
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Net patient service revenue $4,042,000 $2,687,000
Contributions 5,000 22,000
Net assets released from restrictions 5,000 —
Other revenue 27,000 32,000
Total revenue, gains, and other support 4,079,000 2,741,000
Expenses:
Salaries and benefits 2,714,000 1,835,000
Medical supplies and drugs 1,042,000 675,000
Insurance and other 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest 16,000 19,000
Total expenses 3,929,000 2,648,000
Operating income 150,000 93,000
Other income:
Investment income 13,000 6,000
Excess of revenue over expenses and change in
unrestricted net assets $ 163,000 $ 99,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency 
Statements of Changes in Net Assets 
Years Ended December 31, 20X5 and 20X4
20X5
Unrestricted net assets:
Excess of revenue over expenses $163,000
Increase in unrestricted net assets 163,000
Temporarily restricted net assets:
Contributions 9,000
Net assets released from restrictions (5,000)
Increase in temporarily restricted net 
assets 4,000
Permanently restricted net assets:
Contributions 10,000
Increase in permanently restricted net 
assets 10,000
Increase in net assets 177,000
Net assets, beginning of year 252,000
Net assets, end of year $429,000
See accompanying notes to financial statements.
20X4
$ 99,000 
99,000
5,000
5,000
6,000
6,000
110,000
142,000
$252,000
AAG-HCO APP A
2 0 6 Health Care Organizations
Sample Not-for-Profit Home Health Agency 
Statements of Cash Flows 
Years Ended December 3 1 , 20X5 and 20X4
20X5 20X4
Cash flows from operating activities:
Cash received from patients and
third-party payors $3,721,000 $2,542,000
Other receipts from operations 22,000 32,000
Cash paid to employees and suppliers (3,679,000) (2,541,000)
Interest paid (11,000) (14,000)
Nonoperating revenue 23,000 22,000
Net cash provided by operating activities 76,000 41,000
Cash flows from investing activities:
Purchase of equipment (30,000) (19,000)
Purchase of investments (10,000) (15,000)
Net cash used in investing activities (40,000) (34,000)
Cash flows from financing activities:
Proceeds from contributions restricted for:
Endowment 10,000 6,000
Other financing activities:
Payment of long-term debt (13,000) —
Net cash provided by (used in) financing
activities (3,000) 6,000
Net increase in cash and cash equivalents 33,000 13,000
Cash and cash equivalents, beginning of year 41,000 28,000
Cash and cash equivalents, end of year $ 74,000 $ 41,000
(continued)
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Sample Not-for-Profit Home Health Agency 
Statements of Cash Flows 
(continued) 
Years Ended December 31, 20X5 and 20X4
20X5
Reconciliation of change in net assets to net 
cash provided by operating activities:
Change in net assets $177,000
Adjustments to reconcile change in net assets 
to net cash provided by operating activities:
Increase in permanently restricted net 
assets (10,000)
Provision for bad debts 46,000
Depreciation 21,000
Amortization of deferred financing charges 5,000
(Increase) decrease in:
Accounts receivable (322,000)
Other receivables (5,000)
Increase (decrease) in:
Accounts payable, accrued payroll, and 
vacation costs 163,000
Estimated third-party payor settlements 1,000
Net cash provided by operating activities $ 76,000
See accompanying notes to financial statements.
20X4
$110,000
(6,000)
21,000
15,000
5,000
(150,000)
4,000
38,000
4,000
$ 41,000
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Sample Not-for-Profit Home Health Agency 
Notes to Financial Statements4 
Years Ended December 3 1 , 20X5 and 20X4
1. Description of Organization and Summary of Significant Accounting 
Policies
Organization. The Sample Home Health Agency (the Agency) was incorpo­
rated in 20X0 in New State as a not-for-profit corporation. The Agency provides 
health and supportive services to individuals at their homes, primarily in the 
New State area.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in 
highly liquid debt instruments with an original maturity of three months or less.
Investments. Investments, which consist of U.S. Treasury obligations, are 
measured at fair value in the balance sheet. Investment income (including 
realized gains and losses on investments, interest and dividends) is included 
in excess of revenues over expenses unless restricted by donor or law. Unreal­
ized gains and losses on investments, if any, are excluded from excess of 
revenues over expenses.
Equipment. Equipment is recorded at cost. Depreciation is computed using 
the straight-line method over the estimated useful lives of the assets.
Deferred financing costs. Deferred financing costs are being amortized using 
the effective interest method over the term of the related financing agreement.
Donor restrictions. The Agency reports gifts of cash and other assets as 
restricted support if they are received with donor stipulations that limit the 
use of the donated assets. When a donor restriction expires, that is, when a 
stipulated time restriction ends or purpose restriction is accomplished, tempo­
rarily restricted net assets are reclassified as unrestricted net assets and 
reported in the statement of operations as net assets released from restrictions. 
When long-lived assets are placed in service, thus satisfying purpose restric­
tions, the amount is included as a change in net assets, restricted and unre­
stricted. Donor-restricted contributions whose restrictions are met within the 
same year as received are reflected as unrestricted contributions in the accom­
panying financial statements.
The Agency reports gifts of equipment (or other long-lived assets) as unre­
stricted support unless explicit donor stipulations specify how the donated 
assets must be used. Gifts of long-lived assets with explicit restrictions that 
specify how the assets are to be used and gifts of cash or other assets that must 
be used to acquire long-lived assets are reported as restricted support. Absent 
explicit donor stipulations about how long those long-lived assets must be 
maintained, the Agency reports expirations of donor restrictions when the 
donated or acquired long-lived assets are placed in service.
4 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue 
recognition and includes a sample disclosure in paragraph 37 of the SOP for material differences between 
an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is effective for 
audits of periods ending on or after June 30, 2000. SOP 00-1 is included in appendix E to this Guide.
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Net patient service revenue. Net patient service revenue represents the 
estimated net realizable amounts from patients, third-party payors, and others 
for services rendered.
Charity care. The Agency has a policy of providing charity care to patients 
who are unable to pay. Such patients are identified based on financial informa­
tion obtained from the patient and subsequent analysis. Since the Agency does 
not expect payment, estimated charges for charity care are not included in 
revenue.
Income taxes. The Agency has been recognized by the Internal Revenue 
Service as a not-for-profit corporation as described in Sec. 501(c)(3) of the 
Internal Revenue Code (IRC) and is exempt from federal income taxes on 
related income pursuant to Sec. 501(a) of the IRC.
Excess of revenue over expenses. The statement of operations includes excess 
of revenue over expenses. Changes in unrestricted net assets which are excluded 
from excess of revenue over expenses, consistent with industry practice, include 
unrealized gains and losses on investments other than trading securities, 
permanent transfers of assets to and from affiliates for other than goods and 
services, and contributions of long-lived assets (including assets acquired using 
contributions which by donor restriction were to be used for the purposes of 
acquiring such assets).
2. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes:
20X5
Charity care $ —
Purchase of equipment 9,000
$9,000
Net assets were released from donor restrictions by incurring expenses 
satisfying the restricted purposes or by occurrence of other events specified by 
donors:
20X5 20X4
Charity care expenditures $5,000 $ —
3. Permanently Restricted Net Assets
Permanently restricted net assets are restricted in perpetuity, the income 
from which is expendable to support:
20X5
Program A activities $10,000
Any activities of the Agency 80,000
$90,000
4. Third-Party Rate Adjustments and Revenue
Approximately 38 percent in 20X5 and 37 percent in 20X4 of net patient 
service revenue was derived under federal and state third-party reimburse­
ment programs. These revenues are based, in part, on cost reimbursement 
principles and are subject to audit and retroactive adjustment by the respective
20X4
$ _
80,000
$80,000
20X4
$5,000
$5,000
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third-party fiscal intermediaries. In the opinion of management, retroactive 
adjustments, if any, would not be material to the financial position or results 
of operations of the Agency.
5. Internally-Designated Assets
The Board of Directors has designated investments aggregating $100,000 to 
be used for future major capital improvements. Those assets are classified in 
the balance sheet as long-term investments.
6. Long-Term Debt
Long-term debt at December 31, 20X5 and 20X4, is as follows:
20X5
Note payable to bank, interest at 15 percent, 
payable in monthly installments of $2,200 per 
month, including interest, collateralized by 
equipment with a depreciated cost of $42,000 $118,000 
Less current maturities 13,000
$105,000
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20X4
$131,000
13,000
$118,000
Scheduled maturities of long-term debt at December 31, 20X5, are as follows:
Year Ending December 31, Amount
20X6 $ 13,000
20X7 13,000
20X8 13,000
20X9 13,000
20Y0 13,000
Thereafter 53,000
Total $118,000
7. Classification of Expenses
_______________Program________________ General and
Total A  B  C  Administrative
Expenses incurred 
for the year 
ended December 
31, 20X5, were 
for:
Salaries and
benefits $2,714,000 $1,363,000 $699,000 $363,000 $289,000
Medical supplies 
and drugs 1,042,000 511,000 246,000 285,000
Insurance and 
other 90,000 58,000 32,000
Provision for bad 
debts 46,000 16,000 30,000
Depreciation 21,000 5,000 16,000
Interest 16,000 10,000 3,000 3.000
Total expenses $3,929,000 $1,963,000 $978,000 $648,000 $340,000
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Program________________ General and
Total A  B  C  Administrative
Expenses incurred 
for the year 
ended December 
31, 20X4, were 
for:
Salaries and
benefits $1,835,000 $ 915,000 $463,000 $216,000 $241,000
Medical supplies 
and drugs 675,000 335,000 211,000 129,000
Insurance and 
other 83,000 64,000 19,000
Provision for bad 
debts 21,000 21,000
Depreciation 15,000 6,000 9,000
Interest 19,000 12,000 5,000 2,000
Total expenses $2,648,000 $1,353,000 $679,000 $345,000 $271,000
(The preparer of the financial statements may wish to include a brief descrip­
tion of the types of programs.)
8. Charity Care
Charity care represented approximately 3 percent and 4 percent of visits in 
20X5 and 20X4, respectively.
9. Risks and Uncertainties Disclosures*
10. Pension Plan*
11. Postretirement Benefits*
12. Fair Value of Financial Statements*
13. Concentrations of Credit Risk*
14. Investments*
* The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A 
HEALTH MAINTENANCE ORGANIZATION
Sample Not-for-Profit Health Maintenance Organization 
Balance Sheets 
June 3 0 , 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash and cash equivalents $2,937,000 $1,021,000
Premiums receivable, net of allowance for
doubtful accounts of $36,000 in 20X5 and
$42,000 in 20X4 358,000 407,000
Other receivables 263,000 261,000
Supplies 190,000 184,000
Prepaid expenses 197,000 99,000
Total current assets 3,945,000 1,972,000
Property and equipment, net 5,756,000 5,626,000
State guaranty fund deposit 150,000 150,000
Debt issuance costs, net of accumulated
amortization of $42,000 in 20X5 and $39,000
in 20X4 18,000 21,000
Total assets $9,869,000 $7,769,000
Liabilities and Net Assets
Current liabilities:
Unsecured 12 percent note payable to a bank $ — $ 44,000
Current maturities of long-term debt 241,000 109,000
Accounts payable—medical services 2,245,000 1,471,000
Other accounts payable and accrued expenses 829,000 661,000
Unearned premium revenue 141,000 202,000
Total current liabilities 3,456,000 2,487,000
Long-term debt, less current maturities 4,295,000 2,382,000
Total liabilities 7,751,000 4,869,000
Net assets—unrestricted 2,118,000 2,900,000
Total liabilities and net assets $9,869,000 $7,769,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Health Maintenance Organization 
Statements of Operations and Changes in Net Assets 
Years Ended June 3 0 , 20X5 and 20X4
20X5 20X4
Revenue:
Premiums earned $27,682,000 $22,500,000
Coinsurance 689,000 500,000
Interest and other income 242,000 100,000
Total revenue 28,613,000 23,100,000
Expenses:
Salaries and benefits 16,154,000 13,328,000
Medical supplies and drugs 8,507,000 5,988,000
Insurance 3,963,000 2,463,000
Provision for bad debts 19,000 20,000
Depreciation 367,000 336,000
Interest 385,000 375,000
Total expenses 29,395,000 22,510,000
Operating income (loss) (782,000) 590,000
Net assets, beginning of year 2,900,000 2,310,000
Net assets, end of year $ 2,118,000 $ 2,900,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Health Maintenance Organization 
Statements of Cash Flows 
Years Ended June 30, 20X5 and 20X4
__20X5 20X4
Cash flows from operating activities:
Cash received from premiums, stop-loss 
insurance recoveries, and coinsurance 
Cash paid to employees and to providers of 
health care services 
Interest and other income received 
Interest paid
Net cash provided by operating activities
Cash flows from investing activities:
Capital expenditures
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from long-term debt 
Principal payments on long-term debt 
Principal payments on note payable
Net cash provided by (used in) financing 
activities
Net increase in cash and cash equivalents 
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
$28,969,000 $24,410,000
(28,405,000) (22,818,000)
230,000 90,000
(382,000) (372,000)
412,000 1,310,000
(497,000) (121,000)
(497,000) (121,000)
2,300,000 _
(255,000) (1,000,000)
(44,000) —
2,001,000 (1,000,000)
1,916,000 189,000
1,021,000 832,000
$ 2,937,000 $ 1,021,000
( continued)
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Sample Not-for-Profit Health Maintenance Organization 
Statements of Cash Flows 
(continued) 
Years Ended June 30, 20X5 and 20X4
20X5 20X4
Reconciliation of change in net assets to net 
cash provided by operating activities:
Change in net assets $(782,000) $ 590,000
Adjustments to reconcile change in net 
assets to net cash provided by operating 
activities:
Depreciation and amortization 370,000 339,000
Provision for bad debts 19,000 20,000
(Increase) decrease in:
Premiums receivables 30,000 64,000
Other current assets 230,000 (93,000)
Increase (decrease) in:
Accounts payable—medical services 774,000 335,000
Other accounts payable and accrued
expenses (168,000) (60,000)
Unearned premium revenue (61,000) 115,000
Net cash provided by operating activities $ 412,000 $1,310,000
See accompanying notes to financial statements.
AAG-HCO APP A
216 Health Care Organizations
Sample Not-for-Profit Health Maintenance Organization 
Notes to Financial Statements5 
June 3 0 , 20X5 and 20X4
1. Organization
The Sample Health Maintenance Organization (the HMO) was incorporated 
in 20X0 in New State as a not-for-profit corporation for the purpose of providing 
comprehensive health care services on a prepaid basis and for the purpose of 
establishing and operating organized health maintenance and health care 
delivery systems.
The HMO has been determined to be a qualified health maintenance organi­
zation under Title XIII of the Public Health Service Act.
2. Summary of Significant Accounting Policies
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in 
highly liquid debt instruments with an original maturity of three months or less.
Supplies. Inventories of drugs and other supplies are stated at the lower of 
cost (first-in, first-out) or market.
Property and equipment. Property and equipment are recorded at cost. 
Maintenance and repairs are charged to expense, and betterments are capital­
ized. Property and equipment costing approximately $700,000 was financed by 
health maintenance organization initial development grants received in 20X1 
and 20X2 from the U.S. Department of Health and Human Services (HHS). 
This property will be owned by the HMO as long as the equipment and facilities 
are used for projects related to the objectives of the Public Health Service Act.
Depreciation is computed using the straight-line method over the estimated 
useful lives of the related assets as follows:
Building 40 years
Improvements 20-25 years 
Data processing and laboratory
equipment and automobiles 3—7 years
Medical equipment 10 years
Office equipment 5—10 years
Amortization of debt issuance costs. Debt issuance costs are deferred and 
amortized using the effective interest method over the term of the related debt.
Health care service cost recognition. The HMO contracts with various health 
care providers for the provision of certain medical care services to its members.
5 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue 
recognition and includes a sample disclosure in paragraph 37 of the SOP for material differences 
between an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is 
effective for audits of periods ending on or after June 30, 2000. SOP 00-1 is included in appendix E to 
this Guide.
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The HMO compensates these providers on a capitation basis. As part of a cost 
control incentive program, the HMO retains up to 20 percent of the capitation 
as a risk-sharing fund. In the event of hospital utilization in excess of budget, 
those providers bear the risk to the extent of 15 percent of the capitation fee. 
Operating expenses include all amounts incurred by the HMO under the 
aforementioned contracts.
The cost of other health care services provided or contracted for is accrued in 
the period in which it is provided to a member based in part on estimates, 
including an accrual for medical services provided but not reported to the HMO.
Premiums revenue. Membership contracts are on a yearly basis subject to 
cancellation by the employer group or the HMO upon 30 days written notice. 
Premiums are due monthly and are recognized as revenue dining the period in 
which the HMO is obligated to provide services to members.
Reinsurance (stop-loss insurance). Reinsurance premiums are reported as 
health care costs, and reinsurance recoveries are reported as a reduction of 
related health care costs.
Federal income tax. The HMO is exempt from federal income taxes under 
Sec. 501(c)(4) of the Internal Revenue Code; accordingly, no provision for 
federal income taxes has been made in the accompanying financial statements.
3. Property and Equipment
Property and equipment at June 30, 20X5 and 20X4, consists of the following:
20X5 20X4
Land $ 300,000 $ 300,000
Buildings and improvements 5,473,000 5,459,000
Furniture and equipment 1,786,000 1,303,000
7,559,000 7,062,000
Less accumulated depreciation (1,803,000) (1,436,000)
$5,756,000 $5,626,000
4. Long-Term Debt
Long-term debt is collateralized by assets with a depreciated cost of 
$4,943,000. A summary of long-term debt at June 30, 20X5 and 20X4, follows.
20X5 20X4
HHS loan, interest at 7.5 percent, payable in 
monthly installments of $50,000, including
interest $2,020,000 $ 111,000
HHS loan, interest at 9.25 percent, payable 
in monthly installments of $10,000,
including interest 1,658,000 1,694,000
Secured equipment loans, payable in 
monthly installments of $15,000, including
interest 858,000 686,000
4,536,000 2,491,000 
Less current maturities 241,000 109,000
$4,295,000 $2,382,000
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20X6 $ 241,000
20X7 259,000
20X8 280,000
20X9 800,000
20Y0 2,956,000
$4,536,000
5. State Guarantee Fund Deposit
In August 20X4 the state in which the HMO is domiciled enacted legislation 
specifically governing HMOs. Under this legislation, the corporation is required 
to maintain a deposit of $150,000 with the director of the division of insurance 
of the state.
6. Employee Retirement Plan
The HMO has a contributory defined contribution retirement plan covering 
substantially all employees. Expense determined in accordance with the plan 
formula (4 percent to 10 percent of eligible covered compensation) was $354,000 
and $275,000 for the years ended June 30, 20X5 and 20X4, respectively.
7. Stop-Loss Insurance
The HMO entered into a stop-loss insurance agreement with an insurance 
company to limit its losses on individual claims. Under the terms of this 
agreement, the insurance company will reimburse the HMO approximately 25 
percent of the cost of each member’s annual hospital services, in excess of a 
$1,000 deductible, up to a lifetime limitation of $500,000 per member. In the 
event the HMO ceases operations, (a) plan benefits will continue for members 
who are confined in an acute care hospital on the date of insolvency until their 
discharge, and (b ) plan benefits will continue for any other member until the 
end of the contract period for which premiums have been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are 
included in insurance expense (Note 9) in 20X5 and 20X4, respectively. Ap­
proximately $600,000 and $400,000 in stop-loss insurance recoveries are de­
ducted from insurance expense in 20X5 and 20X4, respectively.
Included in other receivables is approximately $50,000 recoverable from 
insurers.
8. Malpractice Claims
Malpractice claims have been asserted against the HMO by various claim­
ants. The claims are in various stages of processing, and some may ultimately 
be brought to trial. In the opinion of counsel, the outcome of these actions will 
not have a significant effect on the financial position or the operating income 
of the HMO. Incidents occurring through June 30, 20X5, may result in the 
assertion of additional claims. Other claims may be asserted arising from past 
services provided. Management believes that these claims, if asserted, would 
be settled within the limits of insurance coverage.
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9. Classification of Expenses
20X5 20X4
Program activities 26,921,000 20,909,000
General and administrative 2,474,000 1,601,000
$29,395,000 $22,510,000
10. Risks and Uncertainties Disclosures*
11. Pension Plan*
12. Postretirement Benefits*
13. Fair Value o f Financial Instruments*
14. Concentrations o f Credit Risk*
* The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR AN 
AMBULATORY CARE ORGANIZATION 
Sample Not-for-Profit Ambulatory Care, Inc. 
Balance Sheets 
December 3 1 , 20X5 and 20X4
See accompanying notes to financial statements.
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Assets
Current assets:
Cash
Patient accounts receivable, net of allowance 
for doubtful accounts of $15,000 in 20X5 and 
$5,000 in 20X4 
Estimated retroactive 
adjustments—third-party payors 
Accounts receivable-other 
Supplies
Prepaid expenses and deposits
Total current assets
Property and equipment, at cost:
Land
Land improvements
Buildings
Equipment
Less accumulated depreciation
Property and equipment, net
Other assets:
Advances receivable
Total assets
Liabilities and Net Assets
Current liabilities:
Notes payable 
Accounts payable
Accrued payroll, benefits, and taxes 
Estimated retroactive 
adjustments—third-party payors 
Financing advance from third-party payors
Total current liabilities
Net assets—unrestricted
Total liabilities and net assets
20X5 20X4
$ 65,000 $ 76,000
290,000 278,000
19,000 32,000
13,000 8,000
21,000 18,000
5,000 9,000
413,000 421,000
100,000 100,000
322,000 322,000
682,000 682,000
1,390,000 1,389,000
2,494,000 2,493,000
217,000 100,000
2,277,000 2,393,000
14,000 5,000
$2,704,000 $2,819,000
$ 138,000 $ 144,000
52,000 87,000
33,000 22,000
30,000 24,000
— 1,000
253,000 278,000
2,451,000 2,541,000
$2,704,000 $2,819,000
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Sample Not-for-Profit Ambulatory Care, Inc. 
Statements of Operations and Changes 
in Net Assets 
Years Ended December 3 1 , 20X5 and 20X4
20X5 20X4
Revenue and gains:
Net patient service revenue $ 860,000 $ 357,000
Other 29,000 15,000
Total revenue and gains 889,000 372,000
Expenses:
Salaries and benefits 485,000 243,000
Medical supplies and drugs 189,000 66,000
Insurance 154,000 98,000
Provision for bad debts 14,000 4,000
Depreciation 117,000 100,000
Interest 20,000 18,000
Total expenses 979,000 529,000
Operating loss (90,000) (157,000)
Net assets, beginning of year 2,541,000 2,698,000
Net assets, end of year $2,451,000 $2,541,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Ambulatory Care, Inc. 
Statements of Cash Flows 
Years Ended December 3 1 , 20X5 and 20X4
20X5
Cash flows from operating activities:
Cash received from patients and third-party
payors $866,000
Cash received from others 21,000
Interest received 3,000
Interest paid (15,000)
Cash paid to employees and suppliers (870,000)
Net cash provided by (used in) operating
activities 5,000
Cash flows from investing activities:
Purchase of equipment (1,000)
Advances made to XYZ Affiliate (9,000)
Net cash used in investing activities (10,000)
Cash flows from financing activities:
Proceeds from notes payable —
Payments on notes payable (6,000)
Net cash provided by (used in) financing
activities (6,000)
Net increase (decrease) in cash (11,000)
Cash, beginning of year 76,000
Cash, end of year $ 65,000
20X4
$368,000
6,000
11,000
(16,000)
(432,000)
(63,000)
(4,000)
(5,000)
(9,000) 
144,000
144,000 
72,000 
4,000 
$ 76,000
(continued)
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Sample Not-for-Profit Ambulatory Care, Inc. 
Statements of Cash Flows 
(continued) 
Years Ended December 3 1 , 20X5 and 20X4
20X5
Reconciliation of change in net assets to net 
cash provided by (vised in) operating 
activities:
Change in net assets
Adjustments to reconcile change in net assets 
to net cash provided by (used in) operating 
activities:
Depreciation 
Provision for bad debts
(Increase) decrease in:
Patient accounts receivable 
Other current assets
Increase (decrease) in:
Accounts payable and accrued payroll, 
benefits, and taxes 
Other current liabilities
Net cash provided by (used in) operating 
activities $ 5,000
See accompanying notes to financial statements.
$ (90,000)
117,000
14,000
(12,000)
1,000
(24,000)
(1,000)
20X4
$(157,000)
100,000
4,000
(19,000)
(2,000)
10,000
1,000
$ (63,000)
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Sample Not-for-Profit Ambulatory Care, Inc. 
Notes to Financial Statements6 
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant Accounting 
Policies
Organization. Ambulatory Care, Inc. was incorporated on September 7, 
20X3, in New State, to operate an ambulatory care health facility to treat or 
prevent injury and disease, to provide funds or to expend funds to further the 
treatment or prevention of injury or disease, and to develop and participate in 
activities designed to promote the general health of the community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and 
GHI Hospital—entered into a members’ agreement to develop this ambulatory 
care center. In accordance with this agreement, each hospital contributed 
capital of $947,000 to Ambulatory Care, Inc. Ambulatory Care, Inc. began 
operations in October 20X3.
Use of estimates. The preparation of financial statements in conformity with 
generally accepted accounting principles requires management to make esti­
mates and assumptions that affect the reported amounts of assets and liabili­
ties and disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.
Supplies. Supplies are stated at the lower of cost (first-in, first-out) or net 
realizable value.
Depreciation. Depreciation of property and equipment is computed on the 
straight-line method over the estimated lives of depreciable assets.
Third-party contractual adjustments. Retroactively calculated third-party 
contractual adjustments are accrued on an estimated basis in the period the 
related services are rendered. Net patient service revenue is adjusted as 
required in subsequent periods based on final settlements.
Net patient service revenue. Patient service revenue is reported at the esti­
mated net realizable amounts from patients, third-party payors, and others for 
services rendered.
Charity care. Ambulatory Care, Inc. has a policy of providing charity care to 
patients who are unable to pay. Such patients are identified and related charges 
are estimated, based on financial information obtained from the patient and 
subsequent analysis. Since management does not expect payment for charity 
care, the estimated charges are excluded from revenue.
Income taxes. Ambulatory Care, Inc. has been recognized by the Internal 
Revenue Service as a not-for-profit corporation as described in Sec. 501(c)(3) of 
the Internal Revenue Code (IRC) and is exempt from federal income taxes on 
related income pursuant to Sec. 501(a) of the IRC.
2. Advances Receivable
In May 20X4, Ambulatory Care, Inc. entered into a five-year agreement with 
XYZ Affiliates (XYZ). Under this agreement, XYZ is to provide emergency 
medical services as well as charge and bill each patient treated at Ambulatory
6 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue 
recognition and includes a sample disclosure in paragraph 37 of the SOP for material differences between 
an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is effective for 
audits of periods ending on or after June 30, 2000. SOP 00-1 is included in appendix E to this Guide.
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Care, Inc. Ambulatory Care, Inc. has guaranteed that XYZ will collect at least 
$18,000 per month during the term of this agreement. In any month in which 
XYZ does not collect the minimum guarantee, Ambulatory Care, Inc. advances 
funds to XYZ to cover the deficiency. Such advances are to be repaid to the 
extent XYZ’s net cash collections exceed the minimum guarantee amount. 
Management estimates that the advances will be fully recovered in 20X8.
3. Related-Party Transactions
During 20X3, Ambulatory Care, Inc. entered into a contract with one of the 
member hospitals (the managing hospital) for the management of the business 
and affairs of Ambulatory Care, Inc. Under this agreement, Ambulatory Care, 
Inc. pays $4,000 per month to the managing hospital. The agreement with the 
managing hospital was to remain in effect through December 31, 20X5, but has 
been extended on a month-to-month basis.
In addition, during 20X4 each hospital loaned $48,000 to Ambulatory Care, 
Inc. in the form of promissory notes at an interest rate of prime rate plus 1 
percent (effective rates of 10 percent and 9 percent in 20X5 and 20X4, respec­
tively). Of the total $144,000 liability, $48,000 is payable on demand after 
November 28, 20X5, to one member hospital, with the remaining portion 
($96,000) payable on demand after December 8, 20X5, to the other two member 
hospitals. During 20X5, Ambulatory Care, Inc. paid $2,000 to each member 
hospital, thereby reducing the obligation to $138,000.
4. Revenue From Contracting Agencies
Ambulatory Care, Inc. participates as a provider of health care services to Blue 
Cross, Medicare, and County Indigent Plan patients. Reimbursement for covered 
services is based on tentative payment rates. Final reimbursement is determined 
after submission of annual cost reports and audits thereof by the fiscal intermedi­
aries. Provisions for estimated reimbursement adjustments are reported in the 
financial statements in the period that the services are rendered.
5. Charity Care
Ambulatory Care, Inc. has a policy of providing charity care to indigent 
patients in emergency situations. These services, which are excluded from 
revenues, amounted to $27,000 and $13,000 in 20X5 and 20X4, respectively, 
when measured at Ambulatory Care, Inc.’s established rates.
6. Classification of Expenses
______________ Program________________  General and
Total A  B  C  Administrative
Expenses incurred 
for the year 
ended December 
31, 20X5, were 
for:
Salaries and
benefits $485,000 $216,000 $102,000 $121,000 $46,000
Medical supplies 
and drugs 189,000 98,000 43,000 48,000 _
Insurance 154,000 79,000 45,000 14,000 16,000
Provision for bad 
debts 14,000 9,000 5,000
Depreciation 117,000 100,000 — 17,000 —
Interest 20,000 9,000 — — 11,000
Total expenses $979,000 $511,000 $190,000 $205,000 $73,000
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Expenses incurred 
for the year 
ended December 
31, 20X4, were 
for:
Salaries and
benefits $243,000 $111,000 $46,000 $ 57,000 $29,000
Medical supplies 
and drugs 66,000 31,000 15,000 20,000 _
Insurance 98,000 45,000 19,000 26,000 8,000
Provision for 
bad debts 4,000 _ 4,000 _
Depreciation 100,000 56,000 — 44,000 —
Interest 18,000 7,000 — — 11,000
Total expenses $529,000 $250,000 $84,000 $147,000 $48,000
(The preparer of the financial statements may wish to include a brief descrip­
tion of the types of programs.)
7. Risks and Uncertainties Disclosures*
8. Pension Plan*
9. Postretirement Benefits*
10. Fair Value of Financial Instruments*
11. Concentrations of Credit Risk*
* The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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Appendix B 
Background Information and Basis 
for Conclusions
1. This appendix provides background information and discusses the 
comments received on the April 14, 1995 exposure draft that preceded this 
Audit and Accounting Guide (Guide)— Proposed Audit and Accounting Guide 
Health Care Organizations and the basis for key conclusions in this Guide.
Background Information
2. In 1989, the AICPA Health Care Committee (“the Committee”) com­
pleted a total rewrite of the guide. Since then, conforming changes have been 
made to update the guide for newly issued technical pronouncements. In June 
1993, the FASB issued FASB Statement No. 116, Accounting for Contributions 
Received and Contributions Made (“Contributions”), and FASB Statement No. 
117, Financial Statements of Not-for-Profit Organizations (“Display”). These 
Statements provide broad standards and introduce new concepts for which 
there is no detailed implementation guidance. FASB Statement No. 117 per­
mits the AICPA to provide more specific reporting guidance. Specifically, 
paragraph 3 of FASB Statement No. 117 states:
"Within the parameters of the Statement, the AICPA or another appropriate 
body, following the process described in AICPA Statement of Auditing Stand­
ards (SAS) No. 69, The Meaning of Present Fairly in Conformity With Generally 
Accepted Accounting Principles in the Independent Auditor’s Report, may 
provide more specific reporting guidance for certain not-for-profit organiza­
tions."
The Guide provides this guidance as it relates to providers of health care 
services.
3. In April 1995, the Committee released an exposure draft of a proposed 
Audit and Accounting Guide Health Care Organizations (ED) for public com­
ment. The committees received 40 comment letters on the ED. The committees 
redeliberated the issues based on the comments received. This appendix dis­
cusses the key issues in the ED and comments received on those issues, as well 
as the basis for AcSEC’s conclusions on those and certain other issues.
Basis for Conclusions
Contributions and Display
4. FASB Statements No. 116 and No. 117 allow more flexibility in finan­
cial reporting than currently exists within the health care industry. The most 
prominent flexibility relates to the elimination of the requirements to present 
a classified balance sheet and income statement as compared to the statement 
of activities.
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5. FASB Statements No. 116 and No. 117 apply to all not-for-profit 
enterprises, regardless of whether or not the entity is a business enterprise. 
The majority of tax-exempt health care organizations, however, operate as 
business enterprises (i.e., are essentially self-sustaining from fees charged for 
goods and services). The Committee believes that the uniformity and useful­
ness of financial reporting for business enterprise organizations would be 
enhanced if  the implementation guidance for FASB Statements No. 116 and 
No. 117 were consistent with the objectives of business enterprise financial 
reporting. The Committee points to the provisions in FASB Concept Statement 
No. 4, paragraph 8, which clearly supports the use of business enterprise 
financial reporting objectives for those organizations:
"Some organizations have no ownership interest but are essentially self-sus­
taining from fees they charge for goods and services. Examples are those private 
nonprofit hospitals...that may receive relatively small amounts of contributions 
and grants, but finance their capital needs largely from the proceeds of debt 
issues and their operating needs largely from service charges rather than from 
private philanthropy or governmental grants. As a result, assessments of 
amounts, timing, and uncertainty of cash flows become the dominate interest 
of their creditors and other resource providers and profitability becomes an 
important indicator of performance. Consequently, the objectives of Concepts 
Statement 1 may be more appropriate for those organizations."
6. Based on the theoretical support provided in FASB Concepts State­
ment No. 4, as well as the FASB allowance for more specific guidance (see 
paragraph 2 of this appendix), chapter 1 of the Guide defines four types of 
operating structures that are found within the industry: (1) not-for-profit 
business-oriented organizations, (2) investor-owned health care enterprises, 
(3) governmental health care organizations, and (4) not-for-profit, nonbusi­
ness-oriented organizations. This Guide provides specific reporting guidance 
for not-for-profit business-oriented organizations, investor-owned enterprises 
and governmental entities. (Not-for-profit nonbusiness organizations follow 
guidance for not-for-profit entities provided in the Audit and Accounting Guide 
Not-for-Profit Organizations.) The Guide recommends that these entities pro­
vide a classified balance sheet and a statement of operations. The Guide also 
encourages natural class reporting on the face of the financial statements, with 
disclosure of functional details in the footnotes.
7. A number of respondents to the ED were concerned that because the 
exposure draft of the Guide did not require an entity to distinguish between 
operating activities and nonoperating activities that such distinctions were no 
longer permissible. In response to these concerns, the Guide was clarified to 
incorporate paragraph 23 of FASB Statement No. 117. This paragraph specifi­
cally allows additional classifications within a statement of operations. Like 
FASB Statement No. 117, however, the Guide neither requires nor precludes 
such classifications.
Assets Whose Use is Limited
8. Several comments were received on the ED requesting specific guid­
ance to allow internally designated funds to be disclosed on the face of the 
financial statements. In response to these comments, the Committee clarified 
the Guide to require cash and claims to cash that meet one of the following 
criteria to be reported separately and excluded from current assets:
a. restricted as to withdrawal or use for other than current operations,
b. designated for expenditure in the acquisition or construction of 
noncurrent assets,
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c. required to be segregated for the liquidation of long-term debts, or
d. required by a donor-imposed restriction that limits their use to 
long-term purposes.
Consistent with comments received from a rating agency, the Guide requires 
internally designated funds to be reported separately from externally desig­
nated funds either in the notes to or on the face of the financial statements. The 
Committee believes this separation is beneficial due to the degree of control an 
organization maintains over internally designated funds.
Investments
9. Chapter 4, as presented in the Exposure Draft, was re-drafted to 
conform with the provisions of FASB Statement No. 124, Certain Investments 
Held by Not-For-Profit Organizations. This Standard requires fair value ac­
counting for marketable equity and debt securities. The majority of respon­
dents to the ED favored an income recognition approach similar to FASB 
Statement No. 115, Accounting for Certain Investments in Debt and Equity 
Securities. They believe such an approach is essential because it would foster 
greater consistency among not-for-profit and for-profit entities. Accordingly, 
an approach similar to FASB Statement No. 115 (i.e., the differentiation of 
trading securities vs. available-for-sale securities) was incorporated into the 
Guide. (The FASB specifically prohibited the use of a held-to-maturity category 
by not-for-profit organizations.)
Accounting for Donor-Imposed Restricted Contributions on 
Long-Lived Assets
10. The majority of comments received on accounting for donor-imposed 
restrictions on contributions of long-lived assets concurred with the Health 
Care Committee’s conclusion that the expiration of donor imposed restrictions 
on long-lived assets should be recognized when the asset is placed in service 
(rather than as depreciated as permitted by FASB Statement No. 116). Other 
respondents disagreed with the Health Care Committee’s position for various 
reasons. After considering each comment on the issue, the Committee con­
cluded that it would maintain the position set forth in the ED. The Committee 
believes this approach is easier to implement, it provides for uniformity in 
reporting within the industry and, because the donations are excluded from 
operating results, an appropriate matching of revenues and expenses occurs.
Use of a Performance Indicator
11. The Guide stresses the importance of the performance indicator and, 
in an effort to ensure consistency within the industry, provides specific guid­
ance on what the performance indicator should represent. This guidance is 
consistent with performance criteria historically used in the health care indus­
try, to the extent allowed under the provisions of FASB Statement No. 117. 
Specifically, the Guide states that health care organizations should report the 
results of their operations separately from—
а. Transactions with owners acting in that capacity.
b. Equity transfers involving other entities that control the reporting 
entity, sure controlled by the reporting entity, or are under common 
control with the reporting entity.
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c. Receipt of restricted contributions, including temporary restrictions 
(such as time or purpose) or permanent restrictions.
d. Contributions of (and assets released from donor restrictions related 
to) long-lived assets.
e. Unrealized gains and losses on investments not restricted by donors 
or by law, except for those investments classified as trading securi­
ties.
f . Investment returns restricted by donors or by law.
g. Other items that are required by GAAP to be reported separately 
(such as extraordinary items, the effect of discontinued operations, 
or the cumulative effect of accounting changes).1
12. In its deliberations, the FASB discussed the use of the word net 
income to describe the performance indicator of not-for-profit health care 
organizations. The Board concluded that the term net income is an inappropri­
ate term to describe the performance indicator of a not-for-profit organization 
and that descriptive terms such as revenues over expenses, revenues and gains 
over expenses and losses, earned income or performance earnings would be more 
appropriate. Accordingly, this guide requires the use of such descriptive terms 
instead of net income to describe the performance indicator of not-for-profit 
organizations.
Definition of a Governmental Entity
13. Subsequent to the release of the ED, the FASB and the GASB agreed 
on the definition of a governmental entity. Paragraph 1.02 of the Guide 
incorporates that definition.
Effective Date
14. Several comment letters were received expressing concern about the 
effective date of the Guide. In response to these comments, the Committee 
revised the effective date to fiscal years beginning after June 15, 1996, with 
earlier application permitted.
Status of Audit and Accounting Guides in the 
GAAP Hierarchy
15. In several instances the Guide provides more specific reporting re­
quirements than FASB Statements No. 116 and No. 117 (see paragraphs 4 
through 6, 8, 10, and 11). In the deliberation of the Guide, the question has 
arisen regarding the status of the guide in the GAAP hierarchy, given the fact 
that AICPA Audit and Accounting Guides are “Level B” GAAP while FASB 
Statements are “Level A”. In discussing the issue the Committee and the 
Accounting Standards Executive Committee referred to paragraph 49 of FASB 
Statement No. 117, which states that the AICPA:
“may provide more specific reporting guidance for certain not-for profit organi­
zations. SAS 69 requires that an entity adopt cleared AICPA Industry Audit
and Accounting Guides, and cleared AICPA Statements of Position that become
1 Governmental enterprises should report extraordinary items and the effect of discontinued 
operations in the statement of operations immediately preceding net income; the cumulative effect of 
an accounting change should be reported as an adjustment to beginning fund balance in the period of 
the change. Investor-owned enterprises should report extraordinary items, the effect of discontinued 
operations and the cumulative effect of an accounting change in the statement of operations immedi­
ately preceding net income.
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effective after March 15, 1992. As used in SAS 69, cleared means that the FASB 
has indicated that it does not object to the issuance of the proposed pronounce­
ment.”
The FASB has indicated that it does not object to the more specific reporting 
requirements contained in this guide for health care organizations.
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Appendix C
Statement of 98-2
Position
Accounting for Costs of 
Activities of Not-for-Profit 
Organizations and State and 
Local Governmental Entities 
That Include Fund Raising
March 11, 1998
Amendment to
AICPA Audit and Accounting Guides 
Health Care Organizations,
Not-for-Profit Organizations, and
Audits of State and Local Governmental Units
[See note on following page.]
Issued by the Accounting 
Standards Executive Committee
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NOTE
[SOP 98-2 is incorporated within Chapter 13 and Appendix A of the Not-for- 
Profit Organizations Guide as shown below:
Introduction: Paragraph 1 incorporated in Paragraph 13.52.
The remainder is deleted.
Scope: Deleted.
Conclusions: Paragraphs 7-19 incorporated in Paragraphs 13.53-13.65.
Effective Footnote 1 to Chapter 13 
Date:
Appendix A: Incorporated in Appendix A to Chapter 13.
Appendix B: Incorporated in Paragraphs 6-11 of Appendix A of the Guide.
Appendix C: Incorporated in Paragraphs 37-66 of Appendix A of the Guide.
Appendix D: Selected paragraphs incorporated in Appendix E to Chapter 13.
Appendix E: Incorporated in Appendix B to Chapter 13.
Appendix F: Incorporated in Appendix C to Chapter 13.
Appendix G: Incorporated in Appendix D to Chapter 13.
Appendix I: Changes made as indicated in Chapter 13.
The table of contents, summary, foreword, scope paragraph, and appendix H 
have been deleted.]
SOP 98-2 can be found in its entirety in the AICPA publication Technical 
Practice Aids.
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Appendix D
Statement of 99-1
Position
Guidance to Practitioners in 
Conducting and Reporting on 
an Agreed-Upon Procedures 
Engagement to Assist 
Management in Evaluating the 
Effectiveness of Its Corporate 
Compliance Program
May 21, 1999
Issued Under the Authority of the 
Audit Standards Board
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NOTE
This Statement of Position presents the recommendations of the 
AICPA Health Care Pilot Task Force regarding the application of 
Statements on Standards for Attestation Engagements to agreed- 
upon procedures attestation engagements performed to assist a 
health care provider in evaluating the effectiveness of its corporate 
compliance program consistent with the requirements of a Corporate 
Integrity Agreement entered into with the Office of Inspector General 
of the U.S. Department of Health and Human Services. The Auditing 
Standards Board has found the recommendations in this Statement 
of Position to be consistent with existing standards covered by Rule 
202 of the AICPA Code of Professional Conduct. AICPA members 
should be prepared to justify departures from the recommendations 
in this Statement of Position.
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SUMMARY
This Statement of Position (SOP) provides guidance to practitioners in conduct­
ing and reporting on an agreed-upon procedures engagement performed pur­
suant to the AICPA Statements on Standards for Attestation Engagements to 
assist a health care provider in evaluating the effectiveness of its corporate 
compliance program consistent with the requirements of a Corporate Integrity 
Agreement (CIA) entered into with the Office of Inspector General (OIG) of the 
U.S. Department of Health and Human Services. CIAs are specific to the entity 
involved; consequently, users of this SOP should be familiar with the specific 
requirements of the entity’s CIA.
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Guidance to Practitioners in Conducting and 
Reporting on an Agreed-Upon Procedures 
Engagement to Assist Management in 
Evaluating the Effectiveness of Its 
Corporate Compliance Program
Introduction and Background
.01 Within the past several years, the health care industry has experi­
enced a significant increase in the number and magnitude of allegations of 
fraud and abuse involving federal health care programs (for example, Medicare 
and Medicaid) and private health care insurance. These allegations have 
triggered regulatory scrutiny, litigation, significant monetary settlements, and 
negative publicity related to—among other things—coding and billing prac­
tices, patient referrals, cost reporting, quality of care, and clinical practices. 
Typically, as part of the global resolution of these allegations, the entity enters 
into a Corporate Integrity Agreement (CIA) with the Office of Inspector Gen­
eral (OIG) of the U.S. Department of Health and Human Services. Such 
agreements require that management annually report on its compliance with 
the terms of the CIA and that there be an assessment of the entity’s compliance 
with the CIA. This assessment includes a billing analysis, which may be 
performed by an independent review organization (such as a practitioner or 
consultant) or the provider (if permitted by the OIG), and an agreed-upon 
procedures engagement.
.02 This SOP provides guidance to practitioners in conducting and report­
ing on an agreed-upon procedures engagement performed pursuant to the 
American Institute of Certified Public Accountants (AICPA) Statements on 
Standards for Attestation Engagements (SSAEs) to assist an entity in evalu­
ating the effectiveness of its corporate compliance program consistent with the 
requirements of a CIA.1 The terms of a CIA are unique to the entity; 
consequently, users of this SOP need to be familiar with the actual CIA and 
its requirements.
.03 This SOP applies to agreed-upon procedures engagements to assist in 
evaluating an entity’s compliance for a specified period. Such engagements 
should follow the AICPA attestation standards, including SSAE No. 1, Attesta­
tion Standards (AICPA, Professional Standards, vol. 1, AT sec. 100); SSAE No.
3, Compliance Attestation (AICPA, Professional Standards, vol. 1, AT sec. 500); 
and SSAE No. 4, Agreed-Upon Procedure's Engagements (AICPA, Professional 
Standards, vol. 1, AT sec. 600). The engagement should be conducted in 
accordance with standards established by the AICPA, including the criteria set 
forth in this SOP. However, this SOP is not intended to provide all the required
1 The practitioner also might be engaged to assist in other areas beyond an agreed-upon 
procedures engagement such as providing consulting services in connection with evaluating the 
company’s billing practices, policies, and procedures as required by the CIA or in implementing, 
assessing, and reporting on voluntarily adopted compliance programs. In addition, the practitioner 
may assist in preparing an entity’s self-disclosure reports to federal health agencies related to billing 
errors and other compliance matters. Similarly, practitioners may be involved in an entity’s prepara­
tion of government-required (but not CIA-imposed) compliance reporting (for example, contract 
requirements for Medicare part C) beyond an agreed-upon procedures engagement.
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criteria set forth in individual CIAs, nor all the applicable standards estab­
lished by the AICPA. Additionally, the SOP contains some guidance that may 
be applied in evaluating an organization’s corporate compliance program, even 
though the program was not imposed by a CIA.
Overview of a Typical Corporate Integrity Agreement
.04 A CIA is an agreement between a health care provider and the OIG 
in conjunction with a global settlement of a fraud investigation. Such an 
agreement typically seeks to establish a compliance program within the health 
care provider (for example, hospital, clinical lab, physician group) that will 
promote compliance with the requirements of Medicare, Medicaid, and all 
other federal health care programs.
.05 CIAs are case-specific. Their terms are tailored to address the organ­
izational and operating deficiencies related to providing and billing for health 
care services that have been identified by the OIG, the entity, or others. Detailed 
compliance requirements are imposed as a condition for continued participa­
tion in federal health care programs. A sample CIA, provided by the OIG and 
intended to identify potential requirements, is included in appendix A, “Sam­
ple Corporate Integrity Agreement.” Typical agreements cover five years and 
require the entity to address the following areas:
•  Appointment of a compliance officer and establishment of a compli­
ance committee
•  Establishment of a code of conduct
•  Establishment of policies and procedures regarding the compliance 
program
•  Development of an information and education program as to CIA 
requirements, compliance program and code of conduct
•  Annual assessment of billing policies, procedures, and practices
•  Establishment of a confidential disclosure program
•  Prohibition of employment of excluded or convicted persons
•  Notification to OIG of investigation or legal proceedings
•  Reporting of credible evidence of misconduct
•  Notifications to OIG of new provider locations
•  Provision of implementation and annual reports
•  Proper notification and submission of required reports
•  Granting of OIG access to documents and individuals to conduct 
assessments
•  Documentation of record retention requirements
•  Awareness of disclosure criteria
•  Agreement to comply with certain default provisions, penalties, and 
remedies
•  Review of rights as to dispute resolution
•  Review of effective and binding agreement clauses
Conditions for Engagement Performance
.06 A practitioner may perform an agreed-upon procedures engagement 
related to management’s compliance with a CIA if all of the conditions specified 
in SSAE No. 4 (AT sec. 600.10) and SSAE No. 3 (AT sec. 500.09-.11) are met.
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.07 As discussed more fully in the SSAEs noted in paragraph .06, man­
agement’s assertions as to its compliance must be capable of evaluation against 
reasonable criteria that either have been established by a recognized body or 
are stated in or attached to the practitioner’s report in a sufficiently clear and 
comprehensive manner. Generally, to avoid confusion, management’s asser­
tions, which are based on the specific terms of its CIA, should be attached to 
the practitioner’s report. If  the entity is not subject to a CIA, management may 
develop its assertions using the model CIA. A sample based on the model CIA, 
which is not meant to be all-inclusive, is included as appendix B, “Sample 
Statement of Management’s Assertions.”
Establishing an Understanding With the Client
.08 The practitioner should document the understanding in the working 
papers, preferably through a written communication with the client, such as 
an engagement letter. Appendix C, “Sample Engagement Letter,” contains a 
sample engagement letter that may be used for this kind of engagement.
Users' Responsibilities
.09 Users typically would be the management of the health care provider 
and the OIG. Management is responsible for ensuring that the entity complies 
with the requirements of the CIA. That responsibility encompasses (a) identi­
fying applicable compliance requirements, (b) establishing and maintaining 
internal control policies and procedures to provide reasonable assurance that 
the entity complies with those requirements, (c) evaluating and monitoring the 
entity’s compliance, and (d ) preparing reports that satisfy legal, regulatory, or 
contractual requirements. Management’s evaluation may include documenta­
tion such as accounting or statistical data, policy manuals, accounting manu­
als, narrative memoranda, procedural write-ups, flowcharts, completed 
questionnaires, internal auditors’ reports, and other special studies or analy­
ses. The form and extent of documentation will vary depending on the nature 
of the compliance requirements and the size and complexity of the entity. 
Management may engage the practitioner to gather information to assist it in 
evaluating the entity’s compliance. Regardless of the procedures performed by 
the practitioner, management must accept responsibility for its assertions and 
must not base such assertions solely on the practitioner’s procedures.
.10 Specified users are responsible for the sufficiency (nature, timing, and 
extent) of the agreed-upon procedures because they best understand their own 
needs. The specified users assume the risk that such procedures might be 
insufficient for their purposes. In addition, the specified users assume the risk 
that they might misunderstand or otherwise inappropriately use findings 
properly reported by the practitioner.
Practitioner's Responsibilities
.11 The objective of the practitioner’s agreed-upon procedures is to pre­
sent specific findings to assist users in evaluating an entity’s compliance with 
the requirements specified in the CIA. (See appendix D, “Sample Procedures.”)
.12 The practitioner’s procedures generally may be as limited or extensive 
as the specified users desire, as long as the specified users agree upon the 
procedures performed or to be performed and take responsibility for the 
sufficiency of the agreed-upon procedures for their purposes.
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.13 To satisfy the requirements that the practitioner and the specified 
users agree upon the procedures performed or to be performed and that the 
specified users take responsibility for the sufficiency of the agreed-upon proce­
dures for their purposes, ordinarily the practitioner should communicate di­
rectly with and obtain affirmative acknowledgment from each of the specified 
users. For the purposes of these engagements, an effective way to obtain this 
agreement ordinarily is to distribute a draft of the report, detailing the proce­
dures, that is expected to be issued to the OIG with a request for any comments 
it may have.
.14 To avoid possible misunderstandings, the practitioner should circu­
late the draft with a legend stating that these are the procedures expected to 
be performed, and unless informed otherwise, the practitioner assumes that 
there are no additional procedures that he or she is expected to perform. A 
legend such as the following might be used.
This draft is furnished solely for the purpose of indicating the form of report that 
we would expect to be able to furnish pursuant to the request by Management of 
[Provider] for our performance of limited procedures relating to [Provider’s] 
compliance with the Corporate Integrity Agreement with the Office of Inspector 
General (OIG) of the U.S. Department of Heath and Human Services. Based on 
our discussions with [Provider], it is our understanding that the procedures 
outlined in this draft report are those we are expected to follow. Unless informed 
otherwise within ninety (90) days of this transmittal, we shall assume that there 
are no additional procedures that we are expected to follow. The text of the 
definitive report will depend, of course, on the results of the procedures.
Involvement of a Specialist2
.15 The practitioner’s education and experience enable him or her to be 
knowledgeable about business matters in general, but he or she is not expected 
to have the expertise of a person trained for or qualified to engage in the 
practice of another profession or occupation. In certain circumstances, it may 
be appropriate to involve a specialist to assist the practitioner in the perform­
ance of one or more procedures. The following are examples:
•  An attorney might provide assistance concerning the application of 
laws, regulations, or rules to a client’s situation.
•  A medical specialist might provide assistance in understanding the 
characteristics of diagnosis codes documented in patient medical records.
.16 The practitioner and the specified users should agree to the involve­
ment of a specialist in assisting a practitioner in the performance of an 
agreed-upon procedures engagement. This agreement may be reached when 
obtaining agreement on the procedures performed or to be performed and 
acknowledgment of responsibility for the sufficiency of the procedures, as 
discussed previously. The practitioner’s report should describe the nature of 
the assistance provided by the specialist.
.17 A practitioner may agree to apply procedures to the report or work 
product of a specialist that does not constitute assistance by the specialist to 
the practitioner in an agreed-upon procedures engagement. For example, the 
practitioner may make reference to information contained in a report of a 
specialist in describing an agreed-upon procedure. However, it is inappropriate
2 A specialist is a person (or firm) possessing special skill or knowledge in a particular field other 
than the attest function. As used herein, a specialist does not include a person employed by the 
practitioner’s firm who participates in the attestation engagement.
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for the practitioner to agree to merely read the specialist’s report solely to 
describe or repeat the findings, or to take responsibility for all or a portion of 
any procedures performed by a specialist or the specialist’s work product.
Internal Auditors and Other Personnel3
.18 The agreed-upon procedures to be enumerated or referred to in the 
practitioner’s report are to be performed entirely by the practitioner except as 
discussed in paragraphs .16-.18 of this SOP. However, internal auditors or 
other personnel may prepare schedules, accumulate data, perform an internal 
assessment of management’s compliance, or provide other information for the 
practitioner’s use in performing the agreed-upon procedures.
.19 A practitioner may agree to perform procedures on information docu­
mented in the working papers of internal auditors. For example, the practi­
tioner may agree to—
•  Repeat all or some of the procedures.
•  Determine whether the internal auditors’ working papers contain 
documentation of procedures performed and whether the findings 
documented in the working papers are presented in a report by the 
internal auditors.
.20 However, it is inappropriate for the practitioner to—
•  Agree to merely read the internal auditor’s report solely to describe or 
repeat its findings.
•  Take responsibility for all or a portion of any procedures performed by 
internal auditors by reporting those findings as the practitioner’s own.
•  Report in any manner that implies shared responsibility for the 
procedures with the internal auditors.
Planning the Engagement
.21 Planning an agreed-upon procedures engagement involves working 
with the users to develop an overall strategy for the expected conduct and scope 
of the engagement. To develop such a strategy, practitioners should have 
adequate technical training and proficiency in the attestation standards and 
have adequate knowledge in health care regulatory matters to enable them to 
sufficiently understand the events, transactions, and practices that, in their 
judgment, have a significant effect on the presentation of the assertions.
Working Papers
.22 The practitioner should prepare and maintain working papers in 
connection with an engagement under the attestation standards; such working 
papers should be appropriate to the circumstances and the practitioner’s needs 
on the engagement to which they apply.
.23 Concern over access to the practitioner’s working papers might cause 
some clients to inquire about working paper requirements. In situations where 
the practitioner is requested to not maintain copies of certain client documen­
tation, or to not prepare and maintain documentation similar to client documents,
3 SAS No. 65, The Auditor’s Consideration of the Internal Audit Function in an Audit of 
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 322), does not apply to 
agreed-upon procedures engagements.
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the practitioner may refer to the Auditing Interpretation, “The Auditor’s 
Consideration of the Completeness Assertion” (AICPA, Professional Stand­
ards, vol. 1, AU sec. 9326.06-.17), for guidance. See the Attest Interpretation, 
“Providing Access to or Photocopies of Working Papers to a Regulator” (AICPA, 
Professional Standards, vol. 1, AT sec. 9100.58), for guidance related to provid­
ing access to or photocopies of working papers to a regulator in connection with 
work performed on an attestation engagement.
Management's Representations
.24 The practitioner should obtain written representation from manage­
ment on various matters including the following:
a. Acknowledging management’s responsibility for complying with the 
CIA
b. Acknowledging management’s responsibility for establishing and 
maintaining effective internal control over compliance
c. Stating that management has performed an evaluation of the entity’s 
compliance with CIA-specified requirements
d. Stating management’s assertions about the entity’s compliance with 
all aspects of the CIA, including the specific issues that gave rise to 
the CIA4
e. Stating that management has disclosed to the practitioner all known 
noncompliance with the CIA
f. Stating that management has made available all documentation 
relating to compliance with the CIA
g. Stating management’s interpretation of any compliance require­
ments that have varying interpretations
h. Stating that management has disclosed any communication from 
regulatory agencies, internal auditors, legal counsel, and other par­
ties concerning matters regarding the design, implementation, and 
monitoring of the policies and procedures in place, including commu­
nication received between the end of the reporting period and the 
date of the practitioner’s report (the date of signature)
i. Stating that management has disclosed any known noncompliance 
occurring subsequent to the end of the reporting period
j. Describing any related material fraud or abuse, other fraud, abuse 
or illegal acts that, whether or not material, involve management or 
other employees who have a significant role in the entity’s design, 
implementation, and monitoring of the policies and procedures in 
place upon which compliance is based
4 Depending on the circumstances, representations in the following areas might be appropriate.
• Violations or possible violations of laws or regulations, such as those related to the Medicare 
and Medicaid antifraud and abuse statutes
• Compliance of third-party billings with applicable coding guidelines (for example, ICD-9-CM, 
CPT) and laws and regulations (including medical necessity, proper approvals, and proper 
rendering of care)
• Proper filing of all required Medicare, Medicaid, and similar reports under the applicable 
reimbursement rules and regulations (including nature of costs—allowable, patient-related, 
properly allocated, in accordance with applicable rules and regulations, properly adjusted to 
reflect prior audit adjustments) and adequacy of disclosures (including disputed costs)
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k. Stating that management has disclosed to the practitioners, orally 
or in writing, information about past noncompliance issues covered 
in the settlement agreement that gave rise to the CIA and the related 
corrective measures taken to support compliance in those areas
Management’s refusal to furnish all appropriate written representations con­
stitutes a limitation on the scope of the engagement sufficient to require 
withdrawal from the engagement.
Reporting Considerations
.25 A practitioner should present the results of applying agreed-upon 
procedures to the specific subject matter in the form of findings. The practi­
tioner should not provide negative assurance about whether the assertion is 
fairly stated in accordance with established or stated criteria. For example, the 
practitioner should not include a statement that “nothing came to my attention 
that caused me to believe that the assertion is not fairly stated in accordance 
with (established or stated) criteria.”
.26 The practitioner should report all findings from the application of the 
agreed-upon procedures. The concept of materiality does not apply to findings 
to be reported in an agreed-upon procedures engagement unless the definition 
of materiality is agreed to by the specified users. Any agreed-upon materiality 
limits should be described in the practitioner’s report.
.27 The practitioner has no obligation to perform procedures beyond the 
agreed-upon procedures. However, if noncompliance related to management’s 
assertion comes to the practitioner’s attention by other means, such informa­
tion ordinarily should be included in his or her report.
.28 The practitioner may become aware of noncompliance related to 
management’s assertion that occurs subsequent to the reporting period but 
before the date of the practitioner’s report. The practitioner should consider 
including information regarding such noncompliance in his or her report. 
However, the practitioner has no responsibility to perform procedures to detect 
such noncompliance other than obtaining management’s representation about 
noncompliance in the subsequent period.
.29 The practitioner should follow the reporting guidance in SSAE No. 4 
(AT sec. 600.33-38). A sample report is included in appendix E, “Sample 
Report.”
.30 Evaluating compliance with certain requirements may require inter­
pretation of the laws, regulations, rules, contracts, or other agreements that 
establish those requirements. In such situations, the practitioner should con­
sider whether he or she is provided with the reasonable criteria required to 
evaluate an assertion under the third general attestation standard. If  these 
interpretations are significant, the practitioner may include a paragraph stat­
ing the description and the source of interpretations made by the entity’s 
management. An example of such a paragraph, which should precede the 
procedures and findings paragraph(s), follows:
We have been informed that, under [name of entity’s] interpretation of [identify
the compliance requirement], [explain the nature and source of the relevant
interpretation].
.31 The date of completion of the agreed-upon procedures should be used 
as the date of the practitioner’s report.
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Appendix A
Sample Corporate Integrity Agreement 
Between the Office of Inspector General 
of the Department of Health and 
Human Services and [Provider]
I. Preamble
[Provider] ( “[Provider]”) hereby enters into this Corporate Integrity Agree­
ment (“CIA”) with the Office of Inspector General (“OIG”) of the United States 
Department of Health and Human Services (“HHS”) to ensure compliance by 
its employees with the requirements of Medicare, Medicaid and all other 
Federal health care programs (as defined in 42 U.S.C. 1320a-7b(f)) (hereinafter 
collectively referred to as the “Federal health care programs”). [Provider's] 
compliance with the terms and conditions in this CIA shall constitute an 
element of [Provider’s] present responsibility with regard to participation in 
the Federal health care programs. Contemporaneously with this CIA, 
[Provider] is entering into a Settlement Agreement with the United States, and 
this CIA is incorporated by reference into the Settlement Agreement.
II. Term of the CIA
The period of the compliance obligations assumed by [Provider] under this 
CIA shall be 5 years from the effective date of this CIA (unless otherwise 
specified). The effective date of this CIA will be the date on which the final 
signatory of this CIA executes this CIA (the “effective date”).*
m . Corporate Integrity Obligations
[Provider] shall establish a compliance program that includes the following 
elements:
A. Compliance Officer
Within ninety (90) days after the effective date of this CIA, [Provider] 
shall appoint an individual to serve as Compliance Officer, who shall 
be responsible for developing and implementing policies, procedures, 
and practices designed to ensure compliance with the requirements 
set forth in this CIA and with the requirements of the Federal health 
care programs. The Compliance Officer shall be a member of senior 
management of [Provider], shall make regular (at least quarterly) 
reports regarding compliance matters directly to the CEO and/or to 
the Board of Directors of [Provider] and shall be authorized to report 
to the Board of Directors at any time. The Compliance Officer shall 
be responsible for monitoring the day-to-day activities engaged in by 
[Provider] to farther its compliance objectives as well as any report­
ing obligations created under this CIA. In the event a new Compli­
ance Officer is appointed during the term of this CIA, [Provider] shall 
notify the OIG, in writing, within fifteen (15) days of such a change.
* Source: Office of the Inspector General of the United States Department of Health and 
Human Services.
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[Provider] shall also appoint a Compliance Committee within ninety 
(90) days after the effective date of this CIA. The Compliance Com­
mittee shall, at a minimum, include the Compliance Officer and any 
other appropriate officers as necessary to meet the requirements of 
this CIA within the provider’s corporate structure (e.g., senior execu­
tives of each major department, such as billing, clinical, human 
resources, audit, and operations). The Compliance Officer shall chair 
the Compliance Committee and the Committee shall support the 
Compliance Officer in fulfilling his/her responsibilities.
B. Written Standards
1. Code of Conduct. Within ninety (90) days of the effective date of 
this CIA, [Provider] shall establish a Code of Conduct. The Code of 
Conduct shall be distributed to all employees within ninety (90) days 
of the effective date of this CIA. [Provider] shall make the promotion 
of, and adherence to, the Code of Conduct an element in evaluating 
the performance of managers, supervisors, and all other employees. 
The Code of Conduct shall, at a minimum, set forth:
a. [Provider’s] commitment to full compliance with all stat­
utes, regulations, and guidelines applicable to Federal 
health care programs, including its commitment to pre­
pare and submit accurate billings consistent with Federal 
health care program regulations and procedures or in­
structions otherwise communicated by the Health Care 
Financing Administration (“HCFA”) (or other appropriate 
regulatory agencies) and/or its agents;
b. [Provider’s] requirement that all of its employees shall be 
expected to comply with all statutes, regulations, and 
guidelines applicable to Federal health care programs and 
with [Provider’s] own policies and procedures (including 
the requirements of this CIA);
c. the requirement that all of [Provider’s] employees shall be 
expected to report suspected violations of any statute, 
regulation, or guideline applicable to Federal health care 
programs or with [Provider’s] own policies and procedures;
d. the possible consequences to both [Provider] and to any 
employee of failure to comply with all statutes, regula­
tions, and guidelines applicable to Federal health care 
programs and with [Provider’s] own policies and proce­
dures or of failure to report such non-compliance; and
e. the right of all employees to use the confidential disclosure 
program, as well as [Provider’s] commitment to confiden­
tiality and non-retaliation with respect to disclosures.
Within ninety (90) days of the effective date of the CIA, each 
employee shall certify, in writing, that he or she has received, 
read, understands, and will abide by [Provider’s] Code of Conduct. 
New employees shall receive the Code of Conduct and shall 
complete the required certification within two (2) weeks after the 
commencement of their employment or within ninety (90) days of 
the effective date of the CIA, whichever is later.
[Provider] will annually review the Code of Conduct and will make 
any necessary revisions. These revisions shall be distributed within
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thirty (30) days of initiating such a change. Employees shall 
certify on an annual basis that they have received, read, under­
stand and will abide by the Code of Conduct.
2. Policies and Procedures. Within ninety (90) days of the effective 
date of this CIA, [Provider] shall develop and initiate implemen­
tation of written Policies and Procedures regarding the operation 
of [Provider’s] compliance program and its compliance with all 
federal and state health care statutes, regulations, and guide­
lines, including the requirements of the Federal health care pro­
grams. At a minimum, the Policies and Procedures shall 
specifically address [insert language relevant to allegations in the 
case]. In addition, the Policies and Procedures shall include disci­
plinary guidelines and methods for employees to make disclosures 
or otherwise report on compliance issues to [Provider] manage­
ment through the Confidential Disclosure Program required by 
section III.E. [Provider] shall assess and update as necessary the 
Policies and Procedures at least annually and more frequently, as 
appropriate. A summary of the Policies and Procedures will be 
provided to OIG in the Implementation Report. The Policies and 
Procedures will be available to OIG upon request.
Within ninety (90) days of the effective date of the CIA, the 
relevant portions of the Policies and Procedures shall be distrib­
uted to all appropriate employees. Compliance staff or supervisors 
should be available to explain any and all policies and procedures.
C. Training and Education
1. General Training. Within ninety (90) days of the effective date 
of this CIA, [Provider] shall provide at least two (2) hours of 
training to each employee. This general training shall explain 
[Provider’s]:
a. Corporate Integrity Agreement requirements;
b. Compliance Program (including the Policies and Proce­
dures as they pertain to general compliance issues); and
c. Code of Conduct.
These training materials shall be made available to the OIG, upon 
request.
New employees shall receive the general training described above 
within thirty (30) days of the beginning of their employment or 
within ninety (90) days after the effective date of this CIA, which­
ever is later. Each year, every employee shall receive such general 
training on an annual basis.
2. Specific Training. Within ninety (90) days of the effective date of 
this CIA, each employee who is involved directly or indirectly in 
the delivery of patient care and/or in the preparation or submis­
sion of claims for reimbursement for such care (including, but not 
limited to, coding and billing) for any Federal health care pro­
grams shall receive at least [insert number of training hours] 
hours of training in addition to the general training required 
above. This training shall include a discussion of:
a. the submission of accurate bills for services rendered to 
Medicare and/or Medicaid patients;
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b. policies, procedures and other requirements applicable to 
the documentation of medical records;
c. the personal obligation of each individual involved in the 
billing process to ensure that such billings are accurate;
d. applicable reimbursement rules and statutes;
e. the legal sanctions for improper billings; and
f. examples of proper and improper billing practices.
These training materials shall be made available to OIG, upon 
request. Persons providing the training must be knowledgeable 
about the subject area.
Affected new employees shall receive this training within thirty 
(30) days of the beginning of their employment or within ninety 
(90) days of the effective date of this CIA, whichever is later. I f  a 
new employee has any responsibility for the delivery of patient 
care, the preparation or submission of claims and/or the assign­
ment of procedure codes prior to completing this specific training, 
a [Provider] employee who has completed the substantive training 
shall review all of the untrained person’s work regarding the 
assignment of billing codes.
Each year, every employee shall receive such specific training on 
an annual basis.
3. Certification. Each employee shall certify, in writing, that he or 
she has attended the required training. The certification shall 
specify the type of training received and the date received. The 
Compliance Officer shall retain the certifications, along with 
specific course materials. These shall be made available to OIG 
upon request.
D. Review Procedures
[Provider] shall retain an entity, such as an accounting, auditing or 
consulting firm (hereinafter “Independent Review Organization”), to 
perform review procedures to assist [Provider] in assessing the 
adequacy of its billing and compliance practices pursuant to this CIA. 
This shall be an annual requirement and shall cover a twelve (12) 
month period. The Independent Review Organization must have 
expertise in the billing, coding, reporting and other requirements of 
the Federal health care programs from which [Provider] seeks reim­
bursement. The Independent Review Organization must be retained 
to conduct the assessment of the first year within ninety (90) days of 
the effective date of this CIA. For purposes of complying with this 
review procedures requirement, the OIG at its discretion, may per­
mit the [Provider] to utilize internal auditors to perform the re­
view(s). In such case, the [Provider] will engage the Independent 
Review Organization to verify the propriety of the internal auditors’ 
methods and accuracy of their results. The [Provider] will request 
the Independent Review Organization to produce a report on its 
findings which report shall be included in the Annual Report to the 
OIG.
The Independent Review Organization (or the [Provider], if  permit­
ted by the OIG, as set forth above) will conduct two separate engage­
ments. One will be an analysis of [Provider’s] billing to the Federal 
health care programs to assist the [Provider] and OIG in determining
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compliance with all applicable statutes, regulations, and direc­
tives/guidance (“billing engagement”). The second engagement will 
assist the [Provider] and OIG in determining whether [Provider] is 
in compliance with this CIA (“compliance engagement”).
1. Billing Engagement. The billing engagement shall consist of a 
review of a statistically valid sample of claims for the relevant 
period. The sample size shall be determined through the use of a 
probe sample.1 At a minimum, the full sample must be within a 
ninety (90) percent confidence level and a precision of twenty-five 
(25) percent. The probe sample must contain at least thirty (30) 
sample units and cannot be used as part of the full sample. Both 
the probe sample and the sample must be selected through ran­
dom numbers. [Provider] shall use OIG’s Office of Audit Services 
Statistical Sampling Software, also known as “RAT-STATS”, 
which is available through the Internet at www.hhs.gov/progorg 
/ratstat.html.
Each annual billing engagement analysis shall include the follow­
ing components in its methodology:
a. Billing Engagement Objective: Provide a statement stat­
ing clearly the objective intended to be achieved by the 
billing engagement and the procedure or combination of 
procedures that will be applied to achieve the objective.
b. Billing Engagement Population: Identify the population, 
which is the group about which information is needed. 
Explain the methodology used to develop the population 
and provide the basis for this determination.
c. Sources of Data: Provide a full description of the source of 
the information upon which the billing engagement con­
clusions will be based, including the legal or other stand­
ards applied, documents relied upon, payment data, 
and/or any contractual obligations.
d. Sampling Unit: Define the sampling unit, which is any of 
the designated elements that comprise the population of 
interest.
e. Sampling Frame: Identify the sampling frame, which is 
the totality of the sampling units from which the sample 
will be selected.
As part of the billing engagement:
a. Inquire of management as to the procedures and controls 
affecting the billing process subject to the annual assess­
ment as specified in the CIA. Document that aspect of the 
billing process (e.g., flow of documents, processing activi­
ties), and those controls that will be tested in the sample. 
The documentation may consist of flow charts, excerpts 
from policies and procedures manuals, control question­
naires, etc.
b. Report the sample results, including the overall error rate 
and the nature of the errors found (e.g., no documentation, 
inadequate documentation, assignment of incorrect code).
1 Probe sample is defined as a small, random preliminary sample.
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c. Document findings related to [Provider’s] procedures to 
correct inaccurate billings and codings to the Federal 
health care programs and findings regarding the steps 
[Provider] is taking to bring its operations into compliance 
or to correct problems identified by the audit.
2. Agreed-upon Procedures or Compliance Engagement. An Inde­
pendent Review Organization (or the [Provider], if  permitted by 
the OIG) shall also conduct an agreed-upon procedures or compli­
ance engagement, which shall assist the users in determining 
whether [Provider’s] program, policies, procedures, and opera­
tions comply with the terms of this CIA. This engagement shall 
include a section by section analysis of the requirements of this 
CIA.
A complete copy of the Independent Review Organization’s billing 
and agreed-upon procedures or compliance engagement shall be 
included in each of [Provider’s] Annual Reports to OIG.
3. Disclosure of Overpayments and Material Deficiencies. If, as a 
result of these engagements, [Provider] or the Independent Re­
view Organization identifies any billing, coding or other policies, 
procedures and/or practices that result in an overpayment, 
[Provider] shall notify the payor (e.g., Medicare fiscal intermedi­
ary or carrier) within 30 days of discovering the deficiency or 
overpayment and take remedial steps within 60 days of discovery 
(or such additional time as may be agreed to by the payor) to 
correct the problem, including preventing the deficiency from 
recurring. The notice to the payor shall include:
a. a statement that the refund is being made pursuant to this 
CIA;
b. a description of the complete circumstances surrounding 
the overpayment;
c. the methodology by which the overpayment was determined;
d. the amount of the overpayment;
e. any claim-specific information used to determine the over­
payment (e.g., beneficiary health insurance number, claim 
number, service date, and payment date);
f. the cost reporting period; and
g. the provider identification number under which the repay­
ment is being made.
If [Provider] determines an overpayment represents a material 
deficiency, contemporaneous with [Provider’s] notification to the 
payor as provided above, [Provider] shall also notify OIG of:
a. a complete description of the material deficiency;
b. amount of overpayment due to the material deficiency;
c. [Provider’s] action(s) to correct and prevent such material 
deficiency from recurring;
d. the payor’s name, address, and contact person where the 
overpayment was sent;
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e. the date of the check and identification number (or elec­
tronic transaction number) on which the overpayment was 
repaid.
For purposes of this CIA, an “overpayment” shall mean the 
amount of money the provider has received in excess of the 
amount due and payable under the Federal health care programs’ 
statutes, regulations or program directives, including carrier and 
intermediary instructions.
For purposes of this CIA, a “material deficiency” shall mean 
anything that involves: (i) a substantial overpayment or improper 
payment relating to the Medicare and/or Medicaid programs; (ii) 
conduct or policies that clearly violate the Medicare and/or Medi­
caid statute, regulations or directives issued by HCFA and/or its 
agents; or (iii) serious quality of care implications for federal 
health care beneficiaries or recipients. A material deficiency may 
be the result of an isolated event or a series of occurrences.
4. Verification/Validation. In the event that the OIG determines 
that it is necessary to conduct an independent review to determine 
whether or the extent to which [Provider] is complying with its 
obligations under this CIA, [Provider] agrees to pay for the rea­
sonable cost of any such review or engagement by the OIG or any 
of its designated agents.
E. Confidential Disclosure Program
Within ninety (90) days after the effective date of this CIA, [Provider] 
shall establish a Confidential Disclosure Program, which must include 
measures (e.g., a toll-free compliance telephone line) to enable employ­
ees, contractors, agents or other individuals to disclose, to the Compli­
ance Officer or some other person who is not in the reporting individual’s 
chain of command, any identified issues or questions associated with 
[Provider’s] policies, practices or procedures with respect to the Federal 
health care program, believed by the individual to be inappropriate. 
[Provider] shall publicize the existence of the hotline (e.g., e-mail to 
employees or post hotline number in prominent common areas).
The Confidential Disclosure Program shall emphasize a non-retribu­
tion, non-retaliation policy, and shall include a reporting mechanism 
for anonymous, confidential communication. Upon receipt of a com­
plaint, the Compliance Officer (or designee) shall gather the infor­
mation in such a way as to elicit all relevant information from the 
individual reporting the alleged misconduct. The Compliance Officer 
(or designee) shall make a preliminary good faith inquiry into the 
allegations set forth in every disclosure to ensure that he or she has 
obtained all of the information necessary to determine whether a 
further review should be conducted. For any disclosure that is suffi­
ciently specific so that it reasonably: (1) permits a determination of 
the appropriateness of the alleged improper practice, and (2) pro­
vides an opportunity for taking corrective action, [Provider] shall 
conduct an internal review of the allegations set forth in such a 
disclosure and ensure that proper follow-up is conducted.
The Compliance Officer shall maintain a confidential disclosure log, 
which shall include a record and summary of each allegation re­
ceived, the status of the respective investigations, and any corrective 
action taken in response to the investigation.
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[Provider] shall not hire or engage as contractors any “Ineligible 
Person.” For purposes of this CIA, an “Ineligible Person” shall be any 
individual or entity who: (i) is currently excluded, suspended, de­
barred or otherwise ineligible to participate in the Federal health 
care programs; or (ii) has been convicted of a criminal offense related 
to the provision of health care items or services and has not been 
reinstated in the Federal health care programs after a period of 
exclusion, suspension, debarment, or ineligibility.
Within ninety (90) days of the effective date of this CIA, [Provider] 
will review its list of current employees and contractors against the 
General Services Administration’s List of Parties Excluded from 
Federal Programs (available through the Internet at 
http://www.amet.gov/epls) and the HHS/OIG Cumulative Sanction 
Report (available through the Internet at http://www.dhhs.gov/pro- 
gorg/oig) to ensure that it is not currently employing or contracting 
with any Ineligible Person. Thereafter, [Provider] will review the list 
once semi-annually to ensure that no current employees or contrac­
tors are or have become Ineligible Persons.
To prevent hiring or contracting with any Ineligible Person, 
[Provider] shall screen all prospective employees and prospective 
contractors prior to engaging their services by (i) requiring appli­
cants to disclose whether they are Ineligible Persons, and (ii) 
reviewing the General Services Administration’s List of Parties 
Excluded from Federal Programs (available through the Internet at 
http://www.amet.gov/epls) and the HHS/OIG Cumulative Sanction 
Report (available through the Internet at http://www.dhhs.gov/ 
progorg/oig).
I f  [Provider] has notice that an employee or agent is charged with a 
criminal offense related to any Federal health care program, or is 
suspended or proposed for exclusion during his or her employment 
or contract with [Provider], within 10 days of receiving such notice 
[Provider] will remove such employee from responsibility for, or 
involvement with, [Provider’s] business operations related to the 
Federal health care programs until the resolution of such criminal 
action, suspension, or proposed exclusion. I f  [Provider] has notice 
that an employee or agent has become an Ineligible Person, 
[Provider] will remove such person from responsibility for, or involve­
ment with, [Provider’s] business operations related to the Federal 
health care programs and shall remove such person from any position 
for which the person’s salary or the items or services rendered, 
ordered, or prescribed by the person are paid in whole or in part, 
directly or indirectly, by Federal health care programs or otherwise 
with Federal funds at least until such time as the person is reinstated 
into participation in the Federal health care programs.
G. Notification of Proceedings
Within thirty (30) days of discovery, [Provider] shall notify OIG, in 
writing, of any ongoing investigation or legal proceeding conducted 
or brought by a governmental entity or its agents involving an 
allegation that [Provider] has committed a crime or has engaged in 
fraudulent activities or any other knowing misconduct. This notifi­
cation shall include a description of the allegation, the identity of the
F. Ineligible Persons
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investigating or prosecuting agency, and the status of such investi­
gation or legal proceeding. [Provider] shall also provide written 
notice to OIG within thirty (30) days of the resolution of the matter, 
and shall provide OIG with a description of the findings and/or 
results of the proceedings, if any.
H. Reporting
1. Credible evidence of misconduct. If [Provider] discovers credible 
evidence of misconduct from any source and, after reasonable in­
quiry, has reason to believe that the misconduct may violate criminal, 
civil, or administrative law concerning [Provider’s] practices relating 
to the Federal health care programs, then [Provider] shall 
promptly report the probable violation of law to OIG. Defendants 
shall make this disclosure as soon as practicable, but, not later 
than thirty (30) days after becoming aware of the existence of the 
probable violation. The [Provider’s] report to OIG shall include:
a. the findings concerning the probable violation, including 
the nature and extent of the probable violation;
b. [Provider’s] actions to correct such probable violation; and
c. any further steps it plans to take to address such probable 
violation and prevent it from recurring.
To the extent the misconduct involves an overpayment, the report 
shall include the information listed in section III.D.3 regarding 
material deficiencies.
2. Inappropriate Billing. If [Provider] discovers inappropriate or 
incorrect billing through means other than the Independent Re­
view Organization’s engagement, the provider shall follow proce­
dures in section III.D.3 regarding overpayments and material 
deficiencies.
IV. New Locations
In the event that [Provider] purchases or establishes new business units 
after the effective date of this CIA, [Provider] shall notify OIG of this fact within 
thirty (30) days of the date of purchase or establishment. This notification shall 
include the location of the new operation(s), phone number, fax number, 
Federal health care program provider number(s) (if any), and the corresponding 
payor(s) (contractor specific) that has issued each provider number. All employ­
ees at such locations shall be subject to the requirements in this CIA that apply 
to new employees (e.g., completing certifications and undergoing training).
V. Implementation and Annual Reports
A  Implementation Report
Within one hundred and twenty (120) days after the effective date of 
this CIA, [Provider] shall submit a written report to OIG summariz­
ing the status of its implementation of the requirements of this CIA. 
This Implementation Report shall include:
1. the name, address, phone number and position description of the 
Compliance Officer required by section III.A;
2. the names and positions of the members of the Compliance Com­
mittee required by section III.A;
3. a copy of [Provider’s] Code of Conduct required by section III.B.1;
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4. the summary of the Policies and Procedures required by section
III.B.2;
5. a description of the training programs required by section III.C 
including a description of the targeted audiences and a schedule 
of when the training sessions were held;
6. a certification by the Compliance Officer that:
a. the Policies and Procedures required by section III.B have 
been developed, are being implemented, and have been 
distributed to all pertinent employees;
b. all employees have completed the Code of Conduct certifi­
cation required by section III.B.1; and;
c. all employees have completed the training and executed 
the certification required by section III.C;
7. a description of the confidential disclosure program required by 
section III.E;
8. the identity of the Independent Review Organization(s) and the 
proposed start and completion date of the first audit; and
9. a summary of personnel actions taken pursuant to section III.F.
B. Annual Reports
[Provider] shall submit to OIG an Annual Report with respect to the
status and findings of [Provider’s] compliance activities. The Annual
Reports shall include:
1. any change in the identity or position description of the Compli­
ance Officer and/or members of the Compliance Committee de­
scribed in section III.A;
2. a certification by the Compliance Officer that:
а. all employees have completed the annual Code of Conduct 
certification required by section III.B.1; and
b. all employees have completed the training and executed 
the certification required by section III.C;
3. notification of any changes or amendments to the Policies and 
Procedures required by section III.B and the reasons for such 
changes (e.g., change in contractor policy);
4. a complete copy of the report prepared pursuant to the Inde­
pendent Review Organization’s billing and compliance engage­
ment, including a copy of the methodology used;
5. [Provider’s] response/corrective action plan to any issues raised 
by the Independent Review Organization;
6. a summary of material deficiencies reported throughout the 
course of the previous twelve (12) months pursuant to III.D.3 and
III.H;
7. a report of the aggregate overpayments that have been returned 
to the Federal health care programs that were discovered as a 
direct or indirect result of implementing this CIA. Overpayment 
amounts should be broken down into the following categories: 
Medicare, Medicaid (report each applicable state separately) and 
other Federal health care programs;
AAG-HCO APP D
256 Health Care Organizations
8. a copy of the confidential disclosure log required by section III.E;
9. a description of any personnel action (other than hiring) taken by 
[Provider] as a result of the obligations in section III.F;
10. a summary describing any ongoing investigation or legal proceed­
ing conducted or brought by a government entity involving an 
allegation that [Provider] has committed a crime or has engaged 
in fraudulent activities, which have been reported pursuant to 
section III.G. The statement shall include a description of the 
allegation, the identity of the investigating or prosecuting agency, 
and the status of such investigation, legal proceeding or requests 
for information;
11. a corrective action plan to address the probable violations of law 
identified in section III.H; and
12. a listing of all of the [Provider’s] locations (including locations and 
mailing addresses), the corresponding name under which each 
location is doing business, the corresponding phone numbers and 
fax numbers, each location’s Federal health care program 
provider identification number(s) and the payor (specific contrac­
tor) that issued each provider identification number.
The first Annual Report shall be received by the OIG no later than 
one year and thirty (30) days after the effective date of this CIA. 
Subsequent Annual Reports shall be submitted no later than the 
anniversary date of the due date of the first Annual Report.
C. Certifications
The Implementation Report and Annual Reports shall include a certi­
fication by the Compliance Officer under penalty of perjury, that: (1) 
[Provider] is in compliance with all of the requirements of this CIA, to 
the best of his or her knowledge; and (2) the Compliance Officer has 
reviewed the Report and has made reasonable inquiry regarding its 
content and believes that, upon such inquiry, the information is accurate 
and truthful.
VI. Notifications and Submission of Reports
Unless otherwise stated in writing subsequent to the effective date of this 
CIA, all notifications and reports required under this CIA shall be submitted 
to the entities listed below:
OIG: Civil Recoveries Branch—Compliance Unit 
Office of Counsel to the Inspector General 
Office of Inspector General 
U.S. Department of Health and Human Services 
Cohen Building, Room 5527 
330 Independence Avenue, SW 
Washington, DC 20201 
Phone 202-619-2078; Fax 202-205-0604
[Provider]:
[Address and Telephone number of Provider’s Compliance Contact]
VII. OIG Inspection, Audit and Review Rights
In addition to any other rights OIG may have by statute, regulation, or 
contract, OIG or its duly authorized representative(s), may examine 
[Provider’s] books, records, and other documents and supporting materials for
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the purpose of verifying and evaluating: (a) [Provider’s] compliance with the 
terms of this CIA; and (b) [Provider’s] compliance with the requirements of the 
Federal health care programs in which it participates. The documentation 
described above shall be made available by [Provider] to OIG or its duly authorized 
representative(s) at all reasonable times for inspection, audit or reproduction. 
Furthermore, for purposes of this provision, OIG or its duly authorized repre- 
sentative(s) may interview any of [Provider’s] employees who consent to be inter­
viewed at the employee’s place of business during normal business hours or at 
such other place and time as may be mutually agreed upon between the 
employee and OIG. [Provider] agrees to assist OIG in contacting and arranging 
interviews with such employees upon OIG’s request. [Provider’s] employees 
may elect to be interviewed with or without a representative of [Provider] present.
VIII. Document and Record Retention
[Provider] shall maintain for inspection all documents and records relating 
to reimbursement from the Federal health care programs or to compliance with 
this CIA one year longer than the term of this CIA (or longer if otherwise 
required by law).
IX. Disclosures
Subject to HHS’s Freedom of Information Act (“FOIA”) procedures, set forth 
in 45 C.F.R. Part 5, the OIG shall make a reasonable effort to notify [Provider] 
prior to any release by OIG of information submitted by [Provider] pursuant to 
its obligations under this CIA and identified upon submission by [Provider] as 
trade secrets, commercial or financial information and privileged and confidential 
under the FOIA rules. [Provider] shall refrain from identifying any information 
as trade secrets, commercial or financial information and privileged and confi­
dential that does not meet the criteria for exemption from disclosure under FOIA.
X. Breach and Default Provisions
[Provider] is expected to fully and timely comply with all of the obligations 
herein throughout the term of this CIA or other time frames herein agreed to.
A  Stipulated Penalties for Failure to Comply with Certain Obligations
As a contractual remedy, [Provider] and OIG hereby agree that failure 
to comply with certain obligations set forth in this CIA may lead to the 
imposition of the following monetary penalties (hereinafter referred to 
as “Stipulated Penalties”) in accordance with the following provisions.
1. A Stipulated Penalty of $2,500 (which shall begin to accrue on the 
day after the date the obligation became due) for each day, 
beginning 120 days after the effective date of this CIA and con­
cluding at the end of the term of this CIA, [Provider] fails to have 
in place any of the following:
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a. a Compliance Officer;
b. a Compliance Committee;
c. a written Code of Conduct;
d. written Policies and Procedures;
e. a training program; and
f . a Confidential Disclosure Program;
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2. A Stipulated Penalty of $2,500 (which shall begin to accrue on the 
day after the date the obligation became due) for each day 
[Provider] fails to meet any of the deadlines to submit the Imple­
mentation Report or the Annual Reports to the OIG.
3. A Stipulated Penalty of $2,000 (which shall begin to accrue on the 
date the failure to comply began) for each day [Provider] :
a. hires or contracts with an Ineligible Person after that 
person has been listed by a federal agency as excluded, 
debarred, suspended or otherwise ineligible for participa­
tion in the Medicare, Medicaid or any other Federal health 
care program (as defined in 42 U.S.C. 1320a7b(f)). This 
Stipulated Penalty shall not be demanded for any time 
period if [Provider] can demonstrate that it did not dis­
cover the person’s exclusion or other ineligibility after 
making a reasonable inquiry (as described in section III.F) 
as to the status of the person;
b. employs or contracts with an Ineligible Person and that 
person: (i) has responsibility for, or involvement with, 
[Provider’s] business operations related to the Federal 
health care programs or (ii) is in a position for which the 
person’s salary or the items or services rendered, ordered, 
or prescribed by the person are paid in whole or in part, 
directly or indirectly, by the Federal health care programs 
or otherwise with Federal funds (this Stipulated Penalty 
shall not be demanded for any time period during which 
[Provider] can demonstrate that it did not discover the 
person’s exclusion or other ineligibility after making a 
reasonable inquiry (as described in III.F) as to the status 
of the person);
c. employs or contracts with a person who: (i) has been 
charged with a criminal offense related to any Federal 
health care program, or (ii) is suspended or proposed for 
exclusion, and that person has responsibility for, or in­
volvement with, [Provider’s] business operations related 
to the Federal health care programs (this Stipulated Pen­
alty shall not be demanded for any time period before 10 
days after [Provider] received notice of the relevant matter 
or after the resolution of the matter).
4. A Stipulated Penalty of $1,500 (which shall begin to accrue on the 
date the [Provider] fails to grant access) for each day [Provider] 
fails to grant access to the information or documentation as 
required in section V of this CIA.
5. A Stipulated Penalty of $1,000 (which shall begin to accrue ten
(10) days after the date that OIG provides notice to [Provider] of 
the failure to comply) for each day [Provider] fails to comply fully 
and adequately with any obligation of this CIA. In its notice to 
[Provider], the OIG shall state the specific grounds for its deter­
mination that the [Provider] has failed to comply fully and ade­
quately with the CIA obligation(s) at issue.
B. Payment of Stipulated Penalties
1. Demand Letter. Upon a finding that [Provider] has failed to 
comply with any of the obligations described in section X.A and
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determining that Stipulated Penalties are appropriate, OIG shall 
notify [Provider] by personal service or certified mail of (a) 
[Provider’s] failure to comply; and (b) the OIG’s exercise of its 
contractual right to demand payment of the Stipulated Penalties 
(this notification is hereinafter referred to as the “Demand Letter”).
Within fifteen (15) days of the date of the Demand Letter, 
[Provider] shall either (a) cure the breach to the OIG’s satisfaction 
and pay the applicable stipulated penalties, or (b ) request a 
hearing before an HHS administrative law judge (“ALJ”) to dis­
pute the OIG’s determination of noncompliance, pursuant to the 
agreed-upon provisions set forth below in section X.D. In the event 
[Provider] elects to request an ALJ hearing, the Stipulated Pen­
alties shall continue to accrue until [Provider] cures, to the OIG’s 
satisfaction, the alleged breach in dispute. Failure to respond to 
the Demand Letter in one of these two manners within the allowed 
time period shall be considered a material breach of this CIA and 
shall be grounds for exclusion under section X.C.
2. Timely Written Requests for Extensions. [Provider] may submit a 
timely written request for an extension of time to perform any act 
or file any notification or report required by this CIA. Notwith­
standing any other provision in this section, if OIG grants the 
timely written request with respect to an act, notification, or 
report, Stipulated Penalties for failure to perform the act or file 
the notification or report shall not begin to accrue until one day 
after [Provider] fails to meet the revised deadline as agreed to by 
the OIG-approved extension. Notwithstanding any other provi­
sion in this section, if OIG denies such a timely written request, 
Stipulated Penalties for failure to perform the act or file the 
notification or report shall not begin to accrue until two (2) 
business days after [Provider] receives OIG’s written denial of 
such request. A “timely written request” is defined as a request in 
writing received by OIG at least five (5) business days prior to the 
date by which any act is due to be performed or any notification 
or report is due to be filed.
3. Form of Payment. Payment of the Stipulated Penalties shall be 
made by certified or cashier’s check, payable to “Secretary of the 
Department of Health and Human Services,” and submitted to 
OIG at the address set forth in section VI.
4. Independence from Material Breach Determination. Except as 
otherwise noted, these provisions for payment of Stipulated Pen­
alties shall not affect or otherwise set a standard for the OIG’s 
determination that [Provider] has materially breached this CIA, 
which decision shall be made at the OIG’s discretion and governed 
by the provisions in section X.C, below.
C. Exclusion for Material Breach o f  this CIA
1. Notice of Material Breach and Intent to Exclude. The parties 
agree that a material breach of this CIA by [Provider] constitutes 
an independent basis for [Provider’s] exclusion from participation 
in the Federal health care programs (as defined in 42 U.S.C. 
1320a7b(f)). Upon a determination by OIG that [Provider] has 
materially breached this CIA and that exclusion should be im­
posed, the OIG shall notify [Provider] by certified mail of (a) 
[Provider’s] material breach; and (b) OIG’s intent to exercise its
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contractual right to impose exclusion (this notification is herein­
after referred to as the “Notice of Material Breach and Intent to 
Exclude”).
2. Opportunity to Cure. [Provider] shall have thirty-five (35) days 
from the date of the Notice of Material Breach and Intent to 
Exclude Letter to demonstrate to the OIG’s satisfaction that:
a. [Provider] is in full compliance with this CIA;
b. the alleged material breach has been cured; or
c. the alleged material breach cannot be cured within the 
35-day period, but that: (i) [Provider] has begun to take 
action to cure the material breach, (ii) [Provider] is pursu­
ing such action with due diligence, and (iii) [Provider] has 
provided to OIG a reasonable timetable for curing the 
material breach.
3. Exclusion Letter. I f  at the conclusion of the thirty-five (35) day 
period, [Provider] fails to satisfy the requirements of section
X.C.2, OIG may exclude [Provider] from participation in the 
Federal health care programs. OIG will notify [Provider] in writ­
ing of its determination to exclude [Provider] (this letter shall be 
referred to hereinafter as the “Exclusion Letter”). Subject to the 
Dispute Resolution provisions in section X.D, below, the exclusion 
shall go into effect thirty (30) days after the date of the Exclusion 
Letter. The exclusion shall have national effect and will also apply 
to all other federal procurement and non-procurement programs. 
I f  [Provider] is excluded under the provisions of this CIA, 
[Provider] may seek reinstatement pursuant to the provisions at 
42 C.F.R. §§1001.3001-3004.
4. Material Breach. A material breach of this CIA means:
a. a failure by [Provider] to report a material deficiency, take 
corrective action and pay the appropriate refunds, as pro­
vided in section III.D;
b. repeated or flagrant violations of the obligations under 
this CIA, including, but not limited to, the obligations 
addressed in section X.A of this CIA;
c. a failure to respond to a Demand Letter concerning the 
payment of Stipulated Penalties in accordance with sec­
tion X.B above; or
d. a failure to retain and use an Independent Review Organi­
zation for review purposes in accordance with section III.D.
D. Dispute Resolution
1. Review Rights. Upon the OIG’s delivery to [Provider] of its De­
mand Letter or of its Exclusion Letter, and as an agreed-upon 
contractual remedy for the resolution of disputes arising under 
the obligation of this CIA, [Provider] shall be afforded certain 
review rights comparable to the ones that are provided in 42 
U.S.C. §§1320a7(f) and 42 C.F.R. §1005 as if they applied to the 
Stipulated Penalties or exclusion sought pursuant to this CIA. 
Specifically, the OIG’s determination to demand payment of 
Stipulated Penalties or to seek exclusion shall be subject to review
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by an ALJ and, in the event of an appeal, the Departmental Appeals 
Board (“DAB”), in a manner consistent with the provisions in 42
C.F.R. §§1005.2-.21. Notwithstanding the language in 42 C.F.R. 
§1005.2(c), the request for a hearing involving stipulated penalties 
shall be made within fifteen (15) days of the date of the Demand 
Letter and the request for a hearing involving exclusion shall be 
made within thirty (30) days of the date of the Exclusion Letter.
2. Stipulated Penalties Review. Notwithstanding any provision of 
Title 42 of the United States Code or Chapter 42 of the Code of 
Federal Regulations, the only issues in a proceeding for stipulated 
penalties under this CIA shall be (a) whether [Provider] was in full 
and timely compliance with the obligations of this CIA for which the 
OIG demands payment; and (b) the period of noncompliance. 
[Provider] shall have the burden of proving its full and timely 
compliance and the steps taken to cure the noncompliance, if any. If 
the A U  finds for the OIG with regard to a finding of a breach of this 
CIA and orders [Provider] to pay Stipulated Penalties, such Stipu­
lated Penalties shall become due and payable twenty (20) days after 
the A U  issues such a decision notwithstanding that [Provider] may 
request review of the A U  decision by the DAB.
3. Exclusion Review. Notwithstanding any provision of Title 42 of 
the United States Code or Chapter 42 of the Code of Federal 
Regulations, the only issues in a proceeding for exclusion based 
on a material breach of this CIA shall be (a) whether [Provider] 
was in material breach of this CIA; (b) whether such breach was 
continuing on the date of the Exclusion Letter; and (c) the alleged 
material breach cannot be cured within the 35-day period, but that
(i) [Provider] has begun to take action to cure the material breach,
(ii) [Provider] is pursuing such action with due diligence, and (iii) 
[Provider] has provided to OIG a reasonable timetable for curing 
the material breach.
For purposes of the exclusion herein, exclusion shall take effect 
only after an A U  decision that is favorable to the OIG. [Provider’s] 
election of its contractual right to appeal to the DAB shall not 
abrogate the OIG’s authority to exclude [Provider] upon the issu­
ance of the ALJ’s decision. If  the A U  sustains the determination 
of the OIG and determines that exclusion is authorized, such 
exclusion shall take effect twenty (20) days after the A U  issues 
such a decision, notwithstanding that [Provider] may request 
review of the ALJ decision by the DAB.
4. Finality of Decision. The review by an A U  or DAB provided for 
above shall not be considered to be an appeal right arising under 
any statutes or regulations. Consequently, the parties to this CIA 
agree that the DAB’s decision (or the ALJ’s decision if  not ap­
pealed) shall be considered final for all purposes under this CIA 
and [Provider] agrees to waive any right it may have to appeal the 
decision administratively, judicially or otherwise seek review by 
any court or other adjudicative forum.
XI. Effective and Binding Agreement
Consistent with the provisions in the Settlement Agreement pursuant to 
which this CIA is entered, and into which this CIA is incorporated, [Provider] 
and OIG agree as follows:
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a. This CIA shall be binding on the successors, assigns and transferees 
of [Provider];
b. This CIA shall become final and binding on the date the final 
signature is obtained on the CIA;
c. Any modifications to this CIA shall be made with the prior written 
consent of the parties to this CIA; and
d. The undersigned [Provider] signatories represent and warrant that 
they are authorized to execute this CIA. The undersigned OIG 
signatory represents that he is signing this CIA in his official capac­
ity and that he is authorized to execute this CIA.
On Behalf of [Provider]
[Please identify all signatories]
[Date]
[Date]
[Date]
ON BEHALF OF THE OFFICE OF INSPECTOR GENERAL 
OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Lewis Moris [Date]
Assistant Inspector General for Legal Affairs 
Office of Inspector General 
U.S. Department of Health and Human Services
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Appendix B 
Sample Statement of Management's Assertions
[Date]
In connection with the Corporate Integrity Agreement (CIA) entered into with 
the Office of the Inspector General of the United States Department of Health 
and Human Services dated [date], we make the following assertions, which are 
true to the best of our knowledge and belief.
Governance
Within 90 days of the date of the CIA, we—
1. Established a Compliance Committee, which meets at least monthly 
and requires a quorum to meet.
2. Appointed to our Compliance Committee members who include at a 
minimum those individuals specified in the CIA.
3. Delegated to the Compliance Committee the authority to implement 
and monitor the CIA, as evidenced by the organization chart or the 
Compliance Committee’s charter.
4. Appointed a compliance officer, who reports directly to the individual 
specified in the CIA.
We appointed a compliance officer who—
1. Has sufficient staff and resources to carry out his or her responsibilities.
2. Actively participates in compliance training.
3. Has authority to conduct full and complete internal investigations 
without restriction.
4. Periodically revises the compliance program to meet changing cir­
cumstances and risks.
Billing Practices, Policies, and Procedures
Although no system of internal controls can provide absolute assurance that 
all bills comply in all respects with Medicare, Medicaid, and other federal 
health care program guidelines, we are not aware of any material weaknesses 
in our billing practices, policies, and procedures. Billings to third-party payors 
comply in all material respects with applicable coding principles and laws and 
regulations (including those dealing with Medicare and Medicaid antifraud and 
abuse) and only reflect charges for goods and services that were medically 
necessary, properly approved by regulatory bodies (e.g., the Food and Drug 
Administration), if  required and properly rendered. [Insert other assertions as 
necessary to address matters covered in the CIA.] Any Medicare, Medicaid, and 
other federal health program billing deficiencies that we identified have been 
properly reported to the applicable payor within 60 days of discovery of the 
deficiency.
Corporate Integrity Policy
1. Our policy was developed and implemented within [number] days of 
execution of the CIA.
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2. The policy addresses the Company’s commitment to preparation and 
submission of accurate billings consistent with the standards set 
forth in federal health care program statutes, regulations, proce­
dures and guidelines or as otherwise communicated by Health Care 
Financing Administration (HCFA), its agents or any other agency 
engaged in the administration of the applicable federal health care 
program.
3. The policy addressed the specific issues that gave rise to the settle­
ment, as well as other risk areas identified by the OIG in published 
Fraud Alerts issued through [date].
4. Further details on the development and implementation of our policy 
were provided to the OIG in our letter dated [date].
5. Our policy was distributed to all employees, physicians and inde­
pendent contractors involved in submitting or preparing requests for 
reimbursement.
6. We have prominently displayed a copy of our policy on the Company’s 
premises.
Information and Education Program
As discussed more fully in our letter to the OIG dated [date], we conducted an 
Information and Education Program within [number] days of the CIA. The 
Information and Education Program requires that each officer, employee, agent 
and contractor charged with administering federal health care programs (in­
cluding, but not limited to billers, coders, nurses, physicians, medical records, 
hospital administration and other individuals directly involved in billing fed­
eral health care programs) receive at least [number] hours of training.
The training provided to employees involved in billing, coding, and/or charge 
capture consisted of instructions on submitting accurate bills, the personal 
obligations of each individual to ensure billings are accurate, the nature of 
company-imposed disciplinary actions on individuals who violate company 
policies and/or laws and regulations, applicable federal health care program 
rules, legal sanctions against the company for submission of false or fraudulent 
information, and how to report potential abuses or fraud. The training material 
addresses those issues underlying our settlement with the OIG.
The experience of the trainers is consistent with the topics presented.
Confidential Disclosure Program
Our Confidential Disclosure Program—
1. Was established within [number] days of the CIA.
2. Enables any employee to disclose any practices or billing procedures 
relating to federal health care programs.
3. Provides a toll-free telephone line maintained by the Company, 
which Company representatives have indicated is maintained 
twenty-four hours a day, seven days a week, for the purpose of 
making any disclosures regarding compliance with the Company’s 
Compliance Program, the obligations in the CIA, and Company’s 
overall compliance with federal and state standards.
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4. Includes policies requiring the review of any disclosures to permit a 
determination of the appropriateness of the billing practice alleged 
to be involved and any corrective action to be taken to ensure that 
proper follow-up is conducted.
5. A detailed summary of the communications (including the number 
of disclosures by employees and the dates of such disclosures) con­
cerning billing practices reported as, and found to be, inappropriate 
under the Confidential Disclosure Program, and the results of any 
internal review and the follow-up on such disclosures are summa­
rized in Attachment [title] to our Annual Report.
Excluded Individuals or Entities
Company policy—
1. Prohibits the employment of or contracting with an individual or 
entity that is listed by a federal agency as convicted of abuse or 
excluded, suspended or otherwise ineligible for participation in fed­
eral health care programs.
2. Includes a process to make an inquiry into the status of any potential 
employee or independent contractor.
3. Provides for an annual review of the status of all existing employees 
and contractors to verify whether any individual had been suspended 
or excluded or charged with a criminal offense relating to the provi­
sion of federal health care services.
We are not aware of any individuals employed in contravention of the prohibi­
tions in the CIA.
Record Retention
Our record retention policy is consistent with the requirements of the CIA.
Signed by:
[Chief Executive Officer]
[Chief Financial Officer]
[Corporate Compliance Officer]
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Sample Engagement Letter
The following is an illustration of a sample engagement letter that may be used 
for this kind of engagement.
[C P A  F irm  Letterhead]
[Client’s Name and Address]
Dear____________________ :
This will confirm our understanding of the arrangements for our performance 
of certain agreed-upon procedures in connection with management’s compli­
ance with the terms of the Corporate Integrity Agreement (CIA) with the Office 
of Inspector General (OIG) of the U.S. Department of Health and Human 
Services (HHS) dated [date of CIA] for the period ending [date].
We will perform those procedures enumerated in the attachment to this letter. 
Our responsibility is to carry out these procedures and report our findings. We 
will conduct our engagement in accordance with standards established by the 
American Institute of Certified Public Accountants. Our planned procedures 
were agreed to by management and will be communicated to the OIG for its 
review and are based on the terms specified in the CIA. The sufficiency of these 
procedures is solely the responsibility of the specified users of the report. 
Consequently, it is understood that we make no representation regarding the 
sufficiency of the procedures described in the attachment for the purpose for 
which this report has been requested or for any other purpose.
Management is responsible for the Company’s compliance with all applicable 
laws, regulations, and contracts and agreements, including the CIA. Manage­
ment also is responsible for the design, implementation, and monitoring of the 
policies and procedures upon which compliance is based.
Our engagement to perform agreed-upon procedures is substantially less in 
scope than an examination, the objective of which is the expression of an opinion 
on management’s compliance with the CIA. Accordingly, we will not express 
such an opinion or any other form of assurance thereon.1
1 The independent accountant may wish to include an understanding with the client about any 
limitation or other arrangements regarding liability of the practitioner or the client in the engage­
ment letter. For example, the following might be included in the letter:
Our maximum liability relating to services rendered under this letter (regardless of form of 
action, whether in contract, negligence or otherwise) shall be limited to the charges paid to us 
for the portion of the services or work products giving rise to liability. We will not be liable for 
consequential or punitive damages (including lost profits or savings) even if aware of their 
possible existence.
You will indemnify us against any damage or expense that may result from any third-party 
claim relating to our services or any use by you of any work product, and you will reimburse 
us for all expenses (including counsel fees) as incurred by us in connection with any such claim, 
except to the extent such claim (i) is finally determined to have resulted from our gross negli­
gence or willfu l misconduct or (ii) is covered by any of the preceding indemnities.
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Working papers that are prepared in connection with this engagement are the 
property of the independent accountant. The working papers are prepared for 
the purpose of providing the principal support for the independent accountant’s 
report. At the completion of our work, we expect to issue an agreed-upon 
procedures report in the attached form.
If, however, we are not able to complete all of the specified procedures, we will 
so advise you. At that time, we will discuss with you the form of communication, 
if any, that you desire for our findings. We will ask you to confirm your request 
in writing at that time. If  you request that we delay issuance of our report until 
corrective action is taken that will result in compliance with all aspects of the 
CIA, we will do so only at your written request. Our working papers will be 
retained in accordance with our firm’s working paper retention policy.
The distribution of the independent accountant’s report will be restricted to the 
governing board and management of the Company and the OIG.
Our fees will be billed as work progresses and are based on the amount of time 
required at various levels of responsibility plus actual out-of-pocket expenses. 
Invoices are payable upon presentation. We will notify you immediately of any 
circumstances we encounter that could significantly affect our initial estimate 
of total fees.
We agree that to the extent required by law, we will allow the Comptroller General 
of the United States, HHS, and their duly authorized representatives to have access 
to this engagement letter and our documents and records to the extent necessary 
to verify the nature and amount of costs of the services provided to the Company, 
until the expiration of four years after we have concluded providing services to the 
Company that are performed pursuant to this Engagement Letter. In the event 
the Comptroller General, HHS, or their duly authorized representatives request 
such records, we agree to notify the Company of such request as soon as practicable.
In the event we are requested or authorized by the Company or are required by 
government regulation, subpoena, or other legal process to produce our documents 
or our personnel as witnesses with respect to our engagements for the Company, 
the Company will, so long as we are not a parly to the proceeding in which the 
information is sought, reimburse us for our professional time and expenses, as well 
as the fees and expenses of our counsel, incurred in responding to such requests.
I f  this letter correctly expresses your understanding of this engagement, please 
sign the enclosed copy where indicated and return it to us. We appreciate the 
opportunity to serve you.
Sincerely,_____________________________
[Partner’s Signature]
[Firm Name or Firm Representative]
Accepted and agreed to:________________
[Client Representative’s Signature]
[Title]________________________________
[Date]___________________________ _____
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Sample Procedures
Procedure______________________________________
Governance
1. We read the Company’s corporate minutes and 
organization chart and ascertained that, within 
[number] days of the date of the Corporate Integ­
rity Agreement (CIA), the Company—
a. Established a Compliance Committee, which 
is to meet meets at least monthly and requires 
a quorum to meet.
b. Appointed to its Compliance Committee 
members who include, at a minimum, those 
individuals specified in the CIA.
c. Delegated to the Compliance Committee the 
authority to implement and monitor the CIA, 
as evidenced by the organization chart or the 
Compliance Committee’s charter.
d. Appointed a compliance officer who reports 
directly to the individual specified in the CIA.
2. We interviewed the compliance officer and were 
informed that, in his or her opinion, the Compli­
ance Officer—
a. Has sufficient staff and resources to carry out 
his or her responsibilities.
b. Actively participates in compliance training.
c. Has the authority to conduct full and complete 
internal investigations without restriction.
d. Periodically revises the compliance program 
to meet changing circumstances and risks.
3. We read the OIG notification letter as specified in 
the CIA and noted that the appropriate official 
signed the letter, that it was addressed to the OIG, 
that it covered items (a) through (d ) in Step 1, and 
that it was dated within [number of] days of the 
execution of the CIA.
Billing Practices, Policies, and Procedures
The practitioner might be engaged to provide consulting 
services in connection with the evaluation of the Com­
pany’s billing practices, policies, and procedures. If  so, 
generally no agreed-upon procedures would be per­
formed relating to this area.
Alternatively, if the procedures relating to the Com­
pany’s billing practices, policies, and procedures are 
performed by others such as the Company’s internal 
audit staff, the practitioner performs Steps 4 through 9.
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4. We read the compliance work plan and noted the 
following:
а. The work plan’s stated objectives include the 
determination that billings are accurate and 
complete, for services rendered that have been 
deemed by medical specialists as being 
necessary, and are submitted in accordance 
with federal program guidelines.
b. The work plan sampling methodology sets 
confidence levels consistent with those defined 
in the CIA.
c. The work plan identifies risk areas, as defined 
in the CIA (if applicable), and specifies testing 
procedures by risk area.
d. The work plan specifies that samples are 
taken in risk areas (if applicable) identified by 
the CIA.
e. The work plan includes testing procedures, 
which the practitioner should modify as 
required by the CIA, for the following risks 
areas (if applicable) identified in the CIA:
(1) Clinical documentation, as follows:
(i) No documentation of service
(ii) Insufficient documentation of service
(iii) Improper diagnosis or treatment 
plan giving rise to the provision of a 
medically unnecessary service or 
treatment
(iv) Service or treatment does not conform 
medically with the documented 
diagnosis or treatment plan
(v) Services incorrectly coded
(2) Billing and coding, as follows:
(i) Noncovered or unallowable service
(ii) Duplicate payment
(iii) DRG window error
(iv) Unbundling
(v) Utilization
(vi) Medicare credit balances
[Note to Practitioner: Modify the preceding list as 
required by the CIA.]
5. We selected [quantity] probe samples performed by 
the independent review organization for the 
following risk areas [list risk areas tested]. For the 
probe samples selected, we noted that the—
а. Sample patient billing files were randomly 
selected.
b. Sample size reflected confidence levels 
specified in the CIA.
c. Sample plan describes how missing items (if 
any) would be treated.
Procedure____________________________________ Findings
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d. Patient billing files tested were pulled per the 
listing of random numbers and all patient 
billing files were accounted for in the working 
papers.
e. Work plans for the specific sample described 
the risk areas (if applicable) being tested and 
the testing approach/procedures.
f. Working papers noted the completion of each 
work plan step.
g. Working papers contained a summary of 
findings for the sample.
6. We reperformed the work plan steps [list of specific 
steps performed] for the sample patient billing 
files. The reperformance of work plan steps related 
to the medical review of the sample patient billing 
files was performed by the following individuals 
[note the professional qualifications of individuals 
without listing names]. Any exceptions between 
our findings and the Company’s are summarized 
in the Attachment to this report.
7. We read the summary findings of all internal 
compliance reviews that the Company’s Internal 
Audit department indicated it had performed for 
the Company and noted that all material billing 
deficiencies [specify material threshold as defined 
by the Company] noted therein were discussed in 
written communications addressed to the appro­
priate payor (for example, Medicare Part B carrier) 
and were dated within 60 days from the time the 
deficiency occurred.1
8. We inquired of [individual] as to whether the 
Company took remedial steps within [number of] 
days (or such additional time as agreed to by the 
payor) to correct all material billing deficiencies 
noted in Step 7. We were informed that such 
remedial steps had been taken.
9. By reading applicable correspondence, we noted 
that any material billing deficiencies noted in Step 
7 were communicated to the OIG, including 
specific findings relative to the deficiency, the 
Company’s actions taken to correct the deficiency, 
and any further steps the Company plans to take 
to prevent any similar deficiencies from recurring.
270 Health Care Organizations
1 The CIA provides its own legal definition of a “material deficiency.” Determination of whether 
a billing or other act meets this definition is normally beyond the auditor’s professional competence 
and may have to await final determination by a court of law. Accordingly, to avoid confusion, a 
working definition different from that provided in the CIA (e.g., a specified dollar threshold) may be 
necessary.
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Corporate Integrity Policy
10. We read the Company’s Corporate Integrity Policy 
and noted the following.
a. The policy was developed and implemented 
within [number of] days of execution of the 
CIA.
b. The policy addressed the Company’s commit­
ment to preparation and submission of ac­
curate billings consistent with the standards 
set forth in federal health care program 
statutes, regulations, procedures, and 
guidelines or as otherwise communicated by 
HCFA, its agents, or any other agency 
engaged in the administration of the 
applicable federal health care program.
c. The policy addressed the specific issues that 
gave rise to the settlement, as well as other 
risk areas identified by the OIG in published 
Fraud Alerts issued through [agency].
d. Correspondence addressed to the OIG covered 
the development and implementation of the 
policy.
e. Documentation indicating that the policy was 
distributed to all employees, physicians, and 
independent contractors involved in submit­
ting or preparing requests for reimbursement.
f. The prominent display of a copy of the policy 
on the Company’s premises.
11. We selected a sample of ten employees (involved in 
submitting and preparing requests for reimburse­
ment) and examined written confirmation in the 
employee’s personnel file indicating receipt of a 
copy of the Corporate Integrity Policy.
Information and Education Program
12. We read the Company’s Information and Educa­
tion Program and noted the following.
a. The Information and Education Program 
agenda was dated within [number of] days of 
execution of the CIA.
b. Correspondence covering the development 
and implementation of the Information and 
Education Program was addressed to the OIG.
c. The Information and Education Program re­
quires that each officer, employee, agent, and 
contractor charged with administering federal 
health care programs (including, but not 
limited to billers, coders, nurses, physicians, 
medical records, hospital administration and 
other individuals directly involved in billing 
federal health care programs) receive at least 
[number of] hours of training.
Procedure____________________________________ Findings
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13. We selected a sample of ten employees involved in 
billing, coding and/or charge capture and ex­
amined sign-in logs of the training classes and 
noted that each had signed indicating that they 
had received at least [number of] hours of training 
as specified in the Information and Education Pro­
gram. We also reviewed tests and surveys com­
pleted by each of the ten trained employees noting 
evidence that they were completed.
14. We inquired as to the training of individuals not 
present during the regularly scheduled training 
programs and were informed that each such indi­
vidual is trained either individually or in a separ­
ate make-up session. We inquired as to the names 
of individuals not initially present and selected one 
such individual and examined that individual’s 
post-training test and survey for completion.
15. We read the course agenda and noted that the 
training provided to employees involved in billing, 
coding, and/or charge capture consisted of 
instructions on submitting accurate bills, the 
personal obligations of each individual to ensure 
billings are accurate, the nature of company- 
imposed disciplinary actions on individuals who 
violate company policies and/or laws and regula­
tions applicable to federal health care program 
rules, legal sanctions against the company for sub­
mission of false or fraudulent information, and 
how to report potential abuses or fraud. We also 
noted that the training material addressed the 
following issues which gave rise to the settlement 
[practitioner list].
16. We inquired of the Corporate Compliance Officer 
as to the qualifications and experience of the train­
ers and were informed that, in the Corporate Com­
pliance Officer’s opinion, they were consistent with 
the topics presented.
17. We noted that the Company’s draft Annual Report 
to the OIG dated [date] addresses certification of 
training.
Confidential Disclosure Program
18. We read documentation of the Company’s Confi­
dential Disclosure Program and noted that it—
a. Includes the printed effective date that was 
within [number of] days of execution of the CIA.
b. Consists of a confidential disclosure program 
enabling any employee to disclose any prac­
tices or billing procedures relating to federal 
health care programs.
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c. Provides a toll-free telephone line maintained 
by the Company, which Company representa­
tives have indicated is maintained twenty- 
four hours a day, seven days a week, for the 
purpose of making any disclosures regarding 
compliance with the Company’s Compliance 
Program, the obligations in the CIA, and 
Company’s overall compliance with federal 
and state standards.
d. Includes policies requiring the review of any 
disclosures to permit a determination of the 
appropriateness of the billing practice alleged to 
be involved and any corrective action to be taken 
to ensure that proper follow-up is conducted.
19. We made five test calls to the toll-free telephone 
line (hotline) and noted the following.
a. Each call was captured in the hotline logs and 
reported with all other incoming calls.
b. Anonymity is not discouraged.
20. We noted that the Company included in its draft 
Annual Report addressed to OIG dated [date] a 
detailed summary of the communications (includ­
ing the number of disclosures by employees and the 
dates of such disclosures) concerning billing prac­
tices reported as, and found to be, inappropriate 
under the Confidential Disclosure Program, and 
the results of any internal review and the follow-up 
on such disclosures.
21. We observed the display of the Company’s Confiden­
tial Disclosure Program, including notice of the 
availability of its hotline, on the Company’s premises.
Excluded Individuals or Entities
22. We read the Company’s written policy relating to 
dealing with excluded or convicted persons or 
entities and noted that the policy—
a. Prohibits the hiring of or contracting with an 
individual or entity that is listed by a federal 
agency as convicted of abuse or excluded, sus­
pended, or otherwise ineligible for participa­
tion in federal health care programs.
b. Includes a process to make an inquiry into the 
status of any potential employee or indepen­
dent contractor.
c. Provides for a semi-annual review of the 
status of all existing employees and contrac­
tors to verify whether any individual had been 
suspended or excluded or charged with a cri­
minal offense relating to the provision of 
federal health care services.
Procedure____________________________________ Findings
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23. We selected a sample of ten employees hired over 
the course of the test period as defined in the CIA 
and examined support in the employee’s personnel 
file documenting inquiries made into the status of 
the employee, including documentation of com­
parison to the [source specified in the CIA].
24. We performed the following procedures related to 
the Company’s semi-annual review of employee 
status.
a. Read documentation of the semi-annual re­
view as evidence that a review was performed.
b. Selected and reviewed the lesser of ten or all 
exceptions and determined that such employees 
were removed from responsibility for or involve­
ment with Provider business operations related 
to the Federal health care programs.
c. Examined a notification letter addressed to 
the OIG and dated within 30 days of the em­
ployee’s removal from employment.
d. Inquired of [officer] as to whether he or she 
was aware of any individuals employed in 
contravention of the prohibitions in the CIA. 
If  so, we further noted that [indicate specific 
procedures] to confirm that such situation was 
cured within 30 days by [indicate how situa­
tion was cured].
Annual Report
25. We read the Company’s draft Annual Report dated 
[date] and determined that it included the follow­
ing items, to be modified as appropriate, by the 
practitioner:
a. Compliance Program Charter and organiza­
tion chart
b. Amendments to policies
c. Detailed descriptions of reviews and audits
d. Summary of hotline communications
e. Summary of annual review of employees
f. Cross-referencing to items noted in the CIA
Record Retention
26. We read the Company’s record retention policy and 
noted that it was consistent with the requirements 
as outlined in the CIA.
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Sample Report
Independent Accountant’s Report
[Date]
[Sample Health Care Provider]
Office of Inspector General of the U.S. Department of Health and Human 
Services
We have performed the procedures enumerated in the Attachment, which were 
agreed to by Sample Health Care Provider (Company) and the Office of 
Inspector General (OIG) of the U.S. Department of Health and Human Serv­
ices, solely to assist the users in evaluating management’s assertion about 
[name of entity’s] compliance with the Corporate Integrity Agreement (CIA) 
with the OIG dated [date of CIA] for the [period] ending [date], which is included 
as Attachment A to this report. This agreed-upon procedures engagement was 
performed in accordance with standards established by the American Institute 
of Certified Public Accountants. The sufficiency of these procedures is solely 
the responsibility of the specified users of the report. Consequently, we make 
no representation regarding the sufficiency of the procedures described in 
Attachment B either for the purpose for which this report has been requested 
or for any other purpose.
We were not engaged to and did not perform an examination, the objective of 
which would be the expression of an opinion on management’s compliance with 
the CIA. Accordingly, we do not express such an opinion. Had we performed 
additional procedures, other matters might have come to our attention that 
would have been reported to you.
This report is intended solely for the information and use of the Compliance 
Committee and management of the Company and the OIG, and is not intended 
to be and should not be used by anyone other than those specified parties.
[Include as Attachments the CIA and the summary that enumerates procedures 
and findings.]
[Signature]
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NOTE
This Statement of Position presents the recommendations of the 
AICPA Health Care Third-Party Revenue Recognition Task Force 
with regard to auditing financial statement assertions about third- 
party revenues and related receivables of health care entities. The 
Auditing Standards Board has found the recommendations in this 
Statement of Position to be consistent with existing standards cov­
ered by rule 202 of the AICPA Code of Professional Conduct. AICPA 
members should be prepared to justify departures from the recom­
mendations in this Statement of Position.
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SUMMARY
This Statement of Position (SOP) provides guidance to auditors regarding 
uncertainties inherent in health care third-party revenue recognition. It dis­
cusses auditing matters to consider in testing third-party revenues and related 
receivables, and provides guidance regarding the sufficiency of evidential 
matter and reporting on financial statements of health care entities exposed to 
material uncertainties.
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Auditing Health Care Third-Party 
Revenues and Related Receivables
Introduction and Background
.01 Most health care providers participate in payment programs that pay 
less than full charges for services rendered. For example, some cost-based 
programs retrospectively determine the final amounts reimbursable for serv­
ices rendered to their beneficiaries based on allowable costs. With increasing 
frequency, even non-cost-based programs (such as the Medicare Prospective 
Payment System) have become subject to retrospective adjustments (for exam­
ple, billing denials and coding changes). Often, such adjustments are not known 
for a considerable period of time after the related services were rendered.
.02 The lengthy period of time between rendering services and reaching 
final settlement, compounded further by the complexities and ambiguities of 
reimbursement regulations, makes it difficult to estimate the net patient 
service revenue associated with these programs. This situation has been 
compounded due to the frequency of changes in federal program guidelines.
.03 The AICPA Audit and Accounting Guide Health Care Organizations 
(the Guide) requires that patient revenues be reported net of provisions for 
contractual and other adjustments (paragraph 10.20). As a result, patient 
receivables, including amounts due from third-party payors, are also reported 
net of expected contractual and other adjustments. However, amounts ulti­
mately realizable will not be known until some future date, which may be 
several years after the period in which the services were rendered.
.04 This SOP provides guidance to auditors regarding uncertainties in­
herent in health care third-party revenue recognition. It discusses auditing 
matters to consider in testing third-party revenue and related receivables, 
including the effects of settlements (both cost-based and non-cost-based third- 
party payment programs), and provides guidance regarding the sufficiency of 
evidential matter and reporting on financial statements of health care entities 
exposed to material uncertainties.
Scope and Applicability
.05 This SOP applies to audits of health care organizations falling within 
the scope of the Guide. Its provisions are effective for audits of periods ending 
on or after June 30, 2000. Early application of the provisions of this SOP is 
permitted.
Third-Party Revenues and Related Receivables— 
Inherent Uncertainties
.06 Health care entities need to estimate amounts that ultimately will be 
realizable in order for revenues to be fairly stated in accordance with generally 
accepted accounting principles (GAAP). The basis for such estimates may 
range from relatively straightforward calculations using information that is 
readily available to highly complex judgments based on assumptions about 
future decisions.
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.07 Entities doing business with governmental payors (for example, 
Medicare and Medicaid) are subject to risks unique to the government- 
contracting environment that are hard to anticipate and quantify and that may 
vary from entity to entity. For example—
•  A health care entity’s revenues may be subject to adjustment as a result 
of examination by government agencies or contractors. The audit proc­
ess and the resolution of significant related matters (including disputes 
based on differing interpretations of the regulations) often are not 
finalized until several years after the services were rendered.
•  Different fiscal intermediaries (entities that contract with the federal 
government to assist in the administration of the Medicare program) 
may interpret governmental regulations differently.
•  Differing opinions on a patient’s principal medical diagnosis, including 
the appropriate sequencing of codes used to submit claims for pay­
ment, can have a significant effect on the payment amount.1
•  Otherwise valid claims may be determined to be nonallowable after 
the fact due to differing opinions on medical necessity.
•  Claims for services rendered may be nonallowable if  they are 
later determined to have been based on inappropriate referrals.2
•  Governmental agencies may make changes in program interpreta­
tions, requirements, or “conditions of participation,” some of which 
may have implications for amounts previously estimated.
.08 Such factors often result in retrospective adjustments to interim 
payments. Reasonable estimates of such adjustments are central to the third- 
party revenue recognition process in health care, in order to avoid recognizing 
revenue that the provider will not ultimately realize. The delay between 
rendering services and reaching final settlement, as well as the complexities 
and ambiguities of billing and reimbursement regulations, makes it difficult to 
estimate net realizable third-party revenues.
Management's Responsibilities
.09 Management is responsible for the fair presentation of its financial 
statements in conformity with GAAP. Management also is responsible for 
adopting sound accounting policies and for establishing and maintaining inter­
nal control that will, among other things, record, process, summarize, and 
report transactions (as well as events and conditions) consistent with manage­
ment’s assertions embodied in the financial statements. Despite the inherent 
uncertainties, management is responsible for estimating the amounts recorded 
in the financial statements and making the required disclosures in accordance 
with GAAP, based on management’s analysis of existing conditions.
1 Historically, the Health Care Financing Administration (HCFA) contracted with Peer Review 
Organizations (PROs) to validate the appropriateness of admissions and the clinical coding from 
which reimbursement was determined. Such reviews were typically performed within ninety days of 
the claim submission date. However, the government has modified its policies with respect to such 
reviews and now analyzes coding errors through other means, including in conjunction with investi­
gations conducted by the Office of the Inspector General (OIG) of the U. S. Department of Health and 
Human Services.
2 Effective January 1, 1995, the Limitation on Certain Physician Referrals law prohibited 
physicians from referring Medicare and Medicaid patients to health care organizations with which 
they had a financial relationship for the furnishing of designated health services. Implementing 
regulations have not yet been adopted as of the date of this publication.
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.10 Management’s assertions regarding proper valuation of its revenues 
and receivables are embodied in the financial statements. Management is 
responsible for assuring that revenues are not recognized until their realiza­
tion is reasonably assured. As a result, management makes a reasonable 
estimate of amounts that ultimately will be realized, considering—among 
other things—adjustments associated with regulatory reviews, audits, billing 
reviews, investigations, or other proceedings. Estimates that are significant to 
management’s assertions about revenue include the provision for third-party 
payor contractual adjustments and allowances.
.11 Management also is responsible for preparing and certifying cost 
reports submitted to federal and state government agencies in support of 
claims for payment for services rendered to government program beneficiaries.
The Auditor's Responsibilities
.12 The auditor’s responsibility is to express an opinion on the financial 
statements taken as a whole. In reaching this opinion, the auditor considers 
the evidence in support of recorded amounts. I f  amounts are not known with 
certainty, the auditor considers the reasonableness of management’s estimates 
in the present circumstances. The auditor also considers the fairness of the 
presentation and adequacy of the disclosures made by management.
.13 In planning the audit, the auditor considers current industry condi­
tions, as well as specific matters affecting the entity.3 Among a number of 
things, the auditor’s procedures typically include an analysis of historical 
results (for example, prior fiscal intermediary audit adjustments and compari­
sons with industry benchmarks and norms) that enable the auditor to better 
assess the risk of material misstatements in the current period. When there 
are heightened risks, the auditor performs more extensive tests covering the 
current period. Exhibit 5.1 of the Guide includes a number of examples of 
procedures that auditors may consider.
.14 With respect to auditing third-party revenues, in addition to the usual 
revenue recognition considerations, the auditor considers whether amounts 
ultimately realizable are or should be presently known or are uncertain be­
cause they are dependent on some other future, prospective actions or confirm­
ing events. For example, under a typical fee-for-service contract with a 
commercial payor, if  the provider has performed a service for a covered indi­
vidual, the revenue to which the provider is entitled should be determinable at 
the time the service is rendered. On the other hand, if the service was provided 
under a cost-based government contract, the revenue ultimately collectible 
may not be known until certain future events occur (for example, a cost report 
has been submitted and finalized after desk review or audit). In this case, 
management estimates the effect of such potential future adjustments.
.15 As stated previously, management is responsible for preparing the 
estimates contained in the financial statements. The auditor evaluates the 
adequacy of the evidence supporting those estimates, reviews the facts sup­
porting management’s judgments, and evaluates the judgments made based on 
conditions existing at the time of the audit. The fact that net revenues recorded 
at the time services are rendered differ materially from amounts that ultimately
3 Risk factors, including ones related to legislative and regulatory matters, are discussed 
annually in the AICPA Audit Risk Alert Health Care Industry Developments.
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are realized does not necessarily mean the audit was not properly planned or 
carried out. Similarly, the fact that future events may differ materially from 
management’s assumptions or estimates does not necessarily mean that man­
agement’s estimates were not valid or the auditor did not follow generally 
accepted auditing standards (GAAS) as described in this SOP with respect to 
auditing estimates.
Evidential Matter
.16 The measurement of estimates is inherently uncertain and depends 
on the outcome of future events. Statement on Auditing Standards (SAS) No. 
57, Auditing Accounting Estimates (AICPA, Professional Standards, vol. 1, AU 
sec. 342), and SAS No. 79, Amendment to SAS No. 58, Reports on Audited 
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 508) 
provide guidance to the auditor when the valuation of revenues is uncertain, 
pending the outcome of future events. In the current health care environment, 
conclusive evidence concerning amounts ultimately realizable cannot be ex­
pected to exist at the time of the financial statement audit because the 
uncertainty associated with future program audits, administrative reviews, 
billing reviews, regulatory investigations, or other actions will not be resolved 
until sometime in the future.
.17 The fact that information related to the effects of future program 
audits, administrative reviews, regulatory investigations, or other actions does 
not exist does not lead to a conclusion that the evidential matter supporting 
management’s assertions is not sufficient to support management’s estimates. 
Rather, the auditor’s judgment regarding the sufficiency of the evidential 
matter is based on the evidential matter that is available or can reasonably be 
expected to be available in the circumstances. If, after considering the existing 
conditions and available evidence, the auditor concludes that sufficient eviden­
tial matter supports management’s assertions about the valuation of revenues 
and receivables, and their presentation and disclosure in the financial state­
ments, an unqualified opinion ordinarily is appropriate.
.18 If relevant evidential matter exists that the auditor needs and is 
unable to obtain, the auditor should consider the need to express a qualified 
opinion or to disclaim an opinion because of a scope limitation. For example, if 
an entity has conducted an internal evaluation (for example, of coding or other 
billing matters) under attorney—client privilege and management and its 
legal counsel refuse to respond to the auditor’s inquiries and the auditor 
determines the information is necessary, ordinarily the auditor qualifies his or 
her opinion for a scope limitation.
.19 The auditor considers the reasonableness of management’s assump­
tions in light of the entity’s historical experience and the auditor’s knowledge 
of general industry conditions, because the accuracy of management’s assump­
tions will not be known until future events occur. For certain matters, the best 
evidential matter available to the auditor (particularly as it relates to clinical 
and legal interpretations) may be the representations of management and its 
legal counsel, as well as information obtained through reviewing correspon­
dence from regulatory agencies.
.20 Pursuant to SAS No. 85, Management Representations (AICPA, 
Professional Standards, vol. 1, AU sec. 333), the auditor should obtain written 
representations from management concerning the absence of violations or 
possible violations of laws or regulations whose effects should be considered for 
disclosure in the financial statements or as a basis for recording a loss contin­
gency. Examples of specific representations include the following:
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•  Receivables
— Adequate consideration has been given to, and appropriate provi­
sion made for, estimated adjustments to revenue, such as for 
denied claims and changes to diagnosis-related group (DRG) 
assignments.
— Recorded valuation allowances are necessary, appropriate, and 
properly supported.
— All peer review organizations, fiscal intermediary, and third- 
party payor reports and information have been made available.
•  Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports have been 
properly filed.
— Management is responsible for the accuracy and propriety of all 
cost reports filed.
— All costs reflected on such reports are appropriate and allowable 
under applicable reimbursement rules and regulations and are 
patient-related and properly allocated to applicable payors.
— The reimbursement methodologies and principles employed are 
in accordance with applicable rules and regulations.
— Adequate consideration has been given to, and appropriate provi­
sion made for, audit adjustments by intermediaries, third-party 
payors, or other regulatory agencies.
— All items required to be disclosed, including disputed costs that 
are being claimed to establish a basis for a subsequent appeal, 
have been fully disclosed in the cost report.
— Recorded third-party settlements include differences between 
filed (and to be filed) cost reports and calculated settlements, 
which are necessary based on historical experience or new or 
ambiguous regulations that may be subject to differing interpre­
tations. While management believes the entity is entitled to all 
amounts claimed on the cost reports, management also believes 
the amounts of these differences are appropriate.
•  Contingencies
— There are no violations or possible violations of laws or regula­
tions, such as those related to the Medicare and Medicaid anti- 
fraud and abuse statutes, including but not limited to the 
Medicare and Medicaid Anti-Kickback Statute, Limitations on 
Certain Physician Referrals (the Stark law), and the False Claims 
Act, in any jurisdiction, whose effects should be considered for 
disclosure in the financial statements or as a basis for recording 
a loss contingency other than those disclosed or accrued in the 
financial statements.
— Billings to third-party payors comply in all material respects with 
applicable coding guidelines (for example, ICD-9-CM and CPT-4) 
and laws and regulations (including those dealing with Medicare 
and Medicaid antifraud and abuse), and billings reflect only 
charges for goods and services that were medically necessary; 
properly approved by regulatory bodies (for example, the Food and 
Drug Administration), if required; and properly rendered.
— There have been no communications (oral or written) from regulatory 
agencies, governmental representatives, employees, or others con­
cerning investigations or allegations of noncompliance with laws
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and regulations in any jurisdiction (including those related to the 
Medicare and Medicaid antifraud and abuse statutes), deficien­
cies in financial reporting practices, or other matters that could 
have a material adverse effect on the financial statements.
.21 Management’s refusal to furnish written representations constitutes 
a limitation on the scope of the audit sufficient to preclude an unqualified 
opinion and is ordinarily sufficient to cause an auditor to disclaim an opinion 
or withdraw from the engagement. However, based on the nature of the 
representations not obtained or the circumstances of the refusal, the auditor 
may conclude that a qualified opinion is appropriate.
Potential Departures From GAAP Related to Estimates 
and Uncertainties
.22 In addition to examining the evidence in support of management’s 
estimates, the auditor determines that there has not been a departure from 
GAAP with respect to the reporting of those estimates in the financial state­
ments. Such departures generally fall into one of the following categories:
•  Unreasonable accounting estimates
•  Inappropriate accounting principles
•  Inadequate disclosure
Therefore, in order to render an opinion, the auditor’s responsibility is to 
evaluate the reasonableness of management’s estimates based on present 
circumstances and to determine that estimates are reported in accordance with 
GAAP and adequately disclosed.
.23 As discussed in SAS No. 31, Evidential Matter (AICPA, Professional 
Standards, vol. 1, AU sec. 326), the auditor’s objective is to obtain sufficient 
competent evidential matter to provide him or her with a reasonable basis for 
forming an opinion. As discussed previously, exhibit 5.1 of the Guide provides 
a number of sample procedures that the auditor might consider in auditing an 
entity’s patient revenues and accounts receivable, including those derived from 
third-party payors. For example, the Guide notes that the auditor might “test 
the reasonableness of settlement amounts, including specific and unallocated 
reserves, in light of the payors involved, the nature of the payment mechanism, 
the risks associated with future audits, and other relevant factors.”4
Unreasonable Accounting Estimates
.24 In evaluating the reasonableness of management’s estimates, the 
auditor considers the basis for management’s assumptions regarding the na­
ture of future adjustments and management’s calculations as to the effects of 
such adjustments.5 The auditor cannot determine with certainty whether such 
estimates are right or wrong, because the accuracy of management’s assump­
tions cannot be confirmed until future events occur.
.25 Though difficult to predict, it is reasonable for the auditor to expect 
that management has made certain assumptions (either in detail or in the 
aggregate) in developing its estimates regarding conditions likely to result in 
adjustments. The auditor gathers evidence regarding the reasonableness of the
4 See paragraphs ,25-.28.
5 The lack of such analyses may call into question the reasonableness of recorded amounts.
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estimates (for example, consistency with historical experience and basis of 
management’s underlying assumptions). In evaluating reasonableness, the 
auditor should obtain an understanding of how management developed the 
estimate. Based on that understanding, the auditor should use one or a 
combination of the following approaches:
а. Review and test the process used by management to develop the 
estimate.
b. Develop an independent expectation of the estimate to corroborate 
the reasonableness of management’s estimates.
c. Review subsequent events or transactions occurring prior to comple­
tion of fieldwork (AU sec. 342.10).
.26 Since no one accounting estimate can be considered accurate with 
certainty, the auditor recognizes that a difference between an estimated 
amount best supported by the audit evidence and the estimated amount 
included in the financial statements may be reasonable, and such difference 
would not be considered to be a likely misstatement. However, if the auditor 
believes the estimated amount included in the financial statements is unrea­
sonable, he or she should treat the difference between that estimate and the 
closest reasonable estimate in the range as a likely misstatement and aggre­
gate it with other likely misstatements. The auditor also should consider 
whether the difference between estimates best supported by the audit evidence 
and the estimates included in the financial statements, which are individually 
reasonable, indicate a possible bias on the part of the entity’s management. For 
example, if  each accounting estimate included in the financial statements was 
individually reasonable, but the effect of the difference between each estimate 
and the estimate best supported by the audit evidence was to increase income, 
the auditor should reconsider the reasonableness of the estimates taken as a 
whole (SAS No. 47, Audit Risk and Materiality in Conducting an Audit 
[AICPA, Professional Standards, vol. 1, AU sec. 312.36]).
.27 The auditor recognizes that approaches and estimates will vary from 
entity to entity. Some entities with significant prior experience may attempt 
to quantify the effects of individual potential intermediary or other govern­
mental (for example, the Office of Inspector General and the Department of 
Justice) or private payor adjustments, basing their estimates on very detailed 
calculations and assumptions regarding potential future adjustments. Some 
may prepare cost report6 analyses to estimate the effect of potential adjust­
ments. Others may base their estimates on an analysis of potential adjustments 
in the aggregate, in light of the payors involved; the nature of the payment 
mechanism; the risks associated with future audits; and other relevant factors.
.28 Normally, the auditor considers the historical experience of the entity 
(for example, the aggregate amount of prior cost-report adjustments and previous 
regulatory settlements) as well as the risk of potential future adjustments. The
6 Medicare cost reimbursement is based on the application of highly complex technical rules, 
some of which are ambiguous and subject to different interpretations even among Medicare’s fiscal 
intermediaries. It is not uncommon for fiscal intermediaries to reduce claims for reimbursement that 
were based on management’s good faith interpretations of pertinent laws and regulations. Addition­
ally, the Provider Reimbursement Review Board (PRRB) or the courts may be required to resolve 
controversies regarding the application of certain rules. To avoid recognizing revenues before their 
realization is reasonably assured, providers estimate the effects of such potential adjustments. This 
is occasionally done by preparing a cost report based on alternative assumptions to help estimate 
contractual allowances required by generally accepted accounting principles. The existence of re­
serves or a reserve cost report does not by itself mean that a cost report was incorrectly or 
fraudulently filed.
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fact that an entity currently is not subject to a governmental investigation does 
not mean that a recorded valuation allowance for potential billing adjustments 
is not warranted. Nor do these emerging industry trends necessarily indicate 
that an accrual for a specific entity is warranted.
.29 In evaluating valuation allowances, the auditor may consider the entity’s 
historical experience and potential future adjustments in the aggregate. For 
example, assume that over the past few years after final cost report audits were 
completed, a hospital’s adjustments averaged 3 percent to 5 percent of total filed 
reimbursable costs. Additionally, the hospital is subject to potential billing adjust­
ments, including errors (for example, violations of the three-day window, dis­
charge and transfer issues, and coding errors). Even though specific incidents are 
not known, it may be reasonable for the hospital to estimate and accrue a valuation 
allowance for such potential future retrospective adjustments, both cost-based and 
non-cost-based. Based on this and other information obtained, the auditor may 
conclude that a valuation allowance for the year under audit of 3 percent to 5 
percent of reimbursable costs plus additional amounts for potential non-cost-based 
program billing errors is reasonable.
.30 Amounts that ultimately will be realized by an entity are dependent 
on a number of factors, many of which may be unknown at the time the 
estimate is first made. Further, even if two entities had exactly the same 
clinical and coding experience, amounts that each might realize could vary 
materially due to factors outside of their control (for example, differing appli­
cation of payment rules by fiscal intermediaries, legal interpretations of courts, 
local enforcement initiatives, timeliness of reviews, and quality of documenta­
tion). As a result, because estimates are a matter of judgment and their 
ultimate accuracy depends on the outcome of future events, different entities 
in seemingly similar circumstances may develop materially different esti­
mates. The auditor may conclude that both estimates are reasonable in light 
of the differing assumptions.
Inappropriate Accounting Principles
.31 The auditor also determines that estimates are presented in the 
financial statements in accordance with GAAP. If  the auditor believes that the 
accounting principles have not been applied correctly, causing the financial 
statements to be materially misstated, the auditor expresses a qualified or 
adverse opinion.
.32 Valuation allowances are recorded so that revenues are not recog­
nized until the revenues are realizable. Valuation allowances are not estab­
lished based on the provisions of Financial Accounting Standards Board 
(FASB) Statement of Financial Accounting Standards No. 5, Accounting for 
Contingencies.
.33 The auditor should be alert for valuation allowances not associated 
with any particular program, issue, or time period (for example, cost-report 
year or year the service was rendered). Such a reserve may indicate measure­
ment bias. The auditor also considers the possibility of bias resulting in 
distorted earnings trends over time (for example, building up specific or 
unallocated valuation allowances in profitable years and drawing them down 
in unprofitable years).
Inadequate Disclosure
.34 If the auditor concludes that a matter involving a risk or an uncer­
tainty is not adequately disclosed in the financial statements in conformity
AAG-HCO APP E
Statement of Position 00-1 289
with GAAP, the auditor should express a qualified or adverse opinion. SOP 
94-6, Disclosure of Certain Significant Risks and Uncertainties, provides guid­
ance on the information that reporting entities should disclose regarding risks 
and uncertainties existing as of the date of the financial statements.
.35 In the health care environment, it is almost always at least reason­
ably possible that estimates regarding third-party payments could change in 
the near term as a result of one or more future confirming events (for example, 
regulatory actions reflecting local or national audit or enforcement initiatives). 
For most entities with significant third-party revenues, the effect of the change 
could be material to the financial statements. Where material exposure exists, 
the uncertainty regarding revenue realization is disclosed in the notes to the 
financial statements. Because representations from legal counsel are often key 
audit evidence in evaluating the reasonableness of management’s estimates of 
potential future adjustments, the inability of an attorney to form an opinion on 
matters about which he or she has been consulted may be indicative of an 
uncertainty that should be specifically disclosed in the financial statements.
.36 Differences between original estimates and subsequent revisions 
might arise due to final settlements, ongoing audits and investigations, or 
passage of time in relation to the statute of limitations. The Guide (paragraph 
5.07) requires that these differences be included in the statement of operations 
in the period in which the revisions are made and disclosed, if material. Such 
differences are not treated as prior period adjustments unless they meet the 
criteria for prior period adjustments as set forth in FASB Statement No. 16, 
Prior Period Adjustments.
.37 Disclosures such as the following may be appropriate:
General Hospital (the Hospital) is a (not-for-profit, for-profit, or governmental 
hospital or health care system) located in (City, State). The Hospital provides 
health care services primarily to residents of the region.
Net patient service revenue is reported at estimated net realizable amounts 
from patients, third-party payors, and others for services rendered and includes 
estimated retroactive revenue adjustments due to future audits, reviews, and 
investigations. Retroactive adjustments are considered in the recognition of 
revenue on an estimated basis in the period the related services are rendered, 
and such amounts are adjusted in future periods as adjustments become known 
or as years are no longer subject to such audits, reviews, and investigations.
Revenue from the Medicare and Medicaid programs accounted for approxi­
mately 40 percent and 10 percent, respectively, of the Hospital’s net patient 
revenue for the year ended 1999. Laws and regulations governing the Medicare 
and Medicaid programs are extremely complex and subject to interpretation.
As a result, there is at least a reasonable possibility that recorded estimates 
will change by a material amount in the near term. The 1999 net patient service 
revenue increased approximately $10,000,000 due to removal of allowances 
previously estimated that are no longer necessary as a result of final settle­
ments and years that are no longer subject to audits, reviews, and investiga­
tions. The 1998 net patient service revenue decreased approximately 
$8,000,000 due to prior-year retroactive adjustments in excess of amounts 
previously estimated.
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Appendix 
Other Considerations Related to 
Government Investigations
In recent years, the federal government and many states have aggressively 
increased enforcement efforts under Medicare and Medicaid anti-fraud and 
abuse legislation. Broadening regulatory and legal interpretations have signifi­
cantly increased the risk of penalties for providers; for example, broad inter­
pretations of “false claims” laws are exposing ordinary billing mistakes to 
scrutiny and penalty consideration. In such circumstances, evaluating the 
adequacy of accruals for or disclosure of the potential effects of illegal acts in 
the financial statements of health care organizations is a matter that is likely 
to require a high level of professional judgment.
As previously discussed in this SOP, the far-reaching nature of alleged fraud 
and abuse violations creates an uncertainty with respect to the valuation of 
revenues, because future allegations of illegal acts could, if proven, result in a 
subsequent reduction of revenues. In addition, management makes provisions 
in the financial statements and disclosures for any contingent liabilities asso­
ciated with fines and penalties due to violations of such laws. FASB Statement 
No. 5, Accounting for Contingencies, provides guidance in evaluating contingent 
liabilities, such as fines and penalties under applicable laws and regulations. 
Estimates of potential fines and penalties are not accrued unless their payment 
is probable and reasonably estimable.
The auditor’s expertise is in accounting and auditing matters rather than 
operational, clinical, or legal matters. Accordingly, the auditor’s procedures 
focus on areas that normally are subject to internal controls relevant to 
financial reporting. However, the further that potential illegal acts are removed 
from the events and transactions ordinarily reflected in the financial state­
ments, the less likely the auditor is to become aware of the act, to recognize its 
possible illegality, and to evaluate the effect on the financial statements. For 
example, determining whether a service was medically necessary, obtained 
through a legally appropriate referral, properly performed (including using 
only approved devices, rendered in a quality manner), adequately supervised, 
accurately documented and classified, or rendered and billed by nonsanctioned 
individuals typically is not within the auditor’s professional expertise. As a 
result, an audit in accordance with generally accepted auditing standards 
(GAAS) is not designed to detect such matters.
Further, an audit conducted in accordance with GAAS does not include render­
ing an opinion or any form of assurance on an entity’s compliance with laws 
and regulations.1 Nor does an audit under GAAS include providing any 
assurance on an entity’s billings or cost report. In fact, cost reports typically 
are not prepared and submitted until after the financial statement audit has 
been completed.
1 Even when auditors undertake a special engagement designed to attest to compliance with 
certain provisions of laws, regulations, contracts, and grants (for example, an audit in accordance 
with OMB Circular A-133), the auditor’s procedures do not extend to testing compliance with laws 
and regulations related to Medicare and Medicaid fraud and abuse.
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Certain audit procedures, although not specifically designed to detect illegal 
acts, may bring possible illegal acts to an auditor’s attention. When a poten­
tially illegal act is detected, the auditor’s responsibilities are addressed in SAS 
No. 54, Illegal Acts by Clients (AICPA, Professional Standards, vol. 1, AU sec. 
317). Disclosure of an illegal act to parties other than the client’s senior 
management and its audit committee or board of directors is not ordinarily part 
of the auditor’s responsibility, and such disclosure would be precluded by the 
auditor’s ethical or legal obligation of confidentiality, unless the matter affects 
the auditor’s opinion on the financial statements.2
2 Statement on Auditing Standards No. 54, Illegal Acts by Clients (AICPA, Professional Stand­
ards, vol. 1, AU sec. 317.23) discusses circumstances in which a duty to notify parties outside the 
client of detected illegal acts may exist.
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Appendix F 
Transfers of Assets to a Not-for-Profit 
Organization or Charitable Trust That Raises 
or Holds Contributions for Others
FASB Statement No. 136, Transfers of Assets to a Not-for-Profit Organization 
or Charitable Trust That Raises or Holds Contributions for Others, establishes 
standards for transactions in which an entity—the donor—makes a contribu­
tion by transferring assets to a not-for-profit organization or charitable trust— 
the recipient organization—that accepts the assets from the donor and agrees 
to use those assets on behalf of or transfer those assets, the return on invest­
ment of those assets, or both to another entity—the beneficiary—that is 
specified by the donor. It also establishes standards for transactions that take 
place in a similar manner but are not contributions because the transfers are 
revocable, repayable or reciprocal.
FASB Statement No. 136 requires a recipient organization that accepts cash 
or other financial assets from a donor and agrees to use those assets on behalf 
of or transfer those assets, the return on investment of those assets, or both to 
a specified unaffiliated beneficiary to recognize the fair value of those assets as 
a liability to the specified beneficiary concurrent with recognition of the assets 
received from the donor. However, if the donor explicitly grants the recipient 
organization variance power or if  the recipient organization and the specified 
beneficiary are financially interrelated organizations, the recipient organiza­
tion is required to recognize the fair value of any assets it receives as a 
contribution received. Not-for-profit organizations are financially interrelated 
if (a) one organization has the ability to influence the operating and financial 
decisions of the other and (b) one organization has an ongoing economic interest 
in the net assets of the other.
FASB Statement No. 136 does not establish standards for a trustee’s reporting 
of assets held on behalf of specified beneficiaries, but it does establish standards 
for a beneficiary’s reporting of its rights to assets held in a charitable trust.
FASB Statement No. 136 requires that a specified beneficiary recognize its 
rights to the assets held by a recipient organization as an asset unless the donor 
has explicitly granted the recipient organization variance power. Those rights 
are either an interest in the net assets of the recipient organization, a beneficial 
interest, or a receivable. I f  the beneficiary and the recipient organization are 
financially interrelated organizations, the beneficiary is required to recognize 
its interest in the net assets of the recipient organization and adjust that 
interest for its share of the change in net assets of the recipient organization. 
I f  the beneficiary has an unconditional right to receive all or a portion of the 
specified cash flows from a charitable trust or other identifiable pool of assets, 
the beneficiary is required to recognize that beneficial interest, measuring and 
subsequently remeasuring it at fair value, using a valuation technique such as 
the present value of the estimated expected future cash flows. I f  the recipient 
organization is explicitly granted variance power, the specified beneficiary does 
not recognize its potential for future distributions from the assets held by the 
recipient organization. In all other cases, a beneficiary recognizes its rights as 
a receivable.
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FASB Statement No. 136 describes four circumstances in which a transfer of 
assets to a recipient organization is accounted for as a liability by the recipient 
organization and as an asset by the resource provider because the transfer is 
revocable or reciprocal. Those four circumstances are if (a) the transfer is 
subject to the resource provider’s unilateral right to redirect the use of the 
assets to another beneficiary, (b) the transfer is accompanied by the resource 
provider’s conditional promise to give or is otherwise revocable or repayable, 
(c) the resource provider controls the recipient organization and specifies an 
unaffiliated beneficiary, or (d) the resource provider specifies itself or its 
affiliate as the beneficiary and the transfer is not an equity transaction. If  the 
transfer is an equity transaction and the resource provider specifies itself as 
beneficiary, it records an interest in the net assets of the recipient organization 
(or an increase in a previously recognized interest). I f  the resource provider 
specifies an affiliate as beneficiary, the resource provider records an equity 
transaction as a separate line item in its statement of activities, and the affiliate 
named as beneficiary records an interest in the net assets of the recipient 
organization. The recipient organization records an equity transaction as a 
separate line item in its statement of activities.
FASB Statement No. 136 requires certain disclosures if a not-for-profit organi­
zation transfers assets to a recipient organization and specifies itself or its 
affiliate as the beneficiary or if it includes in its financial statements a ratio of 
fundraising expenses to amounts raised.
FASB Statement No. 136 incorporates without reconsideration the guidance in 
FASB Interpretation No. 42, Accounting for Transfers of Assets in Which a 
Not-for-Profit Organization Is Granted Variance Power, and supersedes that 
Interpretation. This Statement is effective for financial statements issued for 
fiscal periods beginning after December 15, 1999, except for the provisions 
incorporated from Interpretation No. 42, which continue to be effective for fiscal 
years ending after September 15, 1996. Earlier application is encouraged. 
FASB Statement No. 136 may be applied either by restating the financial 
statements of all years presented or by recognizing the cumulative effect of the 
change in accounting principle in the year of the change. Readers should refer 
to the full text of FASB Statement No. 136.
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Appendix G 
Information Sources
Further information on matters addressed in this Guide is available through 
various publications and services listed in the table that follows. Many non­
government and some government publications and services involve a charge 
or membership requirement.
Fax services allow users to follow voice cues and request that selected 
documents be sent by fax machine. Some fax services require the user to call 
from the handset of the fax machine, others allow the user to call from any 
phone. Most fax services offer an index document, which lists titles and other 
information describing available documents.
Electronic bulletin board services and web sites allow users to read, copy, and 
exchange information electronically. Most are available using a modem and 
standard communications software. Some bulletin board services are also 
available using one or more Internet protocols.
Recorded announcements allow users to listen to announcements about a 
variety of recent or scheduled actions or meetings.
All telephone numbers listed are voice lines, unless otherwise designated as 
fax (f) or data (d) lines. Required modem speeds, expressed in bauds per second 
(bps), are listed for data lines.
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Appendix H 
Schedule of Changes Made to Health 
Care Organizations
Reference 
Chapter 1
Paragraph 2.01
Paragraph 2.01 
(footnote *) 
Paragraphs 2.04 
and 2.06 
Paragraph 2.07
Paragraph 2.12
Former 
paragraphs 
2.13, 2.14, 
and 2.15 
Renumbered 
paragraph 2.15 
Renumbered 
paragraphs 
2.16 and 2.17 
Renumbered 
paragraph 2.21 
Renumbered 
paragraphs 2.23 
and 2.29 
Renumbered 
paragraphs 2.33, 
2.34, and 2.35
Renumbered 
paragraph 2.50 
Renumbered 
paragraph 2.51 
Renumbered 
paragraph 2.51 
(footnote *) 
Renumbered 
paragraph 2.52 
Renumbered 
paragraph 2.52 
(footnote *)
Change
Revised to reflect the issuance of recent 
authoritative literature.
Revised to reflect the issuance of SAS 
No. 83.
Added to reflect the issuance of SAS No. 
89.
Conformed to the terminology used in 
SAS No. 78.
Revised to reflect the issuance of SOP 
00-1.
Revised to reflect the issuance of SAS 
No. 82.
Replaced with new paragraphs 2.13 and 
2.14; Subsequent paragraphs renum­
bered.
Conformed to the terminology used in 
SAS No. 78; Footnote 1 deleted. 
Conformed to the terminology used in 
SAS No. 78.
Revised to reflect the issuance of SOP 
00-1.
Conformed to the terminology used in 
SAS No. 78.
Replaced with new paragraphs 2.33 
through 2.38 to reflect the issuance of 
recent authoritative literature; Subse­
quent paragraphs further renumbered. 
Conformed to the terminology used in 
SAS No. 78.
Revised to reflect the issuance of SAS 
No. 82.
Added to reflect the issuance of SAS No. 
89.
Revised to reflect the issuance of SAS 
No. 85.
Added to reflect the issuance of SAS No. 
89.
Date
July, 2000 
June, 1998 
July, 2000 
June, 1997 
July, 2000 
June, 1998
June, 1998
June, 1997 
June, 1997
July, 2000 
June, 1997
July, 2000 
June, 1997 
June, 1998 
July, 2000
June, 1998 
July, 2000
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Reference 
Paragraph 2.53
Renumbered 
paragraph 2.54
Renumbered 
paragraph 2.54 
Renumbered 
paragraphs
2.55, 2.56, 
and 2.57
Renumbered 
paragraphs 
2.58 and 2.59 
Renumbered 
paragraphs 2.58 
and 2.59 
Former 
paragraphs
2.56, 2.57, 2.58, 
2.59, 2.60, 
and 2.61
Paragraph 3.01 
(footnote *) 
Paragraph 3.02
Paragraph 3.02
Paragraph 3.03 
(footnote *) 
Paragraph 3.03
Paragraph 4.04
Paragraphs 4.04 
and 4.06 
(footnote *) 
Paragraphs 4.04 
and 4.06 
(footnote *) 
Paragraph 4.12
Paragraph 4.12 
(footnote *) 
Paragraph 4.13
Change
Added to reflect the issuance of SOP 
00-1; Subsequent paragraphs further 
renumbered.
Revised to reflect the Single Audit Act 
Amendments of 1996; Footnote 3 de­
leted.
Revised to reflect the issuance of SOP 
98-3.
Revised to reflect the Single Audit Act 
Amendments of 1996.
Revised to reflect the issuance of SOP 
98-3.
Revised to reflect recent amendments to 
Government Auditing Standards.
Replaced with new paragraphs 2.60 
through 2.65 to reflect the issuance of 
recent authoritative guidance.
Added to reflect the issuance of GASB 
Statement No. 34.
Revised to reflect the issuance of FASB 
Interpretation No. 42.
Revised to reflect the issuance of FASB 
Statement No. 136; Footnote ** added. 
Added to reflect the issuance of FASB 
Statement No. 133.
Footnote * revised to reflect the issu­
ance of recent authoritative literature; 
Footnote ** added.
Revised to reflect the issuance of FASB 
Statement No. 130.
Added to reflect the issuance of FASB 
Statement No. 133.
Revised to reflect the issuance of FASB 
Statement No. 137 and a FASB expo­
sure draft.
Revised to reflect the issuance of GASB 
Statement No. 31.
Added to reflect the issuance of GASB 
Statement No. 34.
Added to reflect the issuance of GASB 
Statement No. 31; Subsequent para­
graphs renumbered.
July, 2000
June, 1997 
June, 1998 
June, 1997
June, 1998 
July, 2000
July, 2000
July, 2000 
June, 1997 
July, 2000 
June, 1999
July, 2000 
June, 1998 
June, 1999
July, 2000 
June, 1998 
July, 2000
June, 1998
Date
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Renumbered 
paragraph 4.14 
(footnote *) 
Renumbered 
paragraph 4.14
Renumbered 
paragraph 4.15
Renumbered 
paragraph 4.18 
Renumbered 
paragraph 4.18 
Renumbered 
paragraph 4.18 
(footnote *) 
Paragraph 5.07 
(footnote 2)
Paragraphs 5.09 
and 5.10 
(footnote *) 
Paragraph 5.11 
(footnote *) 
Paragraph 5.11
Reference
Paragraph 5.17 
(footnote *) 
Paragraph 5.17 
(footnote *)
Paragraph 5.18 
(footnote 8a) 
Paragraph 5.23 
(footnote *) 
Paragraph 5.27
Paragraph 5.28
Renumbered 
paragraph 5.30 
Paragraphs 6.01 
and 6.10 
(footnote *) 
Paragraph 6.14
Paragraph 7.03 
(footnote *)
Change
Added to reflect the issuance of FASB 
Statement No. 133.
Footnote * revised to reflect the issu­
ance of recent authoritative literature; 
Footnote ** added.
Revised to reflect the issuance of GASB 
Technical Bulletin 97-1; Footnote added 
to reflect FASB Statement No. 126. 
Revised to reflect the issuance of SAS 
No. 81.
Conformed to the terminology used in 
SAS No. 78.
Added.
Added to reflect the issuance of SOP 
00-1; Subsequent footnotes renum­
bered.
Added to reflect the issuance of GASB 
Statement No. 34.
Added to reflect the issuance of GASB 
Statement No. 33.
Footnote ** revised to reflect the 
issuance of GASB Statement No. 34; 
Footnote *** added to reflect the 
issuance of FASB Statement No. 136. 
Added to reflect the issuance of FASB 
Statement No. 133.
Revised to reflect the issuance of FASB 
Statement No. 137 and a FASB expo­
sure draft.
Added to reflect the issuance of SOP 
00-1.
Added to reflect the issuance of GASB 
Statement No. 34.
Conformed to the terminology used in 
SAS No. 78.
Added to reflect the issuance of SOP 
00-1; Subsequent paragraphs renum­
bered.
Conformed to the terminology used in 
SAS No. 78.
Added to reflect the issuance of GASB 
Statement No. 34.
Conformed to the terminology used in 
SAS No. 78.
Added to reflect the issuance of GASB 
Statement No. 34.
June, 1999
July, 2000
June, 1998
June, 1999
June, 1997 
July, 2000
July, 2000 
July, 2000
June, 1999
July, 2000 
June, 1999
July, 2000 
July, 2000 
July, 2000 
June, 1997
July, 2000 
June, 1997 
July, 2000
June, 1997 
July, 2000
Date
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Reference 
Paragraph 7.18
Paragraph 7.18
Paragraph 7.18
Paragraph 7.19
Paragraph 7.19 
Paragraph 7.20
Paragraph 7.20 
(footnote **) 
Paragraph 7.21
Paragraph 7.24
Paragraph 8.02 
(footnote *) 
Paragraph 8.12
Paragraph 8.16 
(footnote *) 
Paragraphs 8.21 
and 8.23 
(footnote *) 
Paragraph 8.24
Paragraph 8.41
Paragraph 8.42
Renumbered 
paragraph 8.48 
Paragraph 9.02 
(footnote *) 
Paragraph 9.06 
(footnote 2) 
Paragraph 9.08
Paragraph 10.04 
(footnote *) 
Paragraph 10.04 
(footnote *) 
Paragraph 10.07 
(footnote *)
Change
Revised to reflect the issuance of FASB 
Statement No. 125.
Revised to reflect EITF Issue No. 96-19; 
Footnotes * and 1 added.
Footnote * revised to reflect the issu­
ance of a FASB Special Report; Footnote
* added to reflect the issuance of GASB 
Statement No. 34.
Former paragraphs 7.19 and 7.20 
combined.
Revised to reflect EITF Issue No. 96-19. 
Revised to reflect the issuance of FASB 
Statement No. 125; Footnote * added. 
Revised to reflect the issuance of a 
FASB Special Report.
Added to reflect the issuance of FASB 
Statement No. 125; Subsequent para­
graphs renumbered.
Conformed to the terminology used in 
SAS No. 78.
Added to reflect the issuance of GASB 
Statement No. 34.
Revised to reflect the issuance of FASB 
Concepts Statement No. 7.
Added to reflect the issuance of a FASB 
exposure draft.
Added to reflect the issuance of GASB 
Statement No. 34.
Conformed to the terminology used in 
SAS No. 78.
Revised to reflect the issuance of SOP 
00- 1.
Added to reflect the issuance of SOP 
00-1; Subsequent paragraphs renum­
bered; Footnote 3 added.
Conformed to the terminology used in 
SAS No. 78.
Added to reflect the issuance of GASB 
Statement No. 34.
Deleted.
Conformed to the terminology used in 
SAS No. 78.
Added to reflect the issuance of GASB 
Statement No. 33.
Revised to reflect the issuance of GASB 
Statement No. 34.
Added to reflect the issuance of FASB 
Statement No. 136.
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June, 1997 
June, 1999
July, 2000
June, 1997 
June, 1999
June, 1999
July, 2000
June, 1999 
June, 1997 
July, 2000 
July, 2000 
July, 2000 
July, 2000
June, 1997 
July, 2000
July, 2000
June, 1997
July, 2000 
July, 2000
June, 1997 
June, 1999 
July, 2000 
July, 2000
Date
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Paragraph 10.12 
(footnote *) 
Paragraph 10.15 
(footnote *) 
Paragraph 10.15 
(footnote *) 
Paragraph 10.16
Paragraph 10.16 
Renumbered 
paragraph 10.18 
Renumbered 
paragraph 10.18
Reference
Renumbered 
paragraph 10.22 
Renumbered 
paragraph 10.22 
(footnote 4) 
Paragraph 10.24
Renumbered 
paragraph 10.24 
(footnote *) 
Renumbered 
paragraph 10.25 
Renumbered 
paragraph 10.25 
(footnote 5) 
Paragraph 11.01 
(footnote *) 
Paragraph 11.01 
(footnote **) 
Paragraph 11.05 
(footnote *) 
Paragraph 11.08 
(footnote 2) 
Paragraphs
11.10 and 11.12 
(footnotes 4 
and 7) 
Paragraph 11.19
Paragraph 11.20 
(footnote 11) 
Paragraph 11.23
Change
Added to reflect the issuance of GASB 
Statement No. 34.
Revised to reflect the issuance of GASB 
Statement No. 33.
Revised to reflect the issuance of GASB 
Statement No. 34.
Added to reflect the issuance of SOP 98-2; 
Subsequent paragraphs renumbered. 
Revised.
Additional examples added to (g).
Footnote * added to reflect the issuance 
of FASB Statement No. 133; Footnote 3 
revised to reflect the issuance of GASB 
Statement No. 34.
Revised to reflect the issuance of FASB 
Statement No. 131.
Revised to reflect the issuance of GASB 
Statement No. 34.
Added to reflect the issuance of GASB 
Statement No. 33; Subsequent par­
agraph renumbered.
Added to reflect the issuance of GASB 
Statement No. 34.
Conformed to the terminology used in 
SAS No. 78.
Added to reflect the issuance of SOP 
00-1.
Added to reflect the issuance of a FASB 
Exposure Draft.
Added to reflect the issuance of GASB 
Statement No. 34.
Added to reflect the issuance of a FASB 
exposure draft.
Added to reflect FASB EITF Issue No. 
97-2; Subsequent footnotes renumbered. 
Added to reflect FASB EITF Issue No. 
97-2; Subsequent footnotes further 
renumbered.
Footnote * added to reflect the issuance 
of FASB Statement No. 136; Footnote 
10 revised to reflect the issuance of 
GASB Statement No. 34.
Added.
Revised to reflect the issuance of FASB 
Interpretation No. 42.
July, 2000
June, 1999
July, 2000
June, 1998 
July, 2000 
June, 1997
July, 2000 
June, 1998 
July, 2000
June, 1999 
July, 2000
June, 1997 
July, 2000
June, 1999 
July, 2000 
July, 2000 
June, 1999
June, 1999
July, 2000 
June, 1999
June, 1997
Date
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Reference Change Date
Paragraph 11.23 Renumbered and deleted. June, 1999
(footnote 12)
Paragraph 11.24 Added to reflect the issuance of a FASB
(footnote *) exposure draft. July, 2000
Paragraph 11.26 Added to reflect FASB EITF Issue No.
(footnote 13) 97-2; Subsequent footnotes renumbered. June, 1999
Paragraph 11.28 Added to reflect the issuance of a FASB
(footnote *) exposure draft. July, 2000
Paragraph 11.29 Conformed to the terminology used in
SAS No. 78. June, 1997
Chapter 12 Added to reflect the issuance of GASB
(footnote *) Technical Bulletins 98-1 and 99-1. June, 1999
Paragraph 12.01 Revised to reflect the issuance of GASB
(footnote *) Technical Bulletin 2000-1. July, 2000
Paragraph 12.06 Revised to reflect the issuance of SAS
No. 87 and SOP 98-3; Footnote 2 added. June, 1999
Paragraph 12.07 Added to reflect the issuance of SOP
99-1. July, 2000
Paragraphs Revised to make consistent with the
13.02 and 13.06 terminology used in SOP 89-5. June, 1997
Paragraph 14.28 Revised to make consistent with the
terminology used in SOP 90-8. June, 1997
Paragraph 14.31 Revised to reflect the issuance of FASB
Concepts Statement No. 7. July, 2000
Paragraph 14.33 Revised to reflect the issuance of SOP
98-5. June, 1999
Paragraph 14.36 Conformed to the terminology used in
SAS No. 78. June, 1997
Appendix A Revised to reflect the issuance of recent
authoritative literature. July, 2000
Appendix C SOP 98-2 added. June, 1998
Appendix D SOP 99-1 added. July, 2000
Appendix E SOP 00-1 added. July, 2000
Appendix F Added; Subsequent appendixes relet­
tered. July, 2000
Glossary Definition of “in-substance defeasance”
revised. June, 1997
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acquisition costs. Marketing costs that are (a) directly related to the acquisi­
tion of specific subscriber contracts and member enrollment and (b) incre­
mental to general marketing activities.
acute care. Inpatient general routine care provided to patients who are in a 
phase of illness that does not require the concentrated and continuous 
observation and treatment provided in intensive-care units.
advance fee. A payment required to be made by a continuing care retirement 
community (CCRC) resident prior to, or at the time of, admission to the 
CCRC for future services and the use of facilities specified in a contract 
that remains in effect for as long as the resident resides in the CCRC.
advance refunding. A transaction in which refunding debt is issued to pay 
the refunded debt at a specified future date(s), with the proceeds placed in 
trust or otherwise restricted to pay the refunded debt.
allocated loss adjustment expense (ALAE). Claim expense that can be as­
signed to individual claims (for example, attorney’s fees, claim adjusting 
service fees, or court costs).
ambulatory care organization. A partnership, association, corporation, or 
other legal entity organized to deliver health care services to patients that 
come or are brought to a health care facility for a purpose other than 
admission as an inpatient (for example, emergency room services, clinic 
services, or outpatient surgery).
ancillary services. Services performed for diagnostic or therapeutic purposes. 
Ancillary services generally are those special services for which charges in 
addition to routine charges customarily are made (for example, laboratory, 
radiology, surgical, or other services).
anticipated revenues. Amounts including third-party payments (for exam­
ple, those from Blue Cross), contractually or statutorily committed invest­
ment income from sources related to the activities of a continuing care 
retirement community (CCRC), contributions pledged by donors to support 
CCRC activities, periodic fees expected to be collected, or the balance of 
deferred nonrefundable advance fees.
asserted claim. A claim made against a health care organization by or on 
behalf of a patient alleging improper professional service.
assets limited as to use. Assets that are segregated and limited either by the 
Board or management (for example, designated for expenditure in the 
acquisition of property and equipment or for the liquidation of long-term 
debt) or by outside third parties other than a donor or grantor (for example, 
funds under bond agreements or malpractice arrangements) as to how the 
assets may be used.
associated entity. An individual practice association, hospital, medical group, 
or similar health care organization that contracts with a prepaid health 
care provider to provide health care services.
bad-debt expense. The provision for actual or expected doubtful accounts 
resulting from the extension of credit.
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capitation fee. A fixed amount per individual that is paid periodically (usually 
monthly) to a provider as compensation for providing comprehensive 
health care services for the period. The fee is set by contract between a 
prepaid health care plan and the provider. These contracts are generally 
with medical groups, independent practice associations (IPAs), hospitals, 
and other similar providers. Capitation fees may be determined actuarially 
or negotiated based on expected costs to be incurred.
charity care. Health care services that never were expected to result in cash 
inflows. Charity care results from a provider’s policy to provide health care 
services free of charge to individuals who meet certain financial criteria.
claims-made insurance policy. A policy that covers only malpractice claims 
reported to the insurance carrier during the policy term, regardless of the 
date of the incident giving rise to the claim.
clinic. A freestanding facility or part of another health care organization used 
for diagnosis and treatment of outpatients.
commercial paper. Short-term, unsecured promissory notes that represent a 
flexible and low-cost form of short-term financing. Taxable commercial 
paper is sold on a discount basis, rather than on an interest-bearing basis, 
with the discount determined by the maturity of the notes, the creditwor­
thiness of the issuer or its credit support, and general market demand. The 
primary risk is the variable interest rate exposure. Issuance often requires 
some form of credit enhancement or liquidity support.
comprehensive medical plan (CMP). A health plan option that may be avail­
able to Medicare beneficiaries and provides a more limited range of services 
than health maintenance organizations but includes physician services, 
laboratory, radiology, emergency, preventive, and inpatient services. A 
CMP assumes the financial risk for the provision of services and for 
out-of-area coverage.
conditional promise to give. A promise to give that depends on the occur­
rence of a specified future or uncertain event to bind the promisor.
continuing-care contract. An agreement between a resident and a CCRC 
specifying the services and facilities to be provided by the CCRC to a 
resident over an established period of time (usually the remaining life of 
the resident).
continuing care retirement community (CCRC). A legal entity sponsoring 
or guaranteeing residential facilities, meals, and health care services for a 
community of retired persons who may reside in apartments, other living 
units, or in some cases a nursing center. (Also referred to as a residential 
care facility or a life-care retirement community.)
contract period. The period (typically one year) for which premium rates are 
fixed by contract.
contractual adjustments. The differences between revenue at established 
rates and the amounts realizable from third-party payors under contrac­
tual agreements.
contribution. An unconditional transfer of cash or other assets to an entity or 
a settlement or cancellation of its liabilities in a voluntary nonreciprocal 
transfer by another entity acting other than as an owner.
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cost a of acquiring initial continuing-care contracts. Costs incurred to origi­
nate a contract that result from and are essential to the acquisition of the 
initial contracts and are incurred through the date of substantial occu­
pancy but no later than one year from the date of completion of construc­
tion.
These costs include—
•  The costs of processing the contract, such as evaluating the prospective 
resident’s financial condition; evaluating and recording guarantees, 
collateral, and other security arrangements; negotiating contract 
terms; preparing and processing contract documents; and closing the 
transaction.
•  The costs from activities in connection with soliciting potential initial 
residents (such as model units and their furnishings, sales brochures, 
semipermanent signs, tours, grand openings, and sales salaries). 
These costs do not include advertising, interest, administrative costs, 
rent, depreciation, or any other occupancy or equipment costs.
•  The portion of an employee’s compensation and benefits that relates 
to the initial contract acquisitions.
courtesy and policy discounts. The differences between revenue recorded at 
established rates and amounts realizable for services provided to specific 
individuals such as employees, medical staff, and clergy.
credibility. A measure of the statistical significance of a provider’s own data, 
dependent on its stability and volume in relation to the stability and 
volume of the industry data. Actuaries use credibility to blend an estimate 
from a provider’s own experience with a broader estimate based on the 
experience of similar institutions. A provider’s own experience may be 
assigned a credibility weight less than 100 percent due to year-to-year 
volatility. Such volatility is often a function of the size of the provider. 
Large providers generally have less volatility than small providers. In such 
an instance, a broader and more stable body of experience of similar 
providers would be used to supplement the specific provider’s experience.
credit enhancement. Typically, a bank letter of credit that guarantees inves­
tors will receive principal and interest in the event of an issuer default. A 
line of credit provides liquidity support to an issuer but does not provide a 
guarantee of the repayment of principal and interest in the event of issuer 
default. The liquidity support provides a loan to issuers in the event the 
issuer is unable to place large amounts of maturing commercial paper with 
investors.
crossover refunding (also called a delayed defeasance). A type of advance 
refunding in which the old debt is not immediately replaced. The proceeds 
from the new debt, additional cash deposits (if any), and the income earned 
on the related investments are sufficient to pay the principal and any call 
premium of the old debt and the interest on the new debt until the date of 
crossover. Until the crossover, the proceeds from the new debt serve as 
collateral for that debt. The old debt is serviced by the entity until the date 
of crossover, at which time the proceeds from the new debt are used to retire 
the old debt and the entity becomes obligated to service the new debt. The 
old debt remains as a liability on the issuer’s books until the crossover, 
when it is called in accordance with the call provisions of its indenture.
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deductions from revenue. Reductions in gross revenue arising from contrac­
tual adjustments, courtesy and policy discounts, or other adjustments and 
deductions.
defeasance. Legal satisfaction of refunded debt without the debt necessarily 
being retired.
development factor. A computed factor used to project future changes in 
estimated losses from the date of the occurrence of the incident to the 
date-of-claim payment resulting from inflation, claimed cost growth, in­
dustry trends, and court awards. The development factor can be applied to 
incurred losses, paid losses, claim counts, and average values.
diagnosis-related group (DRG). A patient classification scheme that catego­
rizes patients who are related medically with respect to primary and 
secondary diagnosis, age, or complications.
donor-imposed condition. A donor stipulation that specifies a future and 
uncertain event whose occurrence or failure to occur gives the promisor a 
right of return of the assets it has transferred or releases the promisor from 
its obligation to transfer its assets.
donor-imposed restriction. A donor stipulation that specifies the use for a 
contributed asset that is more specific than broad limits resulting from the 
nature of the organization, the environment in which it operates, and the 
purposes specified in its articles of incorporation or bylaws of comparable 
documents for an unincorporated association. A restriction on an organi­
zation’s use of the asset contributed may be temporary or permanent.
endowment fund. An established fund of cash, securities, or other assets used 
to provide income for the maintenance of a not-for-profit organization. The 
use of the assets of the fund may be permanently restricted, temporarily 
restricted, or unrestricted. Endowment funds generally are established by 
donor-restricted gifts and bequests to provide a permanent endowment (to 
provide a permanent source of income) or a term endowment (to provide 
income for a specific period). The principal of a permanent endowment 
must be maintained permanently, that is, not used up, expended, or 
otherwise exhausted—and is classified as permanently restricted net 
assets. The principal of a term endowment must be maintained for a 
specified term and is classified as temporarily restricted net assets. An 
organization’s governing board may earmark a portion of its unrestricted 
net assets as a board-designated endowment (sometimes called funds 
functioning as endowment or quasi-endowment funds) to be invested to 
provide income for a long but unspecified period. The principal of a 
board-designated endowment, which results from an internal designation, 
is not donor restricted and is classified as unrestricted net assets.
enrollee. An individual who is a subscriber or an eligible dependent of a 
subscriber in a prepaid health care plan.
estimated costs of future services. Amounts that are expected to be incurred 
to provide services and the use of facilities to individuals over their 
remaining lives under continuing-care contracts. Examples include resi­
dent care, dietary, health care, facility, general and administrative, inter­
est, depreciation, and amortization costs.
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exposure. The amount of potential claim risk. The basis for reflecting differ­
ences in the claim potential among providers’ bases for charging insurance 
premiums or allocating member contributions to a captive. Exposure bases 
for hospital professional liability include number of occupied beds, outpa­
tient visits, emergency room visits, and number of residents by specialty.
floating rate note (FRN). A debt instrument that allows issuers to borrow at 
a floating short-term rate with a long-term stated maturity without some 
of the risks traditionally associated with commercial paper. The investor 
is subject to principal risk to the degree the issuer’s credit deteriorates or 
investor demand for FRNs decreases. Most health care issuers of FRNs 
require credit enhancement and a bank liquidity facility in conjunction 
with an FRN program.
functional classification. A method of grouping expenses according to the 
purpose for which costs are incurred. The primary functional classifica­
tions are program services and supporting activities.
fund. A self-contained accounting entity set up to account for a specific activity 
or project.
gross service revenues. All revenues from the provision of health care serv­
ices excluding charity care.
health care services. Services provided to individuals related to the diagnosis 
or treatment of physical or mental illness.
health maintenance organization (HMO). A generic group of medical care 
entities organized to provide defined health care services to members in 
return for fixed, periodic premiums (usually paid monthly) that are paid 
in advance.
home health agency. An agency organized to provide health and supportive 
services in a person’s home. These services may include nursing, nutri­
tional, and therapeutic aid (such as physical therapy and dialysis) and the 
rental, as well as sale of medical equipment.
increased limit factor. The relationship between losses limited to a per- 
occurrence limit at which the provider’s own experience is meaningful to 
losses limited to the provider’s total retained limit per occurrence.
incremental costs. Costs that vary with and are directly attributable to 
changes in business, such as an additional employer or HMO contract. 
Fixed costs such as building depreciation or general overhead that do not 
change with the addition or loss of a contract are not incremental costs.
incurred but not reported (IBNR) costs. Costs associated with health care 
services incurred during a financial reporting period but not reported to 
the health care organization until after the financial reporting date.
indenture. An agreement between two or more persons specifying the recip­
rocal rights and duties of the parties under a contract (such as a lease, 
mortgage, or contract between bondholders and the issuer of the bond).
individual practice association (IPA). A partnership, association, corpora­
tion, or other legal entity organized to provide or arrange for the delivery 
of health care services to members of a prepaid health care plan and 
nonmember patients. In return, the IPA receives either a capitation fee or 
a specified fee for services rendered.
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inpatient. Under most circumstances, a patient who is provided with room, 
board, and general nursing service and is expected to remain in the health 
care facility at least overnight and occupy a bed.
in-substance defeasance. A form of advance refunding in which the debtor 
places into an irrevocable trust an amount of assets estimated to be 
sufficient to satisfy all future principal and interest payments of a specific 
obligation. In such cases, the debt is not considered extinguished because 
the debtor is not legally released from being the primary obligor. (Corre­
sponds with the effective date of FASB Statement No. 125, Accounting for 
Transfers and Servicing of Financial Assets and Extinguishments of Li­
abilities, as amended by FASB Statement No. 127, Deferral of the Effective 
Date of Certain Provisions of FASB Statement No. 125.)
integrated delivery system. A provider or group of providers that is organ­
ized to deliver and finance acute and preventive health care services. An 
integrated delivery system generally will provide (or arrange to provide) a 
complete continuum of health care services (inpatient acute care, ambula­
tory care, outpatient surgery, home health care, including long-term care) 
to an enrolled population, generally for fixed prepaid fees called premiums.
interest rate swaps. An agreement to exchange interest payments without 
actually exchanging the underlying principal. The two parties each agree 
to make interest payments based on the calculation formula for the other’s 
debt. Swaps can be used for a variety of purposes, such as to reduce the 
overall cost of borrowing, lock in forward rates, reduce interest rate risk, 
or adjust the ratio of variable and fixed-rate debt liabilities. Interest rate 
swaps do not change the amount or type of debt outstanding, but they do 
affect the issuer’s debt portfolio and risk profile.
intermediate care facility (ICF). A facility that provides care to individuals 
whose mental or physical conditions require services that are above the 
level of room and board and that can be made available only through 
institutional facilities. The care provided at an ICF does not require 
hospitals or skilled nursing facilities.
maintenance costs. Costs associated with maintaining enrollment records 
and processing premium collections and payments.
margin for risk of adverse deviation. Actuarially determined estimate of 
the additional funding requirement to obtain a specific confidence level 
that losses will not exceed the amount paid into the self-insurance fund. 
Margins are determined using statistical simulation techniques.
medical group. An association of physicians and other licensed health care 
professionals organized on a group basis to practice medicine.
medium-term notes. An intermediate-term security offered on a continuous 
basis providing flexibility for an issuer to vary the amount of outstanding 
notes as its funding requirements change. The broad range of possible 
maturities enables an issuer to borrow at the most attractive yield at the 
time of each issuance. They can be issued domestically or abroad.
member. An individual who is enrolled as a subscriber or as an eligible 
dependent of a subscriber in a prepaid health care plan.
multiprovider captive. An insurance company owned by two or more health 
care organizations that underwrites malpractice insurance for its owners.
natural classification. A method of classifying expenditures according to the 
nature of the expense such as salaries and wages, employee benefits, 
supplies, and purchased services.
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net advance refunding. A type of advance refunding in which the proceeds 
from the new debt, additional cash deposits (if any) and the income earned 
on the related investments are sufficient to pay the interest, principal, and 
call premium on the old debt. After the advance refunding, the old debt is 
serviced by the investments in trust and the new debt is serviced by the 
entity.
net service revenue. Gross service revenue less provisions for contractual 
adjustments with third-party payors.
nonfinancial assets. Nonmonetary assets such as inventories or property, 
plant, and equipment.
not-for-profit organization. An entity that possesses the following charac­
teristics that distinguish it from a business enterprise: (a) contributions of 
significant amounts of resources from resource providers that do not expect 
commensurate or proportionate pecuniary return, (b) operating purposes 
other than to provide goods or services at a profit, and (c) absence of 
ownership interests like those of business enterprises. Not-for-profit or­
ganizations possess these characteristics in varying degrees.
nursing center. A facility that provides nursing care to residents with a 
variety of needs or medical conditions. A nursing center may be a compo­
nent of a continuing care retirement community. (Also called a health 
center, skilled-nursing facility, intermediate-care facility, continuing-care 
facility, or basic-care home.)
occurrence-basis policy. A policy that covers claims resulting from incidents 
that occur during the policy term, regardless of when the claims are 
reported to the insurance carrier.
outliers. In referring to the Medicare Prospective Payment System, additional 
payments that are made for cases that either have unusually long lengths 
of stay or have charges in excess of the cost outlier threshold.
outpatient. A patient who is not confined overnight in a health care institu­
tion.
peer review organization (PRO). Under federal statutory provision, PROs 
are required in each state to monitor hospital activity under the prospec­
tive payment system. Each hospital must contract with a PRO, which will 
review (a) the validity of diagnostic information, which establishes the 
diagnosis-related group; (b) the appropriateness of admissions; (c) the 
appropriateness of care to outliers; and (d) the adequacy of care provided.
periodic fees. Amounts paid to a continuing care retirement community by a 
resident at periodic intervals for continuing-care services. Such fees may 
be fixed or adjustable. (Also called maintenance fees or monthly fees.)
periodic interim payment (PIP). A plan under which the health care organi­
zation receives cash payments from a third-party payor (usually Medicare) 
in constant amounts periodically.
permanent restriction. A donor-imposed restriction that stipulates that re­
sources be maintained permanently but permits the organization to use up 
or expend part or all of the income (or other economic benefits) derived 
from the donated assets.
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permanently restricted net assets. The part of the net assets of a not-for- 
profit organization resulting from (a) contributions and other inflows of 
assets whose use by the organization is limited by donor-imposed stipula­
tions that neither expire by the passage of time nor can be fulfilled or 
otherwise removed by the actions of the organization, (b ) other asset 
enhancements and diminishments subject to the same kind of stipulations, 
and (c) reclassification from (or to) other classes of net assets as a conse­
quence of donor-imposed stipulations.
premium. The consideration paid for providing contract coverage. (Also called 
a subscriber fee.)
premium period. The period to which a premium payment applies (generally 
one month) that entitles a member to health care services according to the 
contract provisions.
prepaid health care plan. A plan in which the provider is compensated in 
advance by the sponsoring organization. The sponsoring organization pays 
or compensates the provider based on either a fixed sum or a per-enrollee 
amount. Prepaid health care plans include health maintenance organiza­
tions, preferred provider organizations, eye care plans, dental care plans, 
and similar plans. Under such plans, the financial risk of delivering the 
health care is transferred to the provider of services.
prepaid health care services. Any form of health care service provided to a 
member in exchange for a scheduled payment (or payments) established 
before care is provided, regardless of the level of service subsequently 
provided.
prevailing charge. A charge that falls within the range of charges most 
frequently used in a locality for a particular service or procedure.
primary care. Care that is rendered in an ambulatory fashion, such as in an 
emergency room, an outpatient clinic, or other outpatient department.
prospective payment system (PPS). Medicare payment made at a predeter­
mined, specific rate for each Medicare discharge, based on the patient’s 
diagnosis. Each discharge is classified according to a series of diagnosis- 
related groups. (See also diagnosis-related group.)
provider. A person or entity that undertakes to provide health care services.
providers of prepaid health care services (prepaid health care providers).
Organizations that provide or arrange for the delivery of health care 
services in accordance with the terms and provisions of a prepaid health 
care plan. Providers assume the financial risk of the cost of delivering 
health care services in excess of preestablished fixed premiums. However, 
some or all of the financial risk may be contractually transferred to other 
providers (affiliated entities) or by purchasing stop-loss insurance. Other 
providers of prepaid health care services may include comprehensive 
medical plans, physicians groups (for example, independent practice asso­
ciations), and hospitals.
refundable advance fees. The portion of an advance fee that is payable to a 
resident of a continuing care retirement community or the resident’s 
estate.
refunded debt. Debt for which payment at a specified future date has been 
provided by the issuance of refunding debt.
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refunding debt. Debt issued to provide funds to pay for refunded debt at a 
specified future date.
reported incident. An occurrence identified by a health care organization as 
one in which improper professional service may be alleged at a future time 
that would result in a malpractice claim.
retrospectively rated insurance policy. An insurance policy with a premium 
that is adjustable based on the experience of the insured health care 
organization or group of health care organizations during the policy term.
risk contract. A contract between a provider of health care services and a 
prepaid health care plan that exposes the provider to the uncertainty of 
financial gain or loss by obligating the provider to provide specified health 
care services to enrollees of the plan for a negotiated price, which may be 
an amount per case, service, or day. The price may vary based on the 
volume of services furnished during the contract period.
secondary care. Care that is rendered to inpatients in hospitals that offer 
short-term, acute-care services of either a general or a specialized nature.
self-insurance. That portion of risk or loss assumed by a health care organi­
zation. There is no external insurance coverage.
skilled nursing facilities (SNF). These facilities provide services on a daily, 
inpatient basis. The services provided by an SNF are ordered by a physi­
cian and require the skilled services of technical or professional personnel.
stop-loss (or reinsurance) insurance. A contract in which a company agrees 
to indemnify providers for certain health care costs incurred by members.
subscriber. The person who is responsible for the payment of premiums or 
whose employment is the basis for eligibility for membership in a prepaid 
health care plan.
tail coverage. Insurance designed to cover malpractice claims incurred before, 
but reported after, cancellation or expiration of a claims-made insurance 
policy.
taxable variable rate demand notes. Issuers may call the notes on any 
monthly interest payment date, which provides issuers the opportunity to 
refinance short-term obligations with long-term bonds if market conditions 
make this alternative attractive.
temporarily restricted net assets. The part of the net assets of a not-for- 
profit organization resulting (a) from contributions and other inflows of 
assets whose use by the organization is limited by donor-imposed stipula­
tions that either expire with the passage of time or can be fulfilled and 
removed by actions of the organization pursuant to those stipulations, (b) 
from other asset enhancements and diminishments subject to the same 
kinds of stipulations, or (c) from reclassification to (or from) other classes 
of net assets as a consequence of donor-imposed stipulations, their expira­
tion by passage of time, or their fulfillment and removal by actions of the 
organization pursuant to those stipulations.
tertiary care. Care that is rendered in hospitals that possess the personnel, 
equipment, and expertise to handle complex cases.
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third-party payor. Any agency (such as Blue Cross, Medicare, or commercial 
insurance companies) that contracts with health care organizations and 
patients to pay for the care of covered patients.
trend factor. A factor used in actuarial methodology to adjust ultimate losses 
from historical experience periods to the loss cost levels of the projection 
period, due to the impact of economic, jurisdictional, and social changes 
affecting hospital professional liability loss costs.
trust fund. A fund established with an outside entity to be used for a specific 
purpose, such as to pay malpractice claims and related expenses as they 
arise.
ultimate cost. Total claims payments, including costs associated with litigat­
ing or setting claims.
unasserted claim. A medical malpractice claim that has not been asserted 
formally against a health care provider by or on behalf of a patient alleging 
improper professional service. It may relate to either reported incidents or 
to unreported incidents.
unreported incident. An occurrence in which improper professional service 
may have been administered by a health care provider, which may result 
in a malpractice claim of which the provider is not yet aware.
unrestricted net assets. The part of net assets of a not-for-profit organization 
that is neither permanently restricted nor temporarily restricted by donor- 
imposed stipulations.
voluntary health and welfare organizations. Organizations formed for the 
purpose of performing voluntary services for various segments of society. 
They are tax-exempt (organized for the benefit of the public), supported by 
the public, and operated on a not-for-profit basis. Most voluntary health 
and welfare organizations concentrate their efforts and expend their re­
sources in an attempt to solve health and welfare problems of society and, 
in many cases, those of specific individuals. As a group, voluntary health 
and welfare organizations include not-for-profit organizations that derive 
their revenue primarily from voluntary contributions from the general 
public to be used for general or specific purposes connected with health, 
welfare, or community services.
wholly owned captive. An insurance company subsidiary of a health care 
organization that provides malpractice insurance primarily to its parent 
corporation.
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For additional copies of the Health Care Organizations Audit &  A ccounting  
Guide or to automatically receive an annual update —  immediately upon its 
release —  call AICPA Member Satisfaction at 1 -888-777-7077.
Additional Health Care Organization Publications 
Health Care Organizations Audit Risk Alert (A R A )
Find out about current economic, regulatory and professional developments before you per­
form your audit engagement. This ARA will make your audit planning process more efficient 
by giving you concise, relevant information that shows you how current developments may 
impact your clients and your audits. The 2000/01 ARA will be available Fall 2000. 
1999/2000 ARA $12.95 members/$18.50 nonmembers (022237SB)
Checklists and Illustrative Financial Statements for Health Care Organizations
Having been updated to reflect recent AICPA and FASB pronouncements, this aid becomes 
an invaluable tool to both preparers and auditors of employee benefit plan financial statements. 
2000 Checklist $30.00 members/$37.50 nonmembers (008761SB)
Audit and Accounting Guides —  2000 Industry Guides
With conforming changes as of May 1, 2000.
Each 2000 A&A Guide is $39.95 members/$49.95 nonmembers.
• Audits of Agricultural Producers and Agricultural Cooperatives (012355SB)
• Audits of Airlines (013184SB)
• Banks and Savings Institutions (012468SB)
• Brokers and Dealers in Securities (012182SB)
• Audits of Casinos (013151SB)
• Common Interest Realty Associations (012489SB)
• Construction Contractors (012097SB)
• Audits of Credit Unions (012469SB)
• Audits of Employee Benefit Plans (012340SB)
• Audits of Entities With Oil and Gas Producing Activities (012107SB)
• Federal Government Contractors (012439SB)
• Audits of Finance Cos. (012467SB)
• Health Care Organizations (012441SB)
• Audits of Investment Companies (012364SB)
• Life & Health Insurance Entities (012500SB) (New edition as of June 15, 2000)
• Not-for-Profit Organizations (013393SB)
• Audits of Property and Liability Insurance Cos. (011923SB)
• Audits of State and Local Governmental Units (012061SB)
Audit and Accounting Guides —  General Guides
Each A&A Guide is $39.95 members/$49.95 nonmembers.
• Consideration of Internal Control in a Financial Statement Audit (1996) (012451SB)
• Personal Financial Statements (2000) (011137SB)
• Prospective Financial Information (1999) (011179SB)
• Use of Real Estate Appraisal Information (1997) (013159SB)
To order call 1-888-777-7077 or FAX to 1-800-362-5066
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